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Abstract 
Extracellular nucleotides are signalling molecules that can activate cell surface 
purinergic receptors, initiating or modulating cellular responses. The parasitic nematode 
Trichinella spiralis secretes nucleotide-metabolising enzymes potentially capable of 
interfering with this process. In vitro activation of bone marrow-derived mast cells 
(mBMMC) of a mucosal phenotype was used as a model to study the effects of T. 
spiralis excreted/secreted proteins (ES) on purinergic signalling. 
RT-PCR, pharmacological and electrophysiological analyses demonstrated that 
mBMMC express functional A2B, A3, P2Yi, P2Y2, P2X4 and putatively PZYg and 
CysLTl receptors, thus allowing the cells to respond to a range of nucleotides. T. 
spiralis ES modulated mBMMC purinergic receptor activation by metabolising 
extracellular nucleotides. 
Adenine nucleotides induced mBMMC exocytosis, resulting in the release of 
mouse mast cell protease-1 (mMCP-1) and ^-hexosaminidase. The T. spiralis secreted 
5'-nucleotidase (5'-NT) mediated the inhibition of ADP-induced mMCP-1 release. 
Extracellular nucleotides were unable to mediate cytokine production or direct the 
migration of mBMMC. However, adenosine, ADP and ATP stimulated inhibitory 
pathways that led to the down-regulation of LPS-induced TNF-a generation. 
Furthermore, T. spiralis ES reduced the inhibitory effects of ADP. These results show 
that T. spiralis ES can modulate important mast cell effector functions induced by 
nucleotides. 
Immunisation of mice with the T. spiralis recombinant 5'-NT elicited a TH2-
dominated systemic immune response generating high titres of antibodies that could 
neutralise the activity of the 5'-NT in vitro. However, immunisation did not generate a 
sufficiently potent intestinal mucosal immune response, and as such, did not confer 
protection against subsequent T. spiralis infection. 
T. spiralis infection altered the qualitative expression of purinergic receptor sub-
types in the intestinal epithelium. Strains of mice that expel parasites from the intestine 
at slow and fast rates expressed different purinergic receptor sub-types throughout the 
course of infection, suggesting that receptor expression may be linked to the rate of 
parasite expulsion. 
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Chapter 1 
General Introduction 
21 
1.1 Historical perspectives and classification of Trichinella 
The genus Trichinella is composed of parasitic nematodes that belong to the 
order trichuroidea. These parasites constitute an unusual genus of organisms, in that 
they require only one host, and remain intracellular during the majority of their life 
cycle. Trichinella was initially described by Paget and Owen in 1835. They observed 
the coiled larvae in the diaphragm of a cadaver and named them Trichina spiralis from 
the Latin words for hair and coil. Later, in 1896, these parasites were renamed 
Trichinella spiralis the causative agent of the disease trichinellosis. 
For more than a century after its discovery, Trichinella was considered to be a 
single species capable of infecting a wide variety of mammals. It was not until the 
1970's, that distinct biological variants of Trichinella were established as separate 
species in their own right. Currently, the genus Trichinella is classified into two main 
clades; one includes species that encapsulate in host muscle tissue, and a second that 
does not encapsulate following host muscle cell dedifferentiation (Pozio et al., 2001; La 
Rosa et al., 2003; Gasser et al., 2004; Zarlenga et al., 2004). Except for the existence of 
a capsule and size differential in one of the non-encapsulated parasite groups, all species 
and genotypes of the genus Trichinella are morphologically indistinguishable at all 
developmental stages (Pozio et al., 2005). More recently, to aid classification, 
molecular PGR methods have been developed to identify the genotype of individual 
parasite larvae (Zarlenga et al., 1999; Pozio and La Rosa, 2003; Gasser et al., 2004). To 
date, this has enabled the classification of eight species and three distinct genotypes of 
Trichinella (Pozio et ah, 2005) (summarised in Table 1.1). 
The genus Trichinella has the widest geographical distribution and the largest 
range of host species of all parasitic nematodes (Wakelin and Goyal, 1996). 
Camivorism and scavenging are essential components in parasite transmission as 
infection is acquired through the ingestion of raw or undercooked muscle tissue 
containing viable infective (LI) larvae (Despommier, 1983). In terms of epidemiology, 
the Trichinella life cycle has traditionally been considered as two distinct cycles: the 
domestic cycle, involving humans and domesticated animals; and the sylvatic cycle, 
involving wild animals (Campbell, 1983). As shown in Table 1.1, the species T. spiralis 
and T. pseudospiralis have the widest distribution of all the Trichinella species. The 
global prevalence of T. spiralis in both sylvatic and domestic cycles is thought to be due 
to its high reproductive capacity and the global increase in animal and meat trade, which 
22 
Clade 
Species 
Name or 
genotype 
Distinguishing 
characteristics Distribution Life cycle 
Classification 
Reference 
T. spiralis 
Infects 
mammals, 
predominantly 
domestic and 
sylvatic swine 
worldwide 
Domestic 
and 
sylvatic 
Owen, 1835 
T. nativa Tolerant to freezing 
Arctic and 
sub-artic (cold 
climates) 
Sylvatic Britov and Boev, 1972 
Encapsulated 
Clade 1 
T. britovi 
Low 
pathogenicity in 
humans 
Eurasia and 
Africa Sylvatic 
Pozio et al., 
1992 
T. murelli 
Low infectivity 
in swine and 
rats 
North 
America Sylvatic 
Pozio and La 
Rosa, 2000 
T. nelsoni 
Low 
pathogenicity in 
humans 
East Africa Sylvatic Pozio et al., 1992 
Genotype T6 Related to T. 
nativa 
Canada and 
U.S Sylvatic 
Pozio et al., 
1992 
Genotype T8 Related to T. britovi 
South Africa 
Namibia Sylvatic 
Pozio et al., 
1992 
Genotype T9 Related to T. britovi Japan Sylvatic 
Nagano et al., 
1999 
T 
pseudospiralis 
Infects 
mammals and 
birds 
Worldwide Sylvatic Garkavi, 1972 
Non-
encapsulated 
Clade 2 
T. papuae 
Infects 
mammals and 
reptiles 
Papua New 
Guinea Sylvatic 
Pozio et al., 
1999 
T. 
zimbabwensis 
Infects 
mammals and 
reptiles 
Zimbabwe, 
Ethiopia, 
Mozambique 
Sylvatic Pozio et al., 
2002 
Table 1.1 Trichinella species and genotypes 
A summary of the 8 classified species and 3 genotypes of the genus Trichinella. The 
genotypes T6, T8 and T9, are individually distinguishable by molecular analyses but 
have not gained species status, predominantly due to their ability to interbreed with 
related Trichinella species. 
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has transferred T. spiralis from endemic to non-endemic regions (Murrell and Pozio, 
2000). T. pseudospiralis is thought to have been transmitted worldwide, due to its 
unique ability to infect avian hosts. 
1.2 Trichinella spiralis life cycle 
In contrast to many other types of parasitic nematodes that require multiple hosts or 
have free-living life-stages, the entire life cycle of Trichinella is completed within one 
host. As shown in Figure 1-1, the life cycle of Trichinella exhibits several unusual 
characteristics. 
1.2.1 Enteral phase 
The establishment of a successful infection requires the ingestion of infective LI 
larvae existing in muscle tissue. The process of digestion releases the infective larvae 
from the muscle, and the parasites rapidly pass into the small intestine. Parasites are 
then directed to invade the columnar epithelial cells that line the small intestine, by as 
yet unknown environmental cues (Wright, 1979). It is thought that entry is unlikely to 
be via mechanical means as the infective LI larvae do not have a stylet or other oral 
appendages (Bruce, 1970a). Experiments performed in vitro using epithelial cell lines 
have shown that T. spiralis infective larvae do not invade all cell types, a fact that 
argues that invasion is not merely mechanical, but requires a signal from host cells 
which permits or prohibits invasion (ManWarren et al, 1997). Electron microscopic 
examination has shown that the parasites lie directly in the cytoplasm of epithelial cells, 
usually at the crypt-villus junction (Wright, 1979; Dunn and Wright, 1985). Migration 
of worms through enterocytes induces the fusion of adjacent lateral cell membranes 
resulting in a large pocket of shared cytoplasm, or 'syncytium' (Dunn and Wright, 
1985). The infective larvae are approximately 1 mm long and can penetrate the cell 
membranes of up to 45 enterocytes at a time (Despommier, 1993). During the 
development of the parasites, female worms can grow to a length of 3 mm 
(Despommier, 1993). Thus, these parasites can damage significant numbers of cells 
present in the epithelium. It has been suggested that the worms continually move 
through the epithelium (Dunn and Wright, 1985; Wright et al., 1987). It is thought that 
regions of enterocytes damaged by the parasites then die and are sloughed from the 
epithelium in the usual manner (Dunn and Wright, 1985; Wright et al., 1987). 
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Figure 1-1 The life cycle of Trichinella 
Parasites enter a new host during the ingestion of raw/undercooked meat, and infective 
larvae (LI) are released from the nurse cell complex into the stomach [1], Larvae then 
pass into the small intestine and invade the epithelium, where they moult four times, 
achieve adulthood and mate within 30 hours after being ingested [2], On day 6 post-
ingestion, females give birth to newborn larvae and the adult parasites begin to be 
expelled [3], Newborn larvae then migrate around the body via the blood and/or 
lymphatics [4], This phase is associated with occasionally fatal pathology [5], Newborn 
larvae penetrate out of blood/lymph vessels into striated muscle myofibres [6], 
Approximately twenty days after penetrating the muscle, the larva forms the nurse cell 
complex [7], and remains in this state unless calcification due to host immune defences 
occurs [8], (Picture adapted from 'Parasitic Diseases' 4"^  Edition, Apple Trees 
Productions, New York). 
25 
Once established within the epithelial niche, the parasites rapidly moult four 
times over a period of 10-28 hours (Kozek, 1971). After the last moult, the mature adult 
worms immediately mate within a time-frame of 4-5 hours (Kozek, 1971). Individual 
males are known to mate more than once during an infection (Kozek, 1971). However, 
the mechanisms by which male and female worms communicate their position to each 
other in the intestinal milieu are unknown. The gravid females release approximately 
500 to 1500 live juvenile newborn larvae (NBL) each, 3-5 days after mating 
(Khamboonruang, 1971). Once the adult parasites have successfully mated and released 
NBL, they are expelled from the intestine due to a combination of host immune 
responses (Wakelin and Denham, 1983). 
Unlike the LI infective larvae and adult parasites, the NBL have an anterior 
stylet. It is thought that they use this to mechanically penetrate into lymphatic vessels 
and capillaries innervating the lamina propria of the intestinal epithelium (Wang and 
Bell, 1986a). The NBL enter the general circulation via the hepatic portal vein and 
thoracic duct and circulate in the blood for up to 6 hours (Wang and Bell, 1986b). It is 
of note, that this migratory period is the only time in the life cycle when the parasites 
exist in the exfracellular environment. The NBL then use their stylet to penetrate out of 
capillaries and migrate into the surrounding tissues (Despommier, 1993; Wang, 1997). 
This process leads to the destruction of cells and occasionally causes the death of the 
host (Wang, 1997). Only NBL that migrate into striated muscle will ftirther develop into 
infective LI larva. 
1.2.2 Parenteral stage 
Once in striated skeletal muscle, the larvae penetrates a muscle cell and enters a 
stage of development known as the parenteral phase. The parasite then directs the 
fransformation of the muscle cell into a parasite-host cell complex termed the nurse cell 
(Figure 1-2), so called because it provides nutrients for the growth, development and 
maintenance of the larvae (Purkerson and Despommier, 1974). Transformation of the 
muscle cell takes 20 days to complete, during which time the parasite undergoes a 
period of rapid growth (Despommier, 1975). After this phase, the parasites are infective 
to the next host and enter a stage of arrest. The larvae remain within the nurse cell 
complex for the entire life of the host, until ingested by another host or, after a period of 
years, become calcified by host responses (Despommier, 1975). 
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Figure 1-2 The T. spiralis nurse cell 
T. spiralis larvae (L) form encapsulated nurse cell complexes within the striated muscle 
of vertebrate hosts. A dense collagenous capsule surrounds the parasite (C). Light 
microscopy showing the unstained diaphragm of an infected rat. Magnification x40 
The formation of the nurse cell complex initially involves the loss of the classic 
characteristics of differentiated myofibres of muscle cells including the loss of 
myofibrillar proteins such as myosin heavy chain and a- and ^-tropomyosin (Emerson, 
1990; Jasmer, 1990). Furthermore, infected muscle cells are induced to re-enter the cell 
cycle from their terminally differentiated state at the Gq/Gi stage. The host cell nuclei 
divide once and each nucleus then replicates its DNA, before the cell cycle is 
chronically suspended at the Gz/M boarder at approximately day 5 post infection (p. i.), 
resulting in a 4N complement of DNA in infected cell nuclei (Jasmer, 1993). The 
muscle cells also undergo re-differentiation to fonn the nurse cell, gaining 
characteristics such as the development of a collagen capsule, a circulatory network 
surrounding the infected cell and cytoplasmic changes including increased rough 
endoplasmic reticula, and increased Golgi-associated and lysosomal enzyme activity 
(Stewart, 1993). 
The mechanisms driving the fonnation of the nurse cell complex have been the 
subject of a number of studies. The discovery that proteins secreted by the parasite were 
present within the cytoplasm and nucleus of the nurse cell, led to the hypothesis that the 
parasite was directing the development of the nurse cell (Despommier, 1990). However, 
it has also been postulated that re-entry of the myocyte into the cell cycle may account 
for many of the unusual characteristics of the nurse cell, and promote the growth and 
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survival of the parasite (Jasmer, 1995). Delineating the extent to which the parasite 
induces the development of the nurse cell complex is still far from being understood. 
1.3 Trichinellosis 
The most frequent source of human Trichinella infections is through the 
consumption of raw or under-cooked game animals, or pork products from pigs raised 
in farms where rodent populations are able to thrive (Pozio et al., 1993). Herds of swine 
are usually infected by T. spiralis by the animals scavenging on infected rodents, eating 
offal or meat containing parasites in their feed, or as a result of direct transmission from 
other pigs (by cannibalism) (Pozio, 2000). Human infection can also result from the 
consumption of meat from herbivores such as horses (Boireau et al., 2000). It is thought 
that these herbivorous animals become infected whilst grazing in areas contaminated 
with pork scraps or rat carcasses, or from feeds which may be made from contaminated 
meat (Pozio, 2000). 
Trichinella infections have worldwide socioeconomic significance, and within 
Europe are of medical and veterinary concern in France, Germany, Italy, and Spain. 
Trichinellosis outbreaks are foremost in the east and central European countries, where 
infections are increasing (Pozio, 2001). Currently, the EU spends approximately €570 
million per year on screening pigs, horses and boar for Trichinella infection to ensure 
the meat is safe for human consumption (Pozio, 1998; Kapel, 2005). However, these 
measures have not totally eradicated this parasite, and approximately 20,000 cases of 
trichinellosis were reported in Europe during 1991-2000 (Murrell and Pozio, 2000). A 
lack of adequate screening programmes, improper animal husbandry as well as cultural 
preferences for raw meat have led to Trichinella remaining endemic and even re-
emerging in some areas of the world, particularly China and South and Central America 
(Bolpe and Bofi, 2000; Takahashi et al., 2000). 
1.4 Trichinella spiralis secreted proteins 
T. spiralis larvae secrete a multitude of proteins, known as excretory-secretory 
(ES) proteins, during both the enteral and parenteral stages of infection (Despommier, 
1983). The secreted proteins originate from a large secretory organelle termed the 
stichosome, which is characteristic of members of the Trichuroidea order of parasites 
(Chitwood, 1930), and occupies the entire anterior half of the T. spiralis infective larvae 
(Figure 1-3) (Despommier and Muller, 1976). The stichosome develops during 
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maturation of the infective larvae in the nurse cell, and is fully developed by day 16 p. i. 
The stichosome is retained by the infective LI larvae and through to the adult stage 
parasites (Wu, 1955). Experiments using NBL in vitro, have reported that they secrete 
very little protein and have only a rudimentary, undeveloped stichosome (Zarlenga et 
al., 2002; Parkhouse and Clark, 1983). 
Adult female Adult Male 
0.1 mm 
0.1 mmlJ 
Infective muscle 
stage larvae 
0.1 mm 
Figure 1-3 Morphology of T. spiralis adult and infective muscle stage larvae 
The dark-blue region depicts the arrangement of stichocytes in the anterior portion of 
the adult male and female parasites. The dark-blue and red region depicts the 
arrangement of stichocytes in the anterior portion of infective larvae. Pictures 
reproduced from http://www.7>/c/?me//a.org (Villella, 1970). 
The stichosome of T. spiralis infective larvae is composed of a row of 50 to 55 
specialised discoid cells teraied stichocytes, each of which has a diameter of 
approximately 25 |im (Villella, 1970; Despommier and Muller, 1976). Each stichocyte 
contains a single nucleus, mitochondria, Golgi-like complexes, a smooth and rough 
endoplasmic reticulum and multiple dense core secretory granules (Despommier and 
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Muller, 1976). The stichocytes are connected to the oesophageal lumen by a duct 
(Bruce, 1970b; Despommier and Muller, 1976). Upon degranulation, the contents of the 
secretory granules are released into the stichocyte duct, and are subsequently disgorged 
via the oesophagus (Despommier, 1983). 
Proteins secreted by T. spiralis muscle stage larvae and adults can be collected 
from parasites cultured in vitro, thus allowing their content to be analysed. To date, 
substantial immunological, biochemical and molecular studies have focused on the 
muscle stage larvae due in part to the ease with which significant numbers of this stage 
can be recovered and the relatively large quantities of secreted proteins that can be 
collected for analysis compared to other life stages. T. spiralis secreted proteins have 
been detected in epithelial cells invaded by the parasite both in vivo and in vitro, 
suggesting that these proteins may play a role in invasion, migration, host immune 
response evasion, and parasite maintenance in this particular niche (Capo et al, 1986; 
Manwarren et al., 1997). Secreted proteins have also been detected in the cytoplasm and 
nuclei of developing nurse cells, where they are thought to be involved in the formation 
and maintenance of the nurse cell complex through regulating host cell gene expression 
(Despommier et al., 1990; Lee et al., 1991). Furthermore, this theory is supported by 
the observation that when proteins secreted by LI larvae are injected into primary rat 
myocytes in culture, morphological and structural changes are elicited (Leung and Ko, 
1997). Although the molecular mechanisms underlying the changes to the infected host 
cells are currently unknown, proteins that are released by the parasite into host cells are 
likely to be crucial for successful parasitism. 
1.4.1 Biochemical characterisation of T. spiralis secreted proteins 
The number and identity of different types of proteins secreted by T. spiralis is 
largely unknown. To date, only a handful of proteins secreted by T. spiralis have been 
biochemically characterised in vitro, and even fewer have been cloned. The majority of 
studies have focused on characterising enzymatic activities present within the total 
secreted proteins of muscle stage larvae. Advancement in this field has been hampered 
by the amount of secreted proteins recovered from cultured parasites, which in many 
cases precludes the purification of specific proteins. Recently, 2-D gel electrophoresis 
and proteomic analyses have shown that the T. spiralis LI infective larvae secrete at 
least 52 proteins of different size and isoelectric point, and at least 13 different types of 
protein, some of which are completely novel (Robinson and Connolly, 2005). The 
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current knowledge regarding the biochemical activities present in T. spiralis ES is 
described below. 
Nematode parasites including T. spiralis have been widely reported to secrete 
specific factors that modulate the immune responses of their host to facilitate their long-
term survival. In terms of biochemical characterisation, homologues of human 
macrophage migration inhibitory factor (MIF), a protein that interferes with migration 
of cells from the monocytes lineage has been identified in the secreted proteins of a 
variety of parasites including T. spiralis (Pennock et al., 1998; Tan et al., 2001). The T. 
spiralis MIF was shown to inhibit monocyte migration and chemotaxis (Tan et al., 
2001). Human MIF can also profoundly influence T-cell proliferation. However, the T. 
spiralis MIF has no effect on T cells (Tan et ah, 2001). Tan et al., (2001) suggested that 
the secreted MIF may serve to inhibit monocyte migration locally in infected tissue, 
thus reducing the ensuing inflammatory response and aiding parasite survival. 
A number of enzymes that are normally associated with lysosomal function, 
such as proteases, endonucleases and glycosidases have also been reported to be 
secreted by T. spiralis. Proteases secreted by parasites are thought to be involved in a 
wide variety of adaptive functions including tissue penetration, degradation of the 
extracellular matrix, larval migration, immune evasion, digestion and moulting 
(McKerrow, 1989; Shapiro, 1998). Several authors have reported the presence of serine-
and metallo- proteases in the secreted proteins of T. spiralis (Criado-Fomelio et al., 
1992; Takamoto and Sugane, 1993; De Armas-Serra et al., 1995a and 1995b; Todorova 
et al., 1995; Todorova, 2000; Lun et al., 2003). It has also been proposed that 
proteolysis may facilitate enterocyte penetration by the larvae since under in vitro 
conditions the infective larvae secrete enzymes that exhibit gelatinolytic, collagenolytic 
and elastolytic activities and hence would be capable of degrading components of the 
extracellular matrix (Criado-Fomelio et al., 1992; Lun et al., 2003). 
T. spiralis and other types of parasitic nematodes such as Brugia malayi (Murray 
et al., 2005), Nippostrongylus brasiliensis (Dainichi et al., 2001) and Haemonchus 
contortus (Newlands et al., 2001) also secrete protease inhibitors. It is thought that 
nematode protease inhibitors may act as immuno-modulatory factors that contribute to 
the immune evasion strategies of the parasite, for example by inhibiting proteases 
involved in antigen processing and presentation (Nagano et al., 2001; Robinson et al., 
2007). T. spiralis infective larvae secrete a serine protease inhibitor (Nagano et al., 
2001). A recent study has also reported the cloning of a novel cysteine protease-like 
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inhibitor secreted from both infective larvae and adults (Robinson et al., 2007). This 
protein does not appear to exhibit any of the inhibitory effects that are usually 
characteristic of cystatins and has been classified as a divergent form of cystatin, the in 
vivo function of which is unknown (Robinson et al., 2007). 
Double-stranded DNA endonuclease activity was detected in the secreted 
proteins of T. spiralis infective larvae by Mak and Ko (1999). Subsequently, single-
stranded DNA and RNA endonuclease activity (Mak et al., 2000) and DNA-binding 
activity (Mak and Ko, 2001) have also been detected in the ES proteins. The functions 
of the enodonucleases and the DNA binding proteins are still unknown. However, the 
endonuclease activity is postulated to play a role in degrading the host genome, 
dysregulating nucleic acid metabolism, creating chromosomal alterations, and inducing 
the arrest of the infected muscles at the G2/M phase of the cell cycle (Mak and Ko, 
1999; Mak et al., 2000; Jasmer, 1993). Furthermore, Mak and Ko (2001) have 
suggested that the DNA binding activity in ES may play a crucial role in the 
reorganisation of host muscle cells by modulating host gene expression. 
Other lysosomal-type enzymes have also been detected in the secreted proteins 
of T. spiralis. The lysosomal degradation of glycosphingolipids with small carbohydrate 
chains requires the presence of non-enzymatic cofactors such as the ganglioside GM2-
activator protein (GM2AP), and prosaposin, the precursor of sphingolipid activator 
proteins (saposins). Recently, a prosaposin homologue (Selkirk et al., 2004) and a 
highly unusual GM2AP (Bruce et al., 2006) were identified in the ES proteins of T. 
spiralis. The identification of classic lysosomal-type proteins in T. spiralis ES, and the 
localisation of the prosaposin homologue to secretory lysosome-type structures in the 
stichisome has led to speculation that secretion from lysosomes may constitute an 
additional pathway distinct from the stichocyte granules usually associated with 
secreted protein storage and release (Selkirk et al., 2004). It has been postulated that the 
T. spiralis secreted prosaposin and GM2AP are involved in intestinal epithelial cell 
invasion either by disruption of the lipid membrane of the cell or through the activation 
of lipases, which in turn may play a role in epithelial cell invasion (Selkirk et al., 2004; 
Bruce et al., 2006). 
Recently, Bruce and Gounaris (2006) also identified a novel A^-acetyl-P-
hexosaminidase activity in the secreted proteins of T. spiralis. The enzyme specifically 
hydrolyses glycans commonly occurring on mammalian glycoproteins and other 
glycoconjugates such as the major sulphated aminosugar in mucus glycoproteins (Bruce 
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and Gounaris, 2006). It has been proposed that by cleaving terminal carbohydrate 
residues from glycoconjugates during the intestinal phase of infection, the 7V-acetyl-P-
hexosaminidase could act in concert with other hydrolytic enzymes to facilitate parasite 
invasion. Unexpectedly, although the A^-acetyl-P-hexosaminidase and GM2AP would 
usually work together in the lysosome to degrade gangliosides, the secreted T. spiralis 
homologues do not (Bruce et al, 2006); again highlighting how functionally divergent 
parasite proteins can be compared to their mammalian counterparts. 
Phosphorylation of proteins by protein kinases can alter their enzymatic 
activities and other properties, and represents a major method of regulating metabolic 
pathways, gene expression, cell cycle progression and a plethora of other functions 
(Hunter, 1995). At least one and possibly two distinct serine/threonine protein kinases 
able to phosphorylate both endogenous and exogenous substrates have been detected in 
the secreted proteins of T. spiralis (Arden et al., 1997). The major endogenous 
substrates phosphorylated among the proteins secreted by the parasite were 
polypeptides of 50 and 55 kDa (Arden et al., 1997). These were identified as 
differentially glycosylated variants of a 35 kDa protein (Arden et al., 1997). On the 
basis that secreted ES proteins were able to phosphorylate exogenous substrates such as 
myelin basic protein, MyoD and histone HI, Arden and co-workers (1997) suggested 
that these serine/threonine protein kinases may be involved in the invasion and 
migration of larvae through the intestinal epithelium, or the development of the nurse 
cell complex. 
T. spiralis also secretes a range of enzymes capable of degrading and utilising 
extracellular nucleotides (Gounaris et al., 2001; Gounaris, 2002; Gounaris et al., 2004). 
Although the functions of these enzymes have been characterised biochemically, their 
exact role in vivo has yet to be determined. As nucleotides are extracellular signalling 
molecules capable of activating cell membrane-bound purinergic receptors, it has been 
postulated that the T. spiralis-SQCxetQA enzymes could regulate the availability of local 
nucleotides, resulting in alteration of purinergic receptor activation on immune cells and 
thus modulation of the ensuing inflammatory response (Gounaris, 2002; Gounaris and 
Selkirk, 2005). Ultimately, this may serve to prolong parasite survival in both the 
enteral and parenteral niche. 
T. spiralis has been reported to secrete a 17 kDa nucleoside diphosphate kinase 
(NDPK) (Gounaris et al., 2001). This kinase exhibits broad specificity in that it can 
readily accept y-phosphate from either adenosine or guanidine triphosphate (ATP and 
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GTP respectively). The NDPK uses the y-phosphate to form a phosphohistidine 
intermediate prior to donating the phosphate to adenosine, guanidine, uridine or cytidine 
diphosphates (ADP, GDP, UDP and CDP respectively) (Gounaris et al., 2001). 
Additionally, this enzyme undergoes auto-phosphorylation using y-phosphate derived 
from ATP and GTP substrates (Gounaris et al., 2001). NDPKs are usually intracellular 
'house-keeping' enzymes that maintain levels of intracellular nucleotide pools (de la 
Rosa et al., 1995). Although the in vivo role of this secreted enzyme is unknown, it has 
been postulated that it might function to modulate levels of adenine and uridine 
nucleotides in order to influence cellular function via regulating cell membrane 
purinergic receptor activation (Gounaris et al., 2001). 
T. spiralis infective larvae also secrete a novel 5'-nucleotidase (5'-NT) of 67 
kDa, which is homologous to enzymes of the 5'-nucleotidase family in terms of protein 
sequence, but unique in terms of its enzymatic properties (Gounaris et al., 2004). This 
enzyme is unusual in that it exhibits both apyrase (nucleoside 5'-diphosphate hydrolysis, 
NDP^NMP + Pi) and 5'-nucleotidase (nucleoside 5'-monophosphate hydrolysis, 
N M P ^ N + Pi) activities (Gounaris et al., 2004). The secreted 5'-NT catalyses the 
hydrolysis of nucleoside 5'-monophosphates with a preference for adenosine 
monophosphate (AMP), and 5'-diphosphates in the order of UDP»ADP. Furthermore, 
the secreted 5'-nucleotidase is unique amongst enzymes of this kind in that hydrolysis of 
diphosphate nucleosides is enhanced by Mg^ "^  ions and a reducing environment. Thus, it 
is possible that optimal conformation for catalysis is achieved upon secretion of the 
enzyme into the relatively reducing host environment. Unlike some other types of 5'-
nucleotidases, this enzyme cannot catalyse the hydrolysis of nucleoside 5'-triphosphates 
(Gounaris et al., 2004). 
A secreted adenosine deaminase with an apparent molecular mass of 38 kDa has 
also been detected in the secreted proteins of T. spiralis (Gounaris, 2002). The secreted 
adenosine deaminase catalyses the irreversible hydrolytic deamination of adenosine to 
inosine and ammonia and appears to be similar in terms of activity to other enzymes of 
this kind (Cristalli et al., 2001). 
It has been proposed that the T. spiralis secreted 5'-nucleotidase and adenosine 
deaminase may form a nucleotide catabolising cascade, with the 5'-nucleotidase 
hydrolysing ADP/UDP to AMP/UMP and AMP to adenosine, which is further 
hydrolysed to inosine by the adenosine deaminase (Gounaris and Selkirk, 2005). During 
the enteral and migratory phase of infection, the T. spiralis parasites cause extensive 
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cellular damage as they migrate through the host, resulting in the release of nucleotides 
into the extracellular environment. These nucleotides could then bind to purinergic 
receptors present on surrounding cells, alerting the attention of immune cells to the 
presence of the parasite. Due to the far-reaching effects purinergic receptor activation 
can have on the functions of immune cells, the secretion of a cascade of nucleotide 
metabolising enzymes by the parasite may be a strategy to divert the host immune 
response, thus promoting parasite survival. 
1.5 Purinergic signalling 
As previously mentioned, purinergic signalling is a term used to describe the 
interaction of extracellular nucleotides with membrane-bound purinergic receptors 
found on many different cell types. The crucial factors that regulate purinergic 
signalling are the stimulation of nucleotide release from the intracellular environment, 
the metabolism of nucleotides by extracellular enzymes and the presence of specific 
purinergic receptor sub-types that selectively bind to the nucleotides and initiate signal 
transduction. This has imposed a layer of complexity to the understanding and 
quantification of the pharmacologically active nucleotides. 
The first description of extracellular signalling by purine nucleotides was by 
Drury and Szent-Gyorgyi (1929) in a seminal paper reporting the activities of adenine 
compounds on the mammalian heart. However, the existence of plasma membrane 
receptors for extracellular nucleotides, were not formally recognised until 1976 
(Bumstock, 1976). Spedding and Weetman (1976), subsequently suggested that 
separate receptors responded to adenosine and ATP. By 1978, receptors for purines 
were subdivided into P1 receptors responsive to adenosine, and P2 receptors responsive 
to ATP and ADP nucleotides (Bumstock, 1978). Several years later, subdivision of P2 
receptors into P2X and P2Y sub-types was made on the basis of phannacological data 
(Bumstock and Kennedy, 1985). The P2Y receptor family also includes receptors for 
extracellular pyrimidine nucleotides such as UDP and UTP (Seifert and Schultz, 1989). 
Hence, in this context, the term 'purinergic signalling' is a misnomer, as it is used to 
describe receptor activation induced by either purine or pyrimidine nucleotides. Over 
the past decade, purines and pyrimidines have been shown to be physiological 
regulators of wide range of cellular functions including cell growth, differentiation and 
death, and very importantly the development of pro- and anti-inflammatory immune 
responses. The following section describes the current families of known purinergic 
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receptor sub-types, and details some of the major effects nucleotides and nucleosides 
can have on different cell types. 
1,5.1 PI receptors 
There are four known G-protein coupled PI adenosine receptors, Ai, A2A, Ais 
and As, each with varying affinity for this agonist. The general characteristics of the 
different sub-types of PI receptors are summarised in Table 1.2. A; and Az* receptors 
are activated by nanomolar concentrations of adenosine, whereas A2B and A3 receptors 
require micromolar concentrations for activation (Jin et al., 1997; Fredholm et al., 
2001a). Extracellular adenosine levels under physiological conditions are between 30 
and 300 nM, which would be sufficient to induce 10 to 50% of the maximal response of 
Al and AJA receptor activation (Winn et ah, 1981; Zetterstrom et al., 1982). In 
inflammatory situations the extracellular levels of adenosine can rise to 10-100 [iM, 
thus resulting in the additional activation of A2B and A3 receptors (Hasko et al., 2004). 
Generally, adenosine produced in during inflammation reduces tissue injury and 
promotes repair by several receptor-mediated mechanisms, thus acting to dampen 
inflammatory responses (Fredholm, 2007). 
The nucleoside inosine can bind to rodent A3 receptors in the range of 10-50 p.M 
(Jin et ah, 1997), and is also a weak agonist of recombinant, human A| and A3 receptors 
(Fredholm et al., 2001b). Normal interstitial concentrations of inosine are similar to 
those reported for adenosine. However, during tissue ischemia inosine concentrations 
can rise to greater than 1 mM, and activate A3 receptors (Jones et al., 1977; Ehlert, 
1992). High extracellular concentrations of inosine have also been reported to have 
immunosuppressive properties when acting via A3 receptors (Gomez and Sitkovsky, 
2003). 
PI receptors usually transduce activation signals through heteromeric G proteins 
that can either stimulate (Gs) or inhibit (Gi/o) adenylyl cyclase, the enzyme that catalyses 
the formation of cAMP. The PI receptors A2A and AzB signal primarily via Gs, resulting 
in activation of adenyl cyclase, an increase in cyclic AMP production and activation of 
protein kinase A (PKA). A, and A3 receptors have been shown to interact with multiple 
G proteins, with pathways varying between different cell systems that can result in the 
inhibition of adenylyl cyclase (Palmer et al., 1995). Adenosine receptors are also 
coupled via distinct G-proteins to other effector systems, including potassium and 
calcium channels, phospholipase C, phosphodiesterases, cGMP and mitogen activated 
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protein kinases (Theil et al., 2003). This enables PI receptors to modulate many 
different cellular functions and explains how activation of these receptors has such 
diverse effects on different cell types. 
Receptor 
Agonist type and 
concentration required 
for activation 
Affinity for 
adenosine 
Primary G protein 
coupling/second 
messenger 
Al Adenosine (3-30 nM) Inosine (300 |iM)§ High 
Gi/o; inhibition of 
adenylate cyclase 
Aia Adenosine (1-20 nM) High Gs; activation of 
adenylate cyclase 
A2B Adenosine (5-20 |iM) Low Gs; activation of 
adenylate cyclase 
As 
Adenosine (>1 |iM) 
Inosine (1 |iM )§ 
Inosine* (10-50 |iM) 
Low Gi/o; inhibition of 
adenylate cyclase 
Table 1.2 Characteristics of PI receptors 
This table summarises the data on the potency of adenosine and inosine at human and 
rodent PI receptors, and was adapted from Fredholm, 2007. § Inosine is a weak agonist 
at recombinant heterologously expressed human Ai and A3 receptors (Fredholm et al., 
2001b). * Inosine binds to rodent A3 receptors (Jin et al., 1997). 
1.5.2 P2Y receptors 
P2Y receptors are G-protein-coupled receptors (GPCR) composed of 7 
hydrophobic transmembrane (7 TM) regions connected by 3 extracellular loops and 3 
intracellular loops. On the basis of their structure, these receptors belong to the 
rhodopsin family of 7 TM GPCRs. Primitive P2Y-like receptors appear to have 
emerged early in evolution and are thought to have existed for more than 450 million 
years (Schultz and Schoneberg, 2003), consistent with the view that purinergic 
signalling may be among the oldest signalling mechanisms (Dranoff et al., 2000). 
Structurally related groups of GPCRs within the rhodopsin family include cysteinyl 
leukotriene receptors, proteinase activated receptors and glycoprotein hormone 
receptors (Fredriksson et al., 2003; Costanzi et al, 2004). Currently, there are eight 
human, and seven murine P2Y receptors formally recognised by the 'international union 
of pharmacology': P2Yi, P2Y2, P2Y4, P2Y6, P2Yn, P2Y,2, P2Y,3 and P2Y,4 
(Abbracchio et al., 2006). Rodents express orthologues of all the P2Y receptors except 
P2Y]|. Each receptor is responsive to a different range of nucleotide agonists as 
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summarised in Table 1.3. Species-specific differences in ligand specificity and affinity 
also occur within the group of mammalian P2Y receptors. Notably, although ATP and 
UTP activate the rodent P2Y4 orthologues equipotently, ATP antagonises the human 
P2Y4 receptor (Kennedy et al, 2000). 
Receptor Agonist 
(Human) 
Agonist 
(Murine) 
Primary G protein 
coupling/second 
messenger 
Selected 
references 
P2Yi ADP » A T P ADP>ATP Gq/ii;PLCp 
activation 
Ayyanathan et 
1996; 
Janssens et al, 
1996; 
Tokuyama et 
a/., 1995 
P2Y2 ATP=UTP UTP=ATP Gq/ii;PLCp 
activation 
Lustig et al., 
1993; Parr et 
a/., 1994; 
Lazarowski et 
a/., 1995 
P2Y4, UTP UTP=ATP Gq/ii;PLCp 
activation 
Suarez-Huerta 
et al., 2000; 
Communi et 
al., 1996a 
P2Y6 U D P » U T P UDP>UTP> ADP 
Gq/ii; PLCp 
activation 
Lazarowski et 
a/., 2001; 
Communi et 
al., 1996b 
P2Yii ATP No receptor Gq/ii;PLCp 
activation 
Communi et 
a/., 1999 
P2Yi2 ADP ADP Gi/o; inhibition of 
adenylate cyclase 
Von Kugelgen 
et al., 2001; 
Hollopeter et 
a/., 2001 
P2Yi3 ADP ADP>ATP Gi/o; inhibition of 
adenylate cyclase 
Zhang et al., 
2002; 
Communi et 
aA,:2001; 
Marteau et al., 
2003 
P2Yi4 
UDP-
glucose>UDP-
galactose 
UDP-
glucose 
Gi/o; inhibition of 
adenylate cyclase 
Chambers et 
al., 2000; 
Freeman et al., 
2001 
Table 1.3 Cloned human and murine P2Y receptor sub-types 
This table summarises information relating to cloned mammalian P2Y receptors that 
have been proven to mediate actions of extracellular nucleotides when functionally 
expressed in heterologous assay systems. 
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Recently, it has been reported that the cysteinyl leukotriene receptors 1 and 2 (CysLTRl 
and 2) can be stimulated by nanomolar concentrations of UDP (Mellor et al., 2001 and 
2003). This showed for the first time, that other GPCRs of the rhodopsin family can 
respond to nucleotides. 
There are several known orphan GPCRs with sequences related to those of the 
P2Y family, many of which have unknown functions (Fredricksson et al., 2003). Very 
recently, the orphan GPCR, GPR17 originally discovered by Blasius et al., 1998, has 
been reported to be activated by both CysLT receptor ligands and uridine nucleotides 
(Ciana et al., 2006). This correlates with this GPCR being at an intennediate 
phylogenetic position between P2Y and CysLT receptors (Blasius et al., 1998). As yet 
GPR17 has not been classified as a P2Y receptor. Potentially, a new classification 
system may be required to accommodate the growing number of dualistic receptor sub-
types. The 'deorphanisation' of P2Y-like GPCRs and the identification of their roles is 
expected to provide new insight into the regulatory mechanisms of physiological 
processes (Howard et al., 2001; Fredriksson et al., 2003). Hence, it is likely that in the 
future many more orphan GPCR may be designated as P2Y receptors. Interestingly, 
purinergic receptors can also form heteromeric and homomeric associations with each 
other in the cell membrane, thus potentially altering receptor specificity. For example, 
the PI receptor Ai can associate with the P2Y receptors P2Yi and P2Y2 in vitro, 
resulting in significant changes in ligand binding properties (Yoshioka et al., 2001). 
P2Y receptors can be subdivided into two sub-groups on the basis of their 
structure, phylogeny, amino acid sequence and coupling to G-proteins. P2Y,, 2, 4, 6 and 
P2Yn receptors all principally use Gq/Gn to activate the PLCp/IPg pathway and release 
intracellular calcium, whereas the receptors P2Y]2, 13 and 14 almost always couple to 
Gi/o family of G proteins (displayed in Table 1.3) (Abbrachio et al., 2006). Current 
research is also focusing on evidence that suggests that P2Y receptors can couple 
directly to voltage-gated ion channels at the cell surface via activation of G proteins. 
Primarily, ion channel couplings of P2Y receptors are of major importance in brain 
neurons (Dolphin, 2003). 
Most of the P2Y receptor sub-types are currently lacking selective, potent 
agonists and antagonists (Abbracchio et al., 2001). Considering that most cell types 
express multiple types of purinergic receptors, this makes it very difficult to characterise 
the specific receptor subtypes(s) mediating a response. An extensive research effort to 
design and find selective agonists and antagonists is currently underway. Considerable 
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progress in exploring structure-activity relationships between receptor and ligand has 
been made for the P2Yi and PlYi? receptors and to a lesser extent for the P2Y2 receptor 
(Abbracchio et al., 2001). The majority of antagonists available are nucleotide-
derivatives. For example, adenosine bisphosphate derivatives such as A3P5P act as 
partial antagonists for the P2Yi receptor (Boyer et al., 1996). Non-nucleotide 
compounds are also used as purinergic receptor antagonists. These are usually highly 
negatively charged polycyclic compounds, for example the polysulfonate suramin, and 
the the pyridoxal phosphate derivative PPADS, are general non-selective inhibitors of 
P2Y receptors. As yet, extensive structure-activity relationship manipulations of non-
nucleotide compounds have not resulted in antagonists of nanomolar affinity. 
1.5.3 P2X receptors 
P2X receptors are ligand gated ion channels that gate extracellular cations in 
response to ATP only. There are seven different P2X receptor subtypes, P2X1-7, which 
are 40-50% identical in amino acid sequence. Channels form as multimers of several 
subunits, where each subunit has two transmembrane domains. P2X receptor diversity is 
further expanded, as some sub-types can form heteromeric associations with other P2X 
receptor sub-types. To date, P2X1/P2X5 (Le et al, 1999), PZXi/PZXg (King et al., 
2000), and P2X4/P2X6 (Khakh et ah, 1999) receptor associations have been identified. 
Heterologous expression of cloned P2X receptor subtypes has shown that each receptor 
sub-type has a slightly different response profile in terms of agonist and antagonist 
affinity and selectivity, permeation properties and desensitisation/inactivation rate 
(North, 2002). Signal transduction occurs via fast Na"^  and influx and efflux, 
leading to depolarization of the plasma membrane and an increase in the concentration 
of cytosolic Ca^^. P2X receptors are found ubiquitously and also account for fast 
neurotransmission in excitatory tissues. The P2X7 receptor is unusual amongst the other 
P2X sub-types in that it requires millimolar concentrations of ATP to achieve activation 
(Steinberg et al., 1987; Greenberg et al., 1988). P2X7 receptor activation may also 
induce the opening of a nonselective pore permeable to large organic molecules up to 
900 Da (North, 2002; North and Suprenant, 2000). Continuous activation of this 
receptor results in the formation of a large non-selective transmembrane pore that can 
cause perturbations in ion homeostasis and finally result in cell death (Di Virgilio, 1995; 
Suprenant et al., 1996). The ability of P2X receptors to mediate the responses of many 
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types of immune cells has prompted a great deal of interest in this area over the recent 
years. 
1.6 Nucleotide release and uptake 
Nucleotides can be released from cells in both regulated and non-regulated 
manners. Tissue damage results in the non-regulated release of large amounts of 
nucleotides into the extracellular environment. However, nucleotides, particularly ATP 
are released in a regulated manner from many excitatory and secretory tissues. For 
example, neurons, chromaffin cells, platelets, mast cells and pancreatic acinar cells can 
all release ATP by regulated exocytosis (Evans et al., 1992; Bumstock, 1997; Sorensen 
and Novak, 2001). Enhanced release of nucleotides also occurs after the mechanical 
stimulation of many different cell types, including endothelial, epithelial and glial cells 
(Vlaskovska et al., 2001; Bumstock, 1999; Parr et al., 1994). Nucleotides are also 
released from some non-secretory cell types in response to agonists. For example, 
studies have shown that treatment of coronary endothelial cells with ADP (Buxton et 
al., 2001), and stimulation of COS-7 fibroblast-like cells and HEK-293 kidney cells 
with UTP results in the release of ATP (Ostrom et al., 2000). An alternative mechanism 
for the release of nucleotides into the extracellular space via vesicular trafficking has 
also recently been proposed by Bodin and Bumstock (2001). They observed that ATP 
released from endothelial cells was dependent on vesicular formation from the Golgi 
apparatus, suggesting that ATP release could also be mediated by vesicular exocytosis. 
Mechanisms also exist that allow cells to take-up extracellular adenosine. 
Movement of adenosine across the cell membrane is mediated by equilibrative 
nucleoside transporters (ENT) (Baldwin et al., 2004). Adenosine formed intracellularly 
due to the metabolism of ATP will be transported out of cells until an equilibrium is 
reached with the extemal environment. In a similar mamier, extracellular adenosine is 
transported into cells when intracellular adenosine levels are low. By regulating the 
concentration of adenosine available to cell surface receptors, these transporters are 
thought to influence many physiological and inflammatory processes (Musa et al., 
2002; Ackley et al., 2003). 
1.7 Extracellular nucleotide metabolism 
The concentration and types of extracellular nucleotides available to interact 
with purinergic receptors is regulated by several families of ubiquitously distributed 
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membrane-bound and secreted nucleotide metabolising enzymes that rapidly catalyse 
the breakdown and interconversion of nucleotides (Zimmermarm, 2000). Extracellular 
ecto-nucleotidases are expressed by most if not in all cell types. Several families of 
ectoenzymes participate in the degradation and interconversion of extracellular 
nucleotides. 
Most prominent of these families are the members of the ecto-nucleotidase 5'-
triphosphate diphosphohydrolase (E-NTPDase) family. Eight members of this family 
(E-NTPDasel-8) have been described so far. E-NTPDases 1 ,2 ,3 and 8 are cell surface-
associated, whereas the remaining four types are intracellular enzymes. E-NTPDase 1 
(otherwise known as ecto-ATPDase, CD39, apyrase), hydrolyses both nucleoside 
triphosphates and nucleoside diphosphates; E-NTPDase 2 (ecto-ATPase, CD39L1), 
hydrolyses nucleoside triphosphates; and E-NTPDase 3 (ectoATPDase, CD39L3), 
hydrolyses both nucleoside triphosphates and nucleoside diphosphates (Zimmermann, 
2000; Lazarowski et al. 2003a). The secreted enzyme, NTPDaseS (CD39L4), may be 
responsible for soluble nucleotidase activities and preferentially catalyses the hydrolysis 
of nucleoside diphosphates and to a lesser extent nucleoside triphosphates (Mulero et 
al., 1999). The more recently described E-NTPDase 8 hydrolyses adenine and uridine 
nucleotide di- and tri-phosphates (Bigormesse et al., 2004). 
The ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP) family are cell 
surface trans-membrane metalloenzymes that can hydrolyse nucleoside 5'-triphosphate 
(NTP) to nucleoside monophosphate (NMP) and nucleoside 5'-diphosphate (NDP) to 
NMP. UDP-glucose, the natural agonist of the P2Yi4 receptor, and other nucleotide 
sugars are also substrates of E-NPP isoenzymes (Lazarowski, 2003b). The E-NPP 
family comprises five members. However, currently only the activities of E-NPP 1-3 
have been characterised (Coding et al., 2003). 
The abundant GPI-linked enzyme ecto-5'-nucleotidase (otherwise known as 
CD73) can convert NMP to nucleoside plus orthophosphate and is the major 
contributing factor to the accumulation of extracellular adenosine from AMP 
(Zimmermann, 1996). 
Extracellular nucleotide interconverting activities such as nucleoside 
monophosphate- and diphosphate-kinases have also been described. For example, the 
activity of ecto-nucleoside diphosphate kinase (NDPK) catalyses transphosphorylation 
reactions such as the reversible phosphorylation of UDP or GDP by ATP (e.g., ATP + 
UDP =;ADP + UTP) and adenylyl kinase can transphosphorylate 2ADP to ATP and 
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AMP (2ADP ==ATP + AMP) (Yegutkin et ai, 2001 and 2002; Donaldson al., 2002; 
Picher and Boucher, 2003). In many instances both ATP-consuming and ATP-
generating pathways co-exist on the cell surface, providing a mechanism for regulating 
the duration and magnitude of purinergic signalling (Yegutkin et al., 2001). 
Extracellular adenosine is mainly formed by the breakdown of intracellular or 
extracellular adenine nucleotides (Zimmermann, 2000). Extracellular adenosine can be 
catabolised to inosine by cell membrane-bound adenosine deaminase (ADA). 
Intracellular adenosine can either be deaminated to inosine by ADA, or phophorylated 
to AMP by adenosine kinase (ADK). When ADA is blocked or genetically deleted as in 
SCID (severe combined immunodeficiency) mice, the enzymatic capacity of ADK is 
exceeded and adenosine levels rise rapidly. This leads to defective lymphocyte function, 
which is thought to be partly due to the accumulation of intracellular and extracellular 
adenosine (Apasov and Sitkovsky, 1999). This highlights the critical importance of 
adenosine metabolising enzymes in regulating immune cell function. 
Local availability of extracellular nucleotides and nucleosides to cells of the 
immune system are implicated extensively in regulation of inflammation and are known 
to have immuno-modulatory effects (Cronstein, 1994; Linden, 2001). Notably, 
nucleotide metabolising enzymes such as CD39 and CD39L1 are expressed on a wide 
variety of immune cell types including dendritic cells, macrophages, and activated B 
lymphocytes (La Sala et al., 2003). The presence of extracellular nucleotide 
metabolising enzymes play an important role in the modulation of immune responses. 
Recently, the coordinate expression of E-NTPDase 1 (CD39) and ecto-5'-nucleotidase 
(CD73) on T cells has been reported to be a marker of immuno-suppressive regulatory 
T cells (Deaglio et al., 2007). Furthermore, T regulatory (Treg) cells from E-NTPDase 
1-deficient mice (which have a lower capacity to metabolize extracellular ATP) show 
impaired suppressive properties in vitro and fail to block allograft rejection in vivo 
(Deaglio et al., 2007). CD39 expression was found to be induced by the Treg cell-
specific transcription factor Foxp3 and its catalytic activity was also enhanced by T-cell 
receptor (TCR) ligation. Activated Treg cells are therefore able to abrogate ATP-related 
effects such as P2 receptor-mediated cell toxicity and ATP-driven maturation of 
dendritic cells (Borsellino et al., 2007). Other studies have also shown that nucleotide 
metabolising enzymes can have immunomodulatory effects. For example, 
monocyte/macrophages from E-NTPDase 1 -null mice display an impaired chemotactic 
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response to ATP, associated with P2Y receptor-mediated signahng pathway 
desensitization (Goepfert et al., 2001). 
1.8 Purinergic signalling in immune cells 
Nucleotides released from cells are thought to act as 'danger signals' to alert the 
immune response of abnormal cell death or cell stress. Extracellular nucleotides and 
nucleosides play complex roles in activating and regulating the immune response. The 
balance between pro- and anti-inflammatory immune responses is critical for avoiding 
excess tissue damage. The modulation of inflammatory processes and immune 
responses by the P2Y and P2X receptor agonist ATP is complex and results from 
specific effects on a wide variety of immune cells. In many scenarios, ATP promotes 
inflammatory immune responses (La Sala et al., 2003). The metabolism of ATP to 
adenosine by extracellular nucleotide metabolising enzymes results in the formation of 
adenosine which can act as a suppressive tissue protecting signal, in a negative feedback 
manner (Bours et ah, 2006). This paradigm holds true especially for neutrophils and 
macrophages/monocytes and to a lesser extent, lymphocytes and dendritic cells. The 
following section highlights some of the far-reaching effects nucleotides can have on 
the functions of many different immune cell types. 
1.8.1 Dendritic cells 
Dendritic cells (DCs) play a major role in the initiation and regulation of innate 
and adaptive immunity. Low concentrations of ATP released from damaged or stressed 
cells directs the migration of immature dendritic cells towards the source of ATP 
release. In this scenario the release of nucleotides acts as a 'danger signal', alerting the 
initiation of an appropriate immune response. In contrast, high concentrations of ATP 
inhibit the migratory capacity of DCs through P2Yn receptor activation (Idzko et al., 
2002). These differing responses highlight the concentration-dependent effects 
nucleotides can have on immune cell types, and may be a mechanism for limiting over-
exuberant immune responses. Dendritic cells also express high levels of the receptor 
P2X7, which explains why these cells are exceedingly sensitive to the cytotoxic activity 
of ATP and readily undergo apoptosis. 
ATP released from stressed or damaged cells also induces an alternative pathway 
of DC maturation, characterized by the up-regulation of costimulatory membrane 
molecules but the absence of IL-12 and inflammatory cytokine and chemokine 
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production (la Sala et ai, 2001, 2002). This response appears to be mediated by 
activation of the P2Yii receptor (Wilkin et ai, 2001). DCs matured in the presence of 
ATP have an impaired capacity to promote type 1 polarization of naive T lymphocytes, 
favouring instead the development of Th2 lymphocytes (la Sala et al, 2001, 2002). This 
is proposed to be beneficial to survival, by limiting inflammatory ThI responses (la Sala 
et al., 2003). 
1.8.2 Monocytes and Macrophages 
An important component of the innate immune response, phagocytic circulating 
monocytes and tissue-dwelling macrophages principally contribute to chronic 
inflammatory responses. Monocytes and macrophages express multiple sub-types of 
P2Y and P2X receptors and all PI receptors (summarised in Bours et al., 2006). It has 
been reported that during inflammatory and immune responses, extracellular ATP and 
ADP can induce upregulated expression of adhesion molecules on monocytes (Ventura 
and Thomopoulos, 1991), thus allowing them to firmly tether to endothelial cells and 
subsequently transmigrate through the endothelium and enter sites of inflammation 
(Goepfert et al., 2001). UDP signalling via the P2Y6 receptor stimulates monocytes to 
increase chemokine production, thus promoting the recruitment of other leukocytes to 
sites of inflammation (Wamey et al., 2001; Cox et al., 2005). In contrast, adenosine has 
a more inhibitory effect on the adhesion of monocytes to the vascular endothelium and 
chemotactic responses (Pike and Snyderman, 1981; Okusa et al., 2000), thus limiting 
the accumulation of macrophages at inflamed/damaged sites. 
Extracellular nucleotides also have a considerable impact on cytokine 
production by monocytes and macrophages. Many studies have reported that high 
concentrations of ATP signalling via the PZX? receptor can stimulate the production of 
IL-la, IL-ip, TNF-a, IL-6 and IL-18 (Bours et al., 2006). In contrast, adenosine, acting 
through multiple PI receptor sub-types inhibits de-novo and LPS-induced 
proinflammatory cytokine production from monocytes and macrophages (Bours et al., 
2006; Hasko et al., 1998). Hence, nucleotides and nucleosides can drastically promote 
or inhibit inflammatory immune responses. 
An important function of macrophages is phagocytosis and removal of harmful 
pathogens. Activation of macrophages by LPS and ATP, ADP or UDP enhances nitric 
oxide (NO) synthesis (Tonetti et al., 1994) and the production of reactive oxygen 
species (ROS) (Murphy et al., 1993). Activation of the apoptotic PZX? receptor 
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expressed by monocytes/macrophages can also trigger cell death (Murgia et ah, 1992). 
These mechanisms act to enhance pathogen killing, even at the expense of the survival 
of the cell, and terminate potentially aberrant inflammatory responses by over-activated 
macrophages. Thus in general, nucleotides such as ATP dramatically activate pro-
inflammatory responses of monocytes/macrophages, whereas adenosine acts to dampen 
down these responses. 
1.8.3 Lymphocytes 
Lymphocyte responsivity to nucleotides was discovered almost thirty years ago. 
In 1978, Gregory and Kern reported that extracellular ATP stimulated proliferation of 
thymocytes. Since then, the field of purinergic signalling in T lymphocytes has 
dramatically expanded, and the effects of nucleotides and adenosine on B lymphocyte 
activation have also been investigated, although the latter to a lesser extent. 
T cells express several P2X receptor sub-types (Chused et a., 1996; Gu et al., 
2000), and can upregulate the expression of P2Y receptors and release ATP during 
activation (Filippini et al., 1990; Somers et al., 1998). Extracellular ATP acting via 
P2X7 receptors can modulate B and T lymphocyte migration by inducing the shedding 
of the adhesion molecule L-selectin (Jamieson et al., 1996). Since this adhesion 
molecule is naturally shed upon lymphocyte activation, ATP may be involved in 
migration of activated lymphocytes to sites of inflammation. Extracellular ATP may 
also be involved in T lymphocyte proliferative responses. However, the data in this area 
is conflicting as ATP has been reported to inhibit (Duhant et al., 2002), or induce the 
proliferation (Budagian et al., 2003) of different types of T cells. 
Adenosine can also affect lymphocyte function. T cells express a variety of Aia, 
A2B and A3 receptor sub-types (summarised in Bours et al., 2006), some of which are 
upregulated upon T cell receptor (TCR) activation (Mirabet et al., 1999; Gessi et al., 
2004). Extracellular adenosine is thought to inhibit antigen-triggered TCR signalling in 
T cells, thus attenuating proliferation and generally playing a role in lymphocyte 
deactivation (Nishida et al., 1984; Mirabet et al., 1999). Cytokine production by 
activated T cells is also generally inhibited by extracellular adenosine (Erdmann et al., 
2005). Furthermore, activation of lymphocyte adenosine receptors in vivo has been 
shown to inhibit lymphocyte-driven inflammatory responses in mice, thus confirming 
the suppressive effects of adenosine (Odashima et al., 2005). The effect of adenosine on 
B lymphocytes has not been as extensively studied as on T lymphocytes. However, B 
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cells are thought to express adenosine AiA and Ai receptors Conigrave et al., 2001; 
Napieralski et al., 2003). Currently, the effects of activation of these adenosine 
receptors on B cell function are still unknown (Conigrave et al., 2001; Napieralski et 
aA,2003X 
1.8.4 Neutrophils 
Neutrophils are the body's first line of defence against pathogens and are critical 
effectors in both innate and humoral immunity. A large body of evidence exists that 
suggests that nucleotides and nucleosides may contribute to the regulation of neutrophil 
function during inflammatory and immune responses. Neutrophils express multiple P2Y 
and P2X receptor sub-types and all four PI receptors (summarised in Bours et al., 
2006). Generally, neutrophil effector functions appear to be enlianced by co-ordinated 
effects of high ATP levels, while increasing adenosine levels predominantly suppress 
effector functions of neutrophils. 
ATP can stimulate neutrophil adhesion to endothelial cells (Freyer et al., 1988), 
which is an important step in the recruitment of circulating neutrophils to extravascular 
inflammatory sites during the early stages of inflammation. Moreover, extracellular 
ATP may further facilitate neutrophil transmigration by increasing endothelial 
permeability via activation of P2Y receptors (Tanaka et al., 2004). The effects of ATP 
on neutrophil migration are still controversial, as it has been reported that ATP can 
promote (Verghese et al., 1996), inhibit (Elferink et al, 1992), or not affect (Aziz and 
Zuzel, 2001) neutrophil migration. It has also been shown that ATP and UTP can prime 
neutrophil bactericidal mechanisms by inducing superoxide anion generation (Melloni 
et al., 1986; Tuluc, 2005), and granule exocytosis (Aziz and Zuzel, 2001; Balazovich 
and Boxer, 1990). Other reports suggest extracellular ATP can delay neutrophil 
apoptosis in synergy with the neutrophil survival factor granulocyte macrophage 
colony-stimulating factor (GM-CSF), thus extending the functional lifespan of 
neutrophils (Gasmi et al., 1996). 
Extracellular adenosine plays a more complex role and acts predominantly to 
protect host tissues from the potentially damaging effects of neutrophils (Gasmi et al., 
1996). Adenosine at micromolar concentrations inhibits the oxidative burst (Cronstein 
et al., 1983) and degranulation (Pasini et al., 1985) of neutrophils through activation of 
Aia and possibly Ag receptors (Bouma et al., 1997; Visser et al., 2000). The effects of 
adenosine on neutrophil recruitment from the circulation appear to be bi-directional and 
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dependant upon its extracellular concentration. Sub-micromolar concentrations of 
adenosine can enhance neutrophil adhesion to the vascular endothelium (Cronstein et 
al., 1992). In contrast, micromolar concentrations of adenosine inhibit adhesion of 
neutrophils to vascular endothelial cells (Kilian et ah, 2005). The inhibitory effects of 
adenosine probably dominate under inflammatory and hypoxic conditions during which 
extracellular adenosine levels rise markedly. 
1.8.5 Eosinophils 
Eosinophils are important effector cells in gastro-intestinal parasitic helminth 
infections (Dixon et al., 2006; Coffman et al., 1989) as well as different pathological 
conditions such as atopic diseases, rhinitis, eczema and asthma (Djukanovic et al., 
1990; Walsh, 1997). ATP, UTP and UDP nucleotides acting via P2Y and possibly P2X 
receptors can stimulate eosinophils in multiple ways. ATP is a chemoattractant for 
eosinophils and as such can direct them to sites of tissue damage (Saito et al., 1991a; 
Burgers et al., 1993). ATP, ADP and UTP are all able to induce the production of 
reactive oxygen metabolites in eosinophils (Idzko et al., 2001) that further eosinophil-
mediated toxicity by damaging parasite structures and surrounding tissues (Rothenberg, 
1998; Frigas and Gleich, 1986). UDP and ATP also trigger the release of pro-
inflammatory cytokines (Idzko et al., 2003), and expression of cell surface adhesion 
molecules that facilitate migration of eosinophils into tissues (Dichmami et al., 2000). 
Conversely, adenosine signalling via the A3 receptor can downregulate C5a mediated 
degranulation and super oxide anion generation in eosinophils thus acting to limit 
inflammatory responses (Ezeamuzie and Phillips, 1999). 
1.8.6 Mast cells 
Mast cells are heavily granulated cells found throughout the body, particularly at 
mucosal sites such as the gastro-intestinal (GI) and respiratory tracts. Mast cells are 
important effector cells in acute IgE-antigen-associated allergic reactions and also 
mediate immunoregulatory functions, through their ability to produce cytokines. Upon 
stimulation, mast cells can be induced to secrete mediators that are either pre-formed 
and granule-associated (for example, histamine, proteoglycans and neutral proteases) or 
are synthesised de-novo (for example cytokines, chemokines, leukotriene C4, 
prostaglandin D2 and platelet activating factor). 
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Mast cells are known to express a range of PI, P2 and cysteinyl leukotriene 
receptors (Feng et al. 2004; Bulanova et al. 2005). Mast cells can respond in multiple 
ways when activated by different nucleotides/nucleosides. This can involve 
degranulation, chemotaxis and alteration of receptor expression. The effects of 
adenosine on mast cells has been the subject of intense research over the past 20 years, 
ever since it was discovered that inhaled adenosine, acting on lung mast cells, induced 
bronchoconstriction in asthmatic but not normal subjects (Cushley et al., 1983; Rafferty 
et al., 1987; Polosa et al., 1995; Forsythe et al., 1999). However, the effects of 
adenosine on mast cells in vivo are very different to the effects observed in vitro. Most 
types of mast cells do not degranulate in response to adenosine in vitro (Marquardt et 
ah, 1994; Schulman et al., 1999), while in comparison the in vivo administration of 
adenosine results in the degranulation of mast cells via activation of Ag receptors (Tilley 
et al., 2000; Zhong et al., 2003; Linden et al., 1999), although the exact mechanisms 
controlling these events are however unknown. 
Recently, experiments using bone marrow-derived mast cells (BMMC) from 
mice lacking the Azs receptor have shown that loss of this receptor results in an 
excessive influx of extracellular calcium through store-operated calcium channels 
following antigen cross-linking of the high affinity IgE receptor FcsRl (Hua et al., 
2007). These findings imply that the Azg receptor acts in concert with other signalling 
pathways to negatively regulate mast cell activation. In contrast, stimulation of mast cell 
A3 receptors by adenosine results in amplification of FceRI-mediated degranulation and 
cytokine production (Laffargue et al., 2002). 
Other experiments using BMMC have demonstrated that prolonged exposure to 
adenosine receptor antagonists mediates the up-regulation of adenosine receptor 
expression, resulting in a hyper-responsiveness to exogenous adenosine (Marquardt et 
al., 1984). Conversely, chronic exposure to the adenosine analogue NECA, results in 
down-regulation of adenosine responsiveness and a decrease in the expression of 
adenosine receptors (Marquardt and Walker, 1987). The physiological relevance of 
these findings are still questionable, as extracellular adenosine is rapidly degraded or 
taken-up by cells, which would limit the long-term exposure of mast cells to this 
nucleoside. Again, these examples show the effects of adenosine on PI receptor 
activation are complex, and may have unexpected impacts on mast cell activation. 
The P2 receptor agonists ATP and ADP can directly induce the degranulation of 
murine mast cells in vitro (Nakamura et al., 1989; Saito et al., 1991b). This may suggest 
49 
that the presence of exogenous adenine nucleotides can promote inflammatory 
responses via the release of pre-formed mast cell mediators including histamine in mice 
(Nakamura et al., 1989; Saito et al., 1991b). However, these effects are species-
dependent, as human mast cells can not be induced to degranulate in response to ATP 
(Schulman et al., 1999). 
The nucleotides ADP, ATP and UTP can also direct the migration of rat mast 
cells in vitro (McCloskey et al. 1999), suggesting that nucleotides released from sites of 
tissue damage may be able to recruit mast cells, thus promoting the development of an 
inflammatory response. 
Nucleotides can also modulate mast cell effector functions activated by other 
signal transduction pathways. For example, antigen-dependent degranulation of mast 
cells and cytokine production is enhanced when purinergic receptors are co-stimulated 
with ATP, UTP, adenosine or inosine (Schulman et al., 1999; Tilley et al., 2000). Thus, 
the release of extracellular nucleotides can promote allergic and inflammatory mast cell 
responses. 
Stimulation of mast cells with ADP and ATP suppresses pro-inflammatory 
cytokine production by mast cells stimulated with peptidoglycan (PGN), a ligand for the 
Toll-like receptor (TLR)-2/TLR-6 heterodimer that mediates innate immune responses 
to Gram-positive organisms (Feng et al., 2004). In a similar manner, ADP can also 
suppress the generation of pro-inflammatory cytokine production by mast cells 
stimulated with the pro-inflammatory lipid mediator LTD4 (Feng et al., 2004). The 
activation of inhibitory pathways by adenine nucleotides may function to prevent the 
over-exuberant secretion of potentially harmful cytokines that would otherwise cause 
extensive tissue pathology. 
1.9 Purinergic signalling in gastrointestinal epithelia 
Epithelial cells maintain physiological homeostasis by regulating the amount of 
fluid in the GI lumen. This cell type achieves this by modifying nutrient and ion 
absorption, and ion secretion. Purinergic receptors play a significant role in regulating 
ion and fluid transport in many types of epithelial tissues including the epithelium of the 
gastro-intestinal (Gl) tract. Purinergic receptors are found on both the basolateral and 
luminal membranes of nearly all epithelia that transports ions. The stimulation of ion 
transport and the flux of water into the lumen that accompanies it are thought to act as a 
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natural defence system that functions to flush away noxious stimuli in the setting of 
cellular damage or inflammation of the intestine. 
All four PI receptor subtypes are known to be involved in adenosine-mediated 
control of ion transport in the gastro-intestinal epithelium. Nucleoside transporters are 
also thought to play an important role in controlling the effect of adenosine at the 
epithelial surface by controlling the extracellular concentration (Szkotak et al, 2003). 
The action of adenosine in the colon is a potent contributing factor in the development 
of secretory diarrhoea in the setting of inflammation. Neutrophils recruited to intestine 
during inflammatory responses are a major source of adenosine, as they release large 
amounts of adenine nucleotides that are rapidly metabolised to adenosine by ecto-5'-
nucleotidase which is highly expressed on gut epithelium (Madara et al., 1993). 
Adenosine induces a direct effect on Cl~ secretion in the colon via Aie-mediated Gs 
activation of adenylyl cyclase, leading to a rise in cAMP that directly activates the cystic 
fibrosis transmembrane conductance regulator protein (CFTR) C P channel (Strohmeier 
et al., 1995; Bucheimer and Linden, 2003). 
Activation of P2 receptors can also activate K"^  secretion in the distal colon and 
C P secretion in the small intestine. P2Y4 receptor stimulation with ATP or UTP has 
been shown to increase C P secretion leading to fluid accumulation in the lumen of the 
small intestine (Cressman et al., 1999; Robaye et al., 2003; Ghanem et al., 2005). To a 
lesser extent, stimulation of basolateral P2Y2 receptors can also stimulate chloride ion 
secretion in the small intestine (Ghanem et al., 2005). Luminal ATP and UTP can 
induce K"^  secretion via the P2Y2 and P2Y4 receptors in the distal colon, resulting in an 
increase in the amount of fluid on the luminal surface of the epithelium (Kerstan et al., 
1998; Matos et al., 2005). 
P2X7 receptors are functionally associated with apoptosis in many different cell 
types, and are also expressed in duodenal villus tip cells (Ralevic et al., 1998; Schulze-
Lohoff et al., 1998). In the intestinal mucosa, epithelia are rapidly regenerated. Stem 
cells located in the crypt base move to the surface, apoptose and get exfoliated into the 
intestine. These dying cells eventually release ATP and may provide an extracellular 
'death' signal. Thus, strategically located P2X7 receptors present on the villus tips may 
ensure intestinal epithelial regeneration (Groschel-Stewart et al., 1999). 
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1.10 Purinergic signalling in haemostatic responses 
Vascular injury leads to the release of nucleotides that can directly activate 
platelets. Platelet activation is characterized by rapid shape change, release of granular 
contents, generation of lipid mediators, and aggregation (Kahner et ah, 2006). 
Activation of purinergic receptors results in signalling via unique signal transduction 
pathways that are important in the regulation of thrombosis and haemostasis. When 
exposed to ADP, P2Yi receptor activation triggers platelets to undergo shape change 
from smooth discs to spiculated spheres which facilitates a weak, transient aggregation 
response (Jin et al., 1998; Hechler et al., 1998a). Subsequent ADP-induced activation of 
platelet P2Yi2 receptors is required for complete platelet aggregation (Jin and Kunapuli, 
1998). Activation of the P2Yi2 receptor plays a pivotal role in platelet function, as it 
amplifies aggregation responses induced by all known platelet agonists (Gachet, 2006). 
Platelets also express P2Xi receptors that are responsive to ATP (MacKenzie et 
al., 1996). P2Xi receptor activation can induce substantial and rapidly reversible shape 
change and centralisation of secretory granules without the release of granular contents 
outside of the cell (Rolf et al., 2001; Toth-Zsamboki et al., 2003). Although ATP is 
unable to directly trigger platelet aggregation, activation of the P2Xi receptor is thought 
to play a priming role in the subsequent activation of the P2Yi receptor (Sage et al., 
2000; Vial et al., 2002). The most significant function of P2Xi receptor activation is 
through its amplifying of platelet responses mediated by lower concentrations of other 
platelet agonists. For example, low-dose collagen-mediated dense granule release and 
aggregation are potentiated in the presence of P2Xi receptor activation (Oury et al., 
2001; 2002). More significantly, P2Xi receptor activation has been reported to be 
essential for enhanced platelet adhesion and thrombus formation under high shear blood 
flow-rates (Hechler et al., 2003). 
Platelets also express the Aia receptor (Haslam and Cusack, 1981). Activation 
of this receptor by adenosine inhibits platelet aggregation induced by other factors such 
as thrombin (Paul et al., 1990). This is thought to act as a regulatory mechanism to 
prevent overexuberant aggregatory responses. 
1.11 Modulation of purinergic signalling by pathogens 
A variety of parasites and pathogens have evolved mechanisms to modulate 
purinergic signalling. Blood feeding insects and ticks (Ribeiro et al., 1985; Ribeiro and 
Francischetti, 2003), parasitic nematodes such as T. spiralis (Gounaris et al., 2001; 
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Gounaris, 2002; Gounaris and Selkirk, 2005), protozoans (Silverman et al., 1998) and 
pathogenic bacteria (Zaborina et al., 1999, 2000; Punj et al, 2000; Melnikov et al., 
2000) have all been reported to secrete nucleotide-metabolising enzymes. In some 
pathogen/parasite types, the role of these secreted enzymes is very obvious. For 
example, blood-feeding ectoparasites cause tissue damage as they probe the host, 
resulting in the release of ADP and ATP which are proinflammatory and immediately 
stimulate platelet aggregation thus halting the flow of blood. To overcome host 
haemostatic responses, arthropods inject salivary apyrase to deplete ADP and ATP from 
the lesion produced by probing mouthparts (Champagne et al., 1995; Area et al., 1999; 
Valenzuela et al., 1998, 2001; Faudry et al., 2004). Bacterial pathogens such as 
Mycobacterium bovis secrete ATPase and nucleoside diphosphate kinase (NDPK) 
enzymes that are able to prevent ATP-induced macrophage apoptosis. Therefore, it was 
suggested that depletion of extracellular ATP by these enzymes promotes the survival 
of mycobacterial-infected cells (Zaborina et al., 1999). 
In comparison, the role of secreted nucleotide-metabolising enzymes in the 
infectivity of parasitic nematodes is far more elusive due to the complex nature of the 
parasites lifecycle and the variety of host cell types it comes into contact with. However, 
interpretation of the physiological effects mediated by these enzymes can be predicted 
from their known substrate specificity. For example, T. spiralis secretes a 5'-NT able to 
hydrolyse ADP, UDP and AMP substrates, an adenosine deaminase and a NDPK with 
trans-phosphorylatory activities (Gounaris, 2002; Gounaris et al., 2001, 2004). This 
suggests that the parasite may secrete these enzymes to modulate physiological and host 
immune responses directed by ADP, UDP and adenosine. 
The nucleotide metabolising enzymes secreted by both ecto- and endo- parasites 
are similar to ubiquitous cellular enzymes involved in intracellular metabolic processes. 
This suggests that these parasites and pathogens have independently adapted genes 
involved in 'house-keeping' events to genes involved in pathogenicity, thus allowing 
them to survive in the otherwise inhospitable environment of their host. Due to the 
conserved nature of the genes encoding secreted nucleotide metabolising enzymes, it is 
likely that annotation of sequenced pathogen/parasite genomes generally categorises 
these enzymes as metabolic without investigating their potential to be secreted enzymes 
involved in pathogenicity. Thus, it is possible that many more species of parasites and 
pathogens may secrete these enzymes. 
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1.12 Host immune responses and effector mechanisms against the enteral stage 
of T. spiralis infection 
Infection with intestinal nematodes induces strong immune responses in the host 
and profound pathological changes to the gut that are associated with eventual parasite 
expulsion. The pathology may have several causes, including direct damage from the 
migration/burrowing activities of the worm or secondary damage resulting from 
opportunistic bacterial infections, or the host's immune response to the parasite or 
bacteria. 
Host genetic factors strongly influence the expulsion of T. spiralis from the 
murine small intestine. Inbred mice strains are classified into rapid- and slow-
responders according to the speed at which they expel parasites from the intestine. 
Rapid-responder mice expel T. spiralis larvae from the intestine within 10 days, and can 
generate protective immune responses against T. spiralis infection when immunised 
with native parasite antigens (Wakelin, 1988; Robinson et al., 1994, 1995a; Wakelin et 
al., 1986). In comparison, slow-responder strains can take up to 17 days to expel 
parasites (Wakelin et al., 1986), and these mice cannot be protected against infection by 
immunisation with native parasite antigens (Wakelin, 1988; Robinson et al., 1994, 
1995; Wakelin et al., 1986). 
Crucially, protection against T. spiralis infection is dependent upon the T cell-
directed development of mucosal mastocytosis in the small intestine (Alizadeh and 
Murrell, 1984; Oku et al, 1984). The following section highlights the specific immune 
responses and effector mechanisms that mediate expulsion of T. spiralis from the GI 
tract. 
1.12.1 The T cell response 
The expulsion mechanism of adult T. spiralis worms from the small intestine is 
a complex immune-mediated process that is orchestrated by activated T helper type 2 
(TH2) cells. As T. spiralis burrows through the epithelium of the small intestine, villous 
atrophy, crypt hyperplasia, increased epithelial permeability, goblet cell and Paneth cell 
hyperplasia, eosinophilia, and infiltration of mucosal mast cell occurs (Garside et al., 
1992, 2000; Kamal et al., 2001). Generally, these responses are controlled by cytokines 
produced by CD4^ T cells. Experiments performed in nude, thymectomised and 
cyclosporine A-treated mice that all lack frilly ftinctional T cells, have proven the T cell-
dependency of both parasite expulsion and the accompanying intestinal pathology 
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(Garside et al., 1992; Manson-Smith et al., 1979). Furthermore, cell transfer studies 
have demonstrated that CD4^ T cells mediate parasite expulsion (Riedlinger et al., 
1986). 
Protective immune responses against gastrointestinal (GI) nematode parasites 
are associated with the production of high levels of the Th2 cytokines IL-3, lL-4, lL-5, 
IL-9 and IL-13 produced by CD4^ T cells, and high levels of IgGl and IgE antibodies 
secreted by B cells (Grencis et al., 1991; Urban et al., 1993; Else et al., 1994). 
Following infection, CD4^ T cells express IL-3, IL-4, IL-5, IL-9, and IL-10 in the 
mesenteric lymph nodes (MLN) (Grencis et al., 1991; Behnke et al., 1993), and are 
subsequently recruited to the intestinal mucosa (McDermott et al., 2001), where they 
mediate immune responses in the intestinal epithelium. 
Generally, due to the counter-regulatory mechanisms of ThI and Th2 cytokines 
(Mosmann and Coffman, 1989), resistance to Gl nematodes is impaired by T helper 
type 1 (THI) responses, which are characterised by elevated levels of lL-12, IFN-y, lL-2 
and the antibody isotype IgG2a. Worm expulsion is enhanced and larval establishment 
in the muscle is reduced in IFN-y knock-out mice (Urban Jr. et al., 2000). This effect 
appears to be caused by increased mastocytosis due to elevated levels of Th2 cytokines, 
particularly IL-10, rather than an intrinsic effect of IFN-y (Helmby and Grencis, 2003a). 
This was concluded on the basis that the in vivo neutralisation of IFN-y in IL-10 knock-
out mice does not alter the rate of expulsion of T. spiralis from the intestine (Helmby 
and Grencis, 2003a). Other cytokines such as IL-12 and IL-18 can also promote the 
development of a ThI response. IL-18 negatively regulates mastocytosis in an IFN-y-
independent manner via inhibition of Th2 cytokine production particularly IL-10 and 
IL-13 (Helmby and Grencis, 2002). In a similar manner, the administration of IL-12 to 
T. spiralis infected animals also suppresses intestinal mast cell responses and transiently 
decreases early Th2 cytokine production (Helmby and Grencis, 2003b). As mucosal 
mastocytosis is crucial for efficient parasite expulsion, it appears that these cytokines 
prolong parasite survival in the GI tract. 
Different mechanisms of immunity operate against adult worms and NBL, and 
this immunity is in part regulated by IL-10 (Helmby and Grencis, 2003). IFN-y is 
crucially involved in protection against NBL, but does not affect the expulsion of adults. 
The mechanism by which IFN-y mediates protection against NBL may include 
enhanced cytotoxic killing by granulocytes, eosinophils and activated macrophages 
(Grove et al., 1977; Gransmuller et al., 1987). Recent work by Beiting et al., (2007) has 
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suggested that CD4(+)CD25(-) effector T cells can suppress inflammation by an lL-10-
dependent mechanism that limits IFN-gamma production and inducible NO synthase 
induction. They also reported that in the absence of IL-10, TGF-P participates in control 
of local inflammation in infected muscle and promotes parasite survival. 
1.12.2 Innate responses of the intestinal epithelium 
Infection with T. spiralis induces mucosal inflammation and changes in the 
general physiology of the small intestine. Alterations include goblet cell hyperplasia and 
increased mucous production, Paneth cell hyperplasia, hypercontractile smooth muscle 
and increased fluid secretion. Several lines of evidence now suggest that these 
physiological changes are directly controlled by activation of the immune system, rather 
than as a non-specific consequence of parasite antigen recognition. For example, 
efficient T. spiralis expulsion requires IL-4 receptor-a expression on non-bone marrow-
derived cells, indicating the importance of non-immune gastrointestinal cells during 
infection (Urban et al., 2001). Consequently, cells of the GI epithelium work as an 
extension of the immune system, directed by Th2 cytokines produced by T cells. 
The small intestinal epithelium is a rapidly renewing layer of cells composed of 
absorptive enterocytes on the villi, and their progenitors in the crypts, goblet cells and 
enteroendocrine cells, and also Paneth cells which occupy the crypts. The intestinal 
epithelium serves as a physical barrier between the external conditions of the gut lumen 
and the internal environment, and transports nutrients, ions and fluids. 
Mouse models of infection using different GI nematodes, including T. spiralis, 
have shown a number of common effects on epithelial cell function. These alterations 
include increased permeability and decreased absorption of glucose, which leads to the 
accumulation of luminal fluid during infection (Madden et al., 2004). Mucosal mast 
cells can also increase epithelial cell secretion through the release of soluble mediators 
such as PGEz and histamine (Castro et al., 1987; Perdue et al., 1991). Interestingly, in 
the absence of nerves (achieved by using neurotoxins), nematodes also have a direct 
antisecretory effect on the epithelial cells response to both PGE2 and histamine 
(Madden et al., 2004). These antisecretory effects are thought to reflect equilibrium 
between effects detrimental to the worm and effects detrimental to the host, thus 
allowing parasite expulsion with minimal disruption to the homeostasis of the GI tract. 
During nematode infections, the level of fluid in the lumen increases and smooth 
muscle becomes hypercontractile (Vermillion and Collins, 1988). This is referred to as 
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the "weep and sweep" response which is thought to facihtate worm expulsion. Increased 
muscle contraction is dependent on CD4^ T cells and major histocompatability complex 
II (MHC II) expression (Vallance et al., 1999). Muscle hypercontraction markedly 
promotes parasite expulsion from the intestine, and cytokines, specifically IL-9, IL-4 
and IL-13 secreted by Th2 type cells, are thought to promote this effect (Khan and 
Collins, 2004; Khan et al., 2003). 
Goblet cell hyperplasia is also a feature of T. spiralis infection (Garside et al., 
1992). Th2 cytokines are postulated to regulate the development of goblet cell 
hyperplasia in the gut during nematode infection via signal transducer and activator of 
transcription factor 6 (Stat6) activation, implicating IL-4 receptor a chain (IL-4Ra) 
ligation by IL-4 or IL-13 (Khan et al., 2001). Goblet cell mucins such as the secreted 
mucin Muc2, and the membrane-bound mucin Muc3, are up-regulated during T. spiralis 
infection (Shekels et al., 2001). Transcripts corresponding to other goblet cell genes 
such as Siat4c involved in mucin sialylation, calcium chloride channel 5 (CLCA5) and 
goblet cell gene 4 (GOB4) involved in mucus secretion, are also upregulated during T. 
spiralis infection (Knight et al., 2004). Expression of these genes promotes the altered 
and increased mucus secretion seen during infections (Miller, 1987), which acts to trap 
the worms and prevent attachment to the epithelial surface. 
In addition, transcripts of a novel lectin termed intelectin-2 is rapidly 
upregulated in goblet cells and Paneth cells during T. spiralis infection (Pemberton et 
al., 2004). Furthermore, upregulated expression of intelectin-2 is absent in strains of 
mice suscepticle to T. spiralis and T. muris infections (Pemberton et al., 2004; Datta et 
al., 2005). The exact function of this novel intelectin variant is currently unknown, 
however the experiments reported by Pemberton et al., (2004) and Datta et al., (2005) 
imply that this molecule is closely associated with effective expulsion of GI parasites. 
Expression of the resistin-like molecule RELMP is also upregulated by goblet cells 
during T. spiralis infection (Artis et al., 2004; Knight et al., 2004). This expression is 
induced by IL-4 and IL-13 cytokines signalling via the IL-4Ra and STAT-6-dependent 
pathway (Artis et al., 2004). The role of this protein in T. spiralis infection is still 
unclear, however it has been suggested to mediate direct anti-parasite effects, tissue 
repair or immune regulation (Artis et al., 2004). 
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1.12.3 The mucosal mast cell response 
Mucosal mast cells play an essential role in host protection against some, but not 
all GI nematode parasites. Expulsion of T. spiralis, Strongyloides ratti, and 
Strongyloides venezuelensis is dependent on the recruitment and expansion of mast 
cells, whereas expulsion of N. brasiliensis is not (Abe et al, 1992; Khan et ah, 1993; 
Ha et al., 1983; Grencis et ah, 1993). T. spiralis infection is an ideal model to study the 
recruitment and expansion of mast cells, and the mast cell effector mechanisms 
deployed during intestinal inflammation. As such, this field of research has received 
much interest over the past 15 years, from mast cell biologists and parasitologists alike. 
T. spiralis infection leads to hyperplasia, differentiation and activation of 
mucosal mast cells (MMC) in the gut and spleen (Gurish et al, 2004; Woodbury et al., 
1984; Miller, 1996). Mast cells are derived Ixom haematopoietic progenitor cells in the 
bone marrow. During the early stages of the infection, the bone marrow environment 
generates mast cell progenitors destined to home to the small intestine (Pemaock and 
Grencis, 2004). These progenitor cells require the expression of the integrin to 
home to the small intestine (Artis et al., 2000; Gurish et al., 2001; Issekutz et al., 2001; 
McDermott et al., 2001). Furthermore, (3? integrin-deficient mice do not possess a 
normal resting mast cell progenitor population in the small intestine, and during T. 
spiralis infection exhibit delayed mastocytosis and aberrantly distributed mast cells in 
the intra-epithelial compartment of the small intestine (Artis et al., 2000). 
During T. spiralis infection the main site of mast cell proliferation is the 
epithelium of the small intestine, rather than the bone marrow or blood (Dillon et al., 
1986). The mast cell hyperplasia seen in the gut is induced and regulated by factors 
acting in the local micro-environment of the intestinal epithelia. Mast cell precursors are 
induced to migrate into the epithelium under the direction of highly regulated integrin 
expression. In the small intestine, the integrin expressed by epithelial cells, 
activates epithelially secreted latent TGF-Pi (Munger et al., 1999). In vitro experiments 
have subsequently shown that TGF-Pi induces mucosal mast cells to express the ae 
chain of the integrin agP? (Wright et al., 2002; Smith et al., 1994). The ligand for aeP? is 
cadherin (Cepek et al., 1994) and this is exclusively expressed by epithelial cells 
(Kilshaw, 1999). Work by Brown et al., (2004) showed that mice lacking the TGF-Pi 
activating integrin avPe exhibited reduced mucosal mast cell recruitment and expression 
of the integrin ue. Hence, TGF-Pi-mediated expression of the ueP? integrin enables the 
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mast cell progenitors to enter the epithelial compartment and allows the retention of 
mucosal mast cells as this cell population matures and expands. 
Mucosal mastocytosis in the intraepithelial compartment is dependent on 
epithelially produced growth factors, as well as Th2 type cytokines and therefore on the 
adaptive CD4^ adaptive T cell response. Stem cell factor (SCF) is an essential growth 
factor for mast cells, and is particularly important for intestinal mucosal mastocytosis. 
The use of SCF receptor (c-kit)-deficient mice (W/Wv), and neutralising monoclonal 
antibodies to SCF or c-kit demonstrated that mastocytosis during T. spiralis infection 
was highly dependent on this growth factor (Grencis et al, 1993; Alizadeh and Murrell, 
1984). The growth factor TGF-Pi also regulates important effector functions of mucosal 
mast cells. In vitro experiments using murine bone marrow-derived mast cells have 
reported that TGF-Pi induces the upregulation of expression and constitutive secretion 
of the P-chymase, mouse mast cell protease-1 (mMCP-1), and the chemokine CCL2 
(Miller et al., 1999; Brown et al., 2003). The release of mMCP-1 from mucosal mast 
cells plays a crucial role in T. spiralis expulsion from the gut of parasitized mice, as 
mice lacking the mMCP-1 gene (mMCP-1 -/-) have longer and more severe infections 
(Knight et al., 2000). In addition, secretion of mMCP-1 also appears to be responsible 
for some of the enteropathy observed in the intestine during infection (Lawrence et al., 
2004). Mast cells releasing mast cell-specific proteases are directly responsible for 
degrading the tight junction protein 'occludin', thereby increasing epithelial paracellular 
permeability (McDermott et al., 2003). Increased permeability of the epithelium has 
been postulated to be an important factor in parasite expulsion by allowing influx of 
solutes and water to 'flush' the parasites out (Murray et al., 1971). It has been reported 
that other mast cell secretagogues such as histamine and prostaglandins mediate similar 
effects on fluid secretion in the presence of IL-4 (Madden et al., 2002). 
The specific association of Th2 cytokines with mucosal mastocytosis has been 
widely shown. In IL-4-deficient mice, expulsion of T. spiralis from the small intestine is 
delayed (Lawrence et al., 1998). Both IL-4 and IL-13 bind to the IL-4 receptor a chain; 
the ligation of this receptor results in the phosphorylation and activation of Stat6, which 
in turn leads to the activation of GATA3. In vivo, both IL-4Ra and Stat6 are required to 
expel adult T. spiralis, and both IL-13 and IL-4 appear to contribute equally to 
protection (Urban et al., 2000). The Th2 cytokine IL-9 also promotes mucosal 
mastocytosis, which leads to the rapid expulsion of T. spiralis from the intestine 
(Faulkner et al., 1997). In a similar manner, the injection of IL-3 prior to T. spiralis 
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infection in mice can promote accelerated parasite expulsion (Korenaga et al, 1996). 
However, IL-3-deficient mice expel T. spiralis at a similar rate to wild-type controls, 
although mast cell number and consequently MCP-1 levels are reduced in the intestine 
(Pennock and Grencis, 2006). This has led to the suggestion that a threshold number of 
mast cells are required to achieve parasite expulsion (Pennock and Grencis, 2006). 
Experimental T. spiralis infection using mast cell deficient mice (W/Wv) results 
in delayed worm expulsion, a reduced Th2 response and a significantly increased ThI 
response (Lawrence et al., 2004). However, the Th2 response remains unaltered in 
mMCP-1 deficient mice (although expulsion is delayed), indicating a potential role for 
mast cells in promoting or amplifying the Th2 responses required for protection against 
intestinal helminths (Lawrence et al., 2004). In a similar manner, IL-3-deficient mice 
exhibit reduced mastocytosis, but also significantly reduced IL-5 and IL-10 production, 
again supporting a paracrine role for mast cells in the perpetuation of a Th2 response 
(Pennock and Grencis, 2006). 
1.12.4 The eosinophil response 
IL-5-dependent eosinophilia is a marker of parasitic infection (Coffiman et al., 
1989). However, although eosinophils are recruited to the gastrointestinal mucosa 
during T. spiralis infection, some reports have suggested that they are not necessary for 
parasite expulsion (Lammas et al., 1992; Hemdon and Kayes, 1992). This contrasts to 
the results reported by Grove and co-workers (1977), where treatment with a polyclonal 
anti-eosinophil anti-sera resulted in elevated levels of muscle stage larvae. Furthennore, 
other research has shown that eosinophils can kill T. spiralis larvae both in vitro 
(Wassom and Gleich, 1979; Kazura and Aikawa, 1980) and in vivo (Gurish et al., 2002; 
Grove et al., 1977). More recent research has shown that eosinophil recruitment is 
required to prevent the encystment of larvae in the muscles, rather than promote the 
expulsion of adult T. spiralis parasites from the intestine (Gurish et al., 2002). This 
further supports the concept that eosinophils play a role in defending the host against 
the migratory phase of T. spiralis larvae. Interestingly, although IL-5 induced 
eosinophilia is not required for expulsion of T. spiralis adults from the intestine during a 
primary infection, eosinophilia does contribute to rapid parasite expulsion during a 
secondary infection, as delayed expulsion rates and an increase in encysted muscle 
larvae are observed in IL-5-deficient mice (Vallance et al., 2000). 
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1.12.5 The humoral response 
During helminth infections, elevated levels of IL-4, IL-5 and IL-13 induce the 
production of IgE and IgGl antibody isotypes, characteristic of a Th2 response. 
Consistent with this, the dominant antigen-specific immunoglobulin isotypes produced 
during T. spiralis infection are IgGl and IgE, with other isotypes produced at lower 
levels (Crandall and Crandall, 1972; Goyal and Wakelin, 1993; Stewart et al, 1999; 
Furze and Selkirk, 2005). Due to the time it takes to generate a humoral response 
against T. spiralis antigens, antibodies are generally regarded to be of more importance 
in protection against re-infection, rather than expulsion of a primary infection. In rats, 
during a secondary T. spiralis infection, ingested parasites are rapidly expelled from the 
intestine, and immunity is maintained for long periods (several weeks to several 
months) following a primary infection (Love et ah, 1976; Alizadeh and Wakelin, 1982). 
This response is mediated by antibodies, as the infusion of purified T. spiralis immune 
IgE into rats has been shown to confer rapid parasite expulsion (Ahmad et al., 1991). 
However, rapid expulsion of adult T. spiralis parasites from the intestine of pre-infected 
animals does not occur in mice, where a less potent and short-lived, larva-specific 
immunity is demonstrated (Bell, 1992). 
A range of studies have also investigated the role of antibodies, particularly IgE, 
during primary T. spiralis infections. A report by Perrudet-Badoux and co-workers 
(1978) showed that outbred mice selected for low antibody production had impaired 
immunity during infection. Other studies in rats also reported that the suppression of 
active IgE responses using anti-IgE antibodies markedly impaired parasite clearance, 
where the target of the IgE antibody for resistance seemed to be the muscle stage larvae 
(Bell et al., 1992; Dessein et al., 1981). In contrast, a separate investigation using 
relatively IgE-deficient SJA/9 inbred mice showed no defect, suggesting protection 
against adults and larvae was not IgE-dependent (Watanabe et al., 1988). A more recent 
study by Gurish et al., (2004) found IgE knock-out mice generated a normal mucosal 
mast cell response, but had lower serum mMCP-1 levels and expelled adult parasites 
more slowly, implying that IgE might promote mast cell activation. The exact role of 
parasite specific IgE responses in mast cell activation during T. spiralis infection is still 
not clear. However, evidence that supports a regulatory role for IgE is emerging, as 
decreased numbers of splenic mast cells were observed in IgE-null mice following T. 
spiralis infection suggesting that IgE may enhance mast cell survival in vivo (Gurish et 
aA,2004y 
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1.13 Aims 
One of the major aims of this study was to determine the modulatory effects T. 
spiralis-sQCXQiQd proteins have on purinergic receptor-induced mucosal mast cell 
activation. This cell type is deemed important to study as intestinal mucosal mast cells 
play a major role in promoting the efficient expulsion of T. spiralis from the intestine. 
To achieve this aim, mast cells of a mucosal phenotype, derived from murine bone 
marrow, were used as an in vitro model of intestinal mucosal mast cells. The purinergic 
receptor sub-types expressed by this cell type were characterised functionally using a 
range of receptor agonists and antagonists. The effects of nucleotides on a variety of 
mast cell effector functions were also determined. The modulatory action of T. spiralis-
secreted and recombinant proteins on mast cell purinergic receptor activation and 
purinergic receptor-mediated effector functions were also assessed in vitro. 
The second major aim of this study was to determine whether immunisation of 
mice with the recombinant form of the T. spiralis 5'-nucleotidase (5'-NT) can provide 
protection against subsequent T. spiralis infection. These experiments were designed to 
examine whether the secreted 5'-NT is required for the promotion of parasite survival in 
the host. The effects of the immunisation on the progress of infection were also 
elucidated by monitoring the kinetics of T. spiralis expulsion from the small intestine, 
enumerating the establishment of muscle stage larvae, and recording the profile of the 
immune response generated. 
The final aim of this thesis was to qualitatively characterise the expression of 
purinergic receptors in the intestinal epithelium during T. spiralis infection. As host 
genetic background can also influence the rate of expulsion of adult worms from the 
small intestine, these experiments were performed in strains of mice that expel parasites 
from the intestine at different rates. The objective of this was to ascertain whether 
alterations in host purinergic receptor expression correlate with the kinetics of parasite 
expulsion. 
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Chapter 2 
Materials and Methods 
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2.1 Chemical reagents 
All chemicals were purchased from Sigma-Aldrich, Fancy Road, Dorset, unless 
stated otherwise. 
2.2 Animal procedures 
All mice and rats were allowed to acclimatise for 7 days prior to use and were 
kept according to Home Office and institutional guidelines. All procedures were carried 
out at the Central Biomedical Services animal facilities at Imperial College London, 
South Kensington. All procedures were performed under project license number PPL 
70/6073. 
2.2.1 Trichinella spiralis infection 
Trichinella spiralis were maintained in adult male Sprague-Dawley rats. To 
obtain muscle stage larvae, rats and mice were infected orally with 6000 and 500 
infective larvae respectively. Infections were allowed to establish for at least 30 days 
before recovery of muscle stage larvae. To isolate adult and new bom larvae from rats, 
animals were infected orally with 10,000 worms. Adults were collected from the 
intestine at either 3 or 6 days post infection. 
2.2.2 Recovery of infective larvae 
To isolate infective larvae, rats or mice were culled by cervical dislocation, 
skinned and eviscerated. Striated muscle tissue was removed from the carcass, chopped 
and blended in a solution of 1% (w/v) pepsin, 1% (w/v) HCl dispersed in tap-water, pre-
warmed to 37°C. The homogenised tissue was digested by incubation, with agitation, 
for 1.5 hours at 37°C. The digested mix was filtered through two layers of cheese cloth 
attached to a Baerman funnel connected to a collection tube. Larvae were allowed to 
sediment for 1 hour, excess digestion fluid removed and larvae washed four times in 
sterile PBS pre-warmed to 37°C. 
2.2.3 Recovery of adult parasites 
The small intestine of infected animals was excised, opened longitudinally and 
laid onto a Baermann funnel covered with a single layer of muslin submerged in 
phosphate buffered saline (PBS) pre-warmed to 37°C. Worms were allowed to migrate 
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out over a 3 hour period. Adults were washed three times in sterile PBS and enumerated 
in a counting chamber (Weber Scientific International, Lancing). 
2.2.4 Bone marrow extraction 
Female BALB/c mice were sacrificed and their femurs removed under sterile 
conditions. Bone marrow was washed from the femurs using a 23-gauge needle and 20-
mL syringe filled with Dulbecco's modified Eagle's medium (DMEM) containing 
100 U/ml penicillin and 100 pg/ml streptomycin. Cells were centrifuged at 230 x g for 
7 minutes at room temperature. After resuspension in 1.5 ml DMEM containing 10% 
(v/v) PCS, 100 U/ml penicillin, 100 jJ-g/ml streptomycin, 2 mM L-glutamine, and 1 mM 
sodium pyruvate (DMEM/PCS), cells were counted in an Improved Neubauer counting 
chamber (x40 magnification), using tryphan blue (0.4% v/v) exclusion to measure 
viability (as described in section 2.6.1). 
2.2.5 Immunisation of NIH mice with T. spiralis recombinant 5'-nucleotidase 
To prepare the immunogen for test mice, the purified recombinant 5'-
nucleotidase (5'-NT) was adjusted to a concentration of 500 p,g/ml with sterile 25 mM 
HEPES; for control mice an equivalent volume of HEPES alone was used. 
Subsequently, an equal volume of 9% (w/v) potassium alum adjuvant (Sigma) dissolved 
in H2O and one drop of phenol red pH indicator dye were added. Subsequently, 1 M 
NaOH was added drop-wise to the solution until the pH indicator dye turned pink 
(indicating a pH of 8.4) and the potassium alum precipitated out of solution. The 5'-
NT/control-adjuvant solution was incubated at room temperature for 30 minutes. The 
samples were then centrifuged at 3000 x g for 10 minutes at room temperature, and the 
resulting supematants removed and retained for use in a protein determination assay (as 
described in section 2.4.1) to elucidate the amount of protein that had bound to the 
adjuvant. The pellet of precipitated potassium alum-5 '-NT/control were then washed 
twice in sterile PBS and the pellets resuspended in the appropriate volume of sterile 
PBS to result in a 500 fxg/ml solution. 
Prior to immunisation, a small volume of blood was collected from 5 female 
NIH mice via puncture of the tail vein. The blood was allowed to clot overnight at 4°C 
and subsequently centrifiaged at 2500 x g for 10 minutes. The serum supernatant was 
removed and stored at -20°C. Groups of 15-test and 15-control female, NIH mice were 
injected subcutaneously with 25 ^g 5'-NT-adjuvant (test), or an equivalent volume of 
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prepared adjuvant alone (control). The animals were subsequently boosted with 12.5 |ag 
5'-NT-adjuvant (test), or an equivalent volume of prepared adjuvant alone (control), 28 
and 42 days after the initial immunisation. 
Prior to challenge with T. spiralis infection, a small volume of blood was 
collected from every mouse in both the test and control groups via puncture of the tail 
vein, and the serum collected as described previously. Both test and control groups of 
mice were infected by oral gavage with 500 T. spiralis infective larvae suspended in 
200 |j,l sterile PBS. At 4 days post-infection (p.i.), 5 mice from both test and control 
groups were sacrificed by intraperitoneal injection of 4 mg sodium pentobarbitone 
(supplied as Pentoject by Central Biomedical Services, Imperial College London), Mice 
were exsanguinated via the femoral artery and blood from individual mice was collected 
and the serum recovered as described previously. Mesenteric lymph nodes and spleen 
were removed aseptically and stored on ice in cold RPMI 1640 (Invitrogen Ltd., 
Paisley, UK). Intestines were removed and adult parasites extracted and counted as 
described in section 2.2.3. To determine the fecundity of adult female parasites, adults 
were subsequently cultured for 18 hours in NBL media (RPMI supplemented with 10 % 
(v/v) PCS, 1% (w/v) glucose, 100 U/ml penicillin, 100 )u.g/ml streptomycin, 20 p,g/ml 
gentamycin, 20 U/ml mystatin and 2 mM L-glutamine), and the NBL collected and 
counted as described in section 2.3.2. At 7 days p.i., 5 mice from both test and control 
groups were sacrificed by cervical dislocation. The intestines were removed and adult 
and NBL parasites counted as for day 4 p.i. At 35 days p.i., 5 mice from both test and 
control groups were sacrificed by intraperitoneal injection of 4 mg sodium 
pentobarbitone. Blood from individual mice was collected and the serum recovered as 
described previously. Infective larvae were recovered from the muscle and enumerated 
as described in section 2.2.2. 
2.2.6 Mucosal epithelial cell extraction from mouse intestine 
6-8 week old Balb/c mice were sacrificed by cervical dislocation and the first 15 
cm of small intestine from the pyloric sphincter removed. The intestine was flushed 
with PBS using a syringe and 21 gauge needle, then placed in fresh PBS. The lympoid 
tissue was removed, and the jejunum bisected longitudinally and chopped into small, 
0.5 cm segments. The tissue was then placed into a siliconised glass beaker and 
incubated in Hanks balanced salt solution (HBSS) (Invitrogen Ltd., Paisley, UK) 
containing 2 mM dithiothreitol (DTT), 5% foetal calf serum (PCS) (Invitrogen Ltd., 
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Paisley, UK) for 15 minutes at 37°C with continuous stirring. The supernatant was 
subsequently removed and discarded. Tissue segments were then incubated in calcium 
and magnesium-free HBSS (HBSS-CMF) (Invitrogen Ltd., Paisley, UK) containing 2 
mM DTT, 5% FCS, 1 mM EDTA at 37°C with continuous stirring. After 20 minutes the 
supernatant containing exfoliated epithelium was removed, filtered through a nylon 100 
P-M cell sieve and centrifuged at 300 x g for 5 minutes at room temperature. Fresh 
HBSS-CMF was added to the tissue and the procedure repeated three times. The cell 
pellets recovered containing epithelial cells were resuspended in PBS, transferred to 1.5 
ml tubes and centrifuged at 500 x g for 5 minutes at room temperature. The supematants 
were subsequently discarded and the cell pellets resuspended in 500 p,l TRIzol 
(Invitrogen) and frozen at -80°C. 
2.3 Preparation of parasite material 
2.3.1 Parasite culture 
Under sterile conditions isolated parasites were washed extensively in sterile 
parasite culture medium [RPMI (GibcoTM, Paisley Scotland) supplemented with 1% 
(w/v) glucose, 100 U/ml penicillin, 100 |ig/ml streptomycin, 20 jxg/ml gentamycin, 20 
U/ml mystatin and 2 mM L-glutamine], pre-warmed to 37°C. Parasites were maintained 
in sterile parasite culture medium at 37°C, 5% CO]. Infective larvae were cultured for 
up to 5 days and adults and NBL for up to 3 days. Medium containing parasite secreted 
proteins was removed daily and replaced with fresh sterile culture media pre-warmed to 
37°C. 
2.3.2 Recovery of newborn larvae 
To collect newborn larvae (NBL), day 6 adults were washed extensively in 
sterile NBL media (RPMI supplemented with 10 % (v/v) FCS, 1% (w/v) glucose, 100 
U/ml penicillin, 100 pg/ml streptomycin, 20 p-g/ml gentamycin, 20 U/ml mystatin and 2 
mM L-glutamine) and cultured at 37°C, 5% CO?. NBL were collected every 24 hours 
for a maximum of 3 days. Adult worms were allowed to sediment in the culture flask 
and the culture medium containing the NBL was removed. The NBL were either 
enumerated in a counting chamber (Weber Scientific International, Lancing), or 
sedimented by centrifugation at 1000 x g and washed three times in PBS, the 
supernatant removed and the pellet of NBL flash frozen in liquid nitrogen and stored at 
-80°C. 
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2.3.3 Collection of parasite secreted proteins 
Medium containing parasite secreted proteins was pooled and filtered through a 
0.2 pm filter (Schleicher and Schuell) and then concentrated in an Amicon concentrator 
(Amicon Inc., Beverly, MA) using a 10 kDa molecular weight cut off. The proteins 
were dialysed against 25 mM HEPES, pH 7.5 and further concentration was carried out 
in Centricon YMIO microconcentrators (Millipore, Bedford, MA). The concentrated 
protein solution was then aliquoted and stored at -20°C. 
2.4 Protein techniques 
2.4.1 Protein determination 
The concentration of secreted proteins was determined using the Bichinchonic 
acid method (BCA assay) (Pierce, Rockford, II) following the manufacturer's 
instructions. Bovine serum albumin ranging in concentration between 0.005-2.0 mg/ml 
was used as a standard. The absorbance at 560 nm was determined using a FLUOstar 
OPTIMA microplate reader (BMG Labtech, Offenberg). 
2.4.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
12% sodium-dodecyl sulphate (SDS) polyacrylamide resolving gels [12% (w/v) 
acrylamide mix (Protogel, National Diagnostics), 0.4 M Tris pH 8.8, 0.1% (w/v) 
ammonium persulphate, 0.1% (v/v) TEMED, 0.1% (w/v) SDS] and stacking gels [5% 
(w/v) acrylamide mix, 0.125 M Tris pH 6.8, 0.625% (w/v) ammonium persulphate, 
0.15% (v/v) TEMED, 0.1 % (w/v) SDS] were loaded with protein samples that had been 
boiled for 4 minutes in SDS-PAGE loading buffer [0.01% (v/v) P-mercaptoethanol, 
0.01% (v/v) bromophenol blue, 0.1 M sucrose, 3% SDS (w/v), 62.5 mM Tris, 2 mM 
Na2EDTA]. Samples were electrophoresed at a constant current of 20 mA in SDS-
PAGE running buffer [25 mM Tris pH 8.3, 192 mM glycine and 1% (w/v) SDS] until 
the leading edge of the dye reached the bottom of the gel. 
Proteins were visualised by staining gels for >1 hour at room temperature in a 
solution of 0.4% (w/v) Coomassie brilliant blue stain, 10% (v/v) acetic acid and 25% 
(v/v) propan-2-ol. Gels were then destained in a solution containing 10% acetic acid 
(v/v) and 25% (v/v) propan-2-ol. 
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2.4.3 Western blotting 
Proteins were transferred to nitrocellulose membranes (Hybond ECL; 
Amersham Pharmacia) using an electrophoretic transfer cell (Biorad) and Towbin buffer 
[25 mM Tris, 192 mM glycine and 20% (w/v) methanol], chilled to 4°C. Prior to 
transfer, the gel, membrane and blotting equipment were equilibrated for 10 minutes in 
chilled Towbin buffer. Electrophoresis was then carried out at 4°C for 2 hours at a 
constant current of 100 mA. 
Following electrophoretic transfer of the protein, the membrane was incubated 
with agitation for 1 hour at room temperature in 50 ml blocking buffer composed of Tris 
buffered saline (TBS) containing: 100 mM Tris pH 7.5, 150 mM NaCl, 5% (w/v) 
skimmed milk powder and 0.3% (v/v) Tween 20. The blocking buffer was then 
removed and the membrane incubated overnight at 4°C with the appropriate primary 
antibody, diluted as required in blocking buffer (as above) containing 0.2% sodium 
azide. The membranes were then washed 3 times, for 15 minutes each, with TBS-0.3% 
(v/v) Tween 20 (TBS-Tween 20) at room temperature. The appropriate quantity and 
type of secondary horseradish peroxidase conjugated (HRP) antibody was diluted in 
TBS-Tween 20 and incubated with the membrane for 1 hour at room temperature. The 
membrane was washed 3 times with TBS-Tween 20 as before and finally with TBS for 
15 minutes. Bound antibodies were then visualised using enhanced chemiluminesence 
(ECL), whereby membranes were submerged for 1 minute in a solution containing: 1.25 
mM luminal, 0.1 M Tris pH 8.5, 0.009% (v/v) hydrogen peroxide and 6.8 |iM p-
coumaric acid. Membranes were rinsed in distilled H2O before exposure to X-ray film. 
2.4.4 Expression of T. spiralis recombinant 5'-nucleotidase in Pichiapastoris 
P. pastoris transformed with pPlCZa containing a 6xHis and c-Myc tagged T. 
spiralis recombinant 5'-NT (Gounaris et al, 2004) was streaked onto YPD agar (1% 
(w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose, 2% (w/v) agar, 0.1 mg/ml 
zeocin) and incubated at 30°C for 3 days. Large scale expression was then carried out 
using a single P. pastoris colony to inoculate 25 ml of buffered glycerol complex 
medium (BMGY) (100 mM potassium phosphate pH 6.0, 1% (w/v) yeast extract, 2% 
(w/v) peptone, 1.34% (w/v) yeast nitrogen base (with ammonium sulphate without 
amino acids, YNB), 4 x 10"^  % (w/v) biotin, 1% (v/v) glycerol) and incubated at 30°C 
with agitation until the culture was calculated to reach an ODeoo value of 2 to 6. The 25 
ml of yeast culture was then transferred into 400 ml BMGY and incubated for a further 
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24 hours at 30°C with shaking. Cells were harvested by centrifugation at 3000 x g for 10 
minutes at room temperature, the supernatant discarded and the cells resuspended in 800 
ml buffered methanol complex medium (BMMY) [lOOmM potassium phosphate pH 
6.0, 1% (w/v) yeast extract, 2% (w/v) peptone, 1.34% (w/v) YNB, 4 x 10"^  % (w/v) 
Biotin, 0.5% (v/v) methanol] to induce protein expression. Cultures were incubated at 
30°C with shaking for 48 hours, with the addition of methanol at a final concentration of 
0.5% (v/v) every 24 hours. Cells were then harvested by centrifugation at 3000 x g for 
10 minutes at 4°C and the supernatant filtered through glass Whattoan paper and 0.2 
p,m filters (Schleicher and Schuell). The supernatant was then concentrated to a final 
volume of approximately 10 ml in an Ami con concentrator (Amicon Inc., Beverley, 
MA) using a 30 KDa molecular weight cut off membrane. The concentrated supernatant 
was dialysed against 6 litres of dialysis buffer pH 8 containing 20 mM NaH2P04, 300 
mM NaCl and 1 mM Imidazole for 16 hours at 4°C. 
2.4.5 Purification of the T. spiralis recombinant 5'-nucleotidase 
The recombinant 5'-NT was purified using nickel-nitrilotriacetic acid (Ni-NTA) 
affinity chromatography. Ni-NTA-agarose beads (Quiagen) were equilibrated with 
dialysis buffer pH 8 (containing 20 mM NaH2P04, 300 mM NaCl and 1 mM imidazole) 
and added to the concentrated 5'-NT yeast supernatant (0.5 ml beads per 400 ml pre-
dialysis expression supernatant), then incubated overnight with rotation at 4°C. The 
slurry was added to a 0.8 x 4 cm, 10ml disposable chromatography column (Bio-Rad), 
the beads allowed to sediment, and the flow-through containing unbound proteins 
decanted. The column was then washed with 10 ml of dialysis buffer to remove 
unbound protein. Bound proteins were subsequently eluted with three 20 ml washes of 
dialysis buffer containing increasing concentrations of Imidazole (1 mM, 10 mM and 
100 mM). The eluted fi-actions were then concentrated and washed with chilled dialysis 
buffer in a Centricon-YMIO micro-concentrator according to the manufacturer's 
instructions (Millipore, Bedford, MA), to a final volume of ~1 ml. Samples were then 
dialysed against 6 L of 25 mM HEPES pH 7.5 and further concentrated to a volume of 
-200 pi. Samples were aliquoted immediately and stored at -20°C. Proteins were 
analysed by SDS-PAGE to confinn the purity of the protein, and Western blotting to 
confirm the presence of the protein using an antibody to the C-myc epitope. 
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2.5 Enzyme assays 
2.5.1 5'-nucleotidase assay 
5'-nucleotidase activity in T. spiralis secreted proteins was measured by 
calculating the amount of inorganic phosphate released from nucleotide diphosphate or 
monophosphate substrates. Samples of T. spiralis secreted proteins or recombinant 5'-
nucleotidase were incubated for 10 minutes at 37°C in a reaction volume of 40pl 
containing 25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM MgCli, 2.5 mM dithiotlireitol 
(DTT) and 2.5 mM of the appropriate nucleotide. Concentrations of NaH2P04 ranging 
from 1-10 nmole were used as a source of inorganic phosphate to calculate a calibration 
curve. 200 |j,l of the chromogenic substrate malachite-green-phosphomolybdate (6 mM 
Malachite green, 2.1 N HCl, 17 mM ammonium molybdate) were then added to the 
reaction/phosphate standard and the absorbance measured at 600 nm using a FLUOstar 
OPTIMA microplate reader (BMG Labtech, Offenberg). In all experiments performed, 
background levels of phosphate detected in individual samples were subtracted from 
actual ODeoo values as appropriate. 
2.5.2 ^-hexosaminidase assay 
Cell supematants were collected from mast cell degranulation assays as 
described in Section 2.7.1. ^-hexosaminidase activity was measured using a 
chromogenic p-nitrophenyl (pNP) linked glycoside as substrate (pNP-P-Glc-NAc) 
(Sigma). Reactions were carried out in 50 |il total volume, containing 15 pil of sample, 
citrate/phosphate buffer pH 4.4 and 2 mM pNP-P-Glc-NAc. Samples were incubated at 
37°C for 30 minutes, and then the reaction was terminated by the addition of 50 p.1 0.4 
M NaiCOs. The amount of pNP released was determined spectrophotometrically by 
measuring the absorbance at 405 nm using a FLUOstar OPTIMA microplate reader 
(BMG Labtech, Offenberg). Results are expressed as the percentage ^-hexosaminidase 
released into the supernatant compared to the amount present in the supernatant 
collected from resting cells. 
2.6 Cell culture 
2.6.1 Trypan Blue exclusion 
Viable cells were counted by resuspending a sample of the cell preparation with 
an equal volume of 0.4% Trypan Blue solution. The number of viable cells that 
excluded dye uptake was determined by light microscopy using a haemocytometer. 
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2.6.2 Mouse bone marrow-derived mast cell culture 
Bone marrow cell cultures were established in a humid 37°C, 5% CO2 incubator 
using 162 cm^ flat-bottomed flasks containing 5x10^ cells/ml in DMEM/FCS [DMEM 
(Invitrogen), 10% PCS (Invitrogen), 2 mM L-glutamine, 100 U/ml penicillin, 100 |^g/ml 
streptomycin, 2.5 |ug/ml fungizone, 1 mM sodium pyruvate] containing 15% (v/v) 
WEHI-3B-conditioned medium as a source of IL-3 (denoted as IL-3 throughout the 
text), 50 ng/ml recombinant rat stem cell factor (Amgen, Thousand Oaks, CA, and R&D 
Systems) and 5 ng/ml recombinant mouse IL-9 (R&D systems). Where stated, 1 ng/ml 
TGF-Pi (R&D systems) was added to the culture media. Cultures were grown for up to 
21 days and passaged at 7 day intervals by centrifuging the cells at 230 x g for 7 
minutes and resuspending in fresh media and growth factors. 
2.6.3 Culture of the WEHI-3B mouse myelomonocyte cell line 
Cultures containing 1x10^ cells/ml were incubated in a humid 37°C, 5% CO2 
incubator. Cells were grown for 4-5 days in culture media (RPMI containing 10% PCS, 
100 U/ml penicillin, 100 pg/ml streptomycin, 2 mM L-glutamine, and 1 mM sodium 
pyruvate) in a humid 37°C, 5% CO; incubator. Cells were centrifuged at 250 x g at 4°C 
for 5 minutes, the supernatant was then filtered through a 0.2 p.m sterile filter and stored 
at -20°C. The cell pellet was then resuspended in RPMI, and 5x10^ cells used to seed 50 
ml of fresh culture media. 
2.6.4 Mast cell histology 
5x10^ mBMMC were cytocentrifuged onto clean glass slides for 5 minutes at 40 
X g. The cytosmears were then air-dried and fixed in Camoys solution (60% v/v ethanol, 
30% v/v chloroform, 10% v/v glacial acetic acid) for 1 hour. Slides were then stained 
with 0.5% (w/v) acidified toluidine blue for 15 minutes, rinsed in distilled water and 
counter stained for 30 seconds in eosin solution (VWR International Ltd., Poole, 
Dorset). Slides were then rinsed in distilled water prior to alcohol dehydration and 
mounting in DePeX (Fischer Scientific UK). Slides were photographed at xlOO 
magnification using a Nikon Eclipse E400 microscope equipped with Lucia G software. 
2.6.5 Culture of spleen and MLN cells for analysis of cytokine production 
Spleen and MLN tissues were collected as described in section 2.2.5. Tissues 
were dissociated through a 100 pm sterile nylon cell strainer and centrifuged at 500 x g 
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for 5 minutes at 4°C. Cells were resuspended in RPMI 1640 supplemented with 2 mM 
L-glutamine, 100 U/ml penicillin, 100 |J.g/ml streptomycin and 10% (v/v) PCS and 
counted as in section 2.6.1. Splenocytes or mesenteric lymph node cells were cultured at 
a density of 5 x 10^ cells/well in round-bottom 96 well sterile plates at 37°C, 5% CO2. 
Where indicated, cells were stimulated using either 8 |J.g/ml recombinant 5'-NT or 1 
M-g/ml staphylococcal enterotoxin B fragment (SEB). Cells from naive mice cultured 
without stimulation were used as controls. Cells were incubated for 72 hours after 
which the supematants were removed and stored at -20°C until use. 
2.6.6 Cell proliferation assay 
Cells were cultured as for cytokine production (section 2.6.6), using round 
bottom 96 well sterile plates. Cell proliferation was assessed by the addition of 1 |a,Ci 
[^H]-thymidine per well for the final 16 hours of incubation. Cells were harvested using 
a Skatron semi-automatic cell harvester. The level of [^H]-thymidine incorporation was 
determined using a Packard tri-carb 1900TR liquid scintillation counter. 
2.7 Mast cell assays 
2.7.1 mBMMC degranulation and cytokine generation assays 
Two week-old mBMMC were collected by centrifiigation at 250 x g for 7 
minutes at 4°C. The supernatant was discarded, and the cell pellet resuspended in fresh 
media and the cell concentration enumerated as described in section 2.6.1. mBMMC at 
a concentration of 2xl0^/ml were then transferred into fresh media and growth factors 
(as detailed in section 2.6.2). 2x10^ cells were then added to individual wells of a sterile 
96-well microplate and the appropriate volume of test reagent/media added. In 
experiments involving T. spiralis ES or 5'-NT, the appropriate nucleotides were pre-
incubated for 30 minutes with the amount of ES or 5'-NT as stated in a buffer 
containing a final concentration of 25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM MgClz 
and 2.5 mM dithiothreitol (DTT). As a positive control, mBMMC were passively 
sensitised with 10 |ig/ml anti-DNP-albumin IgE (Sigma) for 2 hours, prior to washing 
and stimulation with 30 ng/ml DNP-albumin (Sigma) antigen. In some instances, 50 
p-g/ml of the mast cell secretagogue compound 48/80 (Sigma) was used as a positive 
control. For degranulation and cytokine generation experiments, mBMMC were 
incubated with test agonists for 2 hours and 24 hours respectively, at 37°C, in a 
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humidified incubator containing 5% CO2. Samples were then centrifuged for 7 minutes 
at 250 X g, 4°C, and the supernatant carefully removed and stored at -20°C. 
2.7.2 Freshly isolated bone marrow cell chemotaxis assay 
Murine bone marrow was extracted from the femurs of female Balb/c mice as 
described in section 2.2.4. 20 |il of IxlO' bone marrow cells/ml suspended in 
chemotaxis assay buffer were added to the upper wells of chemotaxis plates (ChemoTx, 
5-pm pore size) and 30 p,l of the indicated concentration of test chemoattractant added 
to the lower chamber. After 3 hours incubation at 37°C, migrated cells present in the 
lower wells were removed aseptically and cultured for 14 days with 1 ng/ml TGF-Pi as 
described in section 2.6.3. Cells were lysed by freeze-thawing and the supematants 
subsequently used in mMCP-1 specific ELISAs as detailed in section 2.9.1. 
2.7.3 Immature mast cell chemotaxis assay 
Murine bone marrow extracted firom the femurs of female Balb/c mice (as 
described in section 2.2.4), was cultured in 15% WEHI-conditioned medium and 
DMEM/FCS (DMEM (Invitrogen), 10% PCS (Invitrogen), 2 mM L-glutamine, 100 
U/ml penicillin, 100 jig/ml streptomycin, 2.5 |ig/ml fungizone, 1 mM sodium pyruvate). 
Growth media were replaced every 7 days and cells were cultured for a maximum of 14 
days. Subsequently, 20 |il of IxlO' immature mast cells/ml suspended in chemotaxis 
assay buffer were added to the upper wells of chemotaxis plates (ChemoTx, 5-|im pore 
size) and 30 p]of the indicated concentration of test chemoattractant added to the lower 
chamber. After 3 hours incubation at 37°C, migrated cells present in the lower wells 
were removed, and the wells washed with 25 pi of assay buffer. Cells were 
subsequently stained with rat-anti-mouse c-kit IgG2b-PE (Caltag Laboratories) diluted 
1/100 (v/v), and counted using flow-cytometry as detailed in section 2.9.1. Assays were 
performed in duplicate, and results were expressed as the absolute number of cells 
migrating. 
2.7.4 mBMMC chemotaxis assay 
Chemotactic responses of mature mBMMCs were examined using 96-well 
chemotaxis plates (ChemoTx) with 5-p.m pore size polycarbonate filters. 20 |il of 
BMMCs were added to the top wells at 2 x 10^ cells/ml in RPMl 1640 supplemented 
with 25 mM HEPES and 0.1% (w/v) BSA (chemotaxis assay buffer), and 30 |il of 
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agonist or buffer was added to the lower wells. After 3 hours incubation at 37°C, 
migrated cells present in the lower chamber were counted using a light microscope at 
xlO magnification. Assays were performed in triplicate, and results were expressed as 
the absolute number of cells migrating. 
2.7.5 Calcium mobilisation assays 
Changes in the cytosolic concentration of free Ca^^ were measured using the 
calcium indicator Fura-2-AM. The cells were washed and resuspended to a 
concentration of 0.5 x 10^ cells/ml in Ca^^ flux buffer (Hank's balanced salt solution 
(HBSS) containing 1 mM CaCla, 1 mM MgCla, and 0.1% (w/v) BSA), and labelled with 
5 |a,M Fura-2-AM for 30 min at 37°C in the dark. The labelled cells were washed by 
adding 10 ml of Ca^^ flux buffer and centrifaged at 500 x g for 7 minutes prior to 
resuspention in Ca^ "^  flux buffer to a concentration of 0.5 x 10^ cells/ml. Subsequently 
0.5 X 10^ cells/well were added to a 96-well black fluorescence plate (Nunc), pre-
warmed to 37°C. In some samples, the mBMMC were pre-treated with 
antagonist/vehicle as stated, for 10 minutes. In experiments involving T. spiralis ES or 
5'-NT, the indicated nucleotide was pre-incubated for 30 minutes with the stated amount 
of ES or 5'-NT in a buffer containing a final concentration of 25 mM HEPES pH 7.5, 
150 mM NaCl, 5 mM MgCl; and 2.5 mM dithiothreitol (DTT), prior to addition to cells. 
Changes in intracellular Ca^ "^  concentration induced by stimulation with different test 
agonists were recorded by monitoring the excitation at 340 nm and 380 nm and 
emission at 510 nm in a fluorescence microplate spectrophotometer (FLUOstar 
OPTIMA, BMG Labtech, Offenberg). The relative ratios of fluorescence emitted at 
510 nm were recorded and displayed as a reflection of intracellular concentrations of 
Ca^. 
2.7.6 Conditions for electrophysiology 
Whole cell voltage-clamp recordings were made from mast cells that had been 
maintained in culture for 14 days. The composition of the control extracellular solution 
was (in mM) 145 NaCl, 2.5 KCl, 3 MgClz, 1 CaClz, 10 HEPES, (titrated to pH 7.4 with 
NaOH). Glass microelectrodes were pulled from thick-walled borosilicate glass 
capillaries. Fire-polished pipettes were back-filled with 0.2 |im-filtered intracellular 
solution (composition in mM: 150 KCl, 3 MgClz, 5 EGTA, 10 HEPES; titrated to pH 
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7.4 with KOH). Cells were voltage-clamped using an Axopatch ID amplifier (Axon 
instruments, USA) and low pass filtered at 5 kHz before sampling (2-10 kHz) and 
online capture. Data acquisition was carried out using pClamp software (clampex 7, 
Axon Instruments, USA). Mast cells were usually held at - 60 mV then subjected to a 
step to -80 mV for 100 ms followed by a 500 ms step to -40 mV. A 100 ms step to -110 
mV is followed by a 500 ms ramp change in voltage to +20 mV. Finally a 100 ms step 
to -80 mV precedes a step to the holding potential of -60 mV. This protocol was 
repeated once every 5 seconds and allowed simultaneous measurement of the steady 
state current at particular voltages (for example, the ATP-evoked current at -80 mV) 
and the currents evoked by ATP at different voltages following ramp changes in the 
voltage. All electrophysiological measurements were carried out at room temperature 
(21 - 23°C). Data were analysed using Clampfit software (clampfit 8, Axon Instruments, 
USA), Excel (Microsoft Corporation, USA) and Origin (Microcal, USA). 
2.8 Enzyme-linked immunosorbent assay (ELISA) 
2.8.1 Mouse mast cell protease-1 (mMCP-1) ELISA 
96-well plates (Nunc) were coated with 50 p.1 rat anti mMCP-1 monoclonal 
antibody (2 pg/ml) (Moredun), diluted in 0.1 M sodium carbonate buffer pH 9.6 and 
incubated overnight at 4°C. Plates were then washed 6 times with 154 mM NaCl, 0.05% 
(v/v) Tween 20 and incubated for one hour at room temperature with 50 p,l of BMMC 
supernatant (collected as described in section 2.7.1), or 50pl of mMCP-1 ranging fi-om 
0.5-20 ng/ml diluted in a solution of PBS, 4% BSA (w/v) and 0.05% (v/v) Tween 20. 
Plates were washed 6 times as before and 50 p.1 of rabbit anti-mMCP-1 HRP-conjugated 
antibody (Moredun) diluted 1:1500 in a solution of PBS containing 4% (w/v) BSA, 
0.05% (v/v) Tween 20 was added. The plates were then incubated for 1 hour at room 
temperature. Plates were washed (as before) and 50 p.1 of tetramethylbenzidine (TMB) 
substrate (0.1 mg/ml TMB, 0.001% (v/v) hydrogen peroxide, 0.03 M acetic acid, 0.07 
M sodium acetate) were added to each well and allowed to develop for 10-30 minutes. 
50 |il of 0.1 N HCl acid was then added to each well to terminate the reaction. The 
absorbance at 450 nm was measured using a FLUOstar OPTIMA microplate reader 
(BMG Labtech, Offenberg) and the concentration of mMCP-1 in each test-sample 
determined using the mMCP-1 standard curve. 
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2.8.2 IL-4, IL-5, IL-13, TNF-a ELISAs 
96-well plates (Nunc) were coated overnight at 4°C using 50 )j,l of either anti-
mouse IL-4 (R&D Systems) diluted to 2 pg/ml in PBS, anti-mouse IL-5 (R&D 
Systems) diluted to 0.5 jig/ml in PBS, anti-mouse IL-13 (R&D Systems) diluted to 4 
pg/ml in PBS, or anti-mouse TNF-a (R&D Systems) diluted to 0.8 |ig/ml in PBS. 
Subsequently, the coating antibody was aspirated and the plate washed 3 times with 
wash buffer (0.05% (v/v) Tween 20/PBS) prior to treating the plates with 200 |j,l/well 
blocking buffer (1% (w/v) BSA/PBS) for 1 hour at room temperature. The plates were 
washed as before and 50 |j,l of test supernatant or 50 |il of the appropriate cytokine 
serially-diluted according to the manufacturers' instructions, added per well. All 
dilutions were made using dilution buffer (0.1% BSA (w/v)/PBS pH 7). Plates were 
sealed and incubated at room temperature for 2 hours. Subsequently, samples were 
aspirated and the plates flushed with wash buffer 6 times. 50 pl/well of either 0.2 |ig/ml 
biotinylated anti-mouse IL-4 (R&D Systems), 0.1 [ig/ml biotinylated anti-mouse IL-5 
(R&D Systems), 0.4 p,g/ml biotinylated anti-mouse IL-13 (R&D Systems) or 0.3 pig/ml 
biotinylated anti-mouse TNF-a (R&D Systems) were added and the plates sealed and 
incubated at room temperature for 2 hours. Plates were then washed 3 times as before 
and 50 )li1 of avidin-HRP conjugate (BD Biosciences) diluted 1:1000 in dilution buffer 
was added. Plates were sealed and incubated at room temperature for 30 minutes. Plates 
were then washed 6 times with wash buffer and 50 pi of substrate solution (0.11 M 
acetate buffer pH 5.5, 100 p,g/ml (w/v) TMB diluted in DMSO, 0.1% (v/v) H2O2) added 
per well. Plates were incubated in the dark at room temperature for 30 minutes. The 
reaction was temrinated by the addition of 40 pil 1.8 M H2SO4 and the absorbance 
measured at 450 nm using a FLUOstar optima microplate reader (BMG Labtech, 
Offenberg). 
2.8.3 cAMP ELISA 
Assays for cAMP in cell lysates were carried out using a cAMP Biotrak 
Enzymeimmunoassay (EIA) system according to the manufacturer's instructions 
(Amersham Biosciences). 
2.8.4 Antigen specific serum immunoglobulin ELISAs 
Samples of T. spiralis recombinant 5'-NT were diluted to 5 |ig/ml in coating buffer 
(0.06 M sodium carbonate buffer pH 9.5) and 96-well flat bottom plates were coated 
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with 100 )j.l/well. Plates were sealed and incubated overnight at 4°C. The 5'-NT coating-
antigen was then aspirated and the plates washed 3 times with wash buffer (0.05% 
Tween 20 (v/v), PBS). Plates were subsequently treated with 300 p,l/well blocking 
buffer (5% (v/v) PCS, PBS pH 7.0) for 1 hour at room-temperature. Plates were washed 
as before and 100 |il/well of sera diluted in blocking buffer added. Plates were sealed 
and incubated at room-temperature for 2 hours, prior to washing 3 times with wash 
buffer. Horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgGl (1:4000), 
IgG2a (1:2000), IgG2b (1:3000) and IgM (1:8000) antibodies (Zymed Laboratories, 
CA), and HRP-conjugated goat anti-mouse IgA (1:4000) antibody (Zymed 
Laboratories, CA) were diluted in blocking buffer and 100 pi added per well. Plates 
were sealed and incubated for 2 hours at room-temperature. Plates were subsequently 
washed 6 times with wash buffer prior to addition of 100 p.l/well of substrate solution 
(0.11 M acetate buffer pH 5.5, 100 fJ.g/ml (w/v) TMB diluted in DMSO, 0.1% (v/v) 
H2O2). Plates were incubated in the dark at room-temperature for 30 minutes. The 
reaction was stopped by the addition of 50 p,l 1.8 M H2SO4 and the absorbance 
measured at 450 ran using a FLUOstar optima microplate reader (BMG Labtech, 
Offenberg). 
2.9 Flow Cytometry 
2.9.1 Flow cytometric analysis of mBMMC surface markers 
BMMC were centrifuged at 250 x g for 7 minutes at 4°C and the supernatant 
discarded. Cells were resuspended in FACS buffer (PBS, 0.1% (w/v) BSA, 0.1% (w/v) 
azide) and counted (as described in section 2.6.1). Aliquots of 2x10^ cells were then 
centrifuged at 250 x g for 7 minutes at 4°C, then resuspended in 100 jil FACS buffer. 
Cells were stained by the addition of 1 |ig/ml of either rat anti-mouse c-kit 
phycoerythrin conjugated (R-PE) IgG2b (CALTAG laboratories), rat lgG2b-R-PE 
isotype control antibody (CALTAG laboratories), or the equivalent volume of FACS 
buffer added to them to act as a negative control. Samples were then incubated on ice in 
the dark for 30 minutes, washed twice with FACS buffer and then resuspended in 200 
|il PBS containing 3% (v/v) formaldehyde. To stain for the presence of the high affinity 
IgE receptor FcsRI, cells were prepared as before then incubated on ice with 10 |ig/ml 
anti-DNP-albumin IgE (clone SPE7), for 30 minutes. After washing with FACS buffer, 
cells were incubated on ice in the dark for a further 30 minutes with 1 (J-g/ml fluorescein 
isothiocyanate (FITC)-conjugated rat anti mouse IgE (CALTAG laboratories). The cells 
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were washed twice with FACS buffer then resuspended in 200pl PBS containing 3% 
(v/v) formaldehyde. Cells were analysed using a FACSCalibur flow cytometer (Becton 
Dickinson) and Cell-Quest software with at least 30,000 events counted per sample. 
Forward and side light scatter were used to select cell populations for analysis using 
WinMDI software. 
2.9.2 Cytometric bead analysis (CBA) assay 
Assays for IL-2, IFN-y, TNF-a, IL-4 and IL-5 were carried out using a mouse 
Th1/Th2 cytokine cytometric bead array kit according to the manufacturers instructions, 
using 25 |il of cell supernatant, capture beads, cytokine standards and detection reagent 
(BD Biosciences, Cowley, Oxford). 
2.10 Molecular biology 
2.10.1 RNA extraction from mBMMC 
A Qiagen RNA extraction kit was used to purify RNA fi-om 4x10^ mBMMC 
according to the manufacturer's instructions. The concentration and purity of the RNA 
was then quantified spectrophometrically by measuring the absorbance at 260 nm and 
the absorbance ratio at 260 nm/280 nm respectively. To ensure there was no genomic 
DNA contaminating the sample the extracted RNA was digested with DNasel using a 
micro-midi total RNA purification system (Invitrogen) according to manufacturer's 
instructions. 
2.10.2 RNA extraction from epithelial cells and parasites 
Parasites were firozen in liquid nitrogen and then disrupted using a percussive 
disruptor. The shattered pellet was transferred to a 1.5 ml tube and allowed to thaw. In a 
fume hood, 50pl of extracted epithelial cells or disrupted parasites were resuspended in 
1 ml of TRIzol (Invitrogen). RNA was extracted according to the manufacture's 
instructions. Briefly, this involved incubating the suspension at room temperature for 5 
minutes to allow dissociation of nucleoprotein complexes. 0.2 ml of chloroform was 
added, the tube shaken vigorously for 15 seconds and then left to settle for 2-3 minutes 
at room temperature. Samples were then centrifuged at 12,000 x g for 15 minutes at 
4°C. The clear upper aqueous phase containing the RNA was then carefully removed 
and transferred to a fresh eppendorf tube. The RNA was precipitated by adding 0.5 ml 
of isopropanol and the sample incubated for 10 minutes at room temperature prior to 
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centrifugation for 10 minutes at 12,000 x g, 4°C. The supernatant was removed and the 
gel—like pellet resuspended in 1 ml 75% (v/v) ethanol. The sample was then centrifuged 
at 7,500 X g for 5 minutes at 4°C, the ethanol removed and the RNA pellet left to air-dry 
for 5 minutes. The pellet was finally resuspended in 30 )il RNase free water and tlie 
RNA concentration and purity quantified by measuring the absorbance at 260 nm and 
the absorbance ratio at 260 nm/280 nm respectively, using a spectrophotometer. To 
ensure there was no genomic DNA contaminating the sample the extracted RNA was 
digested with DNasel using a micro-midi total RNA purification system (Invitrogen) 
according to manufacturer's instructions. 
2.10.3 cDNA synthesis 
To a final volume of 13 )il dHzO, 2 p,g of RNA and 1 |ig of oligo-dT (Promega) 
were added. The sample was then incubated at 70°C for 5 minutes (to denature the 
secondary structure of the RNA and allow oligo-dT primers to anneal). The sample was 
immediately placed on ice to prevent the secondary structure of the RNA refonning. 5 
)Lil of 5X M-MLV (murine-Maloney leukaemia virus) buffer (250 mM Tris-HCl pH 8.3, 
375 mM KCl, 15 mM MgClz, 50 mM DTT), 40 U of RNase inhibitor, 200 U of M-
MLV reverse transcriptase and 6.25 mM each of dATP, dTTP, dCTP and dGTP were 
then added to the reaction mix resulting in a final volume of 25 |il. The sample was 
incubated at 37°C for 1 hour and then either used for a PGR reaction directly afterwards 
or heated to 94°C for 5 minutes to denature the reverse transcriptase. 
2.10.4 Polymerase chain reaction 
PCRs to detect the expression of specific mRNA transcripts were carried out in a 
final volume of 25 [il containing 10 mM Tris pH 8.3, 50 mM KCl, 1.5 mM MgCIi, 0.25 
mM each of dATP, dGTP, dCTP, dTTP, 1 unit Taq DNA polymerase, 10 pmoles each 
of forward and reverse primer, and the indicated amount of template DNA. 
Amplification of template DNA was carried out using gene specific primers (detailed in 
Tables 2.1, 2.2 and 2.3) and the following thermal cycle: 
1) 94°C for 10 minutes 
2) 94°C for 30 seconds 
3) Specified annealing temperature for 1 minute 
4) 72°C for 2 minutes 
Steps 2 to 4 were repeated for 34 cycles. 
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5) 72°C for 10 minutes 
Reaction products greater than 250 bp were analysed on 1.5% (w/v) agarose gels, PGR 
products less than 250 bp were analysed on 2% (w/v) agarose gels. 
2.10.5 Agarose gel electrophoresis 
Agarose gels were made by mixing 1% (w/v) agarose with Tris-acetate 
electrophoresis buffer (0.04 M Tris-acetate, 1 mM EDTA) and heated until the agarose 
dissolved. Ethidium bromide (0.2 pig/ml) was then added and the gel allowed to set. 
DNA samples and 0.1 p-g per mm of gel lane width of 1Kb DNA ladder (GeneRuler, 
Fermentas) were loaded onto gels and electrophoresed at 90V until the DNA fragments 
had separated to a sufficient resolution to be identified using UV illumination and 
photography. 
2.10.6 DNA sequencing of PGR products 
PGR products were separated from dNTPs and primers by agarose gel 
electrophoresis. The PGR product was subsequently excised from the gel using a clean 
scalpel blade. PGR products were then purified using a gel extraction kit (Qiagen) and 
eluted in 50 pi of dH20. The DNA concentration and purity was quantified by 
measuring the absorbance at 260 nm and the absorbance ratio at 260 nm/280 nm, using 
a spectrophotometer. PGR products were sequenced by the Advanced Bioteclmology 
Genfre (Imperial Gollege, South Kensington) on a 3100 Genetic Analyzer (Applied 
Biosystems) using ABI BigDyes, where 120-300 ng of template DNA was amplified 
using 12.8 pmol of primer and the following thermal cycle: 
1) 96°G for 10 seconds 
2) 50°G for 5 seconds 
3) 60°G for 4 minutes 
Steps 1 to 3 were repeated for 35 cycles 
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Primer Sequence Annealing 
Temp C O 
Fragment 
Size (bp) 
CysLTRl 
Forward 
5'-GCACCAAGCAGACATTCCTGGAGA-3' 
57 
628 
or 
470 CysLTRl 
Reverse 
5'-AATC ATGTATACTTGGAAGGCTGA-3' 
mMCP-1 
Forward 5'-GGAAAACTGGAGAGAAAGAACCTAC-3' 
57 460 
mMCP-1 
Reverse 5'-GACAGCTGGGGACAGAATGGGG-3' 
P-actin 
Forward 5'-CCCCAGCCATGTACGTAGCCATCC - 3' 55 425 
P-actin 
Reverse 5'-AGAAGCCTCGGGGCATCGGAACGGC-3' 
T. spiralis 
Tubulin 
Forward 
5'-GGTCACATATGCACCGGTGAT-3' 
55 342 
T. spiralis 
Tubulin 
Reverse 
5'-GCTGTTGTATTAGATAACATGC-3' 
T. spiralis 5'-
NT Forward 
5'- GGTTGGGTGAAAACGGTG 3' 
55 325 
T. spiralis 5'-
NT Reverse 
5'- GGACAGTCTCCGCAACGTAG 3' 
Table 2.1 PCR primers 
mMPC-1 primers were designed by Ghildyal et al., 1992. CysLTRl primers were 
designed by Maekawa et al., 2001. 5'-NT and tubulin primers were designed by M. E. 
Selkirk (Imperial College, London). P-actin primers were designed by K. Kitchenen 
(Imperial College, London). Tubulin primers were designed by D. Guiliano (Imperial 
College, London). 
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Primer Sequence Annealing 
Temp CO 
Fragment 
Size (bp) 
A; Forward 5'-TTTGGCTGGAACAACCTGAGTGAG - 3' 
54 264 
Ai Reverse 5'-ATCTTGAGCTCCTTCCCGTAGTAC - 3' 
A2A Forward 5'- TTCAGCCTCTTGGCTATTGCCATC - 3' 
54 216 
A2A Reverse 5'- ATCCTTAGGTAGATGGCCAGCATG - 3' 
A2B Forward 5'- CCACCAACTACTTTCTGGTATCCC - 3' 
54 323 
A2B Reverse 5'- TCTTTACTGTTCCACCCCAGGAAC - 3' 
A3 Forward 5'- AGACCTGCATCCTCCAGGTTAATG - 3' 
54 260 
A3 Reverse 5'- GCTTCCATGCTGTCTCAGAAAAGC - 3' 
P2Y] Forward 5'- CTGTGTCTTATATCCCTTTCC - 3' 
57 410 
P2Yi Reverse 5'-CTCCATTCTGCTTGAACTC - 3' 
P2Y2 Forward 5'- ACCAGCGTGCGGGGAACC - 3' 
57 440 
P2Y2 Reverse 5'- GCATCTCGGGCAAAGCGGACAAGT -3' 
P2Y4 Forward 5'- TGCCTCGTGCCCAACCTCTTCTTT - 3 ' 
57 499 
P2Y4 Reverse 5'- CAGTTGTTCGGCGCTTAGGTGTGC - 3' 
PlYg Forward 5'- CCTGGCACTGGCGGACCTGAT- 3' 
57 452 
P2Y(i Reverse 5'- GGCGGGCCATGCGACAATAAC - 3' 
P2Yi2 Forward 5'- ATCGGTCTTTTGTCAGAACAAGG - 3' 
55 300 
P2Yi2 Reverse 5'- TTCTCCCAGATGTTGATGTAGAG - 3' 
P2Yi3 Forward 5'- TGGCATCAGGTGGTCAGTCACAC - 3' 55 400 
P2Yi3 Reverse 5'- CGCTTGATCCTGCTGTTCTTGCC - 3' 
P2Yi4 Forward 5'- CGTCTTCTACACGGCCATCAC G - 3' 55 264 
P2Yi4 Reverse 5'- TCCAGACACACATTGGCAGCC G - 3' 
Table 2.2. PI and P2Y receptor PCR primers 
Primers were designed by S. Kock (Imperial College, London). 
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Primer Sequence Annealing 
Temp CC) 
Fragment 
Size (bp) 
P2Xi Forward 5'- GAGAGTCGGGCCAGGACTTC - 3' 54 233 
P2Xi Reverse 5'- GCGAATCCCAAACAACTTGA - 3' 
P2X2 Forward 5'- TCCCTCCCCCACCTAGTCAC - 3' 
54 149 
P2X2 Reverse 5'- CACCACCTGCTCAGTCAGAGC - 3' 
P2X3 Forward 5'- CTGCCTAACCTCACCGACAAG - 3' 
54 150 
P2X3 Reverse 5'- AATACCCAGAACGCCACCC - 3' 
P2X4 Forward 5'- CCCTTTGCCTGCCCAGATAT - 3' 
54 145 
P2X4 Reverse 5'- CCGTACGCCTTGGTGAGTGT - 3' 
P2X5 Forward 5'- GGATGCCAATGTTGAGGTTGA - 3' 
54 81 
P2X5 Reverse 5'- TCCTGACGAACCCTCTCCAGT- 3' 
P2Xg Forward 5'- CCCAGAGCATCCTTCTGTTCC - 3' 54 152 
P2X(i Reverse 5'- GGCACCAGCTCCAGATCTCA - 3' 
P2X7 Forward 5'- GCACGAATTATGGCACCGTC - 3' 
54 171 
P2X7 Reverse 5'- CCCCACCCTCTGTGACATTCT - 3' 
Table 2.3 P2X receptor PCR primers 
P2X receptor primers were designed by S. Kock (Imperial College, London). 
2.11 Statistics 
Statistics were performed using the unpaired Student's ?-test assuming unequal 
variances. Levels of significance are indicated as follows: * P<0.05, ** f<0.01 *** 
f <0.001. In all graphs, error bars represent the standard deviation from the mean. 
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Chapter 3 
Characterisation of the modulatory effects of Trichinella 
spiralis secreted proteins on mast cell purinergic receptor 
activation 
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3.1 Introduction 
Extracellular nucleotides released from cells either due to damage or in a 
regulated manner are purinergic signalling molecules that induce a wide variety of 
cellular responses by binding to and activating cell surface purinergic receptors. There 
are two distinct families of purinergic receptors: the PI and P2 classes. The PI family 
are G-protein-coupled receptors of which there are 4 sub-types that differentially 
respond to adenosine and inosine (Fredholm et al., 2001). The P2 family is further 
subdivided into G-protein-coupled P2Y receptors and ligand-gated ion channel P2X 
receptors. Currently, eight human (seven murine) P2Y receptors have been cloned and 
are differentially responsive to ADP, ATP, UDP, UTP and UDP-glucose, with ligand 
affinities depending on the receptor sub-type (von Kugelgen and Wetter, 2000). In 
addition, cysteinyl leukotriene receptors (CysLTl and 2) (Mellor et al, 2001; 2003) and 
the very recently described rat GPR17 receptor (Ciana et al., 2006) have been shown to 
mediate the actions of extracellular UDP. There are seven sub-types of P2X receptors 
and they are all activated by ATP (North, 2002). Purinergic receptors couple to a wide 
variety of intracellular signalling pathways and thus can directly activate or modulate 
many different cellular responses. 
Each purinergic receptor sub-type has a specific pharmacological profile in 
terms of agonist type and affinity, and most cells express multiple receptor sub-types 
(von Kugelgen, 2006). The combined use of sub-type preferential agonists and 
antagonists can allow the characterisation of most purinergic receptors. However, as 
purinergic receptor antagonists and agonists bind to multiple receptor sub-types with 
varying affinities, characterisation of specific receptor sub-types can be complex. 
Recently Trichinella spiralis has been shown to secrete a range of nucleotide 
metabolising enzymes, specifically a 5'-nucleotidase (5'-NT) (Gounaris, 2002; Gounaris 
et al., 2004), a nucleoside diphosphate kinase (NDPK) (Gounaris et al., 2001) and an 
adenosine deaminase (Gounaris, 2002). The 5'-NT is unusual in that it can catalyse the 
hydrolysis of nucleoside 5'-diphosphates and 5'-monophosphates at the same active site 
(Gounaris et al., 2004). The 5'-NT is mono-specific for AMP among the nucleoside 5'-
monophosphates and catalyses the hydrolysis of nucleoside 5'-diphosphates in the order 
of UDP»ADP. Thus, the action of the T. spiralis 5'-NT is hypothesised to limit the 
availability of extracellular nucleoside 5'-diphosphates to interact with P2Y receptors. 
The reaction product of the parasite 5'-nucleotidase acting on AMP would be adenosine, 
86 
which could act as a substrate for the secreted adenosine deaminase leading to the 
accumulation of inosine. The latter would activate A3 receptors and result in limited 
activation of Ai, AiA and Ais adenosine receptors. The 5'-NT shows no activity against 
any nucleoside 5'-triphosphates (Gounaris et ah, 2004). However, the secreted NDPK 
can convert ATP to ADP or UTP to UDP in the presence of nucleoside phosphate 
acceptors, and could work in conjunction with other enzymes to reduce the 
concentration of extracellular nucleoside triphosphates. Secretion of these enzymes is 
expected to alter the amount of extracellular nucleotides available to bind host cell 
purinergic receptors. This is postulated to result in altered cell activation leading to an 
environment more favourable for parasite survival. 
It has been known for many years that the resolution of T. spiralis infection is 
absolutely dependent on mast cells (Alizadeh and Murrell, 1984; Oku et al., 1984). 
However, the exact role of mast cells in parasite clearance from the intestine has yet to 
be fully defined. During T. spiralis infection mast cell progenitors home to the small 
intestine where TGF-Pi produced by epithelial cells induces them to secrete the p-
chymase mouse mast cell protease-1 (mMCP-1) (Miller et al., 1999; Wright et al., 
2002). Mice deficient in mMCP-1 are unable to expel T. spiralis although they develop 
mastocytosis (Knight et al., 2000). One role of mMCP-1 is to degrade the tight-junction 
protein occludin, which increases the enteric 'leakiness' of the gut, disrupting epithelial 
barrier function leading to the influx of solutes and water into the lumen (McDermott et 
al., 2003). This is thought to help flush the parasites out of the intestine (McDennott et 
al., 2003; Murray et al., 1971). Furthermore, TGF-Pi also plays a role in the recruitment 
and distribution of mucosal mast cells in the intestinal epithelial compartment (Wright 
et al., 2002; Smith et al., 1994; Brown et al., 2004). Thus, TGF-Pi is a key regulator of 
mast cell effector function primarily by inducing the secretion of mMCP-1 and 
regulating mast cell distribution within the epithelium. 
To establish a successful infection, T. spiralis infective larvae must burrow into 
the host intestinal epithelium, moult into adults and sexually reproduce (as discussed in 
Chapter 1). As the parasites migrate through the epithelium, considerable cell damage 
occurs. Large numbers of mast cells accumulate in the intestinal epithelium prior to the 
expulsion of T. spiralis from the intestine (Woodbury et al., 1984). Thus, they are 
expected to come into close contact with areas of epithelium damaged by the invading 
parasites. The nucleotides released from damaged and dying cells would potentially be 
able to bind to and activate purinergic receptors on surrounding mucosal mast cells. 
87 
This may act to stimulate increased mast cell effector functions. Hypothetically, the 
secretion of nucleotide metabolising enzymes by T. spiralis may serve to inhibit the 
action of nucleotides in activating host immune responses. Assuming that the parasite 
secretes these enzymes to its advantage, it is possible that they act to specifically 
prolong parasite persistence in the intestinal tract. As mucosal mast cells are the key 
effector cells required to expel T. spiralis from the small intestine it was deemed 
pertinent to test the hypothesis that T. spiralis secreted proteins modulate mast cell 
purinergic receptor activation. 
Mast cells of various types express PI, P2Y and P2X receptor sub-types that can 
be activated in both paracrine and autocrine ways (Feng et al., 2004; Bulanova et al., 
2005; Osipchuk and Cahalan, 1992). Due to the difficulty in isolating significant 
numbers of mucosal mast cells free of contaminating cell types from the intestine (Fox 
et al., 1985; Sellge and Bischoff, 2006), in this study in vitro bone marrow derived mast 
cells (mBMMC) displaying a mucosal phenotype were used. Studies by Miller et al., 
(1999) and Wright et al, (2002) have described cell culture conditions utilising lL-3, 
IL-9, SCF and TGF-Pi that leads to the development of mature mast cells from murine 
bone marrow within 14 days. Importantly, these mast cells have a mucosal phenotype as 
assessed by mMCP-1 secretion and toluidine blue staining, thus providing a useful 
model to study the effects of T. spiralis secreted proteins on purinergic signalling. 
This chapter focuses on the initial characterisation of mouse bone marrow-
derived mast cell (mBMMC) cultures and the identification of functional purinergic 
receptors. A variety of selective purinergic receptor antagonists and agonists were used 
to define which mBMMC purinergic receptor sub-types were functionally expressed. 
Aspects of intracellular signal transduction pathways activated by nucleosides and 
nucleotides were also investigated to aid purinergic receptor characterisation. The 
regulatory effects of T. spiralis secreted nucleotide metabolising enzymes on the type 
and availability of extracellular nucleotides able to activate mBMMC purinergic 
receptors was investigated. 
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3.2 Results 
3.2.1 Characterisation of mBMMC cultures 
Previous work by Miller et al, (1999) and Wright et al, (2002) has described 
culture conditions conducive to developing mast cells from bone marrow in a relatively 
short, 14-day time frame. This in vitro cell type is similar to the mucosal mast cells 
found in the intestinal epithelium of T. spiralis infected mice as they can be induced to 
secrete the |3-chymase mouse mast cell protease-1 (mMCP-1), a key effector molecule 
required for efficient parasite expulsion. 
Culture conditions defined by Miller et al., (1999) were used to generate mature 
mouse bone marrow-derived mast cells (mBMMC). Murine bone marrow cell 
suspensions were cultured with 15% WEHI-conditioned medium as a source of IL-3, 5 
ng/ml IL-9 and 50 ng/ml stem cell factor (SCF). Throughout the text the 15% WEHI-
conditioned medium is referred to as lL-3. Cells were cultured in the absence or 
presence of 1 ng/ml TGF-Pi to ensure the known inhibitory effects of TGF-Pi on FcsRl 
expression (Gomez et ah, 2005) did not adversely effect mast cell development. FACS 
analysis was utilised to monitor the development of the mBMMC cultures over a three-
week period. Toluidine blue staining of day-14 mBMMC cultures was also used to 
confirm the sulphated acid mucopolysaccharide content of mast cell granules, indicative 
of mature mast cells. 
Samples of cells were removed from the culture medium at, 0 (undifferentiated 
bone marrow), 4, 7, 14 and 21 days post-initiation of bone marrow cell culture. Cells 
were stained with antibodies corresponding to the mast cell markers c-kit and FcsRl, 
and analysed by FACS (isotype control staining is shown in Appendix 1-1). Mouse 
bone marrow cells were stained individually with anti-c-kit-PE and anti-IgE-FITC 
antibodies and dual-stained with both types of antibodies. Representative results 
showing logio fluorescence intensity dot plots of cells cultured in the absence or 
presence of TGF-Pi are shown in Figures 3-1 and 3-2 respectively. Both bone marrow 
cell cultures, regardless of the presence of TGF-Pi, showed increased staining for cell 
surface c-kit and FcsRl receptors as indicated by positive shifts in fluorescence intensity 
during 21 days of culture (Figures 3-1 and 3-2). As seen in the fluorescence intensity dot 
plots (Figures 3-1 and 3-2), from day-14 onwards, the culture conditions employed 
resulted in a relatively homogenous population of c-kit"^ and FcsRl^ cells, unaffected by 
the addition of TGF-Pi. 
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Figure 3-1 c-kit and FcsRI staining in mBMMC cultures grown in the absence of 
TGF-p, 
Representative density dot plots of total nucleated cells showing staining of mouse bone 
marrow cells with (A) anti-c-kit-PE antibody (c-kit), (B) IgE followed by anti-IgE-FITC 
antibody (FcsRI) and (C) both PE and FITC-labelled antibodies. Murine bone marrow was 
cultured with IL-3, IL-9 and SCF in the absence of TOF-P, and sampled at various time 
points up to 21 days. Samples were analysed by flow cytometry and data shown are 
representative of at least two separate experiments. 
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Figure 3-2 c-kit and F C E R I staining in mBMMC cultures grown in the presence of 
TGF-Pi 
Representative density dot plots of total nucleated cells showing staining of mouse bone 
marrow cells with (A) anti-c-kit-PE antibody (c-kit), (B) IgE followed by anti-IgE-FITC 
antibody (FcsRI) and (C) both PE and FITC-labelled antibodies. Murine bone marrow was 
cultured with IL-3, IL-9 and SCF in the presence of TGF-|3, and sampled at various time 
points up to 21 days. Samples were analysed by flow cytometry and data shown are 
representative of at least two separate experiments. 
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The percentage of cells stained positive for c-kit and FcsRI were calculated 
using the quadrant statistics obtained from the fluorescence dot plots (data from two 
separate FACS experiments) (Figure 3-3). Single c-kit and FcsRI staining are shown in 
Figure 3-3 (A) and (B) respectively and dual c-kit and FcsRI staining is shown in Figure 
3-3 (C). The percentage of c-kit positive cells in the bone marrow cell population 
increased rapidly during the first 7 days of culture, and reached 99 ± 0.5% and 93 + 8% 
by day-14, in the absence or presence of TGF-Pi respectively [Figure 3-3 (A)]. During 
the first 7 days of culture, the development of FcsRI positively stained-cells increased at 
a slower rate than that observed for c-kit staining [compare Figure 3-3 (A) and (B)]. 
However, after an initial 7 day lag period, the percentage of cells expressing FcsRI rose 
very rapidly and by day-14 had reached 91 + 11% and 94 + 5% in the absence or 
presence of TGF-Pi respectively [Figure 3-3 (B)]. Dual staining presented a similar 7 
day lag phase [Figure 3-3 (C)]. However, from day-7 onwards c-kit positive cells 
upregulated FcsRI expression, peaking at day 14 where the percentage of cells positive 
for both mast cell markers was 90 ± 6.7% and 94.7 + 5% in the absence or presence of 
TGF-Pi respectively [Figure 3-3 (C)]. A trend of reduced c-kit and FcsRI cell surface 
expression was noted at day-21, however this was shown to be statistically non-
significant (Figure 3-3). 
FACS analysis measuring side scatter was also used to assess the size and 
granularity of the bone marrow cell population. Mature mast cells are very granular and 
as such have high side scatter properties when analysed by FACS. Uncultured bone 
marrow cells (day-0) had very low side scatter suggesting the absence of granules 
(Figure 3-4). From day-7 of culture onwards, the cell population showed an increase in 
side scatter consistent with the granularity associated with mature mast cells. No 
obvious differences in side scatter were associated with the presence or absence of 
TGF-Pi [compare Figure 4-4 (A) and (B)]. This implies TGF-PJ does not alter the 
overall granularity of the bone marrow cell population. 
To further confirm the granularity of mature day 14 mBMMC, histological 
analysis was used. Cells were immobilised on glass slides, fixed with Camoy's solution, 
stained with toluidine blue and photographed at XI00 magnificafion (Figure 3-5). Cells 
cultured in the absence or presence of TGF-Pi stained positive with toluidine blue and 
only a few contaminating cell types were observed [Figure 3-5 (A)]. Cells cultured with 
TGF-Pi appeared to have more densely stained granules than cells cultured without 
TGF-P,. The optimal time point to use the mBMMC was chosen to be 14 days as 
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Figure 3-3 The percentage of c-kit^ and FceRI^ cells in mBMMC cultures 
grown in the presence and absence of TGF-p, 
Murine bone marrow cells cultured with IL-3, IL-9 and SCF in the presence or 
absence of TGF-P, were sampled at various time points up to 21 days. Flow 
cytometry was used to calculate the percentage of total nucleated cells positive 
for c-kit and FcsRI. Data shown are + s.d.m. of at least two separate 
experiments. 
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Figure 3-4 The granularity of mBMMC cultures grown in the presence or 
absence of TGF-Pj 
Representative dot plots showing forward and side scatter properties of murine bone 
marrow during 3 weeks of culture in media containing (A) SCF, IL-3, IL-9 and (B) 
SCF, IL-3, IL-9 and TGF-Pj. Samples were analysed by flow cytometry and data 
shown are representative of at least two separate experiments. 
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Figure 3-5 The expression of mMCP-1 and the morphology of niBMMC 
grown in the absence or presence of TGF-Pj 
A) Toluidine blue stained cytospins of mBMMC cultured in the absence or 
presence of TGF-(3,. Representative photographs at xlOO magnification are shown. 
B) Representative reverse transcriptase (RT)-PCR analysis of mMCP-1 expression 
(lane M) in mBMMC cultured in the absence or presence of TGF-(3,. PCR 
amplification of |3-actin was used as a control (lane C). Samples were analysed on 
a 1.5 % (w/v) agarose gel and PCR fragment size was evaluated using a 1000 base 
pair (bp) DNA ladder (lane L). C) mBMMC cultured in the absence or presence of 
TGF-f3i were stimulated for 2 hrs by crosslinking the FceRI receptor using IgE 
and antigen (Ig+Ag), or using media alone (Neg). Data were analysed using the 
unpaired two-tail Student's Mest and represent two experiments, showing the 
mean + s.d.m of triplicate cultures. Significance values are shown relative to cells 
treated with media alone, *** p< 0.001. 
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maximal cell surface expression of c-kit and FcsRI was observed and the cells appeared 
granular by FACS and toluidine blue staining. 
The expression and secretion of mMCP-1 was also assessed to confirm the 
mBMMC were of a mucosal phenotype. Non-quantitative reverse transcriptase-PCR 
(RT-PCR) using mMCP-1-specific primers highlighted expression of mRNA transcripts 
corresponding to mMCP-1 in mBMMC regardless of the culture conditions used 
(Figure 3-5 (B)]. As shown in Figure 3-5 (C), mBMMC cultured with TGF-pi 
spontaneously secreted approximately 1000-fold more mMCP-1 than mBMMC cultured 
without TGF-(3i. These results confirm that TGF-Pi induces the mBMMC to 
spontaneously secrete more mMCP-1 which is consistent with the cells being of a 
mucosal phenotype. Cross-linking of FcsRI using IgE and antigen induced the 
mBMMC to degranulate releasing significant amounts of mMCP-1 [Figure 3-5(C)]. 
This further confirms the cells are mature and express active cell surface FceRl. 
3,2,2 Characterisation of mBMMC purinergic receptor expression 
Upon the establishment of an in vitro culture system for the generation of 
mBMMC, a non-quantitative reverse transcriptase-PCR (RT-PCR) approach was 
utilised to determine the expression of mRNA transcripts in mBMMC that correspond 
to PI, P2Y and P2X receptors. The presence of mRNA transcripts does not directly 
correspond to levels of cell surface protein expression and conversely absence of 
mRNA transcripts does not necessarily correspond to absence of the expressed protein. 
However, this method was used to give a general insight into the purinergic receptors 
expressed by mBMMC. 
To ensure all the purinergic receptor primer pairs amplified PCR products of the 
expected size, control template cDNA isolated fi-om murine spleen (or other organs 
where indicated) was used and the results displayed in Appendix 1-2. Unless stated 
otherwise, all primer pairs amplified PCR products of the expected size fi-om template 
mBMMC cDNA (expected PCR product sizes are displayed in the Materials and 
Methods section and are also depicted in Appendix 1.2). In order to standardise cDNA 
levels between batches of RNA, P-actin primers were used as a positive control. To 
exclude the possibility of genomic DNA contaminating mBMMC cDNA preparations, 
all samples of RNA were digested with DNase prior to the RT reaction. To control for 
genomic DNA contamination in RNA preparations, PCRs were carried out using 
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DNase-treated RNA preparations and (B-actin primers. No PCR products were generated 
from all batches of mBMMC RNA used (data shown in Appendix 1-3). Representative 
RT-PCR analysis of expression of all purinergic PI, P2Y and P2X receptor mRNA 
transcripts extracted from day 14 mBMMC cultured in the absence or presence of TGF-
Pi are shown in Figures 3-6, 3-7 and 3-8 respectively. 
Of the P1 receptors, only the A2B and A3 transcripts were found to be expressed 
at high levels, and this pattern did not seem to be altered by the presence of TGF-Pi 
(Figure 3-6). Low levels of transcripts corresponding to the Ai and AzA receptors were 
weakly detected by RT-PCR in mBMMC cultured in the absence of TGF-pi, and this 
was less apparent in mBMMC cultured in the presence of TGF-Pi (Figure 3-6). 
Regardless of the culture conditions used, mBMMC strongly expressed transcripts 
corresponding to the P2Yi receptor and to a lesser extent, transcripts for the P2Y2 and 
P2Yi4 receptors (Figure 3-7). As the cysteinyl leukotriene receptor 1 (CysLTl) has 
recently been found to bind, and be activated by UDP (Mellor et ai, 2001), primers 
were used to detect expression of this receptor transcript (Figure 3-7). Because murine 
CysLTl receptor cDNA is known to have two isoforms that results from the alternate 
splicing of a gene with 4 exons (Maekawa et al., 2001), primers were used that detected 
both isoforms resulting in PCR products of two different sizes (628 bp and 470 bp) 
depending on the isoforms present. PCR performed using mBMMC cDNA as a 
template produced PCR products of approximately 900 bp and 200 bp, which differed 
from the expected sizes (Figure 3-7). To determine whether the PCR fragments 
produced were an aberrant result due to non-specific primer binding, the PCR fragments 
were purified from the agarose gel and the 3'-end of the PCR product partially 
sequenced using the reverse primer. The sequencing results confirmed the small (-200 
bp) PCR fragment corresponded to murine CysLTl cDNA, the results of which are 
shown in Appendix 1-5. However, the large PCR fragment corresponded to prosaposin 
mRNA, indicating the primers had non-specifically amplified template cDNA 
(Appendix 1-6). These results indicate that mBMMC express transcripts corresponding 
to the CysLTRl, but do not highlight the type of splice variant expressed. 
RT-PCR using primers designed for the detection of P2X receptors, amplified 
transcripts corresponding to the sub-types P2X| and P2X4 (Figure 3-8). The PCR 
fragments produced were at very low levels and no differences between culture 
conditions were observed (Figure 3-8). 
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Figure 3-6 Expression of purinergic PI receptor subtypes in mBMMC 
Representative reverse transcriptase (RT)-PCR analysis of PI receptor expression 
in mBMMC cultured in the absence or presence of TGF-P,. PCR amplification of 
(3-actin was used as a control (lane C). Samples were analysed on a 1.5 % (w/v) 
agarose gel and PCR fragment size was evaluated using a 1000 base pair (bp) 
DNA ladder (lane L). 
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Figure 3-7 Expression of purinergic P2Y receptor subtypes and CysLTRl in 
mBMMC 
Representative reverse transcriptase (RT)-PCR analysis of P2Y receptor 
expression in mBMMC cultured in the absence or presence of TGF-P,. PCR 
amplification of |3-actin was used as a control (lane C). Samples were analysed on 
a 1.5 % (w/v) agarose gel and PCR fragment size was evaluated using a 1000 
base pair (bp) DNA ladder (lane L). 
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Figure 3-8 Expression of purinergic P2X receptor subtypes in niBMMC 
Representative reverse transcriptase (RT)-PCR analysis of P2X receptor 
expression in mBMMC cultured in the absence or presence of TGF-|3,. PCR 
amplification of |3-actin was used as a control (lane C). Samples were analysed on 
a 2 % (w/v) agarose gel and PCR fragment size was evaluated using a 1000 base 
pair (bp) DNA ladder (lane L). 
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3.2.3 Pharmacological characterisation of mBMMC purinergic receptors 
The initial characterisation of the development of mBMMC cultures described 
in sections 3.2.1 and 3.2.2 shows the presence of TGF-Pi does not adversely affect the 
development of mBMMC during the first 14 days of culture and does not noticeably 
alter purinergic receptor expression at the mRNA level. Furthermore, as TGF-Pi 
induced the secretion of large quantities of mMCP-1 from mBMMC in vitro, it was 
deemed important to include this growth factor in all mBMMC cultures used. In all 
further experiments unless stated otherwise, the term mBMMC refers to cells cultured 
with IL-3, IL-9, SCF and TGF-Pi for 14 days. 
To determine whether mBMMC expressed functional receptors for nucleotides 
and nucleosides, qualitative changes in intracellular Ca^ "^  levels were monitored as an 
indicator of receptor activation. mBMMC at a concentration of 0.5x10'/ml were 
incubated with the inactive, esterated (AM) form of the fluorescent probe Fura-2, which 
can passively diffuse across cell membranes. Once inside the cell, Fura-2-AM is cleaved 
by esterases resulting in the active cell impermeable indicator Fura-2. The excitation 
peak for Fura-2 shifts from 380 nm in the absence of Ca^^ to 340 nm in the presence of 
Ca^^. Changes in the 340/380 fluorescence ratio emitted from labelled mBMMC were 
monitored for a maximum of 150 seconds post receptor stimulation and are displayed as 
an indicator of changes in cytosolic Ca^^ levels. 
To investigate the presence of functional PI receptors, of which there are four 
different sub-types (Ai, AzA, A2B and A3), Fura-2-AM-loaded mBMMC were stimulated 
with the PI receptor ligands adenosine and inosine. Stimulation of mBMMC with the 
A3 receptor ligand, inosine, at concentrations ranging from 1 mM to 100 nM did not 
induce any changes in levels of cytosolic Ca^^ (Figure 3-9). This suggests inosine does 
not activate an intracellular signalling pathway that leads to an increase in intracellular 
Ca^^ levels. In contrast, adenosine, the PI receptor agonist capable of signalling via all 4 
receptor sub-types (A,, Aia, A2B and A3) elicited rapid, sustained elevations in 
intracellular Ca^^ levels in a dose dependent manner when used at concentrations 
ranging from 1 mM to 1 |iM (Figure 3-9). Only a very small increase in cytosolic Ca^^ 
levels were observed when 1 jiM concentrations of adenosine were used, and no changes 
in Ca^ "^  levels were seen when 100 nM concentrations of adenosine was applied to the 
mBMMC (Figure 3-9). 
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Figure 3-9 Calcium mobilisation in mBMMC stimulated with nucleosides 
Calcium mobilisation induced by stimulation of 0.5 x 10^ fura-2-AM loaded 
mBMMC with the indicated concentration of inosine and adenosine. Traces 
display the 340/380 fluorescence ratio emitted at 510 nm over a time period of 
150 seconds. The depicted results are from single experiments representative of 
at least three performed. 
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3.2.3.1 Pharmacological characterisation of PI receptor sub-types 
To further investigate which PI receptor sub-type adenosine was signaUing via, 
a range of PI receptor antagonists and agonists were used. A standard method of pre-
incubating the antagonist with fura-2-AM-loaded mBMMC for at least 10 minutes at 
37°C was used for all experiments described. Many of the antagonists used were only 
soluble in non-physiological vehicles such as DMSO and ethanol (as detailed in the 
Materials and Methods section) which can interfere with normal cell function. To 
ensure the effect of all the antagonists tested were due to intrinsic antagonistic 
properties and not the vehicle they were dissolved in, mBMMC were pre-incubated with 
the relevant concentration of vehicle alone and stimulated with the nucleotide as a 
positive control. 
To determine whether adenosine was signalling via the A, receptor, the 
competitive Ai receptor antagonist DPCPX was used. A small reduction in adenosine 
(100 |iM) induced Ca^ "^  mobilisation was observed when 1 mM concentrations of 
DPCPX were used (Figure 3-10). However, DPCPX was unable to completely 
antagonise adenosine (100 |iM) induced Ca"^ mobilisation in mBMMC at 
concentrations ranging from 1 mM to 100 |iM (Figure 3-10). Considering DPCPX has 
previously been reported to antagonise Ai receptors in a variety of rat cell types with K| 
values in the low nM range (Lohse et ah, 1987), it appears unlikely that the A] receptor 
is mediating the adenosine induced Ca^^ flux. This is consistent with the RT-PCR data, 
where expression of the Ai receptor was not detected. 
To investigate the involvement of the A;* receptor in adenosine mediated 
mobilisation, the receptor antagonist ZM241385 was utilised. ZM241385 was pre-
incubated with mBMMC at concentrations ranging from 1 mM to 1 ^M. Wlien used at 1 
HM, ZM241385 was capable of partially reducing adenosine (100 |iM)-induced Ca^^ 
mobilisation (Figure 3-10). Concentrations of ZM241385 at and above 10 p.M 
completely inhibited adenosine induced Ca^ "^  mobilisation (Figure 3-10). Concentrations 
of ZM241385 below 1 |a,M are required to inhibit the rodent A2a receptor (Poucher et 
al., 1995; Koshiba et al, 1997). Hence the results observed here do not conclusively 
confirm the involvement of the A2a receptor. 
To characterise the involvement of the Aas receptor in adenosine mediated Ca^ ^ 
mobilisation, the relatively widely used antagonist of murine Aig receptors ailoxazine, 
and a recently described Azs receptor antagonist MRS 1754, were tested in the Ca^^ 
mobilisation system. Ailoxazine inhibited Ca^^ mobilisation in a dose-dependent 
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Figure 3-10 Calcium mobilisation in mBMMC pre-incubated with PI 
receptor antagonists and stimulated with adenosine 
Calcium flux induced by pre-incubating 0.5 x 10^ fura-2-AM loaded mBMMC 
for 10 minutes with the indicated concentration of the A, receptor antagonist 
DPCPX, the Aja receptor antagonist ZM241385 and the A g^ receptor antagonist 
Alloxazine. Calcium flux was subsequenfly induced by stimulation with 100 pM 
adenosine in the presence and absence (control) of antagonist. Traces display the 
340/380 fluorescence ratio emitted at 510 nm over a time period of 150 seconds. 
The depicted results are from single experiments representative of at least three 
performed. 
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manner and completely blocked 100 |j,M adenosine elicited mobilisation when 
used at 100 |iM concentrations (Figure 3-10). The specificity of alloxazine for murine 
A2B receptors is relatively low. Previous reports have concluded that it is only 9-fold 
more selective for the Aib receptor than for the Az* receptor (Brackett et al, 1994). 
Hence the antagonistic effect may be attributed to interactions with A2B or other PI 
receptors. 
The A2B receptor antagonist, MRS 1754, at concentrations ranging from 10 to 
100 p,M was unable to block either 10 jiM or 100 p,M concentrations of adenosine-
induced Ca^^ mobilisation in mBMMC (Figure 3-11). MRS 1754 has been shown to 
have excellent selectivity at human Azs receptors but is only 8.5 fold more selective for 
rat A2B receptors than for Ai receptors (Kim et al, 2000). However, no antagonism was 
observed, potentially indicating that neither the Ais nor Ai receptors are mediating the 
adenosine-induced increase in cytosolic Ca^ "^ . 
To assess the contribution of the A3 receptor to adenosine-mediated calcium 
mobilisation, the A3 receptor-selective agonist IB-MECA was used. Notably, IB-MECA 
was able to induce mobilisation in mBMMC at concentrations ranging from 100 
|iM to 100 nM (Figure 3-12). As IB-MECA is a selective A3 receptor agonist at 
concentrations below 1 jiM (Fredholm et al., 2001), this result strongly supports the 
involvement of an active cell surface A3 receptor. To further investigate the 
involvement of the A3 receptor in adenosine mediated mobilisation, the moderately 
selective A3 receptor antagonist MRS 1523 was used. This antagonist inhibited 
adenosine induced mobilisation in a dose dependent manner at concentrations 
ranging from 100 |iM to 1 |iM (Figure 3-12). As this antagonist has been reported to 
inhibit the A3 receptor at 5 p,M concentrations (Gao et al., 2000), this potentially 
indicates adenosine is signalling via the A3 receptor in mBMMC. 
3.2.3.2 Pharmacological characterisation of P2Y receptor sub-types 
To investigate the presence of functional P2Y receptors, of which there are 
seven different sub-types (P2Yi, P2Y2, P2Y4, P2Y6, P2Y|2, P2Yi3 and P2Y14) Fura-2-
AM-loaded mBMMC were stimulated with a variety of P2Y receptor ligands. Each P2Y 
receptor has a different profile of selectivity and specificity for nucleotide 5'-
diphosphates and 5'-triphosphates. To initially determine whether mBMMC express any 
P2Y receptors that couple to pathways that induce increased cytosolic levels, cells 
were stimulated with a variety of different nucleotides at a range of concentrations. 
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Figure 3-11 Calcium mobilisation in mBMMC pre-incubated with the Ajg 
receptor antagonist MRS1754 and stimulated with adenosine 
Calcium flux induced by pre-incubating 0.5 x 10^ fura-2-AM loaded mBMMCs 
for 10 minutes with the indicated dose of the A2g receptor antagonist MRS 1754 
and subsequently stimulated with the indicated concentration of adenosine. 
Traces display the 340/380 fluorescence ratio emitted at 510 nm over a time 
period of 150 seconds. The depicted results are from single experiments 
representative of at least three performed. 
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Figure 3-12 Calcium responses of mBMMC stimulated with the A3 receptor 
agonist IB-MECA and the A3 receptor antagonist MRS 1523 
Calcium mobilisation induced by stimulation of 0.5 x lO'' fura-2-AM loaded 
mBMMCs with the indicated concentration of the A3 receptor specific agonist 
IB-MECA. 0.5 X IQG fura-2-AM loaded mBMMC were pre-incubated for 10 
minutes with indicated concentration of MRS 1523 and subsequently stimulated 
with 10 M adenosine. Traces display the 340/380 fluorescence ratio emitted at 
510 nm over a time period of 150 seconds. The depicted results are from single 
experiments representative of at least three performed. 
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Stimulation of mBMMC with AMP at concentrations ranging from 1 mM to 100 nM 
did not lead to any alterations of intracellular Ca^ "^  levels (Figure 3-13). This result is 
consistent with there being no known cell surface P2Y receptor for AMP (Abbracchio et 
al., 2005). Stimulation of mBMMC with ADP at concentrations ranging from 100 |iM 
to 10 nM stimulated a rapid, sustained increase in cytosolic Ca^^ levels and this effect 
was concentration-dependent (Figure 3-13). In theory, the ADP-induced signal could be 
mediated via multiple P2Y receptor sub-types that bind ADP. The P2Yi, P2Yi2 and 
P2Yi3 receptors can all be activated by ADP (von Kugelgen, 2006). As shown in Figure 
3-13, ATP at concentrations ranging from 100 |iM to 100 nM also induced rapid 
elevations in intracellular levels in mBMMC. The magnitude of the Ca~^ response 
induced was dependent on the concentration of ATP (Figure 3-13). ATP could be 
signalling via a variety of murine P2Y receptor sub-types, as it preferentially binds to 
the P2Y2 and P2Y4 receptors and to a lesser extent the P2Yi and P2Yi3 receptors. In 
addition, ATP can also signal via ligand-gated ion channel P2X receptors. 
To detemiine whether mBMMC have functional cell surface P2Y receptors 
responsive to uridine nucleotides, cells were stimulated with UMP, UDP and UTP. 
UMP at concenfrations ranging from 1 mM to 100 nM did not induce any alterations in 
cytosolic Ca^ "^  levels (Figure 3-14). This is consistent with there being no known 
purinergic receptor that binds to UMP. UDP at concentrations at and above 100 jj.M 
elicited rapid sustained increases in intracellular Ca^^ levels (Figure 3-14). UDP signals 
via the P2Y6 receptor and can also signal via the CysLTl receptor, so it is likely that 
mBMMC express either one or both of these receptors at the cell surface. UTP at 
concentrations at and above 10 |iM was also capable of inducing Ca^^ mobilisation in 
mBMMC in a concentration-dependent manner (Figure 3-14). The P2Y2, P2Y4 and 
P2Y6 receptors can all bind, and be activated by, UTP. Hence it is possible that any 
one, or a combination, of these receptors could be mediating the UTP-induced Ca^^ 
mobilisation in mBMMC. 
The data suggested that a wide variety of active P2Y receptors are 
present on the mBMMC surface as indicated by their responsiveness to ADP, ATP, 
UDP and UTP. To determine which receptor sub-type(s) each nucleotide was signalling 
via, a range of antagonists and agonists were utilised. To confirm ADP was signalling 
via P2Y receptors, the broad specificity P2Y receptor antagonists PPADS and Suramin 
were employed. Both antagonists, when used at concentrations at and above 100 )j.M 
completely blocked 1 jj.M ADP-induced Ca^^ mobilisation (Figure 3-15). Lower 
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Figure 3-13 Calcium mobilisation in mBMMC stimulated with adenine 
nucleotides 
Calcium mobilisation induced by stimulation of 0.5 x lO*" fura-2-AM loaded mBMMC 
with the indicated dose of AMP, ADP and ATP. Traces display the 340/380 
fluorescence ratio emitted at 510 nm over a time period of 150 seconds. The depicted 
results are from single experiments representative of at least three perfomied. 
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Figure 3-14 Calcium mobilisation in mBMMC stimulated with uridine 
nucleotides 
Calcium flux induced by stimulation of 0.5 x lO'^  fura-2-AM loaded mBMMC with 
the indicated dose of UMP, UDP and UTP. Traces display the 340/380 fluorescence 
ratio emitted at 510 nm over a time period of 150 seconds. The depicted results are 
from single experiments representative of at least three performed. 
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Figure 3-15 Calcium mobilisation in mBMMC pre-incubated with P2Y receptor 
antagonists and stimulated with ADP 
0.5 X 10^ fura-2-AM loaded mBMMC were pre-incubated for 10 minutes with the 
indicated dose of the non-sub-type specific purinergic receptor antagonists PPADS 
and suramin, and the P2Y;2 receptor antagonist MRS2395. Calcium flux was 
subsequently induced by stimulation with 1 )aM ADP in the presence and absence 
(control) of antagonist. Traces display the 340/380 fluorescence ratio emitted at 510 
nm over a time period of 150 seconds. The depicted results are from single 
experiments representative of at least three performed. 
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concentrations of suramin and PPADS (less than 100 j^ M) inhibited ADP induced 
calcium mobilisation in a dose-dependant manner (Figure 3-15). This indicates that 
ADP was signalling via P2Y receptors and also implies that ADP was not being 
metabolised to adenosine (which would activate A3 receptors) by cell surface 
extonucleotidases. To identify the specific P2Y receptor mediating the ADP-induced 
mobilisation, the P2Yi2-specific receptor antagonist MRS2395 was used. As 
shown in Figure 3-15, MRS2395 could only inhibit ADP (1 |j,M) induced Ca^^ 
mobilisation when used at 1 mM concentrations. Previous studies have found MRS2395 
to antagonise P2Yi2 receptors at low-|iM concentrations (Xu et ah, 2002). Hence, it is 
likely that the antagonistic effects observed using 1 mM concentrations of MRS2395 
was due to non-selective P2Y receptor blockade and that P2Yi2 receptor activation is 
not involved in ADP-induced Ca^ "^  flux. 
ADP can also signal via the P2Yi receptor, so the P2Yi receptor antagonist 
A3P5PS was utilised in the Ca^^ mobilisation assays. A3P5PS completely inhibited 
ADP (1 |iM)-induced Ca^^ mobilisation when used at a concentration of 1 mM (Figure 
3-16). 100 |iM concentrations of A3P5PS partially reduced ADP-induced increases in 
cytosolic Ca^^, but had no effect when used at lower concentrations (Figure 3-16). 
Reports in the literature have also documented A3P5PS antagonising P2Y| receptors at 
concentrations in the 100 |iM range (Jin et al, 1998). Therefore, it is possible that the 
P2Yi receptor is mediating the ADP-induced Ca'^ mobilisation. To investigate this 
farther, the relatively newly described competitive P2Y] receptor antagonist MRS2179 
was utilised. This antagonist when used at concentrations at and above 10 |j.M 
completely inhibited ADP (1 |j.M)-induced Ca^ "^  flux (Figure 3-16). To determine 
whether this antagonist was capable of inhibiting higher concentrations of ADP, the 
experiment was repeated using 10 p,M and 100 jiM concentrations of ADP as the 
stimulus. When used at concentrations at and above 10 |J.M, MRS2179 was capable of 
inhibiting 10 |iM ADP elicited Ca^^ flux in a dose dependant manner (Figure 3-16). 
However, MRS2179 was unable to block 100 pM ADP induced Ca^^ mobilisation 
(Figure 3-16). Similar levels of antagonism using MRS2179 have been reported in the 
literature (Feng et al., 2004) indicating that this response is mediated, at least in part, by 
the P2Yi receptor. This is consistent with the RT-PCR data, where the P2Y| receptor 
was readily detectable. 
In order to ascertain whether UDP was signalling via a P2Y receptor, the broad 
specificity purinergic receptor antagonist PPADS and the PZYb receptor-specific 
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Figure 3-16 Calcium responses of mBMMC pre-incubated with the P2Y, receptor 
antagonists and stimulated with ADP 
0.5 X 10^ fura-2-AM loaded mBMMC were pre-incubated for 10 minutes with the 
indicated concentration of the P2Y] receptor antagonists MRS2179 and A3P5PS. Cells 
were subsequently stimulated with 1 piM or the indicated concentration of ADP. Traces 
display the 340/380 fluorescence ratio emitted at 510 nm over a time period of 150 
seconds. The depicted results are from single experiments representative of at least three 
performed. 
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antagonist MRS2578 were used. When mBMMC were stimulated with 100 |iM UDP, 
PPADS at concentrations at and above 10 |_iM completely inhibited intracellular calcium 
mobilisation (Figure 3-17) suggesting that UDP was signalling via a P2Y receptor. As 
shown in Figure 3-17, the more specific P2Y6 receptor antagonist MRS2578 inhibited 
UDP-induced fluxing when used at 100 p-M concentrations. Doses of MRS2578 lower 
than 100 p-M did not antagonise UDP-induced flux in mBMMC (Figure 3-17). To 
confirm whether the CysLTl receptor was also mediating the UDP-induced increases in 
cytosolic Ca^^ in mBMMC, the competitive CysLTl receptor antagonist MK-571 was 
used. Concentrations of MK-571 ranging from 1 pM to 100 pM were unable to 
completely inhibit UDP (100 |iM)-induced increases in cytosolic (Figure 3-17). 
Potentially, the relatively high concentration (100 p,M) of UDP required to activate the 
mBMMC may compete with the antagonist preventing it blocking receptor activation. 
Both mobilisation assays and electrophysiological studies were used to 
determine the P2Y/P2X receptors involved in mediating ATP-induced dose dependent 
elevations in cytosolic Ca^^ levels in mBMMC. To initially confirm the involvement of 
P2Y/P2X receptors, the broad specificity purinergic receptor antagonist suramin was 
utilised. As shown in Figure 3-18, 1 mM concentrations of suramin completely 
inhibited ATP (1 ^M) induced Ca^^ mobilisation in mBMMC. When used at 100 pM 
concentrations, suramin partially inhibited Ca^ "^  mobilisation in mBMMC and had no 
effect when used at lower doses (Figure 3-18). Previous reports have shown that rat 
P2X receptors are not inhibited by 100 pM concentrations of suramin (Buell et ai, 
1996), but P2Y receptors are (von Kugelgen, 2006). This potentially indicates the 
involvement of P2X receptors. To investigate this further, specific P2X receptor 
antagoinsts were used. 
To examine whether the P2Xi receptor was participating in ATP-induced Ca^ "*" 
mobilisation, the partially selective P2Xi receptor antagonist TNP-ATP was used. This 
antagonist completely inhibited 1 |iM ATP-induced Ca^^ mobilisation when used at 
concentrations ranging from 100 pM to 1 mM (Figure 3-18). 10 |iM concentrations of 
TNP-ATP partially inhibited the stimulatory effects of ATP and lower concentrations 
had no antagonistic effects (Figure 3-18). TNP-ATP has been reported to antagonise 
P2Xi and P2X3 receptors at low nM concentrations (Virginio et al., 1998). Considering 
that 100 pM concentrations of TNP-ATP were required to inhibit ATP-induced Ca^ ^ 
mobilisation in mBMMC, it is unlikely the P2X| or P2X3 receptors mediate ATP 
signalling. As the P2X7 receptor has been associated with ATP evoked signalling in 
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Figure 3-17 Calcium mobilisation in mBMMC pre-incubated with P2Yg 
receptor antagonists and CysLTl receptor antagonist stimulated with UDP 
0.5 X 10^ fixra-2-AM loaded mBMMC were pre-incubated for 10 minutes with 
the indicated concentration of the non-sub-type specific purinergic receptor 
antagonist PPADS and the P2Y^ receptor specific antagonist MRS2578. Cells 
were subsequently stimulated with 100 jiM UDP. Traces display the 340/380 
fluorescence ratio emitted at 510 nm over a time period of 150 seconds. The 
depicted results are from single experiments representative of at least three 
performed. 
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Figure 3-18 Calcium mobilisation in mBMMC pre-incubated with P2X receptor 
antagonists and stimulated with ATP 
0.5 X 10^ fura-2-AM loaded mBMMC were pre-incubated for 10 minutes with the 
indicated concentration of the non-sub-type specific purinergic receptor antagonist 
suramin, the P2X, receptor antagonist TNP-ATP and the P2%^ receptor antagonist 
BBG. Cells were subsequently stimulated with 1 piM ATP. Traces display the 
340/380 fluorescence ratio emitted at 510 nm over a time period of 150 seconds. The 
depicted results are from single experiments representative of at least three 
performed. 
murine mast cells previously (Bulanova et al., 2005), the P2X7 receptor antagonist BBG 
was also tested in the Ca^^ mobilisation experimental system. 1 mM concentrations of 
BBG partially inhibited ATP (1 )j,M)-induced Ca~^ mobilisation but at lower 
concentrations had no effect (Figure 3-18). BBG has been reported to inhibit rat P2X7 
receptors at concentrations in the nM range (Jiang et al., 2000) which is not consistent 
with the results seen in this study. This indicates the P2X7 receptor is unlikely to be 
mediating ATP induced Ca^^ mobilisation in mBMMC, which also correlates with the 
RT-PCR data where transcripts corresponding to the P2X7 receptor were not detected. 
3.2.3.3 Pharmacological characterisation of P2X receptor sub-types 
P2X receptors are membrane-bound ion channels that open in the presence of 
ATP and have been extensively characterised using electrophysiology (North, 2002). 
To confirm the involvement of P2X receptors in ATP-mediated mBMMC activation, 
electrophysiology studies were performed to determine whether ATP could induce 
current in mBMMC. As shown in Figure 3-19 (A), ATP (10 fxM) evoked current in 
patch clamped mBMMC, indicating the definite involvement of P2X receptors. The 
decline in the current elicited by ATP during the continued presence of ATP 
(desensitisation) was slow, which is indicative of P2X2 or P2X4 receptor activation 
(Garcia-Guzman et al., 1997; Seguela et al., 1996; Wang et al., 1996) [Figure 3-19 (A)]. 
The most useful distinguishing feature of ATP-evoked currents at P2X4 receptors is 
their potentiation by ivermectin (Khakh et al., 1999). To investigate the involvement of 
the P2X4 receptor further, ATP was applied to the mBMMC in the presence of 
ivermectin. As shown in Figure 3-19 (B), the application of ivermecfin (3 |iM) greatly 
increased the magnitude of current elicited by ATP and reduced the rate of 
desensitisation [compare the time scales in Figure 3-19 (A) and (B)]. This definitively 
indicates the involvement of the P2X4 receptor. The integrated values of current elicited 
in mBMMC when stimulated with ATP and ATP + ivermecfin are summarised in 
Figure 3-19 (C). To fiirther confirm the involvement of the P2X4 receptor, the effect of 
ivermectin on ATP-induced Ca^ "^  mobilisation was also investigated. mBMMC were 
pre-incubated for 10 minutes with 10 p-M ivermectin and subsequently sfimulated with 1 
|iM and 10 p-M concentrations of ATP. As shown in Figure 3-20, stimulation of 
mBMMC with ATP in the presence of ivermectin induced a more prolonged and 
sustained elevation in levels of intracellular Ca^^ than cells treated with ATP only 
(Figure 3-20). This was most notable when 10 pM concentrafions of ATP were used. 
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Figure 3-19 The ability of ATP to elicit currents in mBMMC 
Representative whole cell patch clamping recordings displaying 10 p.M ATP evoked 
inwardly rectifying current in (A) the absence and (B) the presence of 3 )u,M 
ivermectin. In (B), cells were incubated with ivermectin (black line) prior to and 
throughout the application of ATP (red line). (C) shows a bar chart display of the 
relative ability of the indicated concentration of ATP and ivermectin plus ATP, to elicit 
currents in mBMMC. Data shown are + s.d.m. of 4 separate experiments. Significant 
values are relative to cells treated without ivermectin ** p<0.01. 
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Figure 3-20 Calcium mobilisation in mBMMC pre-incubated with ivermectin 
and stimulated with ATP 
Calcium mobilisation induced by stimulation of 0.5 x 10^ fura-2-AM loaded 
mBMMCs pre-incubated with 10 |^ M ivermectin for 10 minutes and stimulated 
with 1 pM and 10 |iM ATP. Traces display the 340/380 fluorescence ratio emitted 
at 510 nm over a time period of 150 seconds. The depicted results are from single 
experiments representative of at least three performed. 
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This result correlates with the data recorded from the patch-clamping study and implies 
that ATP-induced mBMMC activation is mediated by the P2X4 receptor. 
3.2.4 The effects of T. spiralis ES and recombinant 5'-NT on mBMMC purinergic 
receptor activation 
It has been reported that T. spiralis secretes a range of nucleotide-metabolising 
enzymes which act on ADP, UDP, AMP and adenosine (Gounaris, 2002). As 
demonstrated in 'Section 3.2.3', mBMMC express functional purinergic receptors that 
can be activated by ADP, ATP, UDP, UTP and adenosine. T. spiralis secreted proteins 
(ES) could potentially modulate mBMMC purinergic receptor activation by degrading 
extracellular nucleotides/nucleosides thus limiting the concentration and type of 
nucleotides/nucleosides available to interact with mBMMC purinergic receptors. To 
investigate this hypothesis, adenosine, ADP, ATP and UDP were applied to mBMMC 
in the presence of T. spiralis ES or recombinant 5'-nucleotidase (5'-NT), and 
intracellular Ca^ "*" levels monitored. 
To establish that T. spiralis ES itself does not induce signalling events that lead 
to a rise in intracellular Ca^^ within the mBMMC, cells were stimulated in the presence 
or absence of ES. No alterations in cytosolic Ca^^ levels were observed [Figure 3-21 
(control)] indicating that ES can not directly activate the cells in a manner that would 
affect the Ca^^ mobilisation assay. To investigate the effects of T. spiralis ES on 
mBMMC PI receptor activation, a range of concentrations of adenosine were utilised in 
the presence of ES. As shown in Figure 3-21, T. spiralis ES prevented adenosine at 
either 1 |iM or 10 |iM concentrations inducing an increase in the level of cytosolic Ca^^ 
in mBMMC. This suggests that the T. spiralis ES can abolish mBMMC PI receptor 
activation. This effect could be mediated by the secreted adenosine deaminase, which 
can metabolise adenosine to inosine. The presence of T. spiralis ES did not alter Ca^^ 
mobilisation induced by 100 |j,M concentrations of adenosine (Figure 3-21). 
The effect of T. spiralis ES and the recombinant 5'-NT on UDP-induced Ca^ ^ 
mobilisation was also investigated. As shown in Figure 3-22, ES completely ablated 
UDP (100 |iM)-induced Ca^ "^  mobilisation in mBMMC. This effect could be attributed 
to the 5'-NT activity present in T. spiralis ES which can degrade extracellular UDP to 
UMP, thus preventing P2Y/CysLT receptor activation. To verify that this was due to the 
action of the T. spiralis 5'-nucleotidase, UDP was applied to the mBMMC in the 
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Figure 3-21 Calcium mobilisation in mBMMC stimulated with adenosine in 
the presence of T. spiralis ES 
Calcium mobilisation induced by stimulation of 0.5 x 10*" fura-2-AM loaded 
mBMMCs with the indicated concentration of adenosine in the presence or 
absence of 40 p,g/ml T. spiralis secreted products (ES) as described in the 
Materials and Methods section. Traces display the 340/380 fluorescence ratio 
emitted at 510 nm over a time period of 150 seconds. The depicted results are 
from single experiments representative of at least three performed. 
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Figure 3-22 Calcium mobilisation in mBMMC stimulated with UDP pre-
incubated with T. spiralis ES and recombinant 5-nucleotidase (5'-NT) 
Calcium mobilisation induced by stimulation of 0.5 x 10^ fura-2-AM loaded mBMMC 
with 100 )J.M UDP in the presence or absence of 40 |ig/ml T. spiralis secreted products 
(ES) and 10 |J.g/ml 5'-NT and 100 |iM UDP as described in the materials and methods 
section. Traces display the 340/380 fluorescence ratio emitted at 510 nm over a time 
period of 150 seconds. The depicted results are from single experiments representative 
of at least three performed. 
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presence of 5 or 10 jJ-g/ml recombinant 5'-NT. The presence of the recombinant T. 
spiralis 5'-NT alone, did not induce any changes in cytosolic Ca~^ levels (Figure 3-22), 
indicating that it was not directly activating the mBMMC in this assay. Application of 
either 5 |ig/ml or 10 ng/ml concentrations of 5'-NT reduced the magnitude of 
intracellular mobilised by UDP to virtually basal levels (Figure 3-22). This 
correlates with the results seen when UDP was applied to mBMMC in the presence of 
T. spiralis ES. This confirms that the ablation of UDP-induced mobilisation was 
due to the action of the T. spiralis 5'-NT, which catalyses the hydrolysis of UDP to 
UMP, thus preventing mBMMC P2Y6/CysLT receptor activation. 
In order to determine the effect of T. spiralis ES on ADP-induced Ca"^ 
mobilisation in mBMMC, 1,10 and 100 piM concentrations of ADP were applied in the 
presence or absence of ES. The presence of ES resulted in complete ablation of Ca^^ 
mobilisation in mBMMC stimulated with 1 |iM ADP (Figure 3-23). This suggests that 
ADP was metabolised, preventing activation of mBMMC ADP and adenosine 
receptors. The presence of ES did not alter the increase in cytosolic Ca""^  induced by 10 
p.M and 100 |iM concentrations of ADP (Figure 3-23). This suggests that the mBMMC 
were still being stimulated either by P2Y or PI receptors. This was investigated further 
by use of the A3 and P2Yi receptor antagonists MRS 1523 and MRS2179 respectively, 
at concentrations previously shown to antagonise mBMMC activation. As shown in 
Figure 3-23, the P2Yi receptor antagonist MRS2179 did not alter the level of cytosolic 
induced by 10 p,M ADP applied in the presence of ES. In contrast, preincubation of 
the mBMMC with the A3 receptor antagonist MRS 1523 completely inhibited Ca^^ 
mobilisation induced by 10 |iM ADP applied in the presence of ES (Figure 3-23). This 
result shows that the continued elevation in cytosolic Ca^^ levels observed when 10 )j.M 
ADP is used in the presence of ES, is due to activation of the A3 receptor by adenosine. 
When the same experiment was performed using 100 faM ADP, the preincubation of 
mBMMC with MRS2179 slightly reduced the level of cytosolic induced by ADP 
applied in the presence of ES (Figure 3-23). The A3 receptor antagonist partially 
inhibited mobilisation induced by 100 |iM ADP applied in the presence of ES, 
indicating that the Ca^^ mobilisation was mediated by both the A3 and P2Y| receptors at 
these concentrations (Figure 3-26). 
To further identify the role of T. spiralis 5'-NT in mediating the effects observed 
with ES on ADP (Figure 3-24), concentrations of ADP ranging from 1 |iM to 100 jxM 
were applied to mBMMC in the presence of 5 p,g/ml or 10 |ag/ml 5'-NT (Figure 3-24). 
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Figure 3-23 Calcium mobilisation in mBMMC pre-treated with the P2Y, and A3 
receptor antagonists and subsequently stimulated with ADP in the presence of T. 
spiralis ES 
0.5 X 10^ fbra-2-AM loaded mBMMC were pre-incubated for 10 minutes with 100 
|iM of the P2Y, receptor antagonist MRS2179 or 10 |^ M of the A3 receptor antagonist 
MRS 1523. Cells were subsequently stimulated with the indicated concentration of 
ADP in the absence or presence of 40 )j,g/ml T. spiralis secreted products (ES) as 
described in the Materials and Methods section. Traces display the 340/380 
fluorescence ratio emitted at 510 nm over a time period of 150 seconds. The depicted 
results are from single experiments representative of at least three performed. 
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Figure 3-24 Calcium mobilisation in mBMMC stimulated with ADP in the 
presence of T. spiralis recombinant 5'-nucleotidase (5'-NT) 
Calcium flux induced by stimulation of 0.5 x 10^ fura-2-AM loaded mBMMCs 
stimulated with the indicated concentration of ADP, in the absence or presence of 
5 and 10 |ig/ml 5'-NT as described in the Materials and Methods section. Traces 
display the 340/380 fluorescence ratio emitted at 510 nm over a time period of 
150 seconds. The depicted results are from single experiments representative of at 
least three performed. 
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The presence of either concentration of 5'-NT was sufficient to completely inhibit 1 |.iM 
ADP-induced calcium flux (Figure 3-24), indicating the prevention of P2Y and PI 
receptor activation. The magnitude of Ca^^ mobilisation induced by 10 jj-M and 100 [j-M 
concentrations of ADP was reduced in a dose dependent manner by the presence of 
increasing concentrations of 5'-NT (Figure 3-24). The continued fluxing observed when 
10 p,M and 100 |aM concentrations of ADP were applied to mBMMC in the presence of 
either concentration of 5'-NT implies cell surface P2Y and/or PI receptors were still 
activated. 
To determine whether activation of PI receptors by adenosine or activation of 
P2Y receptors by ADP was responsible for the continued fluxing observed in mBMMC 
stimulated with ADP in the presence of 5'-NT, the P2Y] receptor antagonist MRS2179 
and the Ag receptor antagonist MRS 1523 were utilised at concentrations previously 
shown to antagonise mBMMC activation. As shown in Figure 3-25, the P2Yi receptor 
antagonist MRS2179 did not alter the level of cytosolic induced by 10 piM ADP 
applied in the presence of 5'-NT. In contrast, preincubation of the mBMMC with the A3 
receptor antagonist MRS 1523 completely inhibited Ca^ "^  mobilisation induced by 10 p,M 
ADP applied in the presence of 5'-NT (Figure 3-25). This result shows that the 
continued elevation in cytosolic levels observed when 10 )j.M ADP was applied in 
the presence of 5'-NT, is due to activation of the A3 receptor by adenosine. When the 
same experiment was performed using 100 |iM ADP, the preincubation of mBMMC 
with MRS2179 did not noticeably alter the level of cytosolic induced by ADP 
applied in the presence of 5'-NT (Figure 3-25). The A3 receptor antagonist nearly 
completely inhibited mobilisation induced by 100 |iM ADP applied in the presence 
of 5'-NT, indicating the increase in cytosolic Ca^ "^  levels was mediated by the A3 
receptor (Figure 3-25). 
It has been reported that T. spiralis ES does not contain an enzyme capable of 
ATP hydrolysis (Gounaris. 2002). Hence, ATP is not expected to be hydrolysed by T. 
spiralis ES. To confirm this, two different concentrations of ATP were applied to 
mBMMC in the presence of ES. As shown in Figure 3-26 T. spiralis ES had no effect 
on ATP induced mobilisation. 
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Figure 3-25 Calcium mobilisation in mBMMC pre-treated with the P2Y, and A^ 
receptor antagonists and subsequently stimulated with ADP in the presence of T. 
spiralis recombinant 5'-nucleotidase 
0.5 X 10^ fura-2-AM loaded mBMMC were pre-incubated for 10 minutes with 100 |J.M 
of the P2Yi receptor antagonist MRS2179 or 10 |iM of the Ag receptor antagonist 
MRS 1523. Cells were subsequently stimulated with the indicated concentration of 
ADP in the absence or presence of 10 p-g/ml 5' -NT as described in the Materials and 
Methods section. Traces display the 340/380 fluorescence ratio emitted at 510 ran 
over a time period of 150 seconds. The depicted results are from single experiments 
representative of at least three performed. 
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Figure 3-26 Calcium mobilisation in mBMMC stimulated with ATP in the 
presence of T. spiralis ES 
Calcium flux induced by stimulation of 0.5 x 10^ fura-2-AM loaded mBMMCs 
with the indicated concentration of ATP in the absence or presence of 40 pg/ml 
T. spiralis secreted products (ES) as described in the Materials and Methods 
section. Traces display the 340/380 fluorescence ratio emitted at 510 nm over a 
time period of 150 seconds. The depicted results are from single experiments 
representative of at least three perfonned. 
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3.2.5 The effect of nucleotides on intracellular signalling pathways 
All cloned and functionally defined P1 and P2Y receptors are able to couple via 
a range of G-proteins that activate phospholipase C (PLC)-dependent pathways and 
stimulate or inhibit adenylyl cyclase activity. The specific downstream signalling 
transduction pathway is thought to depend not only on the purinergic receptor sub-type 
activated, but also on the cell type expressing the receptor (Ralevic and Bumstock, 
1998). However, some purinergic receptors, especially those of the PI receptors 
primarily signal via the same intracellular transduction pathways regardless of the cell 
type they are expressed in (Fredholm et al., 2001). Hence, characterisation of 
intracellular signalling pathways can aid determination of some mBMMC purinergic 
receptor sub-types. As shown thus far, adenosine, ADP, ATP, UDP and UTP can all 
induce increased levels of cytosolic Ca^ "^  in mBMMC. This suggests the involvement of 
the signalling enzyme phospholipase C (PLC), which induces an increase in inositol 
phosphates and leads to the mobilisation of Ca^ "^  from intracellular stores (Mak et al., 
2001). The increase in intracellular levels can then directly control cell function by 
activating other pathways. 
To investigate whether PLC was required for the mobilisation observed 
when nucleosides/nucleotides were applied to mBMMC, assays were performed using 
the PLC antagonist U73122. As a control for any potential non-specific action of 
U73122, the non-reactive analogue U73433 was used as a negative control. U73122 (10 
|iM) completely inhibited cytosolic mobilisation induced by 100 nM 
concentrations of ADP and ATP (Figure 3-27). When 1 tiM concentrations of ADP 
were used as stimuli, U73122 (10 jxM) inhibited the majority of the Ca^ "^  mobilisation 
response (Figure 3-27). In contrast U73122 (10 |iM) only partially inhibited 1 |iM ATP-
induced mobilisation (Figure 3-27). Preincubation of mBMMC with U73122 (10 
jiM) inhibited adenosine (10 |iM) and UDP (100 p-M) induced Ca^ "'" fluxing (Figure 3-
28). The negative control, U73433, had no negative effect on nucleofide induced 
calcium mobilisation in mBMMC (see Figures 3-27 and 3-28). These results suggest 
that mBMMC purinergic receptor activation by ADP, adenosine and UDP requires PLC 
activity for mobilisation of cytosolic Ca^^. Higher concentrations (1 piM) of ATP were 
not totally dependent on PLC activation for cytosolic Ca^^ mobilisation. This potentially 
indicates the involvement of P2X receptors that can directly allow the influx of 
extracellular Ca^^ without PLC activation. 
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Figure 3-27 Adenine nucleotide induced PLC related calcium mobilisation in 
mBMMC 
Calcium mobilisation was induced by application of the indicated concentration 
of nucleotide to 0.5 x 10^ fura-2-AM loaded mBMMC pre-incubated for 10 
minutes with the indicated dose of the PLC antagonist U73122, the inactive 
negative control analogue U73433 and media alone (control). Traces display the 
340/380 fluorescence ratio emitted at 510 nm over a time period of 150 seconds. 
The depicted results are fi-om single experiments representative of at least three 
performed. 
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Figure 3-28 UDP and adenosine induced PLC related calcium mobilisation in 
mBMMC 
Calcium mobilisation induced by stimulation of 0.5 x 10^ fura-2-AM loaded 
mBMMC pre-incubated for 10 minutes with the indicated dose of the PLC 
antagonist U73122 and the inactive negative control analogue U73433 and 
subsequently stimulated with the indicated concentration of 
nucleotide/nucleoside. Traces display the 340/380 fluorescence ratio emitted at 
510 nm over a time period of 150 seconds. The depicted results are from single 
experiments representative of at least three performed. 
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To determine whether these nucleosides and nucleotides could induce 
mobilisation of intracellular stores of Ca^^, assays were carried out in the absence of 
extracellular Ca^^. As shown in Figure 3-29, the absence of extracellular Ca~^ greatly 
reduced the level of cytosolic Ca^^ mobilised when mBMMC were treated with 10 [iM 
ADP and 10 p.M ATP. This suggests only a small proportion of cytosolic Ca^^ 
mobilised by purinergic receptors activated by ADP and ATP is from intracellular 
stores. The majority of the response is due to extracellular entering the cell. When 
mBMMC were stimulated with adenosine, UDP or UTP in the absence of extracellular 
Ca^^, no mobilisation of cytosolic was observed (Figure 3-29). Considering that 
the Ca^^ mobilisation induced by adenosine and UDP was dependent on PLC activation 
(Figure 3-28), it is likely that stores of intracellular Ca^^ were mobilised, but were 
beyond the limit of detection by the instrument used to monitor the assay. Similar to the 
results observed using ADP and ATP (Figure 3-27), the majority of the response was 
due to extracellular Ca^^ entering the cell. 
To determine whether adenosine, inosine, ADP and UDP exhibited their effects 
through receptors that also coupled to adenylyl cyclase stimulation, cAMP was 
measured in mBMMC incubated for 10 minutes with various concentrations of these 
nucleotides. As displayed in Figure 3-30 (A), adenosine and ADP at concentrations 
ranging from 1 |iM to 100 |iM were equipotent at increasing cAMP levels in a dose 
dependent manner. This suggests the purinergic receptors activated by adenosine and 
ADP couple to intracellular signalling pathways via G-proteins that stimulate adenylyl 
cyclase. 100 p-M concentrations of UDP were found not to stimulate cAMP 
accumulation (the adenylyl cyclase activator forskolin (10 |iM) was used as a positive 
control) [Figure 3-30 (B)]. This suggests G-proteins that stimulate adenylyl cyclase 
were not coupled to the receptor via which UDP was signalling. 
As presented earlier (Figure 3-21) application of adenosine (10 |J,M) in the 
presence of T. spiralis ES ablated Ca^^ mobilisation in mBMMC. To confirm this also 
prevented adenosine induced adenylyl cyclase accumulation, the experiment was 
repeated and cAMP measured. As shown in Figure 3-31 the addition of 10 |iM 
adenosine in the presence of T. spiralis ES prevented cAMP accumulation in mBMMC, 
indicating adenylyl cyclase was not activated. Inosine (10 |iM) did not induce adenylyl 
cyclase activation as no increases in cAMP were observed [Figure 3-31 (A)]. These 
results suggest that T. spiralis ES prevents mBMMC PI receptor activation by 
degradation of adenosine to inosine. To determine whether T. spiralis ES could also 
132 
1 1 1 1 I I 
10 |JM 
ATP 
10 |JM 
ADP 
1—1 1—1 
100 mM 
Adenosine 
1—1 1—1 
' — 
100 |iM 
UDP 
1—1 1—1 
K . 
1 1 1 1 
X ^ 
100 [iM 
UTP 
+ Ca2+ - Ca^ + 
1 Vertical scale bar represents 0.1 units (340/380 fluorescence ratio emitted at 510 nm) 
Horizontal scale bar represents 30 seconds 
Figure 3-29 The effect of extracellular calcium on purinergic receptor 
mediated calcium mobilisation in mBMMC 
Calcium mobilisation induced by stimulation of 0.5 x 10^ ' fura-2-AM loaded 
mBMMC with the indicated type and concentration of nucleoside/nucleotide in 
the presence or absence of 1 mM extracellular calcium. Traces display the 
340/380 fluorescence ratio emitted at 510 nm over a time period of 150 seconds. 
The depicted results are from single experiments representative of at least three 
performed. 
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Figure 3-30 Nucleotide induced adenylyl cyclase related signalling in 
mBMMC 
Accumulation of cAMP in mBMMC stimulated for 10 minutes with the indicated 
concentration of (A) adenosine and ADP and (B) 100 |JM UDP and 10 |JM 
forskolin. Data were analysed using the unpaired two-tail Student's (-test and 
represent the mean ± s.d.m of at least triplicate cultures. Significance values are 
shown relative to cells treated with media alone *** p< 0.001, ** p<0.01, * 
p<0.05. 
134 
0) 
1 
CD 
o 
X 
3 
ISOOn 
1000-
500-
Fi Fi 
Inosine 
Adenosine 
Adenosine + 
50 )ig/ml ES 
I 
0 10 
Concentration (|j,M) 
B 
^ 1250n 
o 10004 
CD 
o 
X 750-
500-
250-
0 
** 
** 
i T 
*** 
T 
- ES 
+ ES 
10 
ADP ()iM) 
100 
Figure 3-31 The effect of T. spiralis ES on adenosine and ADP induced 
adenylyl cyclase related signalling in niBMMC 
Accumulation of cAMP in mBMMC stimulated for 10 minutes (in the presence of 
10 |iM rolipram) with the indicated concentration of adenosine (A) and ADP (B) 
pre-incubated at 37 °C for 1 hour, in the presence/absence of 50 p,g/ml T. spiralis 
secreted proteins (ES). Data were analysed using the unpaired two-tail Student's t-
test and represent the mean + s.d.m of at least triplicate cultures. Significance 
values are shown relative to untreated cells ***p< 0.001, ** p<0.01 * p<0.05 and 
cells treated with the indicated concentration of nucleotide in the 
presence/absence of T. spiralis ES, f p<0.05. 
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inhibit ADP-induced adenylyl cyclase activation, ADP and ES were applied to 
mBMMC. As shown in Figure 3-31 (B), application of 10 and 100 p,M concentrations 
of ADP in the presence of ES did not abolish cAMP accumulation. This correlates with 
the Ca^^ flux data shown in Figure 3-23, where calcium was mobilised even in the 
presence of ES due to stimulation of PI receptors by adenosine. This suggests that 
continuous purinergic receptor stimulation was occurring in the mBMMC via both P2Y 
and PI receptors. 
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3.3 Discussion 
Mucosal mast cells are an important component of the immune response 
associated with the enteric stage of Trichinella spiralis infection. Recent work suggests 
that mucosal mast cells expressing mast cell protease-1 (mMCP-1) directly mediate the 
expulsion of T. spiralis adults from the intestine and contribute to the development of 
the local inflammatory response and the consequent enteropathy seen at this stage of the 
infection (Lawrence et al., 2004; Knight et al., 2000). The level of cellular damage 
caused by adult parasites migrating through the intestinal epithelium is likely to be 
substantial, and result in the release of an abundance of nucleotides and nucleosides into 
the extracellular environment. Considering that T. spiralis secretes nucleotide-
metabolising enzymes, and also the effects nucleotides and nucleosides have on mast 
cell function, it was of interest to determine whether T. spiralis ES could modulate mast 
cell purinergic receptor activation. 
This study was initially designed to characterise the type and nature of 
purinergic receptors present on mucosal mast cells. Mouse bone marrow derived mast 
cells (mBMMC) grown in the presence of transforming growth factor-|3i (TGF-Pi) are 
highly analogous to intestinal mucosal mast cells in that they express the mucosal mast 
cell-specific protease, mMCP-1 (Miller et al., 1999; Wright et al., 2002). An in vitro 
culture method utilising IL-3, IL-9 and SCF was used to generate mouse bone marrow-
derived mast cells (mBMMC) (Miller et al., 1999). Cultures were grown in the absence 
or presence of TGF-Pi and analysed in terms of purity and maturation state for three 
weeks of culture. 
Similar to the findings of Wright et al., (2002), the data presented here show that 
culture of bone marrow cells in the presence of SCF, IL-3 and IL-9, independent of 
TGF-Pi addition, resulted in -50% of cells differentiating into a c-kit-positive 
phenotype within four days. Approximately 25% of the total cell population expressed 
the FcsRI four days post-initiation of culture, which was similar to that recorded by 
Wright et al., (2002). Previous work by Gomez et al, (2005) reported that bone 
marrow-derived mast cells cultured with IL-3 and SCF, then supplemented with TGF-P, 
for 3 days only, resulted in a ~50 % decrease in surface FcsRI expression. In contrast to 
this report, no reduction in cell surface FcsRI expression was observed in day-14 
mBMMC cultured with TGF-Pi. This could potentially be explained by the presence of 
IL-9, which is thought to synergise with SCF in promoting mucosal mast cell 
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maturation (Miller et al., 1999), or be a reflection of the different culture conditions 
used. Consistent with other studies (Miller et al., 1999), after 2 weeks in culture the 
population of bone marrow cells consisted of granular, toluidine blue-positive cells. 
Transcripts corresponding to the mMCP-1 gene were detected by non-quantitative RT-
PCR in day-14 mBMMC regardless of the culture conditions used. This agrees with 
other studies that have suggested that the presence of IL-9 is associated with 
upregulated expression of mMCP-1, albeit to low levels (Miller at al., 1999; Eklund et 
al., 1993). Consistent with other studies, spontaneous secretion of mMCP-1 from 
mBMMC was massively upregulated in the presence of TGF-|3i (Miller et al., 1999; 
Wright et al., 2002). Together these results show day-14 mBMMC cultured in the 
presence of TGF-pi are mature, granular and of a mucosal phenotype. 
It has previously been reported that human and rodent mast cells express a 
variety of functional purinergic PI, P2Y and P2X receptor sub-types (Feng et al., 2004; 
Jaffar and Pearce,1990; Schulman et al., 1999; Tilley et al., 2000; Jin et al., 1997; 
Mellor et al., 2001 and 2003). In the current study, the profile of purinergic receptor 
sub-types functionally expressed by mucosal mBMMC was investigated. Non-
quantitative reverse transcriptase-PCR (RT-PCR) analyses showed that the mBMMC 
expressed a variety of purinergic receptor sub-types. Notably, the presence of TGF-Pi 
did not alter the type of purinergic receptors expressed by the mBMMC. This suggests 
that TGF-Pi cannot induce alteration of purinergic receptor transcription. Subsequently, 
all functional purinergic receptor characterisation studies were performed on mBMMC 
cultured in the presence of TGF-|3i. 
Changes in cytosolic Ca^^ levels were monitored in mBMMC as an initial 
indicator of active purinergic receptors at the cell surface. After binding to their cognate 
ligands, P2Y and PI receptors initiate signalling through multiple types of G-proteins 
(Communi et al., 2000; von Kugelgen, 2006; Fredholm et al., 2001b). This usually 
couples to stimulation of phospholipase C (PLC) followed by increases in inositol 
phosphates and mobilisation of Ca^^ from intracellular stores. Furthermore, Ca^ ^ 
released from intracellular stores can induce the entry of Ca^^ from the extracellular 
environment by activating cell-surface store-operated Ca^^ channels. Activation of these 
channels is linked to the depletion of IP3 sensitive Ca^^ stores and represents the 
principal Ca^^ entry pathway into the cell (Putney et al., 2001; Parekh et al., 1997). The 
exact activation pathway of these Ca^^ channels is still being unravelled (Lewis, 2007). 
ATP-induced opening of P2X receptors can also allow influx of external Ca^^ (North, 
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2002). The collective increase in cytosolic is critical to the induction of many 
different mast cell effector functions such as release of granular contents and 
chemotaxis (Hua et al., 2007; McCloskey et al., 1999; Gilfillan and Tkaczyk, 2006). 
Adenosine, ADP, ATP, UDP and UTP induced Ca^^ mobilisation in the 
mBMMC used in this study. A variety of agonists and antagonists were then used to 
elucidate which purinergic receptor sub-type(s) were activated by the 
nucleo sides/nucleotides tested. The reported effectiveness of a chosen 
agonist/antagonist critically depends on its affinity and selectivity for a species-specific 
receptor sub-type. Ideally, agonists and antagonists should differ in potency by at least 
two orders of magnitude at different receptors to be really usefiil in receptor 
classification. However, most purinergic receptor antagonists and agonists can bind to 
multiple receptor sub-types, and therefore cannot be used to definitively identify a 
receptor (Fredholm et al., 2001b; von Kugelgen, 2006). Still, the combined use of 
antagonists, agonists and characterisation of the intracellular signalling pathways 
activated can aid functional receptor sub-type identification. 
The known pharmacological profile of PI receptors is a valuable tool when 
deciphering the specific receptor sub-types activated. The Ai and AIA receptors have 
high affinities for adenosine and bind sub-micromolar concentrations; in contrast the 
AiB and A3 receptors have low affinity for adenosine and bind micromolar amounts 
(Fredholm et al., 2001a). These differences in ligand affinity have important 
implications, as tissue levels of adenosine are believed to increase into the micromolar 
range during periods of inflammation (Schrader and Gerlach, 1976; Mentzer et al., 
1975). In this study, concentrations of adenosine above 1|LIM activated cell surface 
adenosine receptors, implying the involvement of the A2B and/or A3 receptor. This 
correlates with the data obtained by RT-PCR, where of the PI receptors, only the A2B 
and A3 receptors were detected. This is consistent with other studies that have also 
observed the expression of the A2B and A3 receptors in other types of murine mast cells 
(Salvatore et al., 2000; Marquardt et al., 1994). 
To further confirm that the A] receptor was not mediating the adenosine induced 
cytosolic mobilisation, the competitive A, receptor antagonist DPCPX was used. 
DPCPX is widely used to identify the involvement of A] receptors in rat models, where 
it has been reported to antagonise Ai receptors with Kj values in the low nM range 
(Lohse et al, 1987). DPCPX only antagonised adenosine-induced Ca^' mobilisation 
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when used at 1 mM concentrations. This again suggests the lack of involvement of the 
Ai receptor. 
As many types of murine and human mast cells express functional A]* receptors 
(Marquardt et al, 1994; Salvatore et al, 2000; Feoktistov and Biaggioni, 1998; Suzuki 
et al., 1998) it was deemed important to investigate whether this receptor was involved 
in adenosine related signalling. ZM241385 is a widely used A2A receptor antagonist and 
was originally shown to competitively antagonise rat AiA receptors present in rat PC 12 
(adrenal pheochromocytoma cell line) cell membrane preparations. It exhibits 80-fold 
selectivity for AzA versus Ajb receptors, as well as 500-1000-fold and 500,000-fold 
selectivities for AzA versus Ai and A3 receptors, respectively (Boucher et al., 1995). 
Concentrations of ZM241385 at or above 10 pM were required to inhibit adenosine-
induced Ca'^ mobilisation in mBMMC. This is in contrast to the effects of this 
antagonist on murine T cells (Koshiba et al., 1997) and human cord blood derived mast 
cells (Suzuki et al., 1998), where lower concentrations of ZM241385 antagonise A2A 
receptor activation. However, considering A]A receptors are classically activated by 
sub-micromolar concentrations of adenosine (Fredholm et al., 2001a) and this receptor 
was not detected by RT-PCR analysis using mBMMC RNA, it appears unlikely that this 
receptor is mediating adenosine-induced mBMMC activation. 
Characterisation of Agg receptors has in the recent past been notoriously 
difficult. For this reason, a recently described AIB receptor antagonist MRS 1754 and a 
relatively widely used antagonist of murine A2B receptors, alloxazine, were tested in the 
Ca"^ mobilisation system. Originally described by Kim et al., (2000) MRS 1754 was 
found to have approximately 200-fold selectivity at human AzB versus A, and A3 
receptors. On the basis of the reported human data, all of the concentrations of 
MRS 1754 used would have been expected to block mBMMC A2B receptors. However, 
no inhibition of adenosine-induced Ca^ ^ mobilisation in mBMMC was seen. Currently, 
there have been no reports in the literature characterising the effects of MRS 1754 on 
murine or rat Aie receptors, so the species selectivity of this antagonist is unknown. 
To further investigate the involvement of the A2B receptor in adenosine-
mediated mobilisation, alloxazine was utilised. The experiments reported here 
demonstrated that 100 |J,M concentrations of alloxazine completely ablated adenosine-
elicited Ca^" mobilisation in mBMMC. This result is in keeping with other studies that 
reportedly required relatively high concentrations of alloxazine to inhibit the effects of 
adenosine (Nemeth et at., 2005). However, the antagonistic effects observed with 
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alloxazine needs to be interpreted with caution as a previous pharmacology study has 
shown it can also antagonise the murine A2A receptor and is only -9-fold more selective 
for the A2B receptor (Brackett and Daly, 1994). These results potentially implicate the 
involvement of the A2B receptor in adenosine-mediated signalling in the mBMMC used 
here. This correlates with the pharmacological profile of AIB receptor activation, and the 
RT-PCR data where the A2B receptor was readily detectable. 
To assess the contribution of the A3 receptor to adenosine-mediated Ca"^ 
mobilisation, A3 receptor-selective agonists and antagonists were used. IB-MECA is a 
potent selective agonist of A3 receptors at concentrations below 1 )j.M (Fredholm et al., 
2001a) and is 50-fold selective for rat A3 versus either Ai or Ajk receptors (Gallo-
Rodriguez et al., 1994; Jacobson et al., 1995). IB-MECA-induced Ca""" mobilisation in 
mBMMC at concentrations as low as 100 nM, which is consistent with concentrations 
of IB-MECA required to activate A3 receptor-mediated mobilisation in murine 
primary lung mast cells (Zhong et al, 2003). This result strongly supports the 
involvement of the A3 receptor in adenosine-mediated signalling and also correlates 
with the RT-PCR and ligand affinity data discussed earlier. To reinforce this 
conclusion, MRS 1523, a compound reported to be a moderately selective antagonist for 
the rat (but not human) A3 receptor, with a Ki of 519 nM was used (Li et al., 1998). This 
antagonist can also bind to Ai and A2A receptor sub-types (binding to A2B receptors has 
not been studied) and is only selective for the A3 receptor at concentrations at or below 
1 i^ M (Li et al., 1998). In this study, MRS 1523 inhibited adenosine-induced Ca^' 
mobilisation in mBMMC at concentrations at or above 1 p-M, which is consistent with 
the inhibitory action of this antagonist in other cell types (Gao et al., 2001). The 
stimulation of mBMMC with IB-MECA and the antagonism observed using MRS 1523, 
strongly indicate that the A3 receptor is the dominant PI receptor sub-type mediating 
adenosine-induced Ca^^ mobilisation. This also correlates with the RT-PCR data and 
adenosine affinity profile of mBMMC. Furthermore, this is also concordant with other 
studies using murine mast cells where A3 receptors are responsible for the effects seen 
with adenosine stimulation (Reeves et al., 1997; Tilley et al., 2000; Tilley et al., 2003; 
Zhong et al., 2003). 
The signal transduction mechanisms of adenosine-activated mBMMC were also 
investigated to help further determine the sub-types of PI receptors activated. It is 
generally regarded that A, and A3 receptors couple to G proteins that inhibit adenylyl 
cyclase, and AzA and Ais receptors couple to G proteins that stimulate adenylyl cyclase 
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(Fredholm et al., 2001b; Zhou et al, 1992). In this study, adenosine stimulated adenylyl 
cyclase and coupled to a PLC-dependent increase in cytosolic Ca^^ levels. Hence, it is 
likely that activation of the AzB receptor is occurring in parallel with A; receptor 
activation. Potentially, activation of A2B receptor-subtypes that stimulate adenylyl 
cyclase can mask the inhibitory effects of A3 receptor activation on adenylyl cyclase 
accumulation. This result re-enforces the concept that adenosine is signalling via more 
than one PI receptor, most likely the Ais and A3 receptors. 
The use of the PLC antagonist U73122 demonstrated that PLC activation was 
required for the adenosine-induced increase in cytosolic levels in mBMMC. 
However, in the absence of extracellular Ca^^, no increase in cytosolic levels was 
observed. This result was surprising, as PLC activation is required for the production of 
IP3 which functions to mobilise Ca^^ from intracellular stores such as the endoplasmic 
reticulum. This results in the release of into the cytosol that would be detected by 
Fura-2. It is likely that the amount of mobilised was too small to detect, but 
sufficient to induce the entry of ions from the extracellular environment. This 
probably occurs via stimulation of cell surface store-operated Ca^^ channels, which are 
activated to open when intracellular stores of Ca^^ are depleted (Lewis, 2007). 
Inosine is known to bind to heterologously expressed recombinant rat A3 
receptors in the range of 10-50 p,M, and couple to Ca^^ mobilisation and inhibition of 
adenylyl cyclase (Jin et al., 1997). However, in the experiments perfonned here, 
inosine could not induce mobilisation or alter the basal level of cAMP in 
mBMMC. This was unexpected, as the use of IB-MECA (the A3 receptor agonist) 
definitively confirmed active A3 receptors were present on the mBMMC surface, and 
RT-PCR showed the receptor was expressed. Potentially, the A3 receptor expressed by 
mBMMC may not respond to inosine. Alternatively, inosine may bind to A3 receptors 
on mBMMC, but not activate a PLC-dependent signalling pathway that leads to an 
increase in intracellular Ca^^. The differential responsiveness of the A3 receptor to 
adenosine and inosine potentially suggests that the receptor can couple to alternate 
signal transduction pathways depending on the ligand bound. 
To determine whether T. spiralis secreted proteins (ES) could modulate 
mBMMC PI receptor activation, adenosine and ES were applied to mBMMC and 
cytosolic Ca^ "^  levels monitored. Previous biochemical analysis of T. spiralis ES has 
confirmed the presence of a secreted adenosine deaminase (ADA) capable of 
deaminating adenosine to inosine and ammonia (Gounaris, 2002). T. spiralis ES 
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inhibited <10 |iM concentrations of adenosine mediating mBMMC activation in terms 
of adenylyl cyclase stimulation and cytosolic mobilisation. This effect could be 
attributed to the action of the T. spiralis ADA which would deaminate adenosine to 
inosine. The accumulation of inosine would not induce increased levels of intracellular 
or stimulate adenylyl cyclase in mBMMC. Stimulation of mBMMC with higher 
(100 |J,M) concentrations of adenosine was not altered in the presence of ES, indicating 
adenosine levels were still sufficiently high enough (>1 |j,M) to activate A3/A2B 
receptors. Considering that the specific activity of the adenosine deaminase in T. 
spiralis ES is relatively low (51 mU/mg of ES, where 1 unit is equivalent to the 
deamination of Ijimol adenosine/minute) (Gounaris, 2002), this could account for the 
continued mobilisation of Ca^^ observed when 100 |iM concentrations of adenosine was 
applied in the presence of ES. The results displayed here have definitively shown that T. 
spiralis secreted proteins can modulate mBMMC activation by altering the amount of 
adenosine available to interact with PI receptors. Secretion of adenosine deaminase by 
T. spiralis during the enteral stage of infection may function to interfere with adenosine-
mediated signalling in host mucosal mast cells. This could interfere with mast cell 
effector functions mediated by adenosine, and potentially lead to the enhanced survival 
of the parasite. 
To characterise the specific P2Y receptors mediating the effects of adenine and 
uridine nucleotides, a range of general and selective P2Y receptor antagonists were 
used. The mBMMC used in this study responded to low (100 nM) concentrations of 
ADP. Non-selective P2Y receptor antagonists PPADS and suramin blocked ADP-
mediated signalling, confirming the involvement of P2Y receptors. This also indicated 
that ADP was not hydrolysed by cell surface ecto-nucleotidases to adenosine which 
could in turn activate PI receptors. ADP is known to signal via murine P2Y|, P2Y|2 and 
P2Yi3 receptors (Tokuyama et al., 1995; von Kugelgen et ai, 2001; Zhang et al., 2002), 
so receptor selective antagonists were used to further define the involvement of these 
receptor sub-types. The recently described P2Y|2 receptor antagonist MRS2395 (Xu et 
al, 2002) failed to inhibit ADP-induced signalling when used at concentrations below 1 
mM. Considering that MRS2395 has previously been shown to inhibit ADP-induced 
aggregation in rat platelets with a Ki of 3.1 |iM (Xu et al., 2002), it is likely that the 
antagonistic results obtained using 1 mM concentrations of MRS2395 was due to non-
selective P2Y receptor inhibtion. This indicates the P2Y|2 receptor does not mediate the 
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effects of ADP, which correlates with the RT-PCR data where P2Yi2 receptor mRNA 
was not detected. 
The P2Yi receptor antagonist, A3P5PS, was subsequently used to identify a role 
for the P2Y] receptor in ADP-mediated signalling. Previously, A3P5PS has been found 
to block turkey erythrocyte P2Yi receptor-mediated responses (Boyer et al, 1996) and 
inhibit ADP (10 p,M)-induced shape change of human platelets when used at 
concentrations of 300 p,M (Jin et al., 1998). Concordant with these studies, A3P5PS was 
found to partially inhibit ADP-mediated responses in mBMMC when used at 100 |iM 
concentrations and completely blocked mobilisation when used at 1 mM 
concentrations, indicating the involvement of the P2Yi receptor. 
To farther confirm ADP was signalling via the P2Yi receptor, the more 
selective, competitive, P2Yi receptor antagonist MRS2179 was utilised. 
Pharmacologically relevant (10 jj,M) concentrations of MRS2179 (Boyer et al 1998; 
Waldo et al. 2002) completely blocked 1 juM and 10 jj.M concentrations of ADP-
mediated mobilisation. Considering that MRS2179 is known to be unresponsive at 
the P2Y2, 4, 5, 12 and 13 receptors (von Kugelgen, 2006) it can be suggested that the 
response to ADP is mediated by the P2Yi receptor. Overall, these data confirm the 
involvement of the P2Yi receptor and also correlates with the RT-PCR results where 
P2Yi receptor mRNA was readily detectable. 
Upon activation by ADP, P2Yi receptors couple via Gq proteins, leading to 
stimulation of PLC followed by increases in inositol phosphates and mobilisation of 
intracellular (von Kugelgen and Wetter, 2000). In concordance with the usual 
intracellular signalling pathway activated by P2Y| receptors, ADP at concentrations at 
or above 100 nM mediated PLC-dependent Ca^^ mobilisation in mBMMC. Slightly 
higher, 1 |iM concentrations of ADP were not totally dependent on PLC activation, 
potentially due to the incomplete inhibition of PLC by the antagonist U73122. 
Concentrations of ADP above 1 |j,M also stimulated adenylyl cyclase. This result 
correlates with a similar study using human cord blood-derived mast cells that reported 
that comparable concentrations of ADP initiated Ca^^ fluxing and adenylyl cyclase 
activation via the P2Yi receptor (Feng et al., 2004). The majority of intracellular Ca^^ 
mobilised by ADP in mBMMC was due to the influx of extracellular Ca^ ^ . This 
suggests ADP activation of the P2Yi receptor induced rapid release of Ca^ ^ from the 
endoplasmic reticulum store, followed by a slow and sustained entry of extracellular 
Ca^^ through cell surface store-operated channels. This is consistent with other 
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studies that have reported store operated calcium channels in the plasma membrane of 
mast cells (Chang et aL, 2006; Prakriya and Lewis, 2003). As expected, AMP did not 
induce calcium mobilisation in mBMMC as there is no known receptor for AMP 
(Abbracchio etal, 2005). 
The nucleotide metabolising properties of T. spiralis ES are postulated to also 
alter the amount of ADP available to activate purinergic receptors. Consistent with this 
hypothesis, ES and the recombinant 5'-nucleotidase (5'-NT) completely inhibited ADP 
(1 |iM)-induced intracellular mobilisation in mBMMC. This result was replicated 
using the recombinant 5'-NT strongly suggesting that this was due to the specific-action 
of the 5'-NT which hydrolysed ADP to adenosine thus preventing activation of 
mBMMC P2Yi receptors. This also resulted in the accumulation of sub-micromolar 
concentrations of adenosine which were insufficient to activate As/AZg receptors. This 
effect was concentration dependent, as ES could not inhibit higher concentrations of 
ADP (>1 p.M) activating purinergic receptors that couple to Ca^^ mobilisation or 
adenylyl cyclase stimulation. 
The effect of ES and 5'-NT on ADP-induced mBMMC receptor activation was 
investigated further using P2Yi and A3 receptor antagonists. Inihibition of A3 receptors 
using MRS 1523 completely ablated Ca^^ mobilisation in mBMMC stimulated with 10 
|j,M ADP in the presence of ES. The prevention of P2Yi receptor activation indicates 
that the T. spiralis ES degraded all available ADP, resulting in the formation of 
adenosine which then activated A3 receptors on mBMMC. Although Ca^^ flux induced 
by 100 p,M concentrations of ADP was not altered by the presence of T. spiralis ES, the 
use of As and P2Yi receptor antagonists each partially reduced the level of cytosolic 
Ca^ "^  mobilised. This suggests that the T. spiralis ES did not degrade all of the available 
ADP, which would account for the small Ca^^ flux observed when the A3 receptor was 
blocked. Furthermore, adenosine accumulated to sufficient levels to also activate the 
mBMMC A3 receptor. To characterise the specific involvement of the T. spiralis 5'-NT 
in mediating the degradation of ADP, the experiment was repeated using the 
recombinant protein. Application of ADP in the presence of the 5'-NT and purinergic 
receptor antagonists showed the continued Ca^^ mobilisation was due to stimulation of 
A3 receptors by adenosine. This confirms that the T. spiralis S'-NT is the enzyme in T. 
spiralis ES responsible for ADP hydrolysis. 
As discussed earlier, T. spiralis ES can also inhibit adenosine-mediated 
mBMMC stimulation, putatively via the action of the adenosine deaminase (ADA). The 
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specific involvement of the ADA in the pathway of ADP hydrolysis in mBMMC 
activation is not fully clear. However, the results suggest that the rate of adenosine 
accumulation due to the metabolism of ADP by the 5'-NT occurs more rapidly than the 
rate of deamination of adenosine to inosine by the ADA. This is consistent with the 
ADA having a lower specific activity and rate of substrate hydrolysis than that of the 5'-
NT in T. spiralis ES (Gounaris, 2002). In summary, T. spiralis ES can modulate 
mBMMC purinergic receptor activation by preventing ADP activating P2Yi receptors 
and inducing stimulation of A3 adenosine receptors. Potentially, this could significantly 
perturb ADP-induced mBMMC functions. 
Considering mBMMC expressed functional P2Y receptors, it was of interest to 
determine whether they could also respond to uridine-nucleotides. As expected, UMP 
did not induce mobilisation, which is consistent with there being no known 
receptors for this nucleotide. UDP can signal via the murine P2Y6 receptor (Lazarowski 
et al., 2001), the human CysLTl receptor (Mellor et al., 2001) and the very recently 
described rat GPR17 receptor (Ciana et al., 2006). Nanomolar concentrations of UDP 
are required to stimulate cytosolic Ca^^ mobilisation in murine P2Y6 receptors 
heterologously expressed in human astrocytoma cells (Lazarowski et al., 2001). In 
contrast, another study has reported that the peak response due to P2Y6 receptor 
activation in neurons and glial cells was induced by much higher, 100 p,M 
concentrations of UDP (Calvert et al., 2004). Relatively high (100 fxM) concentrations 
of UDP induced PLC-dependent Ca^^ mobilisation in mBMMC, suggesting the 
mBMMC express functional low-affinity receptors for UDP. 
To determine whether UDP was signalling via a P2Y receptor the broad-
specificity antagonist PPADS was used. PPADS inhibited UDP-induced calcium 
mobilisation, which is consistent with other studies where similar concentrations of 
PPADS reduced UDP-induced activation of recombinant human P2Y6 receptors by 70% 
(Robaye et al., 1997). Of the P2Y receptors, UDP has been reported to only signal via 
the P2Y6 receptor (Lazarowski et al., 2001), hence the more selective, P2Y6 receptor 
antagonist MRS2578 was used. MRS2578 has an IC50 value of 98 nM at recombinant rat 
P2Y6 receptors expressed in human astrocytes (Mamedova et al., 2004). Currently, the 
competitive nature of this antagonist is unknown as there are no radioligands for the 
P2Y6 receptor (Mamedova et al., 2004). MRS2578 completely inhibited Ca^^ 
mobilisation in mBMMC when used at 100 |xM concentrations, implying the 
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involvement of the P2Y6 receptor. However, P2Y6 receptor mRNA was not detected by 
RT-PCR, indicating this receptor is not actively expressed in resting mBMMC. 
Nanomolar concentrations of UDP have recently been reported to be able to 
additionally signal via the CysLTl receptor in human mast cells (Mellor et al., 2001). 
The competitive CysLTl receptor antagonist MK-571 can totally inhibit equimolar 
concentrations of UDP-induced calcium mobilisation in human mast cells, and is 
reported to have no effect at P2Y6 receptors (Mellor et al., 2001). MK-571 partially 
reduced UDP-induced mobilisation in mBMMC when used at 100 pM 
concentrations, suggesting the CysLTl receptor may be mediating the UDP-induced 
response. This correlates with the RT-PCR data where CysLTl receptor mRNA was 
readily detectable. The CysLTl receptor PCR products generated using mBMMC 
cDNA as a template differed from the expected sizes. Partial sequence analysis of the 
two PCR products produced showed that only one of them corresponded to the CysLTl 
receptor. This indicates that mBMMC do express CysLTl receptor mRNA transcripts, 
but due to the primers binding non-specifically to the template cDNA, does not show 
which splice variant they express. 
In terms of intracellular signalling pathways activated in mBMMC, UDP 
signalled via a receptor coupled to a PLC dependent mobilisation of intracellular Ca^^, 
and did not couple to stimulation of adenylyl cyclase. This is consistent with either 
P2Y6 or CysLTl receptor activation which are both able to signal through the IP3 
pathway and couple to G-proteins that do not stimulate adenylyl cyclase (Lazarowski et 
al., 2001; Brink et al., 2003; Capra et al., 2006). All of the intracellular Ca^^ mobilised 
by UDP in mBMMC was due to the influx of extracellular Ca^^. This again suggests 
that receptors that were activated by UDP induced entry of extracellular Ca^^ tlirough 
cell surface store-operated Ca^^ channels. 
On the basis of the results discussed thus far, it is apparent that UDP is 
signalling via a P2Y receptor, most likely the P2Y6 receptor and perhaps also the 
CysLTl receptor. The dose-response profile of UDP is atypical, indicating that a low 
affinity receptor is expressed by the mBMMC. GPR17, a Gi-coupled orphan receptor at 
an intermediate phylogenetic position between P2Y and CysLT receptors, is specifically 
activated by micromolar concentrations of UDP and induces both adenylyl cyclase 
inhibition and intracellular Ca^ "^  increases (Ciana et al., 2006). Due to the very recent 
publication of the GPR17 receptor (Ciana et al., 2006), the expression of this receptor in 
147 
mBMMC was not investigated. However, involvement of this receptor in UDP-
mediated mBMMC activation cannot be ruled out. 
The T. spiralis 5'-NT preferentially hydrolyses UDP»ADP (Gounaris et al, 
2004). To investigate whether T. spiralis ES and recombinant 5'-NT could prevent 
UDP-induced receptor activation in mBMMC, UDP was applied to cells in the presence 
of ES. Interestingly, Ca^^ mobilisation in mBMMC was completely abolished. It was 
postulated that the 5'-NT present in the native ES was responsible for this effect by 
converting UDP to UMP and Pi, which would not stimulate the cells. This was shown to 
be highly likely as application of UDP in the presence of recombinant 5'-NT also 
inhibited UDP-induced Ca^^ flux. Notably, the T. spiralis ES and recombinant 5'-NT 
were able to inhibit UDP-induced signalling in mBMMC even though relatively high 
(100 )iM) concentrations of UDP were applied. This can be explained by the fact that 
mBMMC were insensitive to ten-fold lower concentrations of UDP. This suggests only 
10% of the UDP present had to be degraded to prevent receptor stimulation. In the 
parasitized intestine where extracellular nucleotides released from damaged cells would 
accumulate to high concentrations, the release of secreted 5'-NT by the parasite could 
decrease UDP levels to sub-100 |iM concentrations. This could be sufficient to prevent 
activation of intestinal mucosal mast cells. Potentially, this may affect mast cell effector 
function in a way that would aid parasite survival. 
The effect of UTP on Ca^^ mobilisation in mBMMC was also characterised as 
the cells expressed mRNA transcripts corresponding to the PZYz receptor, of which 
UTP is a principle agonist. UTP at concentrations at and above 10 p,M induced Ca^^ 
mobilisation in mBMMC, potentially signaling via PZY], or P2Y4 receptors (Lustig et 
al, 1993; Suarez-Huerta et al, 2001; Lazarowski et al., 2001 respectively). The profile 
of Ca^^ mobilisation in mBMMC in response to UTP was similar to that observed in 
human mast cells, where >5 |iM concentrations of UTP stimulated receptor activation 
(Feng et al, 2004). As there are currently no P2Y2 receptor selective 
antagonists/agonists, previous studies on human mast cells have concluded that UTP 
signals via the P2Y2 receptor mainly on the basis of RT-PCR data (Schulman et al, 
1999; Feng et al., 2004). In light of these studies and the RT-PCR data observed using 
mBMMC, it is likely that UTP also signals via the P2Y2 receptor in the mBMMC used 
here. The effects of P2Yi4 receptor ligands (such as UDP-glucose, UDP-Galactose, 
UDP-glucuronic acid and N-acetylglucosamine) on mBMMC activation were not 
investigated due to time limitations. Further work characterising the effects of these 
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ligands on P2Yi4 receptor activation in mBMMC could prove interesting as mBMMC 
expressed this receptor. 
ATP signals via a range of P2Y and P2X receptors. In the experiments reported 
here, the application of ATP at concentrations at or above 100 nM stimulated a rapid 
increase in cytosolic levels that required PLC activation. This indicates the 
presence of functional receptors on mBMMC that respond to ATP. This is consistent 
with other studies that have reported that murine, rat and human mast cells express 
functional P2Y and/or P2X receptors that respond to ATP (Bulanova et al, 2005; Jaffar 
and Pearce. 1990; Schulman et al., 1999; Feng et al, 2004). 
To aid characterisation of the P2X/P2Y receptor(s) involved in ATP-mediated 
mBMMC activation, the non-sub-type-selective antagonist suramin was used. ATP-
induced Ca^^ mobilisation in mBMMC was only completely inhibited by very high-1 
mM concentrations of suramin. This suggests the possible involvement of P2X4 
receptors, as they are not inhibited by concentrations of suramin up to 100 |iM (Buell et 
al., 1996). To further determine whether mBMMC express functional P2X receptors, 
the mBMMC were patch-clamped and stimulated with ATP. Electrophysiological 
studies (carried out by A. Mathie, G. Sutton and E. Veale) confmned that ATP elicited 
current in mBMMC, indicating activation of P2X receptors. Sustained application of 
ATP to mBMMC resulted in slow desensitisation, indicative of P2X2, P2X4 or P2X7 
receptor activation (North, 2002). Ivermectin is known to potentiate ATP elicited 
responses at the P2X4 receptor (Khakh et al., 1999) and when used in our experiments 
greatly enhanced the magnitude and length of ATP-evoked currents in mBMMC. 
Ivermectin also induced more sustained elevations in ATP-mediated mobilisation 
in mBMMC, further indicating the involvement of P2X4 receptors. These results are 
consistent with the RT-PCR data, where P2X4 receptor mRNA was the most abundant 
P2X receptor sub-type expressed by the mBMMC. 
As P2X7 receptors have recently been reported to be responsible for a range of 
effects on mBMMC cultured with IL-3 only (Bulanova et al., 2005), the PZX? receptor 
antagonist BBG was used. BBG did not antagonise ATP-induced cytosolic Ca^ "* 
mobilisation at pharmacologically relevant levels (Jiang et al., 2000). This suggests that 
the P2X7 receptor is not mediating the response observed using ATP, which also 
correlates with the RT-PCR data that suggested the P2X7 receptor was not expressed in 
mBMMC. 
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As the expression of P2Xi receptor mRNA was detected by RT-PCR, it was 
possible that this receptor was also functional at the mBMMC surface. The data 
discussed thus far indicates that this is unlikely as P2Xi receptors are known to be 
rapidly desensitised by ATP (North, 2002) and can be blocked by suramin (Evans et al, 
1995). However, to further investigate any potential involvement of the P2Xi receptor 
the semi-selective antagonist TNP-ATP was used. TNP-ATP can antagonise P2Xi and 
P2X 3 receptors at nanomolar concentrations and is at least 1000-fold less effective in 
blocking currents in cells expressing P2X2, P2X4, or P2X7 receptors (Virginio et al., 
1998). Concentrations of TNP-ATP at or above 100 p,M were required to inhibit ATP-
induced calcium mobilisation in mBMMC, indicating that it is unlikely the P2Xi 
receptor mediates ATP signalling. 
Application of ATP in the absence of extracellular Ca^^ induced a small 
mobilisation of Ca^^ from intracellular stores. However, the ATP-induced increase in 
cytosolic Ca^ '*' levels in mBMMC occurred mainly due to the influx of external Ca^^. In 
addition to being a stimulus for P2X receptors, ATP is also a ligand for G-protein 
coupled P2Y receptors, notably P2Yi, P2Y2 and P2Y4. These P2Y receptors can all 
couple through intracellular transduction pathways to activate PLC (Harden et al., 1995; 
Schachter et al., 1996, 1997). The increase in cytosolic Ca^^ induced by 100 nM 
concentrations of ATP was dependent on PLC activation. However, Ca^^ mobilisation 
induced by stimulation of mBMMC with higher concentrations of ATP (1 ^M) was 
only partially dependent on PLC activation. Considering P2X4 receptors operate as 
cation-selective channels permeable to Ca^^ (Soto et al., 1996), activation by ATP 
directly allows Ca^^ to enter the cell, acting parallel to the PLC response. Potentially, 
lower concentrations of ATP may be acting via P2Y receptors and higher concentrations 
via the P2X4 receptor. This could explain why PLC activation was not required at all 
concentrations of ATP tested. Alternatively, the PLC antagonist (U73122) may not have 
been able to fully inhibit such a strong stimulus. Further characterisation of the 
intracellular signalling pathways activated by ATP in mBMMC would prove interesting 
but was beyond the scope of this study. 
The secreted proteins of T. spiralis exhibit 5'-nucleotidase and apyrase activities, 
and as such can degrade nucleoside 5'-diphosphates and nucleoside 5'-monophosphates. 
In contrast, no ATPase activity against any nucleoside 5'-triphosphates has been 
detected in T. spiralis ES (Gounaris, 2004). However, T. spiralis larvae also secrete 
serine/threonine kinases and a nucleoside diphosphate kinase (NDPK) (Arden et al., 
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1997; Gounaris et al., 2001). These enzymes would utilise ATP, and the NDPK would 
convert ATP to ADP or UTP to UDP in the presence of nucleoside phosphate acceptors. 
To investigate the potential modulatory effects of T. spiralis ES on ATP-induced 
mBMMC activation, ATP was applied to mBMMC in the presence of ES. ATP-induced 
mobilisation of cytosolic Ca^^ in mBMMC was not affected by T. spiralis ES, which 
correlates with the lack of known ATPase activity present in ES. 
In summary, mast cells of a mucosal phenotype were successfully derived from 
murine bone marrow. These mBMMC expressed functional Azg, A3, P2Y|, P2Y2 and 
P2X4 receptors. The PZYg and CysLTl receptors were also putatively active at the 
mBMMC surface. Expression of these purinergic receptor sub-types enabled the 
mBMMC to respond to nanomolar concentrations of ADP and ATP, micromolar 
concentrations of adenosine and UTP, and 100 |iM concentrations of UDP. All of the 
nucleosides/nucleotides discussed induced influx of extracellular Ca""^  into the 
mBMMC. In terms of mast cell-function, the influx of Ca""^  is critical for mast cell 
degranulation (Hua et al., 2007; McCloskey et al., 1999; Gilflllan and Tkaczyk, 2006), 
indicating adenosine, ADP, ATP, UDP and UTP may directly induce mast cell mediator 
release. Importantly, T. spiralis ES was able to modulate mBMMC purinergic receptor 
activation by degrading extracellular ADP, UDP and adenosine. Overall, this appeared 
to generally result in reduced P2Y receptor activation, and increased PI receptor 
activation. This result shows for the first time that T. spiralis ES can directly modulate 
mast cell activation. 
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Chapter 4 
Modulation of purinergic receptor-induced mast cell effector 
functions by Trichinella spiralis secreted proteins 
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4.1 Introduction 
It has been known for many years that resolution of the intestinal phase of 
Trichinella spiralis infection is absolutely dependent on mucosal mast cells (Alizadeh 
and Murrell, 1984; Oku et al, 1984). Although the exact role of mast cells in parasite 
clearance from the intestine is yet to be fully defined, the effector functions of mucosal 
mast cells are central to the hosts' mucosal immune response (Pennock and Grencis, 
2006). Recent work suggests that mucosal mast cells contribute to intestinal pathology 
and amplify the protective Th2 immune response (Lawrence et al., 2004). Thus, the 
regulation of mast cell effector functions is crucial for efficient parasite expulsion. 
Mast cells contain cytoplasmic granules that store several preformed 
inflammatory mediators, such as TNF-a, histamine, heparin, serotonin, and proteases 
and other enzymes which are released immediately upon activation of mast cells after 
cross-linkage of FceRI (Benoist and Mathis, 2002; Piliponsky and Levi-Schaffer, 2000). 
Activation of mast cells also induces de Mow-synthesis of inflammatory mediators, 
including a plethora of pro-inflammatory cytokines, Th2 cytokines, immunoregulatory 
cytokines, chemokines, prostaglandins and leukotrienes (Benoist and Mathis, 2002; 
Piliponsky and Levi-Schaffer, 2000; Robbie-Ryan and Brown, 2002; Wedemeyer et al., 
2000). During T. spiralis infection, the release of these products from mucosal mast 
cells is thought to have drastic effects on the gut and can result in increased 
gastrointestinal motility, leukocyte recruitment and activation, and increased epithelial 
permeability (Khan and Collins, 2004; Broaddus and Castro, 1994; Moqbel et al., 1987; 
McDermott et al., 2003). It has recently become apparent that mucosal mast cells may 
also play an important role in amplifying the mucosal TH2 immune response during T. 
spiralis infection by releasing pre-formed and de novo synthesized mediators (Lawrence 
et al., 2004). The release of mediators such as TNF-a, amplify and perpetuate 
inflammatory responses through the recruitment of other cells (Wedemeyer et al., 2000; 
Yu and Perdue, 2001; Aoki et al., 1999; Stenton et al., 1998). TNF-a and mMCP-1 
production by mucosal mast cells are also thought to contribute heavily to the intestinal 
pathology observed during T. spiralis infection (Lawrence et al., 2004) 
Mast cells from a variety of sources are known to express a range of PI, P2Y 
and P2X receptors (Feng et al. 2004; Bulanova et al. 2005). Extracellular nucleosides 
and nucleotides such as adenosine, ADP, ATP, UTP and UDP can directly activate an 
array of mast cell effector functions. For example, inosine and adenosine acting via the 
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A] receptor can directly induce degranulation (Jin et al., 1997; Zhong et al., 2003) and 
prevent apoptosis of mast cells (Gao et al., 2001). ATP can induce the release of (3-
hexosaminidase and leukotrienes from mast cells (Sudo et al., 1996; Nakamura et al., 
1989; Saito et al., 1991b). Furthermore, high (1 mM) concentrations of ATP signalling 
via the P2X7 receptor can directly stimulate pro-inflammatory cytokine production and 
induce apoptosis in mast cells (Bulanova et al., 2005). UDP acting via the CysLTl 
receptor can induce pro-inflammatory cytokine production in mast cells primed with IL-
4 (Mellor et al., 2002). The P2Y receptor ligands, ADP, ATP and UTP are also 
effective chemoattractants for rat mast cells (McCloskey et al., 1999). 
In many scenarios, nucleosides and nucleotides acting via purinergic receptors 
do not directly stimulate immune cells, but 'fine-tune' immune responses already 
activated by other stimuli (La Sala et al., 2003). Activation of purinergic receptors on 
mast cells can modulate many different effector functions induced in response to other 
stimuli. For example, stimulation of the A3 receptor by adenosine results in 
amplification of FcsRI-mediated degranulation and cytokine production (Laffargue et 
al., 2002). ATP can also enhance anti-lgE-mediated histamine release from mast cells 
(Schulman et al., 1999). In other situations, nucleotides can inhibit mast cell effector 
functions. For example, ADP and ATP acting via P2Y receptors can inhibit cytokine 
generation in response to stimulation with peptidoglycan and leukotriene D4 (Feng et 
al., 2004). Although these studies are not all representative of mucosal mast cells, taken 
together they support the concept that mast cells in general express multiple purinergic 
receptor sub-types that can activate and modulate a range of mast cell effector fianctions. 
This is of significance when considering T. spiralis ES contains nucleotide metabolising 
enzymes which can alter mBMMC purinergic receptor activation (as discussed in 
Chapter 3). 
During the intestinal stage of T. spiralis infection, infective larvae invade the 
epithelium, moult, copulate and release new bom larvae, prior to expulsion from the 
intestine. The invasion process damages cells of the epithelium and is expected to 
liberate high concentrations of nucleotides and nucleosides into the extracellular 
environment. The faster and more efficient the host immune response is during this 
stage of the infection, the quicker the parasites are expelled, and the lower the chance of 
infective larvae successfully carrying out their life-cycle (Wassom et al., 1983; Goyal 
and Wakelin, 1993; Brown et al., 2003). Mast cells are a crucial component of the host 
immune response at this stage of the infection, and are required for efficient parasite 
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expulsion (Ha et ah, 1983; Donaldson et ah, 1996; Knight et al., 2000). Potentially, 
secretion of nucleotide metabolising enzymes by the parasite may serve to limit the 
activation of purinergic receptors on mucosal mast cells by hydrolysis of extracellular 
nucleosides and nucleotides. This could benefit parasite survival by restricting the 
activation of mast cell effector functions, which would slow-down the ensuing 
inflammatory response, potentially prolonging parasite persistence in the intestinal tract. 
As shown in chapter 3, mBMMC displaying a mucosal phenotype express 
functional PI, P2Y and P2X receptors that can be activated by a range of nucleosides 
and nucleotides. The aim of this chapter, therefore, was to investigate whether 
nucleosides and nucleotides could induce or modulate mast cell effector functions in 
vitro and determine whether T. spiralis secreted proteins could perturb these effects. 
The effects of nucleosides and nucleotides on major mucosal mast cell effector 
functions, such as degranulation, protease secretion, de novo cytokine generation and 
chemotaxis were characterised in vitro. The regulatory effects of T. spiralis secreted 
nucleotide metabolising enzymes on the type and availability of extracellular 
nucleotides able to activate mBMMC effector functions were also investigated. 
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4.2 Results 
4.2.1 Characterisation of mast cell secretory responses to stimulation with 
nucleosides and nucleotides 
Mast cells are densely packed with cytoplasmic granules that store a variety of 
preformed mediators that have diverse functions. Upon antigen-dependent stimulation, 
the enzyme ^-hexosaminidase (P-hex) is co-released with other pre-fomied mast cell 
effector molecules such as histamine, heparin proteoglycan, chondroitin sulphate E 
proteoglycan and leukotriene C4 (Razin et ah, 1983; Schwartz et al., 1979, 1981 and 
1982). As P-hex is associated with mast cell granules, the activity of this enzyme was 
measured as a general marker of mast cell degranulation. Murine mast cell protease-1 
(mMCP-1) is a crucial effector molecule required for efficient expulsion of T. spiralis 
from the intestine of parasitized animals (Knight et al., 2000). A substantial body of 
evidence exists to support the hypothesis that TGF-Pi plays a central role in mMCP-1 
secretion from mast cells by a mechanism that is distinct from antigen-mediated 
degranulation (Wastling et al., 1997; Miller et al., 1999; Wright et al., 2002). Although 
a significant proportion of mMCP-1 is secreted by a process that by-passes the secretory 
granules (Brown et al., 2003) mBMMC can also release mMCP-1 when sfimulated with 
general mast cell secretagogues such as compound 48/80 (De Jonge et al., 2004). Thus, 
it was deemed pertinent to investigate whether activation of purinergic receptors by 
nucleosides and nucleotides could induce mMCP-1 release from mBMMC. In order to 
assess the ability of nucleosides and nucleotides to induce the release of P-hex and 
mMCP-1, mBMMC were stimulated with a range of concentrations of nucleosides and 
nucleotides for a short 2-hour period. 
4.2.1.1 p-hexosaminidase release from mBMMC 
mBMMC that had been washed in DMEM to remove background levels of p-
hex activity were resuspended in fresh media and growth factors (lL-3, IL-9, SCF and 
TGF-Pi) to maintain cell viability. 2x10^ mBMMC were subsequently stimulated with a 
variety of different types of nucleosides and nucleotides at a range of concentrations. 
The level of P-hexosaminidase activity in mBMMC supematants and lysed mBMMC 
were measured to calculate the overall percentage release, which was calculated 
according to the formula [S/L] x 100, where S and L refer to the absorbance detected in 
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equal volumes of supernatant and lysed cells respectively, after subtraction of the 
background absorbance of media alone. 
The background level of spontaneous P-hex release from mBMMC was very 
low, as shown in Figures 4-1, 4-2 and 4-3. This indicates the cells were viable and had 
not degranulated prior to stimulation with the test agonist. To confirm the mBMMC 
were responsive to extracellular stimuli, the mBMMC were passively sensitised with 
anti-DNP IgE and subsequently stimulated with DNP-antigen to induce degranulation. 
mBMMC were also passively sensitised with anti-DNP IgE alone, to control for any 
potential effects the addition of IgE could have on the cells. As shown in Figures 4-1, 
4-2 and 4-3, the addition of anti-DNP IgE alone did not significantly alter the 
background level of spontaneous P-hex released from mBMMC. Cross-linkage of 
mBMMC FcsRI using anti-DNP IgE and DNP antigen induced a 29.6 ± 5.9 % increase 
in P-hex release (Figures 4-1, 4-2 and 4-3), indicating that the mBMMC have functional 
FcsRI. To confirm the responsiveness of mBMMC to non-antigen-dependent 
stimulation, the non-specific, polyamine mast cell secretagogue compound 48/80 
(c48/80) was also used as an additional positive confrol. c48/80 is thought to activate 
mast cells by directly stimulating Gi proteins (Mousli et al, 1989, 1990) and can induce 
degranulation resulting in P-hex release. As shown in Figures 4-1, 4-2 and 4-3, c48/80 
induced high levels of P-hex release (59.7 ± 10.7 %), further confirming the 
responsiveness of mBMMC to external stimuli. 
The nucleosides inosine and adenosine did not significantly alter p-hex release 
at any of the concentrations tested (Figures 4-1, (A) and (B) respectively). This 
indicates inosine and adenosine cannot activate intracellular signalling pathways that 
induce mBMMC degranulation. As displayed in Figure 4-2, the adenine nucleotides 
ADP and ATP could not induce P-hex release when used at concentrations ranging from 
1 to 10 p-M. However, at concentrations of 50 pM and 100 |iM, both ADP and ATP 
induced small, but statistically significant increases in P-hex release (Figure 4-2 (A) and 
(B) respectively). This suggests that adenine nucleotides at high micromolar 
concentrations can weakly induce exocytosis in mBMMC. Both ADP and ATP induced 
concentration dependent P-hex release from mBMMC, and this effect was maximal 
when 1 mM concentrations were used (37.6 ± 12.9% and 32.4 ± 7.2% for ADP and 
ATP respectively). These results suggest binding of ADP and ATP to purinergic 
receptors expressed on mBMMC, can couple to intracellular signal transducfion 
pathways that directly stimulate mBMMC degranulation. In contrast, the uridine 
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Figure 4-1 P-hexosaminidase release from mBMMC in response to 
nucleosides 
mBMMC were incubated for two hours with the indicated concentrations of (A) 
inosine and (B) adenosine. Released ^-hexosaminidase (|3-hex) was measured as 
described in the 'Materials and Methods' section and is displayed as a percentage 
relative to total cell content. 50 |ig/ml of the non-specific secretagogue c48/80 
and stimulation of the FceRI receptor by crosslinking IgE and antigen (IgE + Ag) 
were used as positive controls. Data were analysed using the unpaired two-tail 
Student's ^-test and represent two experiments, showing the mean + s.d.m of 
triplicate cultures. Significance values are shown relative to cells treated with 
media alone *** p< 0.001, ** p<0.01. 
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Figure 4-2 P-hexosaminidase release from mBMMC in response to adenine 
nucleotides 
mBMMC were incubated for two hours with the indicated concentrations of (A) 
ADP and (B) ATP. Released ^-hexosaminidase (P-hex) was measured as 
described in the 'Materials and Methods' section and is displayed as a percentage 
relative to total cell content. 50 |ig/ml of the non-specific secretagogue c48/80 
and stimulation of the FcsRl receptor by crosslinking IgE and antigen (IgE + Ag) 
were used as positive controls. Data were analysed using the unpaired two-tail 
Student's ?-test and represent two experiments, showing the mean + s.d.m of 
triplicate cultures. Significance values are shown relative to cells treated with 
media alone *** p< 0.001, ** p<0.01. 
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Figure 4-3 P-hexosaminidase release from mBMMC in response to uridine 
nucleotides 
mBMMC were incubated for two hours with the indicated concentrations of (A) 
UDP and (B) UTP. Released ^-hexosaminidase ((3-hex) was measured as 
described in the 'Materials and Methods' section and is displayed as a percentage 
relative to total cell content. 50 |ig/ml of the non-specific secretagogue c48/80 
and stimulation of the FcsRI receptor by crosslinking IgE and antigen (IgE + Ag) 
were used as positive controls. Data were analysed using the unpaired two-tail 
Student's r-test and represent two experiments, showing the mean + s.d.m of 
triplicate cultures. Significance values are shown relative to cells treated with 
media alone *** p< 0.001, ** p<0.01. 
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nucleotides, UDP and UTP, at concentrations ranging from 1 p,M to 100 |iM did not 
effect P-hex release (Figure 4-3), indicating that the mBMMC purinergic receptors 
activated by these nucleotides do not couple to intracellular signal transduction 
pathways that induce granule exocytosis. 
4.2.1.2 mMCP-1 release from mBMMC 
To determine whether nucleosides and nucleotides could induce the release of 
mMCP-1 from mast cell granules, mBMMC cultured in the absence or presence of 
TGF-Pi were stimulated with a range of concentrations of inosine, adenosine, ADP, 
ATP, UDP and UTP. The experiment was initially executed using mBMMC that had 
been cultured without TGF-Pi. This was performed to ensure the up-regulatory effect 
TGF-Pi has on mMCP-1 expression and secretion did not mask any potential 
modulatory effects of nucleosides and nucleotides on mMCP-1 release. To remove 
background levels of mMCP-1 and to maintain cell viability, mBMMC were washed in 
DMEM and re-suspended in fresh media and growth factors (IL-3, lL-9, SCF +/- TGF-
Pi). 2x10^ mBMMC were subsequently stimulated with a variety of different types of 
nucleosides and nucleotides at a range of concentrations, and mMCP-1 levels measured 
by ELISA. 
The background level of mMCP-1 release from mBMMC cultured without 
TGF-pi was low (0.9 ± 0.3 ng/ml) (Figures 4-4, 4-5 and 4-6), indicating that the cells 
were viable and had not degranulated prior to stimulation with the test agonist. Cross-
linkage of FcsRl using anti-DNP IgE and DNP-antigen was used as a positive control. 
This induced the secretion of 6.6 ± 1.4 ng/ml mMCP-1, which approximately equates to 
a 7.3 fold increase in mMCP-1 release (Figures 4-4, 4-5 and 4-6). This suggests that 
mBMMC can release mMCP-1 in response to antigenic stimuli. mBMMC were also 
passively sensitised with anti-DNP IgE alone, to control for any potential effects the 
addition of IgE could have on the cells. As shown in Figures 4-4, 4-5 and 4-6, the 
addition of anti-DNP IgE alone did not significantly alter the background level of 
spontaneous mMCP-1 released from mBMMC, suggesting IgE alone cannot induce 
mBMMC degranulation. 
As in the case of P-hex release (Figure 4-1), the nucleosides inosine and 
adenosine did not affect mMCP-1 release (Figure 4-4 (A) and (B) respectively). This 
implies inosine and adenosine cannot bind purinergic receptors that stimulate the release 
of mMCP-1-containing granules from mBMMC. In contrast, ADP and ATP induced a 
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Figure 4-4 mMCP-1 secretion by mBMMC (-TCF-P,) in response to 
nucleosides 
mBMMC cultured without TGF-(3| were stimulated with the indicated 
concentration of (A) inosine and (B) adenosine. Stimulation of the FceRl receptor 
by crosslinking IgE and antigen (IgE + Ag) was used as a positive control. Culture 
supematants were tested for mMCP-1 by ELISA. Data were analysed using the 
unpaired two-tail Student's f-test and represent two experiments, showing the 
mean + s.d.m of triplicate cultures. Significance values are shown relative to cells 
treated with media alone, *** p< 0.001. 
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Figure 4-5 mMCP-1 secretion by mBMMC (-TGF-P,) in response to adenine 
nucleotides 
mBMMC cultured without TGF-(3j were stimulated with the indicated 
concentration of (A) ADP and (B) ATP. Stimulation of the FcsRI receptor by 
crosslinking IgE and antigen (IgE + Ag) was used as a positive control. Culture 
supematants were tested for mMCP-1 by ELISA. Data were analysed using the 
unpaired two-tail Student's ^-test and represent two experiments, showing the 
mean + s.d.m of triplicate cultures. Significance values are shown relative to cells 
treated with media alone, *** p< 0.001, ** p<0.01. 
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Figure 4-6 mMCP-1 secretion by mBMMC (-TGF-P,) in response to uridine 
nucleotides 
mBMMC cultured without TGF-P, were stimulated with the indicated 
concentration of (A) UDP and (B) UTP. Stimulation of the FcsRl receptor by 
crosslinking IgE and antigen (IgE + Ag) was used as a positive control. Culture 
supematants were tested for mMCP-1 by ELISA. Data were analysed using the 
unpaired two-tail Student's f-test and represent two experiments, showing the 
mean + s.d.m of triplicate cultures. Significance values are shown relative to cells 
treated with media alone,*** p< 0.001. 
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dose-dependent increase in mMCP-1 release from mBMMC (Figure 4-5). ADP at 
concentrations ranging from 1 fxM to 100 pM induced a statistically significant increase 
in mMCP-1 secretion [Figure 4-5 (A)]. ATP at concentrations ranging from 10 |iM to 
100 |iM also induced a statistically significant increase in mMCP-1 release [Figure 4-5 
(B)]. This result suggests ADP and ATP activate purinergic receptors that induce 
mMCP-1 release. Furthermore, ADP and ATP appear to be more potent stimulators of 
mMCP-1 secretion than P-hex release (compare Figure 4-2 with Figure 4-5). As shown 
in Figure 4-6 (A), stimulation of mBMMC with UDP at concentrations ranging from 1 
|iM to 100 |j,M did not alter mMCP-1 release. In a similar manner, UTP at 
concentrations ranging from 1 |iM to 10 |iM could not induce increased mMCP-1 
release [Figure 4-6 (B)]. However, UTP at 100 (iM concentrations induced a statistically 
significant increase in mMCP-1 release from mBMMC [Figure 4-6 (B)]. 
To investigate whether the presence of TGF-Pi altered the effects of nucleosides 
and nucleotides on mMCP-1 secretion, the experiments were repeated using mBMMC 
cultured with TGF-Pi. Cultures maintained with TGF-[3i spontaneously secreted 
significantly higher basal levels of mMCP-1 than mBMMC cultured in the absence of 
TGF-Pi (0.27 ± 0.28 p,g/ml and 0.9 ± 0.3 ng/ml respectively) (compare Figure 4-1 with 
Figure 4-7). This was expected, as TGF-Pi is known to upregulate mMCP-1 secretion 
from mBMMC by 100-1000 fold (Miller et al., 1999). Antigen-dependent stimulation 
of mBMMC induced by cross-linkage of FcsRI using anti-DNP IgE and DNP-antigen, 
stimulated an approximately 9.6-fold increase in mMCP-1 release (Figures 4-7, 4-8, 4-
9). This shows that antigenic stimulation of mBMMC can induce the release of 
statistically significant amounts of mMCP-1. The presence of IgE alone did not 
significantly alter background levels of mMCP-1 secretion (Figure 4-7, 4-8, 4-9), which 
is consistent with the results obtained using mBMMC cultured without TGF-Pi. 
The addition of inosine and adenosine did not induce increased mMCP-1 
secretion from mBMMC [Figure 4-7 (A) and (B) respectively]. This is consistent with 
the results observed using mBMMC cultured without TGF-P, (Figure 4-4) and the P-
hex activity assays (Figure 4-1). 
As shown in Figure 4-8 (A) and (C), ADP and ATP respectively, at 
concentrations ranging from 10 p,M to 100 |LiM induced a dose dependent increase in 
mMCP-1 secretion from mBMMC. Again, this correlates with the results observed 
when mBMMC cultured without T G F - P J were used [compare Figure 4 - 5 (A) and (B) 
with Figure 4-8 (A) and (C)]. To confirm ADP and ATP were not metabolised by cell-
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Figure 4-7 mMCP-1 secretion by mBMMC in response to nucleosides 
mBMMC cultured with TGF-P, were stimulated with the indicated concentration 
of (A) inosine and (B) adenosine. Stimulation of the FcsRI receptor by 
crosslinking IgE and antigen (IgE + Ag) was used as a positive control. Culture 
supematants were tested for mMCP-1 by ELISA. Data were analysed using the 
unpaired two-tail Student's f-test and represent two experiments, showing the 
mean + s.d.m of triplicate cultures. Significance values are shown relative to cells 
treated with media alone, *** p<0.001 
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Figure 4-8 mMCP-1 secretion by mBMMC in response to adenine nucleotides and 
their analogues 
mBMMC were stimulated with the indicated concentration of (A) ADP, (B) ADP- pS, (C) 
ATP and (D) ATP-yS. Stimulation of the FcsRI receptor by crosslinking IgE and antigen 
(IgE + Ag) was used as a positive control. Data were analysed using the unpaired two-tail 
Student's r-test and represent two experiments, showing the mean + s.d.m of triplicate 
cultures. Significance values are shown relative to cells treated with media alone, *** p< 
0.001, ** p<0.01, * p<0.05. 
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Figure 4-9 mMCP-1 secretion by mBMMC in response to uridine nucleotides 
mBMMC were stimulated for 2 hrs with the indicated concentration of (A) UDP 
and (B) UTP. Stimulation of the FceRI receptor by crosslinking IgE and antigen 
(Ig+Ag) was used as a positive control. Data were analysed using the unpaired 
two-tail Student's ?-test and represent two experiments, showing the mean + s.d.m 
of triplicate cultures. Significance values are shown relative to cells treated with 
media alone, *** p< 0.001. 
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surface ecto-nucleotidases to a product that was responsible for the observed effects, the 
highly stable, non-hydrolysable nucleotide analogues ADP-PS and ATPyS were used. 
Both analogues at concentrations ranging from 10 |iM to 100 )a,M induced a dose-
dependent increase in mMCP-1 release [Figure 4-8 (B) and (D)], confirming that it was 
indeed ADP and ATP that induced the mMCP-1 release. 
UDP at concentrations ranging from 1 |iM to 100 |iM could not induce increased 
mMCP-1 secretion from mBMMC [Figure 4-9 (A)]. This correlates with the results 
observed when UDP was incubated with mBMMC cultured without TGF-P, [compare 
Figures 4-6 (A) with 4-9 (A)]. As shown in Figure 4-9 (B), UTP at concentrations 
ranging from 1 |iM to 100 |iM could not induce increased mMCP-1 secretion from 
mBMMC. The effects of UTP on mMCP-1 secretion from mBMMC appears to be 
inconsistent, as mBMMC cultured without TGF-Pi appeared to release mMCP-1 in 
response to high (100 |iM) concentrations of UTP [compare Figure 4-6 (B) with Figure 
4-9(B)]. 
4.2.1.3 Characterisation of P2Y receptor-induced mMCP-1 secretion 
As shown in Chapter 3, mBMMC express functional P2Y receptors that are 
responsive to a wide range of ADP concentrations (100 nM-1 mM). Furthermore, the 
use of antagonists pin-pointed the P2Yi receptor as the major P2Y receptor sub-type via 
which ADP was signalling. Considering ADP can induce mMCP-1 release from 
mBMMC, it was of interest to determine whether this also occurred via P2Y| receptor 
activation. To investigate this, the non-subtype-selective P2Y receptor antagonists 
suramin and PPADS, and the P2Yi-selective receptor antagonist MRS2179 were used. 
mBMMC were preincubated with the indicated concentrations of antagonist for 10 
minutes prior to stimulation with concentrations of ADP that induced statistically 
significant increases in mMCP-1 release. Unexpectedly, application of the antagonists 
alone (suramin, PPADS and MRS2179) induced a small but significant increase in the 
background level of mMCP-1 secretion (Figure 4-10). This could be an artefact of the 
experimental procedure, or indicate that the antagonists generally do slightly increase 
the basal level of mMCP-1 secretion. However, the small increase in background 
mMCP-1 levels did not interfere with the overall purpose of the experiment. 
Pre-incubation of mBMMC with suramin or PPADS significantly reduced the 
amount of mMCP-1 released in response to 10 |iM concentrations of ADP [Figure 4-10 
(A) and (B)]. These effects occurred in an ADP-concentration-dependent manner due to 
169 
2.5-1 
"05 
o 2.0-
<o o 
1.5-
rL 1.0-
0. 
O 0.5-
E 
0.0-
- Suramin 
+ Suramin 
ttt 
I 1 
*** 
I 
* 
Q 
* * * 
*** X, 
0 10 50 
ADP (|iM) 
B 
2.5n 
u 2.0-1 
o 
X 1.54 
§ 
1.0 -
Q. 
o 0.54 
0.0-
1 -PPADS 
I + PPADS 
ttt 
I 1 
o.ri 
1 
** 
a 
*** 
I 
10 
ADP (iilVI) 
50 
2.5-1 
o 2.0-
CO 
o 
X 1.5-
~D) 
1.0-
DL 
o 0.5-
E 
0.0-
- MRS2179 
+ l\/IRS2179 
ttt 
I 1 
*** 
TT 
I 1 
*** 
t 
I 1 
Jd £ l 
* * 
Q 
* * 
0 10 50 
ADP (laM) 
Figure 4-10 ADP induced mMCP-1 secretion by mBMMC treated with P2Y 
receptor antagonists 
mBMMC were pre-incubated for 10 minutes with 100 uM of the general P2Y receptor 
antagonists (A) suramin and (B) PPADS, and with (C) 100 jiM of the P2Y, specific 
antagonist MRS2179. Cultures were subsequently stimulated with the indicated 
concentration of ADP and cell supematants were tested for mMCP-1 by ELISA. Data 
were analysed using the unpaired two-tail Student's /-test and represent two 
experiments, showing the mean + s.d.m of triplicate cultures. Significance values are 
shown relative to cells treated with media/antagonist alone *** p< 0.001, ** p<0.0], * 
p<0.05 and the indicated concentration of ADP in the absence/presence of antagonist, 
1 1 1 p< 0 .001,11 P<0.01, t p<0.05. 
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suramin and PPADS being surmountable antagonists of P2Y receptors. To further 
characterise via which receptor sub-type(s) ADP was signalling, the more specific P2Yi 
receptor antagonist, MRS2179 was utilised [Figure 4-10 (C)]. MRS2179 significantly 
reduced the level of mMCP-1 released in response to 10 and 50 juM concentrations of 
ADP. This indicates ADP is signalling via the P2Yi receptor, which correlates with the 
observations reported in Chapter 3. 
4.2.1.4 Modulation of adenine nucleotide-induced mMCP-1 secretion by T. spiralis 
secreted proteins and recombinant 5'-NT. 
T. spiralis secretes a range of nucleotide-metabolising enzymes which can 
directly metabolise extracellular ADP, AMP, and adenosine (Gounaris, 2002). As 
demonstrated in Chapter 3, mBMMC P2Yi receptor activation can be modulated by T. 
spiralis excretory/secretory proteins (ES). This effect was attributed to the action of the 
T. spiralis 5'-nucleotidase (5'-NT), which hydrolysed ADP to AMP and AMP to 
adenosine, thus limiting P2Yi receptor activation. T. spiralis ES does not contain 
ATPase activity against any nucleoside 5'-triphosphates (Gounaris, 2002), and thus 
cannot directly hydrolyse ATP. However, T. spiralis larvae also secrete serine/threonine 
kinases and a nucleoside diphosphate kinase (NDPK) (Arden et al, 1997; Gounaris et 
al., 2001). The serine/threonine kinases would utilise ATP, and the NDPK would 
convert ATP to ADP in the presence of nucleoside diphosphate acceptors. 
Considering that ADP and ATP both stimulate mBMMC to release mMCP-1, it 
was deemed important to investigate the potential modulatory effects that T. spiralis ES 
and recombinant 5'-nucleotidase (5'-NT) have on adenine nucleotide-induced mMCP-1 
secretion. In order to investigate this, the indicated concentration of nucleotide was 
applied to mBMMC in the presence of ES or 5'-NT (as described in the Materials and 
Methods section). Initially, to establish that T. spiralis ES and the recombinant 5'-NT do 
not induce signalling events that lead to mMCP-1 release from mBMMC, they were 
applied to the mBMMC in the absence of nucleotides. As shown in Figure 4-11, ES and 
the 5'-NT did not alter the background level of mMCP-1 secretion. The presence of ES 
significantly reduced the amount of mMCP-1 secreted from mBMMC when the latter 
were stimulated with 10 jiM concentrations of ADP [Figure 4-11 (A)]. This indicates 
that T. spiralis ES can modulate mBMMC effector functions in vitro. Potentially, this 
effect could be mediated by the secreted 5'-NT, which would hydrolyse ADP to AMP, 
and AMP to adenosine, thus preventing P2Yi receptor activation. The inhibitory effect 
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Figure 4-11 mMCP-1 secretion by mBMMC in response to ADP in the 
presence of T. spiralis ES and 5'-NT 
mBMMC were stimulated with the indicated concentration of ADP in the 
presence of (A) 100 pig/ml ES and (B) 15 |ig/ml 5'-NT, as described in the 
Materials and Methods section. Culture supematants were removed and tested for 
mMCP-1 by ELISA. Data were analysed using the unpaired two-tail Student's t-
test and represent two experiments, showing the mean + s.d.m of triplicate 
cultures. Significance values are shown relative to cells treated without ADP, *** 
p< 0.001 and cells treated with ADP in the presence/absence of ES/5-NT, 1 1 1 P< 
0 . 0 0 1 , F T P < 0 . 0 1 . 
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of ES on ADP-induced mMCP-l secretion was limited by the rate of ADP hydrolysis, 
as ES could not inhibit mMCP-l release from mBMMC stimulated with 50 }J.M or 100 
|iM concentrations of ADP [Figure 4-11 (A)]. To confirm the ADP metabolising 
properties observed in ES were due to the action of the 5'-NT, the recombinant 5'-NT 
was used in the mMCP-l secretion assay. The presence of the recombinant 5'-NT 
induced a statistically significant reduction in mMCP-l release in response to 10 |iM, 50 
|j,M and 100 |a.M concentrations of ADP [Figure 4-11 (B)]. The degree of inhibition was 
dependent on the concentration of ADP used, where lower ADP concentrations were 
antagonised by 5'-NT more readily than higher ADP concentrations. This result 
confirms the modulatory effect T. spiralis ES has on ADP-induced mMCP-l release is 
due to the action of the 5'-NT. 
The potential modulatory effects of T. spiralis ES were also analysed using ATP 
as a substrate. The presence of ES significantly reduced ATP (10 p,M)-induced mMCP-
1 secretion from mBMMC [Figure 4-12 (A)], which was unexpected as ES did not alter 
ATP-induced mobilisation (as discussed in Chapter 3). This effect was dependent 
on the rate of ATP hydrolysis as ES did not alter the effect of 50 |iM or 100 p,M 
concentrations of ATP on mMCP-l release from mBMMC [Figure 4-12 (A)]. This 
putatively suggests T. spiralis ES contains enzymes that can metabolise low but not 
high concentrations of ATP. To determine whether the modulatory effects of ES on low 
concentrations ATP were due to the action of the 5'-nucleotidase, the experiment was 
repeated using the T. spiralis recombinant 5'-NT. As shown in Figure 4-12 (B), the 
recombinant 5'-NT did not alter the amount of mMCP-l released from mBMMC in 
response to 10 p-M, 50 piM and 100 |iM concentrations of ATP. This suggests that the 
5'-NT is not the enzyme in T. spiralis ES responsible for ATP metabolism. 
4.2.1.5 The secretory pathway of adenine nucleotide induced mMCP-l secretion 
The constitutive release of mMCP-l from mBMMC has previously been 
reported to be partially dependent on de novo protein synthesis and Golgi directed 
transport (Brown et al., 2003), which explains how mMCP-l is consfitutively released 
from mBMMC in the absence of antigen mediated IgE/FcsRI activation. mMCP-l is 
packaged in the Golgi complex and then stored in the granules of mBMMC (Brown et 
al., 2003; Miller et al., 1999; Wright et al., 2002), thus it was of interest to determine 
whether adenine nucleotides induced mMCP-l release from mast cell granules, or 
increased the constitutive secretion of mMCP-l. To investigate this, Brefeldin A (BFA) 
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Figure 4-12 mMCP-1 secretion by mBMMC in response to ATP pre-
incubated with T. spiralis ES and 5'-NT 
mBMMC were stimulated with the indicated concentration of ATP in the presence 
of (A) 100 |ig/ml ES and (B) 15 |ig/ml 5'-NT as described in the Materials and 
Methods section. Culture supematants were removed and tested for mMCP-1 by 
ELISA. Data were analysed using the unpaired two-tail Student's f-test and 
represent two experiments, showing the mean + s.d.m of triplicate cultures. 
Significance values are shown relative to cells treated without ATP, *** p< 0.001 
and cells treated with ATP in the presence/absence of ES/5-NT, 1 1 p<0.0]. 
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was used to disrupt the Golgi complex, and cyclohexamide (CHX) was used to inhibit 
protein synthesis. Considering mBMMC are highly susceptible to BFA- and CHX-
induced cell death, these inhibitors were used at concentrations known not to affect 
mBMMC viability (Brown et al, 2003). 
mBMMC were cultured for 24 hours with media supplemented with either 
CHX, BFA or vehicle alone [Figure 4-13 (A) and (B)]. Cells were subsequently 
stimulated with 10 |iM and 100 [xM concentrations of ADP and ATP (Figure 4-13 (A) 
and (B) respectively). In the absence of nucleotide stimulation, CHX and BFA 
significantly reduced the background level of mMCP-1 secretion by 44 + 9.8% and 46 + 
13.1% respectively (Figure 4-13). This is consistent with the inhibitory effects of CHX 
and BFA on mMCP-1 secretion observed by Brown et al., (2003) and suggests CHX 
had inhibited protein synthesis and BFA had disrupted the Golgi complex. 
The application of 10 |iM ADP in the presence of CHX or BFA induced a 
statistically significant increase in mMCP-1 release, however this was lower than the 
amount of mMCP-1 released from mBMMC stimulated with 10 p-M ADP only [Figure 
4-13 (A]. The presence of CHX or BFA did not alter 100 |iM concentrations of ADP 
inducing mMCP-1 release from mBMMC [Figure 4-13 (A)]. These results suggest that 
the Golgi complex and de novo protein synthesis are not required for ADP-induced 
mMCP-1 release from mBMMC. 
The application of 10 jiM and 100 piM concentrations of ATP induced a 
statistically significant increase in mMCP-1 release, and this was independent of the 
presence of CHX or BFA [Figure 4-13 (B)]. This suggests that the Golgi complex and 
de novo protein synthesis are not required for ATP-induced mMCP-1 release from 
mBMMC. Furthermore, these results may suggest that ADP and ATP induce the release 
of pre-formed mMCP-1 from mBMMC granules. 
4.2.2 Investigating the role of nucleosides and nucleotides as mast cell 
chemoattractants 
As nucleotides have previously been reported to induce migration of mature rat 
mast cells (McCloskey et al., 1999), it was thought important to investigate whether 
nucleosides and nucleotides could induce migration of mBMMC. The frequency of 
mast cell precursors in murine bone marrow, and the ability of mast cells to proliferate 
determine the extent of mast cell hyperplasia observed in the intestine during T. spiralis 
infection (Reed et al., 1988; Brown et al., 2003; Pennock and Grencis, 2004). Thus, it 
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Figure 4-13 mMCP-1 secretion by mBMMC pre-incubated for 24 hours with 
cyclohexamide and brefeldin A and subsequently stimulated with adenine 
nucleotides 
mBMMC were pre-incubated for 24 hours with methanol vehicle, 120 ng/ml 
cyclohexamide (CHX) and 120 ng/ml brefeldin A (BFA). Cultures were 
subsequently stimulated with the indicated concentration of (A) ADP and (B) 
ATP, and culture supematants subsequently tested for mMCP-1 by ELISA. Data 
were analysed using the unpaired two-tail Student's (-test and represent two 
experiments, showing the mean + s.d.m of triplicate cultures. Significance values 
are shown relative to cells treated with vehicle alone and the indicated 
concentration of nucleotide 1 1 1 P< 0.001,11 p<0.01, t p<0.05. 
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was of interest to determine if nucleotide and nucleotides could direct the migration of 
mast cell precursors. Furthermore, mature mast cells also release factors during 
activation that are chemotactic for immature mast cells (Weller et al., 2005). 
Considering ADP and ATP induce mBMMC to release hexosaminidase and mMCP-1 
from their granules, it was thought interesting to investigate whether stimulation of 
mBMMC with nucleosides and nucleotides could also induce the release of 
chemoattractants for mast cell progenitors. 
4.2.2.1 Mature mBMMC chemotaxis 
Chemotactic responses of mature mBMMC were measured using 96-well 
microchemotaxis plates. After 3 hours incubation at 37°C, cells that had migrated to the 
lower chambers were counted using a light microscope. The mast cell giowth factor 
SCF is a chemoattractant for murine mast cells (Meininger et al., 1992), and was used 
as a positive control in the mBMMC migration assay. As shown in Figure 4-14, SCF 
induced a dose-dependent increase in mBMMC migration, which peaked when 1 nM 
concentrations of SCF were used. This result confirms that the mBMMC were able to 
undergo migration in the assay system and were responsive to chemotactic factors. 
Inosine, adenosine, ADP, ATP, UDP and UTP at concentrations ranging from 1 p,M to 
100 |iM were subsequently utilised in the chemotaxis assay. None of the nucleosides 
and nucleotides tested induced a statistically significant increase in mBMMC migration 
(Figure 4-14). Thus, it appears that these compounds are not chemotactic agents for 
mBMMC. 
4.2.2.2 The chemotactic effect of nucleosides and nucleotides on 2 week-old 
immature mast cells. 
To determine if nucleosides and nucleotides could direct the migration of 
immature mast cells, mouse bone marrow cells that had been cultured for 2 weeks with 
15% WEHI conditioned medium as a source of lL-3 were used in the chemotaxis assay. 
These cells are deemed 'immature' by their ability to populate tissues in vivo after 
intravenous injection in mice (Nakano et al., 1985; Weller et al., 2005). These cells 
were approximately 42 % c-kit"^ as determined by FACS analysis after two weeks of 
culture [Figure 4-15 (A)], thus providing a significant number of c-kit^ cells to use in 
this assay system. The population of immature mast cells, and the indicated 
concentration of test agonist, were applied to the upper and lower wells of the 
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Figure 4-14 The effects of nucleosides and nucleotides on mature niBMMC 
migration 
mBMMC were added to the top wells of a microchemotaxis plate. The indicated 
concentrations of test chemotactic factors or nucleotides were added to the lower 
wells. After 3 hours incubation, migrated cells were removed from the lower wells 
and counted using a light microscope at XI0 magnification. The average number 
of cells migrated to media alone was subtracted from absolute cells counts. Data 
were analysed using the unpaired, two-tail Student's f-test and represent the mean 
+ s.d.m of triplicate cell cultures. Significance values are shown relative to the 
migration of cells to media alone. * p<0.05, ** p<0.01. 
178 
microchemotaxis plate respectively. After 3 hours incubation at 37°C, migrated cells 
were removed from the lower chambers and stained with anti-c-kit-PE. FACS analysis 
was subsequently used to determine the number of c-kit^ cells that had migrated. As 
shown in Figure 4-15 (B), the immature mast cell chemoattractant leukotriene (LT) B4 
(Weller et al, 2005), at concentrations of 100 nM, induced a statistically significant 
increase in the migration c-kit"^  cells. Inosine, adenosine, ADP, ATP, UDP and UTP at 
100 |iM concentrations did not act as chemotactic agents for immature mast cells as no 
alterations in migration were observed [Figure 4-15 (B)]. 
4.2.2.3 The chemotactic effect of nucleosides and nucleotides on freshly isolated 
mouse bone marrow preparations 
Chemotactic responses of mast cell progenitors were also measured using 96-
well microchemotaxis plates. Freshly isolated mouse bone marrow cell suspensions, and 
the indicated concentration of test agonist, were applied to the upper and lower wells of 
the microchemotaxis plate respectively. After 3 hours incubation at 37°C, migrated cells 
were removed from the lower chambers and cultured for 14 days with lL-3, IL-9, SCF 
and TGF-Pi to induce the growth of mature mBMMC high in mMCP-1 levels. Cells 
were then lysed by freeze-thawing and the released mMCP-1 quantified by ELISA. The 
amount of mMCP-1 measured was used as an indicator of mast cell precursor 
migration. 
The lipid mediator LTB4 is a chemoattractant for mast cell progenitors (Weller et 
al., 2005), and was used as a positive control in the migration assay. As shown in Figure 
4-16 (A), LTB4 induced a concentration-dependent increase in mMCP-1 levels that 
peaked when 1 nM was used. This indicates that the mast cell precursors were 
responsive to external stimuli and were able to migrate in the assay system used. 
Inosine, adenosine, ADP, ATP, UDP and UTP at 100 p,M concentrations failed to 
induce a statistically significant increase in mMCP-1 levels, indicating mast cell 
progenitors had not been induced to migrate [Figure 4-16 (B)]. 
To identify whether nucleosides and nucleotides could induce mature mast cells 
to release chemotactic factors that would lead to the recruitment of immature mast cell 
progenitors, cell supematants were taken from mBMMC stimulated for 2 hours with 
100 jj.M inosine, adenosine, ADP, ATP, UDP and UTP. As a positive control, 
supematants were taken from mBMMC sensitised with anti-DNP-lgE and activated by 
the specific antigen DNP-HSA. As shown in Figure 4-16 (C), supematants from antigen 
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Figure 4-15 The effects of nucleosides and nucleotides on immature mast cell 
migration 
The percentage of c-kit^ cells in the total BMMC population was measured by flow 
cytometry. (A) Representative histogram and dot plots showing c-kit staining of mBMMC 
cultured for 2 weeks with 15% WEHI-conditioned medium as a source of IL-3. (B) 2 week 
old mBMMC were added to the top wells of a microchemotaxis plate. Leukotriene B4 or 
100 (iM concentrations of the indicated nucleoside/nucleotides were added to the lower 
wells. After 3 hours incubation, migrated cells were removed from the lower wells and 
stained with anti-c-kit-PE. The number of migrated c-kit^ mBMMC were counted by 
FACS. Data were analysed using the unpaired, two-tail Student's (-test and represent the 
mean + s.d.m of triplicate cell cultures. Significance values are shown relative to the 
migration of cells to media alone. ** p<0.01. 
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Figure 4-16 The effects of nucleosides and nucleotides on the migration of freshly 
isolated bone marrow cells 
Freshly isolated bone marrow cells were added to the top wells of a microchemotaxis plate 
and the indicated concentration of test chemoattractant was added to the bottom well. 
After a 3 hour incubation, migrated cells were cultured for 14 days in the presence of IL-3, 
IL-9, SCF and TGF- Pj. On day 14 the migrated cells were frozen, lysed, and assayed for 
levels of mMCP-1 by ELISA. (A) Dose-dependent migration of bone marrow cells in 
response to LTB4. (B) Migration of bone marrow cells in response to 100 |iM nucleotides 
and 1 nM LTB4. (C) Migration of bone marrow cells in response to supernatant collected 
from day-14 mBMMC stimulated with 100 |iM of the indicated nucleotides and IgE + 
Antigen. Data were analysed using the unpaired two-tail Student's (-test and represent the 
mean + s.d.m of triplicate bone marrow preparations. Significance values are shown 
relative to cells treated with media alone. * p<0.05, *** p<0.001. 
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dependent FceRI stimulated mBMMC induced a statistically significant increase in 
mMCP-1 levels. This indicates mast cell progenitors were induced to migrate and again 
suggests the mast cell precursors were responsive to external stimuli and able to migrate 
in the assay system used. Supematants trom mature mBMMC stimulated with 
nucleosides and nucleotides did not induce a statistically significant increase in mMCP-
1 levels [Figure 4-16 (C)]. This suggests stimulation of mBMMC with nucleosides and 
nucleotides does not induce the release of factors such as LTB4 that are chemotactic for 
mast cell progenitors. 
4.2.3 The effect of nucleotides and T. spiralis ES on cytokine generation in 
mBMMC 
Activation of mast cells by a variety of stimuli can induce de novo-synthesis of 
cytokines. More specifically, adenosine, ATP and UDP have been reported to directly 
induce cytokine production in some mast cell types (Feoktistov and Biaggioni, 1995; 
Ryzhov et al., 2006; Bulanova et al., 2005; Mellor et al., 2002). Furthermore, ADP and 
ATP have been reported to modulate mast cell cytokine production initiated by another 
stimulus (Feng et al., 2004). Thus, it was deemed pertinent to determine whether 
nucleosides and nucleotides could induce de novo generation of cytokine production, or 
modulate cytokine production in mBMMC. 
4.2.3.1 The effect of nucleotides on cytokine generation 
To determine whether nucleotides could induce the de novo generation of 
cytokines, mBMMC were stimulated with 100 |J.M of inosine, adenosine, ADP, ATP, 
UDP and UTP. To ensure the mBMMC could generate cytokines, the cells were 
passively sensitised with IgE and subsequently stimulated with antigen (IgE and Ag). 
Supematants were harvested 24 hours after stimulation and cytokine levels 
subsequently measured by ELISA. FceRl cross-linkage of mBMMC induced 
statistically significant increased levels of TNF-a, IL-4, lL-5 and lL-13 cytokine 
production (Figure 4-17 (A)-(D) respectively). This suggests the mBMMC were able to 
generate cytokines in response to external stimuli, and correlates with other studies that 
have shown FcsRI cross-linkage of mast cells induces de novo cytokine generafion 
(Bradding et al., 1992; Boyce, 2003; Zhao et al., 2005). When used at concentrations of 
100 |iM, inosine, adenosine, ADP, ATP, UDP and UTP did not elicit stafistically 
significant increased TNF-a, IL-4, lL-5 or IL-13 cytokine generafion [Figure 4-17 (A)-
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Figure 4-17 Cytokine production by mBMMCs in response to nucleotides 
mBMMC were stimulated for 24 hrs with 100 |iM nucleotides and IgE + Antigen (IgE + 
Ag). Culture supematants were tested by ELISA for the presence of the cytokines (A) 
TNF-a, (B) IL-4, (C) IL-5 and (D) IL-13. Data were analysed using the unpaired two-tail 
Student's Mest and represent the mean + s.d.m of triplicate cultures. Significance values 
are shown relative to cells treated with media alone. *** p<0.001. 
183 
(D)]. This imphes that nucleosides and nucleotides cannot directly induce mBMMC to 
generate pro-inflammatory or TH2-type cytokines, even when used at relatively high 
concentrations. 
4.2.3.2 The modulatory effects of nucleosides and nucleotides on cytokine 
generation 
As nucleosides and nucleotides could not directly induce cytokine generation in 
mBMMC, the possibility that nucleosides and nucleotides could modulate the effects of 
other stimuli was investigated. It has recently been shown that mast cells express toll-
like receptors (TLRs) (McCurdy et ai, 2001; Supajatura et al, 2001; Varadaradjalou et 
al., 2003). Given that during T. spiralis infection large numbers of mast cells reside in 
the epithelium of the intestine, TLR activation could be an important, but as yet 
unappreciated aspect of their role in intestinal immunology. The TLR-2 ligand 
peptidoglycan (PGN) (a component of Staphylococcus aureus cell walls), and the TLR-
4 ligand lipopolysaccharide (LPS) (from Escherichia coli), activate human mast cells to 
generate TNF-a production (Varadaradjalou et al., 2003). Furthermore, the nucleotides 
ADP and ATP acting as a secondary stimulus have been reported to inhibit PGN-
induced TNF-a generation in human mast cells (Feng et al., 2004). 
To confirm that LPS could induce TNF-a generation in mBMMC via activation 
of TLR-4, cells were stimulated for 24 hours with concentrations of LPS ranging from 1 
ng/ml to 10 p-g/ml. As shown in Figure 4-18, LPS induced a concentration dependent 
increase in TNF-a production, suggesting that the mBMMC express functional TLR-4. 
To determine if nucleosides and nucleotides could modulate LPS-induced TNF-a 
production, mBMMC were incubated for 10 minutes with inosine, adenosine, ADP, 
ATP, UDP and UTP at concentrations ranging from 1-100 p-M and subsequently 
stimulated with 100 ng/ml LPS. As shown in Figure 4-19 (A), inosine did not alter LPS 
induced TNF-a generation in mBMMC. In contrast, when added as a concomitant 
stimulus, adenosine, ADP and ATP induced statistically significant reductions in LPS-
induced TNF-a production (Figure 4-19 (B), (C) and (D) respectively). The inhibitory 
effect occurred in a dose-dependent manner and was maximal when 100 |iM 
concentrations of adenosine, ADP and ATP were used. The uridine nucleotides, UDP 
and UTP did not affect LPS-induced TNF-a generation (Figure 4-19 (E) and (F) 
respectively). These results show adenosine, ADP and ATP are able to attenuate TLR-
4-induced TNF-a generation in mBMMC. 
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Figure 4-18 TNF-a production by mBMMCs in response to LPS 
mBMMC were stimulated for 24 hrs with a range of LPS concentrations. Culture 
supematants were then tested for TNF-a production by ELISA. Data were 
analysed using the unpaired two-tail Student's ^-test and represent the mean + 
s.d.m of triplicate cultures. Significance values are shown relative to cells treated 
with media alone. ** p<0.01, *** p<0.001. 
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Figure 4-19 TNF-a production by mBMMCs in response to 100 ng/ml LPS and 
nucleotides 
mBMMC were stimulated for 24 hrs with 100 ng/ml LPS and the indicated concentration 
of (A) Inosine, (B) Adenosine, (C) ADP, (D) ATP, (E) UDP and (F) UTP. Culture 
supematants were then tested for TNF-a production by ELISA. Data were analysed using 
the unpaired two-tail Student's f-test and represent at least one experiment, showing the 
mean + s.d.m of triplicate cultures. Significance values are shown relative to cells treated 
with media alone, *** p<0.001 and cells treated with 100 ng/ml LPS, t t p<0.01, t t + 
p<0.001 . 
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4.2.3.3 The effect of T. spiralis ES and recombinant 5'-NT on nucleotide-modulated 
cytokine generation 
T. spiralis ES can modulate adenosine- and ADP-induced mBMMC stimulation 
in terms of purinergic receptor activation and mMCP-1 release (section 3.2.4 and 
section 4.2.1.4 respectively). Thus, it was of interest to determine if T. spiralis ES could 
also modulate the inhibitory effects of adenosine and ADP on TLR-4-induced TNF-a 
generation in mBMMC. Adenosine ranging in concentration from 1-100 ^M was 
applied to mBMMC in the absence or presence of T. spiralis ES for 10 minutes prior to 
stimulation with 100 ng/ml LPS. As shown in Figure 4-20, concentrations of adenosine 
at 10 |iM and 100 p.M induced a statistically significant reduction in LPS induced TNF-
a production. The presence of T. spiralis ES did not significantly alter the inhibitory 
effect of 10 |iM and 100 |iM concentrations of adenosine (Figure 4-20). These results 
suggest that in this scenario, T. spiralis ES cannot modulate the inhibitory effects of 
adenosine on TLR-4-induced TNF-a generation in mBMMC. 
As shown in Figure 4-21 (A), the inhibitory effect of 1 jJ-M concentrations of 
ADP on LPS-induced TNF-a generation in mBMMC was ablated in the presence of T. 
spiralis ES. This effect could be mediated by the secreted 5'-NT, and adenosine 
deaminase, thus limiting P2Y and PI receptor activation. This effect was limited by the 
rate of ADP and/or adenosine metabolism, as the ablation of ADP mediated inliibition 
was not observed when 10 p,M and 100 p,M concentrations of ADP were applied to 
mBMMC in the presence of ES [Figure 4-21 (A)] 
To further investigate the role of the 5'-NT in this bio-assay, LPS and ADP were 
applied to the mBMMC in the absence or presence of the recombinant 5'-NT. As shown 
in Figure 4-21 (B), the inhibitory effect of 1 |iM concentrations of ADP was 
ameliorated in the presence of the 5'-NT. These results suggest that the 5'-NT activity 
present in T. spiralis ES is responsible for the observed modulation of the inhibitory 
effects of low (1 }j,M) ADP concentrations on TNF-a generation in mBMMC. However, 
the addition of the 5'-NT did not significantly alter the inhibitory effects of 10 |iM and 
100 |iM concentrations of ADP on LPS-induced TNF-a generation in mBMMC [Figure 
4-21 (B)]. The hydrolysis of ADP by the 5'-NT will result in the accumulation of 
adenosine which also inhibits LPS-induced TNF-a production. Hence, the lack of 
inhibition observed, is likely to be a result of adenosine stimulating PI receptors which 
will continue to suppress TNF-a generation in mBMMC. 
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Figure 4-20 TNF-a production by mBMMCs in response to 100 ng/ml LPS 
and adenosine in the presence of T. spiralis ES 
mBMMC were stimulated for 24 hrs with 100 ng/ml LPS and the indicated 
concentration of adenosine in the absence or presence of T. spiralis ES (as 
described in the Materials and Methods section). Culture supematants were then 
tested for TNF-a production by ELISA. Data were analysed using the unpaired 
two-tail Student's f-test and represent two experiments, showing the mean + s.d.m 
of triplicate cultures. Significance values are shown relative to cells treated with 
100 ng/ml LPS, *** p<0.001 and cells treated with 100 ng/ml LPS and the 
indicated concentration of adenosine t p<0.05, f t p<0.01. 
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Figure 4-21 TNF-a production by mBMMCs in response to 100 ng/ml LPS 
and adenine nucleotides in the presence of T. spiralis ES and 5'-NT 
mBMMC were stimulated for 24 hrs with 100 ng/ml LPS and the indicated 
concentration of ADP in the absence or presence of T. spiralis ES and 5'-NT (as 
described in the Materials and Methods section). Culture supematants were then 
tested for TNF-a production by ELISA. Data were analysed using the unpaired 
two-tail Student's t-test and represent two experiments, showing the mean + s.d.m 
of triplicate cultures. Significance values are shown relative to cells treated with 
100 ng/ml LPS, *** p<0.001, ** p<0.01 and cells treated with 100 ng/ml LPS 
and the indicated concentration of ADP t p<0.05,11 p<0.01. 
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4.3 Discussion 
As demonstrated and discussed in Chapter 3, mBMMC of the mucosal 
phenotype express multiple functional purinergic receptor sub-types responsive to a 
range of nucleosides and nucleotides. This prompted the study presented in this chapter, 
in which the complementary or opposing roles of purinergic receptor activation on mast 
cell effector functions were explored. As T. spiralis secretes nucleotide-metabolising 
enzymes (Gounaris, 2002; Gounaris et al, 2004; Arden et ai, 1997; Gounaris et al, 
2001), that can modulate mBMMC purinergic receptor activation, it was important to 
determine whether mast cell effector functions were also affected. This is discussed in 
the context of the intestinal phase of T. spiralis infection, where mucosal mast cell 
effector functions play a pivotal role in efficient parasite expulsion. 
A wealth of conflicting data surrounds the effects of nucleosides and nucleotides 
on mast cell degranulation. To unequivocally define if inosine, adenosine, ADP, ATP, 
UDP and UTP are secretagogues for mBMMC of the mucosal phenotype, the activity of 
^-hexosaminidase (p-hex) secreted into cell supematants was monitored. Inosine has 
been reported to directly induce degranulation of the rat mast cell-derived basophilic 
leukemia cell line RBL-2H3 in vitro, and induce degranulation of mouse mast cells in 
vivo (Shepherd and Duling, 1996; Jin et al., 1997; Tilley et al., 2000). However, the 
results observed in this study showed that neither inosine nor adenosine could induce 
degranulation of mBMMC. This is consistent with other studies that have reported that 
these nucleosides do not directly induce degranulation of a similar type of mBMMC 
(cultured with IL-3 only) (Marquardt et al., 1994), and human lung mast cells 
(Schulman ef a/., 1999). 
ADP and ATP at concentrations at or above 50 [iM induced a dose-dependent 
increase in (3-hex release. This correlates with another study that suggested that ADP 
could induce modest exocytosis in human mast cells (Feng et al., 2004). ATP has also 
been shown to directly induce exocytosis in the mouse mast cell-like cell line MC-9 
(Sudo et al., 1996) and murine BMMC (cultured with lL-3 only) (Nakamura et al., 
1989). In contrast, a study using human lung mast cells reported that ATP could not 
directly induce degranulation, but only modulate anti-IgE-induced degranulation 
(Schulman et al., 1999), thus emphasizing the functional heterogeneity of mast cells 
from different sources. The uridine nucleotides UDP and UTP did not induce 
degranulation of mBMMC. These results correlate with similar studies that have 
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reported that UDP can not induce exocytosis in human cord blood-derived mast cells 
(Mellor et al., 2002), and that UTP can only enhance antigen-dependent degranulation 
of human lung mast cells (Schulman et al, 1999). 
Mast cells secreting MCP-1 are central to the efficient expulsion of T. spiralis 
infective larvae from the gut (Knight et al., 2000). During T. spiralis infection TGF-Pi 
expressed by the epithelium induces mucosal mast cells to constitutively secrete MCP-1 
(Wastling et al., 1997; Miller et al., 1999; Wright et al., 2002). This occurs in the 
absence of FcsRI cross-linkage, suggesting that antigen-dependent degranulation is not 
required. Considering that extracellular nucleosides and nucleotides play significant 
roles in activating mast cells, it was deemed pertinent to investigate whether they could 
also influence mMCP-l release from mBMMC. 
The adenine nucleotides ADP and ATP induced a dose-dependent increase in 
mMCP-l release from mBMMC independent of the presence of TGF-Pi. Use of the 
stable nucleotide analogues ADP-PS and ATP-yS also induced a dose-dependent 
increase in mMCP-l release from mBMMC, confirming that this effect was due to the 
adenine nucleotides rather than their degradation products. These results show for the 
first time that extracellular nucleotides can directly activate mast cells to secrete the (3-
chymase mMCP-l. Of the nucleosides and nucleotides tested, only adenine nucleotides 
consistently induced both (3-hex and mMCP-l release, potentially implying that these 
two mediators may be released via stimulation of signalling pathways that lead to 
secretion. Unexpectedly, 100 |iM concentrations of UTP induced a modest increase in 
mMCP-l release from mBMMC cultured in the absence of TGF-Pi. Potentially, the 
small increase in mMCP-l release may not have been detected in cells cultured with 
TGF-Pi due to the higher background level of mMCP-l secretion. As UTP did not 
induce mMCP-l release from mBMMC cultured with TGF-Pi, this phenomenon was 
not investigated further. 
As discussed in Chapter 3, ADP and ATP were shown to signal via the P2Y] 
and P2X4 receptors respectively, in mBMMC. However, due to the lack of P2X4 
receptor antagonists (North, 2002), the purinergic receptor via which ATP was inducing 
mMCP-l secretion could not be confirmed. The use of the broad-specificity purinergic 
receptor antagonists suramin and PPADS reduced the amount of mMCP-l released 
from ADP-stimulated mBMMC, suggesting that this process was definitely mediated by 
purinergic receptors. Use of the antagonist MRS2179 confirmed that ADP was 
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signalling via the P2Yi receptor, which correlates with the calcium mobilisation data 
shown in Chapter 3. 
mMCP-1 is packaged in the Golgi complex and subsequently stored in granules 
(Brown et al, 2003). However, the mechanism of constitutive secretion of mMCP-1 
from mBMMC is still not fully understood. Currently, constitutive mMCP-1 secretion 
has been shown to be partially dependent on de novo protein synthesis and subsequent 
Golgi-directed transport (Brown et al., 2003). Some stimuli, such as c48/80 can also 
invoke the release of mMCP-1 directly from mast cell granules (De Jonge et al., 2004). 
To investigate the mechanism of adenine nucleotide-induced mMCP-1 release from 
mBMMC, the inhibitor cyclohexamide (CHX) was used to prevent de novo protein 
synthesis, and Brefeldin A (BFA) was used to disrupt the Golgi complex. In keeping 
with the findings of Brown et al. (2003), 24 hour incubation with CHX or BFA reduced 
the constitutive secretion of mMCP-1 from mBMMC. The subsequent application of 
adenine nucleotides induced a substantial dose-dependent increase in mMCP-1 release. 
This suggests de novo protein synthesis coupled with Golgi-directed transport is not the 
major mechanism by which adenine nucleotides induce mMCP-1 release from 
mBMMC. Therefore, this implies that adenine-nucleotide induced degranulation is the 
likely mechanism by which pre-formed mMCP-1 is released from mBMMC. 
T. spiralis ES significantly reduced mMCP-1 secretion from mBMMC 
stimulated with concentrations of ADP up to 50 |iM. The modulatory effect of T. 
spiralis ES was due to 5'-nucleotidase activity, as the recombinant 5'-NT also 
significantly reduced the amount of mMCP-1 released from mBMMC stimulated with 
concentrations of ADP up to 100 ^M. These results suggest that the T. spiralis secreted 
5'-nucleotidase (5'-NT) metabolised the extracellular ADP to adenosine, thus preventing 
mBMMC P2Yi receptor activation that mediates mMCP-1 release. This effect was 
dependent on the rate of ADP hydrolysis by the secreted 5'-NT. 
T. spiralis ES also mediated a significant reduction in ATP-induced mMCP-1 
release from mBMMC. This was unexpected, as T. spiralis ES does not contain an 
enzyme capable of ATP hydrolysis (Gounaris, 2002). However, T. spiralis larvae 
secrete serine/threonine kinases (Arden et al., 1997) and a nucleoside diphosphate 
kinase (NDPK) (Gounaris et al., 2001), which are capable of utilising ATP. Potentially, 
the secreted serine/threonine kinases and NDPK could utilise and sequester the 
extracellular ATP thus reducing the overall concentration of ATP available to stimulate 
mBMMC. Due to time limitations this parameter was not investigated further. T. 
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spiralis ES did not inhibit mMCP-1 release from mBMMC when stimulated with 
concentrations of ATP above 50 |iM, indicating that the action of ATP-utilising 
enzymes present in ES were reaction rate-limited. Use of the recombinant 5'-NT did not 
modulate ATP-induced mMCP-1 release from mBMMC, fiirther reinforcing the 
concept that ATP-utilising/metabolising enzymes were responsible for the observed 
modulatory effects of ES. 
Murray et al. (1971), originally postulated that an influx of solutes and water 
into the gut lumen during enteric nematode infection may be a method by which the 
host attempts to expel the parasite. More recently, the mechanism that induces increased 
permeability of the intestinal epithelium has been reported to be mediated at least in part, 
by mMCP-1 (McDermott et al., 2003). Degradation of the tight-junction protein 
occludin, by mMCP-1, aids parasite expulsion by increasing the paracellular 
permeability of the jejunum (McDermott ei ah, 2003). Thus, activation of mast cells 
with extracellular adenine nucleotides will potentiate the release of mMCP-1, fiirther 
contributing to the generation of an inhospitable environment for parasites and aiding 
parasite expulsion from the intestine. The secretion of nucleotide metabolising enzymes 
by T. spiralis ES may serve to reduce the amount of extracellular adenine nucleotides 
available to bind to and activate P2Y and P2X purinergic receptors on mucosal mast 
cells, thus limiting mMCP-1 release. This could favour parasite survival by reducing the 
permeability of the intestine, thus restraining the influx of solutes and water that would 
usually flush the parasite away. 
T. spiralis infected mice undergo a transient, but pronounced T cell-dependent 
expansion in the number of their jejunal mast cells (Miller and Jarrett, 1971; Ruitenberg 
and Elgersma, 1976). Jenunal mast cells change their mMCP-1 expression profile in 
response to the stage of infection and their positioning within the jejunum (Friend et al., 
1996; 1998). Thus, the location of mast cells within the intestinal epithelium has 
functional consequences during T. spiralis infection. During this phase of infection, 
large amounts of nucleotides are postulated to be released from damaged intestinal cells 
as the larvae migrate through the epithelium. The nucleotides ADP, ATP and UTP have 
previously been reported to direct the migration of rat bone marrow-derived cells in 
vitro (McCloskey et al., 1999). Thus, it was hypothesised that extracellular nucleosides 
and nucleotides may play a role in regulating the migration of the mature intestinal 
mucosal mast cell population. When this was investigated in vitro, inosine, adenosine, 
ADP, ATP, UDP and UTP were not chemotacfic for mBMMC, even though the cells 
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were able to migrate towards the known mast cell chemoattractant SCF (Meininger et 
al., 1992). It is of note, that the rat BMMC used by McCloskey et al. (1999) were an 
adherent cell type and did not detach from the polycarbonate filter used in the 
chemotaxis assay. In comparison, the mBMMC used in this study were non-adherent in 
culture, and did not remain attached to the underside of the filters during the migration 
assay. Potentially, the inherent differences between these mast cell types may account 
for the discrepancies observed between these studies. 
Mast cell precursors are derived from pluripotent haematopoietic stem cells in 
the bone marrow (Kitamura et al, 1979; 1978). During T. spiralis infection mast cell 
progenitors expressing a4/|37 integrins are produced in the bone marrow directly in 
response to infection (Pennock and Grencis, 2004). The immature precursor cells 
circulate in the periphery prior to homing to the small intestine where they take 3 days 
to mature into toluidine blue-positive mucosal mast cells (Pennock and Grencis, 2004). 
Immature mast cells acquire a mucosal phenotype as they move from the submucosa to 
the intraepithelial area of the lamina propria of the small intestine (Friend et al., 1996). 
Immigration of mast cell precursors through the small intestine occurs at the same time 
as T. spiralis parasites are causing massive cellular damage (day 5-8 post infection) 
(Pennock and Grencis, 2004). It was hypothesised that the expected release of 
nucleosides and nucleotides into the intestinal epithelium could potentially act as 
migratory cues to the mast cell precursors, thus aiding maturation of the cells. The 
immature mast cell chemoattractant Leukotriene B4 (LTB4) induced the migration of c-
kit"^  immature mast cell progenitors, but inosine, adenosine, ADP, ATP, UDP and UTP 
used at relatively high (100 |J,M) concentrations could not induce migration. This result 
suggests that purinergic receptor activation of immature mast cell progenitors does not 
stimulate migration. 
The mechanism by which T. spiralis infection induces qualitative and 
quantitative changes in bone marrow haematopoiesis is still unknown (Pennock and 
Grencis, 2004). Hypothetically, nucleotides and nucleosides released at the intestinal 
site of infection may also serve to recruit mast cell progenitor cells at distal sites. Upon 
access to the general circulation, nucleotides and nucleosides could potentially induce 
the release of increased number of mast cell progenitors from the bone marrow by 
establishing a chemotactic gradient across the sinus endothelium. To investigate this 
idea, freshly isolated bone marrow containing mast cell progenitors were used in 
chemotaxis assays. Although the immature mast cell chemoattractant LTB4 induced the 
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migration of mast cell progenitors, 100 |iM concentrations of inosine, adenosine, ADP, 
ATP, UD? and UTP could not induce migration. 
Activation of mature mast cells by cross-linkage of their FcsRI results in the 
production of factors such as LTB4 that are potent chemoattractants for mast cell 
progenitors (Weller et al, 2005). Considering that nucleotides could induce the 
degranulation of mature mBMMC, it was of interest to determine whether this also 
resulted in the release of chemoattractants for mast cell progenitors. However, 
supematants taken from mature mBMMC incubated with inosine, adenosine, ADP, 
ATP, UDP and UTP did not direct the migration of any mast cell progenitors. These 
results suggest that stimulation of mBMMC with nucleosides and nucleotides cannot 
induce LTB4 release. Taken together these results indicate that nucleosides and 
nucleotides are not chemoattractants for murine bone marrow derived mast cells at any 
stage of their life-history. Further experiments to determine whether nucleotides can 
induce chemokinesis and thus enhance chemotaxis in the presence of other chemotactic 
stimuli could prove interesting. 
Rodent and human mast cells activated in vitro by cross linkage of their FcsRI 
with IgE and antigen can transcribe, translate and secrete several types of 
proinflammatory and regulatory cytokines (Walsh et ah, 1991; Toru et al, 1998; 
Kobayashi et al., 1998; Okayama et al., 1995). Recent reports suggest that mucosal 
mast cells contribute to the induction of protective Th2 responses during T. spiralis 
infection (Lawrence et al., 2004). The mechanisms by which mast cells amplify the 
inflammatory response during T. spiralis infection is unknown at present, but is thought 
to be mediated, in part, by cytokines (Lawrence et al., 2004). It has been reported that a 
variety of mast cell types, and mast cell-like cell lines secrete de novo generated 
cytokines when stimulated with nucleosides and nucleotides. For example, adenosine 
signalling via the A2B receptor in the human mast cell line HMC-1 can induce IL-4, IL-
13 and IL-8 secretion (Ryzhov et al., 2004, 2006; Feoktistov et al., 1995). It has been 
shown thatactivation of the apoptotic PZX? receptor by very high concentrations of ATP 
(3 mM) can induce small increases in IL-6 and IL-13 secretion from mBMMC (cultured 
with IL-3 only) (Bulanova et al., 2005). Currently, there are no reports in the literature 
that implicate the involvement of P2Y receptors in de novo generation of cytokines in 
mast cells. However, a recent study reported that stimulation of the CysLTl receptor 
with UDP, induces IL-4-primed human cord-blood derived mast cells to secrete IL-5, 
TNF-a and MIP-P (Mellor et al., 2002). 
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To determine whether nucleosides and nucleotides could directly stimulate the 
production of cytokines in mBMMC, a panel of Th2 cytokines (IL-4, IL-5, IL-13) that 
have previously been shown to be important in protective responses to helminth 
infections (Mosmann and Coffinan, 1989) were examined. These cytokines are typically 
produced by CD4^ T cells present in the local mesenteric lymph nodes during the 
intestinal phase of infection (Grencis et al., 1991). However, mast cells of various types 
can also generate and release IL-4, IL-5 and IL-13 upon cross-linkage of FceRI 
(Masuda et al., 2002). Each of these cytokines mediate one or more of the central 
features of intestinal inflammation in mouse models. IL-4 is required for efficient 
expulsion of T. spiralis from the intestine (Lawrence et al., 1998) and both IL-4 and IL-
13 can induce mucus secretion from goblet cells (Urban, Jr et al., 2001). IL-13 also 
promotes goblet cell hyperplasia (McKenzie et al., 1998). IL-5 plays a pivotal role in 
regulating eosinophilia (Coffinan et al., 1989) and is required to reduce the number of 
larvae encysting in the muscle (Gurish et al., 2002). As mast cells are also a potent 
source of TNF-a, which can act directly and indirectly to promote intestinal 
inflammation (Bischoff et al., 1999; Lawrence et al., 2004), this cytokine was also 
measured. 
Following passive IgE sensitisation, stimulation of mBMMC with antigen 
induced the release of significant amounts of IL-4, IL-5, IL-13 and TNF-a, which is 
consistent with reports from other groups that have used murine bone marrow-derived 
mast cells (Masuda et al., 2002; Nakamura et al., 1995; Burd et al., 1995; Gordon and 
Galli, 1990). However, relatively high (100 |iM) concentrations of inosine, adenosine, 
ADP, ATP, UDP and UTP in the absence of IgE could not induce the de novo 
generation of any of the cytokines measured. A variety of studies have also reported that 
these nucleosides and nucleotides can not induce cytokine production in other types of 
mast cells. For example, Feng et al. (2004) found that ADP and ATP could not directly 
stimulate cytokine release from human cord blood-derived mast cells. Conversely, it has 
been reported that adenosine can induce cytokine generation in the mast cell line HMC-
1 (Rhyzov et al., 2004, 2006; Feokistov et al., 2003). Interestingly, UDP can also 
induce cytokine generation in human mast cells that have been primed with lL-4 
(Mellor et al., 2002). Further experiments using IL-4 primed mBMMC could prove 
useful in determining whether exposure to this cytokine can alter the responsiveness of 
mBMMC to nucleotides. 
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Within the field of purinergic signalling, there is an increasing understanding 
that stimulation of purinergic receptors by nucleosides and nucleotides may act to 
modulate, rather than directly stimulate mast cell activation. For example, it has been 
widely reported that adenosine and inosine potentiate antigen dependent mast cell 
activation (Tilley et al., 2000; Reeves et al., 1997; Marquardt et al., 1978). Furthermore, 
ADP and ATP have been shown to attenuate peptidoglycan (FGN)-induced TNF-a 
production in human mast cells (Feng et al., 2004). 
The intact intestinal mucosal barrier is relatively impervious to bacteria and 
macromolecules that reside within the lumen of the gut. However, during infection with 
T. spiralis, infective larvae invade and migrate through the intestinal epithelium, leaving 
in their wake a trail of damaged cells (Wright, 1979). Furthermore, the mMCP-1-
dependent increased paracellular permeability disrupts the intestinal epithelial barrier 
function (McDermott et al., 2003; Madden et al., 2002). The altered intestinal 
environment during infection may allow bacterial LPS and other pathogen-associated 
molecular patterns (PAMPS) usually present in the lumen of the gut to come into 
contact with mucosal mast cells and other cell types found in the epithelium. Toll-like 
receptors (TLR) serve as sensors against pathogens that invade the host by recognising 
(PAMPS) (Akira and Hemmi, 2003). Although intestinal mast cells have not been 
shown to express TLRs in vivo, it has been demonstrated that TLR-2, TLR-4 and TLR-6 
are expressed by murine bone marrow-derived mast cells in vitro (McCurdy et al., 2003; 
Supajatura et al., 2002; Matsushima et al., 2004). Given the prime location of mucosal 
mast cells in the intestinal epithelium, recognising PAMPS could be an important but as 
yet uncharacterised aspect of their role in gut immunology. 
TLR-4 is activated by LPS derived from Gram-negative bacteria such as 
Escherichia coli (Hoshino et al, 1999). Activation of mBMMC TLR-4 induces the 
release of TNF-a and other inflammatory cytokines (Supajatura et al, 2001). TNF-a 
can directly and indirectly promote inflammation during the intestinal phase of T. 
spiralis infection (Scales et al, 2004; Lawrence et al., 2004). Furthermore, this cytokine 
is predicted to be released from intestinal mucosal mast cells during T. spiralis infection 
(Lawrence et al, 2004). Although the in vivo effects of TLR activation on the kinetics 
and pathology of T. spiralis infection still remain to be determined, it has been 
postulated that opportunistic bacterial infections may affect the intestinal pathology and 
host immune response (Garside et al, 2000). 
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The TLR-4 hgand LPS induced a dose-dependent increase in TNF-a secretion 
from mBMMC, at levels consistent with that reported by Supajatura et al. (2001). Pre-
treatment of mBMMC with adenosine at concentrations at and above 10 j^M, prior to 
activation with LPS, inhibited TNF-a secretion in a dose-dependent manner. This is 
consistent with a body of evidence that suggests adenosine acts as an anti-inflammatory 
molecule (Linden, 2001; la Sala et al., 2003; Thiel et al., 2003). For example, adenosine 
acting via PI receptors can attenuate TLR-induced TNF-a generation in macrophages 
and monocytes (Hasko et al., 1996, 2000; Pinhal-Enfield et al., 2003). Furthermore, in 
vivo experiments have shown that adenosine can mediate inhibition of LPS-stimulated 
TNF-a production (Salvatore et al., 2000). However, the results presented here show for 
the first time that adenosine can modulate TLR-4 activation in mast cells. Further 
experiments to elucidate the PI receptor sub-type mediating the inhibitory effect of 
adenosine could prove interesting. 
The adenine nucleotides ADP and ATP at concentrations at or above 1 jiM also 
strikingly suppressed TNF-a production by mBMMC stimulated with LPS. This is 
consistent with a similar study that reported that adenine nucleotides inhibit cytokine 
generation in human mast cells stimulated with the TLR-2/TLR-6 ligand peptidoglycan 
(PGN) (Feng et al., 2004). In the study reported by Feng and co-workers (2004), the 
specific purinergic receptor sub-types mediating this effect could not be elucidated, 
despite a range of receptor antagonists being used. Other nucleosides and nucleotides 
such as inosine, UDP and UTP did not affect LPS-induced TNF-a generation. This 
implies a potential lack of involvement of the ag, p2y6/CysLTRl and P2Y2 purinergic 
receptors via which these ligands signal. Further experiments are required to fully 
characterise the antagonistic action of adenosine, ADP and ATP at other TLR-types, 
and to define the purinergic receptors and the intracellular signalling mechanisms 
involved in this phenomenon. Potentially, adenosine and adenine nucleotides signalling 
via purinergic receptors may stimulate a negative feedback mechanism to control 
inflammation in the intestine. 
During T. spiralis infection the concurrent stimulation of TLR-4 and inhibitory 
pathways mediated by adenosine, ADP or ATP, released from damaged or activated 
cells, could potentially prevent over-exuberant secretion of pro-inflammatory cytokines 
such as TNF-a, thus limiting the enteropathy observed during the infection. This may 
benefit the host by reducing the debilitating effects inflammation causes, but also 
benefit the parasite by maintaining an environment in which it can survive. 
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Paradoxically, however, T. spiralis secretes enzymes able to metabolise nucleotides, 
and as a result may be able to inhibit the down-regulatory action of extracellular 
nucleotides. This may actually promote inflammatory cytokine production from mast 
cells, thus potentially enhancing intestinal pathology. When this was investigated in 
vitro, the presence of T. spiralis ES did not alter the inhibitory effect of adenosine on 
LPS-induced TNF-a production. The relatively low specific activity of the adenosine 
deaminase in T. spiralis ES (51 mU/mg of ES, where 1 unit is equivalent to the 
deamination of 1 |imol adenosine/minute) (Gounaris, 2002), could account for the lack 
of modulation of adenosine-induced inhibition observed when concentrations of 
adenosine greater than 10 p,M were used. 
The presence of T. spiralis ES reversed the inhibitory effects of low (1 |iM) 
concentrations of ADP on TLR-4-mediated TNF-a production. Use of the recombinant 
5'-nucleotidase (5'-NT) showed that this was due to the action of the secreted 5'-NT 
which would metabolise the available ADP to adenosine, thus limiting P2Y receptor 
activation. The amount of adenosine resulting from ADP hydrolysis (<1 )j.M) would be 
insufficient to inhibit TLR-4 induced TNF-a secretion. The presence of either T. spiralis 
ES or recombinant 5'-NT was unable to modulate the inhibitory effects of 
concentrations of ADP at or above 10 |iM. Considering that the product of the 
enzymatic action of the 5'-NT acting on ADP would be adenosine, the inhibition of 
TLR-4 mediated TNF-a secretion could be elicited by a combination of both non-
hydrolysed ADP and high concentrations of accumulated adenosine. As mentioned 
previously, the slower rate of adenosine metabolism by the adenosine deaminase may 
account for the continued inhibition observed when concentrations of ADP above 10 
HM were used in the assay. 
Thus, it appears that T. spiralis ES can modulate the inhibitory effects of 
relatively low (1 p,M) concentrations of adenosine and ADP on TLR-4 activation. This 
suggests that T. spiralis ES may promote inflammatory cytokine release from mast cells. 
The relevance of this observation in vivo remains to be detemiined, as one would have 
expected this would be deleterious to the survival of parasites in the host intestinal tract. 
Further investigation of the effects of T. spiralis secreted proteins and nucleotides on 
TLR activation in mast cells is required, especially considering other parasitic helminth 
antigens can regulate TLR responses in diverse immune cells types (Goodridge ei ai, 
2005; Kane et aL, 2004). 
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In summary, this section reveals that ADP and ATP can induce mBMMC 
exocytosis. Importantly, these nucleotides elicit the release of mMCP-1 via a 
mechanism that is not dependent on de novo protein synthesis or the Golgi complex, 
indirectly suggesting adenine nucleotides induce exocytosis of granules containing pre-
formed mMCP-1. ADP appeared to mediate this effect via stimulation of the P2Yi 
receptor. The purinergic receptor via which ATP was acting was not confirmed, but was 
likely to be the P2X4 receptor on the basis of the calcium flux data presented in chapter 
3. Interestingly, T. spiralis ES inhibited ADP-induced mMCP-1 release, and this was 
mediated by the action of the secreted 5'-NT. T. spiralis ES also inhibited ATP-induced 
mMCP-1 release, possibly via the action of the secreted serine/threonine kinases and 
NDPK. Putatively, this could act to perturb mMCP-1 release during the intestinal stage 
of T. spiralis infection, thus reducing the rate of parasite expulsion. The range of 
nucleosides and nucleotides tested could not direct the migration of progenitor, 
immature or mature mBMMC, suggesting these compounds are not chemoattractants 
for this type of mast cell. Furthermore, nucleosides and nucleotides alone could not 
induce the de novo generation of inflammatory or Th2 cytokines in mBMMC. However, 
the simultaneous activation of TLR-4 and purinergic receptors responsive to adenosine, 
ADP or ATP stimulated inhibitory pathways that led to the down-regulation of pro-
inflammatory TNF-a generation. In the presence of T. spiralis ES, the inhibitory effects 
of low (1 |iM) concentrations of ADP were reduced, suggesting that parasite secreted 
proteins may also act to enhance the amount of pro-inflammatory cytokines generated 
by TLR activation. 
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Chapter 5 
The effect of immunisation with the recombinant T. spiralis 
5-nucleotidase on infection outcome in the mouse 
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5.1 Introduction 
During Trichinella spiralis infection, ingested infective larvae invade the small 
intestine. These parasites then rapidly develop into adults and release new bom larvae 
that migrate through the lymphatic and circulatory systems into the host muscle where 
they form nurse cells. Although the intestinal phase of infection is eventually resolved, 
adult parasites are not expelled from the intestine until they have released new bom 
larvae, successfully completing their life cycle. Primary T. spiralis infection stimulates 
strong immune responses in the mouse which are CD4^ T cell-dependent (Grencis et al., 
1985) and polarized towards the Th2 phenotype (Grencis et al., 1991; Finkelman et al., 
1997). The expulsion of T. spiralis from the intestinal compartment is thought to 
involve the complex interplay of both innate and parasite-specific (adaptive) effector 
mechanisms (Knight et al., 2004; Miller, 1987). Primary T. spiralis infection in mice 
leads to a strong long lasting immunity to reinfection, and this immunity can be 
adoptively transferred using T cells present in the mesenteric lymph nodes that are 
rapidly restimulated upon challenge (Wakelin and Wilson, 1979; Grencis and Wakelin, 
1982). Transfer of immunity to a primary T. spiralis infection in the mouse can also be 
achieved using immune sera from animals immunised with parasite antigens (Jarvis and 
Pritchard, 1992; Robinson et al, 1995b). 
High levels of protection against T. spiralis infection can be achieved in mice by 
systemic immunisation with a variety of different types of parasite antigens 
(summarised in Table 5-1). When immunised animals are challenged with T. spiralis 
Antigen preparation Author 
y-irradiated infective larvae harsh et al., 1959 
cmde parasite homogenate 
preparations 
Despommier et al., 1977; Despommier and 
Laccetti, 1981 
secreted parasite antigens (ES) Wakelin et al., 1986; Robinson et al., 1994 
purified secreted antigens Siberstein and Despommier, 1984 
parasite-surface antigens Grencis et al., 1986 
Table 5.1 Native parasite antigens that provide protection against T. spiralis infection 
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infection, worms are expelled more rapidly from the intestine and their growth and 
fecundity are reduced. Thus, it appears that immunisation interferes with the 
development of T. spiralis during the early stages of the enteral phase of its life cycle. 
The majority of immunisation-challenge studies have used native parasite 
antigens and only one example of a non-native protein conferring resistance to T. 
spiralis infection exists (Robinson et al. 1995c). Robinson and co-workers (1995c) 
demonstrated that a synthetic 40-mer peptide of the immunodominant 43 kDa 
glycoprotein secreted by the infective larval LI stage, was able to reduce intestinal 
parasite burden in mice by -50%. Currently, there are no examples in the literature of 
recombinant proteins being used to immunise animals against subsequent T. spiralis 
infection. However, recombinant proteins have successfully been used to immunise 
animals against other types of intestinal helminth infections (Loukas et al., 2004; Ball et 
al., 2007; Tsuji et al., 2001). 
Considering that the secreted T. spiralis 5'-nucleotidase (5'-NT) has already 
been cloned and biochemically characterised (Gounaris et al., 2004), it seemed 
important to establish whether immunisation with this catalytically active recombinant 
protein could protect mice from T. spiralis infection. This enzyme has been postulated 
to affect the function of immune cells (Gounaris et al., 2004) and, as shown in Chapters 
3 and 4 of this work, can modulate mast cell effector functions in vitro. It may therefore 
contribute to the survival of the parasite during the enteric phase of infection. The aim 
of the work described in this chapter was to examine whether immunisation with the 
recombinant 5'-NT could protect mice from T. spiralis infection. Ultimately, the 
purpose of this experiment was to provide insight into the in vivo function of the 
secreted 5'-NT. Moreover, the outcome of this experiment could have implications for 
other intestinal parasites, as it has been suggested that secretion of nucleotide 
metabolising enzymes may be common to other nematode species (Gounaris and 
Selkirk, 2005). Specifically, 5'-nucleotidase activity has been detected in the secreted 
proteins of Nippostrongylus brasiliensis and close homologues of the 5'-nucleotidase 
are present in the Trichuris muris expressed sequence tag dataset (K. Gounaris and M.E. 
Selkirk, unpublished). 
To determine whether immunisation with the recombinant 5'-NT could induce a 
protective effect, the kinetics of T. spiralis expulsion from the small intestine and the 
establishment of muscle stage larvae were characterised. As previous immunisation 
studies using native parasite antigens had shown that the main effect of vaccination was 
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to increase and accelerate antibody and cellular responses to subsequent T. spiralis 
infection (Robinson et al., 1995a), the profile of the immune response generated by 
immunisation with the 5'-NT was also investigated both before and after infection. 
Immunisation of mice with the 5'-NT was expected to generate the production 
and maintenance of high affinity neutralising antibodies, and the induction of a rapid 
secondary immune response involving a number of immune cell types. To confirm this 
had occurred, the serum-titres of 5'-NT-specific antibody isotypes were monitored as 
the course of immunisation was expected to generate plasma cells that secrete isotype-
switched high affinity 5'-NT-specific antibodies. The presence of high titres of 
neutralising antibodies prior to T. spiralis infection would potentially be capable of 
systemically blocking the nucleotide metabolising activity of the 5'-NT present in T. 
spiralis secreted proteins. To examine whether B cell responses stimulated by the 
immunisation had generated neutralising antibodies that would inhibit the nucleotide 
metabolising activity of the 5'-NT, sera from immunised animals were used in 5'-NT 
enzyme activity assays. 
Immunisation of mice with the 5'-NT was also expected to generate 5'-NT-
specific T cells in the mesenteric lymph nodes and spleen. These would be capable of 
rapidly responding to processed parasite-derived 5'-NT-antigen displayed on antigen 
presenting cells during the infection in vivo. To confirm that the immunisation process 
had primed T cells, 5'-NT-specific proliferative responses of mesenteric lymph node 
(MLN) and spleen cells were measured. The profile of 5'-NT-specific cytokine 
production in the MLN was also investigated as a marker of T-helper cell subset 
activity. 
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5.2 Results 
5.2.1 Expression of active recombinant T. spiralis 5-nucleotidase. 
The previously cloned T. spiralis 5'-nucleotidase (5'-NT) (Gounaris et al., 2004) 
was expressed in the yeast Pichia pastoris as a secreted protein. Nickel-chelating 
chromatography was used to purify the protein via a C-terminal polyhistidine tag. As 
shown in Figure 5-1 (A), the purified protein resolved by SDS-PAGE with an apparent 
molecular mass of -66-68 kDa, corresponding very closely to that of the native protein 
(67 kDa) which lacks the histidine tag (Gounaris, 2002). To confirm that the Coomassie 
blue-stained protein eluted by nickel-chelating chromatography was the recombinant 5'-
nucleotidase, Western blotting using an antibody to the C-myc epitope, which had been 
incorporated into the recombinant protein during cloning, was carried out. A single 
band of approximately 66-68 kDa was observed [Figure 5-1 (B)], confirming successful 
purification of the recombinant 5'-NT. 
The purified recombinant 5'-nucleotidase and T. spiralis ES were analysed for 
5'-nucleotidase activity by measuring the amount of inorganic phosphate released from 
nucleotide substrates (as detailed in the Materials and Methods section). The 
nucleotides AMP and UDP, already known to be the preferential substrates for the T. 
spiralis 5'-NT (Gounaris et al., 2004), were used as substrates in the activity assays. As 
shown in Figure 5-2 (A), using excess substrate and optimal buffer conditions (as 
described by Gounaris et al., 2004), the specific activity of the 5'-nucleotidase present in 
T. spiralis ES was established to be 3.77 + 0.4 |imol/min/mg and 0.4 + 0.1 
|imol/min/mg for AMP and UDP respectively. This is consistent with previous reports 
(Gounaris, 2002). In further experiments, 1 |ig and 40 ng were chosen as the optimal 
amounts of ES to use in 5'-nucleotidase activity assays utilising UDP and AMP as 
substrates respectively. The specific activity of the recombinant 5'-nucleotidase utilising 
AMP and UDP as substrates were 36.4 + 3.5 jumol/min/mg and 3.9 + 1.3 jj.mol/min/mg 
respectively [Figure 5-2 (B)]. The purified recombinant 5'-NT exhibited high specific 
activity and was approximately 5 times more active than the enzyme purified previously 
(Gounaris et al., 2004). In further experiments, 100 ng and 15 ng of recombinant 5'-NT 
were used in activity assays utilising UDP and AMP as substrates respectively. 
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Figure 5-1 Ni-NTA purification of the recombinant T. spiralis 5'-NT 
Proteins were resolved by 12% (w/v) SDS-PAGE and visualised by (A) 
Coomassie staining and (B) Western blotting using an antibody to the C-myc 
epitope. Yeast culture supernatant was concentrated, dialysed and applied to a 
Ni-NTA matrix (lane 1). Unbound proteins were removed (lane 2) and the 
matrix washed with buffer containing 1 mM imidazole (lane 3) and 5 mM 
imidazole (lane 4). Strongly bound proteins were eluted using 100 mM 
imidazole (lane 5). The migration of molecular mass markers is indicated in 
kDa. 
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Figure 5-2 Nucleotide substrate specificity of T. spiralis ES and 5'-NT 
T. spiralis ES and 5'-NT were used in phosphate-release assays as detailed in 
Materials and Methods to determine the activity of the native secreted and 
recombinant 5'-nucleotidase. Specific 5'-nucleotidase activities of T. spiralis 
ES (A) and 5'-NT (B) were determined using the substrates AMP and UDP. 
Data represent the mean + s.d.m of 3 batches of ES and one batch of expressed 
5'-nucleotidase. Experiments were performed in triplicate. 
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5.2.2 Analysis of 5-nucleotidase expression and secretion by different T. spiralis 
life-stages. 
To determine the stage specificity of expression of the 5'-NT, reverse 
transcriptase (RT)-PCRs were carried out using DNase-digested RNA extracted from 
muscle stage, adult and new bom larvae. To exclude the possibility of genomic DNA 
contaminating cDNA preparations, control PCRs were carried out using DNase-treated 
RNA and tubulin primers. No PGR products were generated from all batches of RNA 
used, indicating genomic DNA was not contaminating (data shown in Appendix 1-4). In 
order to standardise cDNA levels between batches of RNA, tubulin primers were used 
as a positive control. Representative RT-PCR analyses of T. spiralis 5'-NT expression 
are displayed in Figure 5-3 (A). Adult, newborn larvae and muscle stage larvae strongly 
expressed transcripts corresponding to the 5'-NT [Figure 5-3 (A)], indicating that this 
gene is expressed throughout the parasite life cycle. 
T. spiralis muscle stage larvae secrete the 5'-NT (Gounaris, 2002), thus it was of 
interest to determine whether this enzyme is secreted by other parasite life stages. To 
examine the stage specificity of 5'-NT secretion, ES proteins were collected from adult 
and muscle stage larvae. Western blot analysis using rabbit anti-r. spiralis 5'-NT 
polyclonal antibody sera detected single bands of the correct size (67 kDa) in both adult 
and muscle stage larvae secreted proteins [Figure 5-3 (B)], suggesting this enzyme is 
secreted throughout the enteral and parenteral stages of the life-cycle. 
5.2.3 The effects of immunisation with the recombinant 5'-NT on T. spiralis 
infection 
The extent of protective immunity to T. spiralis infection in the mouse has been 
shown to be greatly influenced by host genetic factors. For example NIH mice naturally 
expel T. spiralis infections more rapidly than G57BL/10 mice (Wakelin and Donachie, 
1983; Wakelin, 1988). Furthermore, immunisation of rapid-responder NIH mice with 
native parasite antigens confers a significant degree of protection against subsequent T. 
spiralis infection. In contrast, immunisation does not affect the expulsion kinetics of 
slow-responder G57BL/10 mice (Robinson et al., 1994, 1995a; Wakelin et ai, 1986). 
For this reason, high-responder NIH mice were used in the immunisation trial described 
here. 
In most model antigen systems, the generation of significant and long-lasting 
immune responses is dependent upon enhancing the immunogenicity of the antigen by 
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tubulin 
5-NT 
Figure 5-3 Stage specificity of 5'-NT expression and secretion 
(A) Reverse transcriptase-PCR analyses of 5'-nucleotidase (5'-NT) and tubulin 
expression using RNA extracted from T. spiralis adult (lane A), newborn larvae 
(lane N) and muscle stage larvae (lane M). (B) Parasite proteins were resolved 
by SDS-PAGE and transferred to nitrocellulose by Western blotting. The lanes 
represent: (1) 2 |a,g recombinant 5'-NT, (2) 20 jig muscle stage larvae ES, (3) 20 
|ig adult ES. The migration of molecular mass markers is indicated in kDa. The 
blot was probed using rabbit anti-J! spiralis 5'-NT polyclonal antibody sera 
diluted 1/500 (vol/vol). 
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delivery with an adjuvant. The mineral gel adjuvant potassium alum has been reported 
to induce TH2-type responses (Grun and Maurer, 1989), and has successfully protected 
mice from T. spiralis infection when used as an adjuvant in immunisation trials using T. 
spiralis antigen preparations (Robinson et al., 1994). Considering that the generation of 
a TH2-type immune response is associated with the expulsion of helminth parasites, this 
adjuvant was used to promote the development of a TH2-type immune response directed 
toward the 5'-NT. 
Mice were initially immunised with a relatively high dose of 5'-NT (25 |j.g) and 
boosted with lower doses (12.5 p-g) 28 and 42 days later. Separate groups of control 
mice were sham-immunised with adjuvant only, in parallel to the 5'-NT-immunised 
animals. The timing of the immunisation schedule was used to allow the development 
of high affinity B cell clones, which require low levels of antigen to undergo affinity 
maturation (Goidl et ah, 1968). 49 days after the original immunisation, immunised and 
control mice were subsequently challenged with 500 T. spiralis infective larvae. The 
kinetics of parasite expulsion from the small intestine were monitored at days 4 and 7 
post infection. The fecundity of female parasites was also assessed in terms of new bom 
larvae production per adult parasite. The effect of immunisation on muscle stage larvae 
establishment was also evaluated 35 days post infection. 
The immune response elicited in immunised-infected and sham-immunised-
infected mice were compared to naive mice in terms of 5'-NT-specific antibody isotype 
profiles, cytokine responses and cellular proliferation in antigen-recall experiments. The 
titres of 5'-NT-specific neutralising antibodies present in the sera of immunised-
infected, sham-immunised-infected and naive animals were also determined by using 
the 5'-NT activity assay. 
5.2.3.1 Anti-recombinant 5'-NT antibody isotype profile 
To determine whether immunisation with the recombinant 5'-NT had induced 
antibody production, relative amounts of 5'-NT-specific IgGl, IgG2a, lgG2b, IgM and 
IgA in the serum were determined by ELISA. Serum was titrated and the levels of 5'-
NT-specific antibody present expressed as optical density at 450 nm. As expected, 
infected sham-immunised animals had low levels of IgGl, IgG2a, IgG2b, IgA and IgM 
antibody isotypes present in their sera, which were not significantly different to 
uninfected sham-immunised animals (Figure 5-4). This is typical of a primary response 
to T. spiralis infection, where elevated levels of these anfibody isotypes are not 
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Sera were collected from control and immunised mice prior to and 4 days post T. 
spiralis infection (D4 PI). Sera were pooled and analysed for 5'-NT-specific 
antibodies by sandwich ELISA using plates coated with 5 |ig/ml recombinant 5'-
NT. Data were analysed using the unpaired students r-test and represent the mean + 
s.d.m (n=3). Significant differences between immunised and control animals are 
indicated *** p< 0.001, ** p<0.01. 
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observed until much later in infection (Goyal and Wakelin, 1993; Furze and Selkirk, 
2005) . 
From the data shown in Figure 5-4, it is clear that the principal isotype induced 
by immunisation with the recombinant protein was IgGl, suggesting immunisation had 
stimulated a Th2 type immune response. Levels of 5'-NT-specific IgGl antibodies were 
elevated in 5'-NT-immunised animals prior to challenge T. spiralis infection and 
continued to bind antigen at dilutions of 1:10000. Levels of the IgG subclasses IgG2a 
and IgG2b were also elevated in animals immunised with the recombinant 5'-NT, and 
sera-titrations of these antibody isotypes continued to bind antigen at dilutions of 1:100 
(Figure 5-4). Infection with T. spiralis did not appear to alter IgGl, IgG2a or IgG2b 
antibody isotype levels in 5'-NT-immunised animals. 
Immunisation of mice with the recombinant 5'-NT did not elevate serum levels 
of IgM or IgA antibody isotypes (Figure 5-4). Furthermore, serum levels of these 
isotypes were not affected by T. spiralis infection (Figure 5-4). In general, these results 
suggest immunisation of mice with the recombinant 5'-NT prepared in alum adjuvant, 
successfully generated 5'-NT-specific antibody responses dominated by an IgGl 
antibody isotype. 
5.2 ,3 .2 Ce l lu lar pro l i f erat ion 
To determine whether immunisation with the 5'-NT had induced antigen-
specific T cells in the mesenteric lymph nodes (MLN) and spleen, cellular 
responsiveness to 5'-NT antigen was assessed (antigen recall). Considering that peak 
cellularity and lymphoblast activity in the MLN occurs on day 4 post-infection during 
secondary T. spiralis infection (Grencis and Wakelin, 1982), proliferative and cytokine 
responses in the MLN were monitored at day 4 post-infection. 
Cells fi-om the MLN [Figure 5-5 (A)], and spleen [Figure 5-5 (B)] of naive 
(uninfected control), infected-5'-NT-immunised and infected-sham-immunised mice 
were stimulated using 8 |j.g/ml 5'-NT, and proliferation assessed by [^H] thymidine 
incorporation. The super-antigen, staphylococcal enterotoxin B fi-agment (SEB), was 
used as a positive control to directly stimulate T cells. In order to determine if 5'-NT-
specific responses were in part due to intrinsic mitogenic properties of the recombinant 
protein, cells from naive animals were stimulated with the recombinant 5'-NT. As 
shown in Figure 5-5, the recombinant 5'-NT did not induce cellular proliferation of 
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(B) were cultured ex vivo for 72 hours and treated with media (control), 1 |j.g/ml 
Staphylococcal Enterotoxin B fragment (SEB) and 8 p-g/ml 5'-NT, with the addition of 1 
|iCi [^H] thymidine for the final 24 hours of culture. Data are shown with each symbol 
representing individual mice. Data were analysed using the unpaired Student's (-test. 
Significance values are are shown relative to infected sham-immunised animals and 
infected 5'-NT-immunsied animals only ***p< 0.001. 
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MLN or spleen cells extracted from naive animals, suggesting that it was not acting as a 
non-specific stimulus. 
Cellular proliferative responses were measured at 4 days post-7. spiralis 
infection, as at this time point both MLN and spleen cells can respond to antigen 
(Grencis and Wakelin, 1982; Robinson et al, 1995a; Wakelin et al, 1985). As shown in 
Figure 5-5, MLN and spleen cells removed from T. spiralis infected animals exhibited 
higher basal rates of proliferation than naive animals, indicative of generalised 
activation by infection. When stimulated with SEE, MLN cells removed from infected-
sham-immunised, and infected-5'-NT-immunised mice, exhibited elevated proliferation 
in comparison to naive animals [Figure 5-5 (A)], fiirther implying that the infection had 
stimulated an immune response local to the intestine. Stimulation with the recombinant 
5'-NT did not induce increased proliferation of MLN cells isolated from infected-5'-NT-
immunised animals, suggesting immunisation with the recombinant 5'-NT had not 
induced the expansion of 5'-NT-specific T cells in the MLN [Figure 5-5 (A)]. 
Stimulation with the recombinant 5'-NT did not induce elevated proliferation in naive or 
T. spiralis infected animals either [Figure 5-5 (A)]. 
When stimulated with SEE, spleen cells removed from naive, infected-5'-NT-
immunised, and infected-sham-immunised mice exhibited similar levels of elevated 
proliferation [Figure 5-5 (B)]. This suggests that at this time point the infection had not 
yet induced a systemic immune response. Stimulation with the recombinant 5'-NT 
induced increased proliferation of spleen cells taken from infected-5'-NT-immunised 
mice only [Figure 5-5 (B)], indicating that the immunisation process had expanded the 
population of 5'-NT-specific T cells in the spleen. 
5.2.3 .3 C y t o k i n e re sponse 
In order to determine if immunisation with the 5'-NT induced differing cytokine 
profiles during T. spiralis infection, MLN cells were isolated and cultured ex vivo for 72 
hours with 8 |ig/ml 5'-NT. Antigen-specific lL-2, lL-4, lL-5, IFN-y and TNF-a levels 
were assessed by using the ED™ cytometric bead array assay. Animals immunised with 
the 5'-NT prior to T. spiralis infection generated significantly higher levels of IL-4 and 
IL-5 (Figure 5-6), indicative of a Th2 type cytokine environment typical of nematode 
infections. Notably, this response was dominated by lL-5, with levels reaching 2573 + 
1296 pg/ml (Figure 5-6). 
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p<0.05,11 p<0.01. 
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Levels of the pro-inflammatory type-1 cytokine TNF-a was also elevated in 
infected-5'-NT-immunised mice compared to infected-sham-immunised animals (Figure 
5-6). Production of cytokines associated with a ThI type environment such as IL-2 and 
IFN-y was slightly increased in T. spiralis infected animals (Figure 5-6). This appeared 
to be independent of immunisation with the 5'-NT as stimulation with the recombinant 
protein did not alter levels of IL-2 or IFN-y. 
5.2 .3 .4 T. spiralis paras i te b u r d e n in mice i m m u n i s e d w i t h the r e c o m b i n a n t 5 ' -NT. 
NIH mice expel T. spiralis adult worms from the intestine within 10 days of 
infection (Robinson et al., 1994). Hence, worm burdens following immunisation with T. 
spiralis recombinant 5'-NT were monitored 4 and 7 days post-infection. No significant 
differences between the numbers of adult worms recovered from sham or 5'-NT 
vaccinated mice at 4 or 7 days post-infection were observed [Figure 5-7 (A)]. The 
fecundity of female worms was also tested by incubating adult worms (both male and 
female) for 18 hours in media containing FCS. The numbers of NBL released were 
counted and are expressed relative to total number of adults cultured. No statistically 
significant differences between 5'-NT-immunised or sham-immunised mice were 
observed [Figure 5-7 (B)], suggesting that immunisation does not appear to affect the 
fecundity of female worms. To determine whether immunisation with the 5'-NT induced 
protective immune responses against establishment of parasites in the muscle, either by 
interfering with new bom larvae survival and migration, or development of the nurse 
cell complex, muscle-stage larvae (MSL) were extracted from mice 35 days post-
infection. As shown in Figure 5-7 (C), slightly reduced numbers of MSL were 
recovered from mice immunised with the 5'-NT, but this was not statistically 
significant. 
5.2 .4 T h e e f f ec t o f sera on 5 ' - N T act iv i ty 
In order to determine whether the immunisation induced the production of 
neutralising antibodies capable of blocking the activity of T. spiralis recombinant 5'-
NT, sera at a final dilution of 1/100 were used in the phosphate-release assays. 
Unexpectedly, sera from uninfected control mice increased the activity of the 
recombinant 5'-NT by approximately 3-fold, in terms of both AMP and UDP hydrolysis 
[Figure 5-8 (A) and (B)]. However, the activity of the recombinant protein was not 
enhanced when sera from 5'-NT-immunised animals was used [Figure 5-8 (A) and (B)]. 
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Prior to infection sera were collected from control (C) and 5'-NT immunised (1) 
mice. Sera were also collected from the same animals 4 days (D4C, D4I) and 
35 days (D35C, D35I) post T. spiralis infection. Sera were diluted 1/100 and 
used in a phosphate release assay utilising (A) 2.5 mM AMP and 15 ng 5'-NT, 
and (B) 2.5 mM UDP and 40 ng 5'-NT. Data were analysed using the unpaired 
two-tail Student's r-test and represent the mean + s.d.m of assays performed in 
duplicate using sera from groups of at least 4 mice mice. Significance values 
are shown relative to nucleotide + 5'-NT, ** p<0.0], *** p<0.00], and 
nucleotide + 5'-NT + sera from immunised and control animals at the 
equivalent time point t t t p<0.01, f t p<0.001. 
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This suggests the presence of a factor, most hkely antibody, in the immune serum that 
inhibited the enhanced activity of the enzyme. It is important to note that control 
reactions (as detailed in the Materials and Methods section) were performed to exclude 
the possibility that enhanced 5'-NT activity or elevated levels of nucleotides were 
present in the sera. Sera extracted from 5'-NT-immunised mice at day 4 and 35 post T. 
spiralis infection consistently inhibited the activity of the recombinant protein [Figure 
5-8 (A) and (B)], indicating that neutralising antibodies were present throughout the T. 
spiralis infection. 
To investigate whether this phenomenon was restricted to the recombinant 5'-
NT, the experiment was repeated using T. spiralis ES containing native 5'-NT activity. 
As shown in Figure 5-9, sera from naive and sham-immunised animals also potentiated 
the hydrolysis of AMP and UDP by the native 5'-NT. In correlation with the data 
observed using the recombinant 5'-NT (Figure 5-8), sera from 5'-NT-immunised 
animals prior to and during T. spiralis infection consistently inhibited the hydrolysis of 
both AMP and UDP [Figure 5-9 (A) and (B)]. This suggests that the neutralising 
antibodies present in the sera of immunised mice recognised both native and 
recombinant forms of the 5'-NT. 
To determine if the inhibitory factor present in sera from 5'-NT-immunised mice 
was an antibody or other protein, sera were heated to 90°C for 10 minutes to denature 
all heat-labile proteins. As shown in Figure 5-10, the inhibitory effect of sera from 5'-
NT-immunised mice on recombinant 5'-NT activity was lost upon heat treatment 
indicating that this effect was due to a heat-labile protein. Heat treatment of sera from 
immunised animals resulted in the potentiation of enzyme activity (Figure 5-10), in a 
similar manner to sera from naive mice (compare Figure 5-9 and 5-10). Therefore, this 
suggests that the factor that resulted in the enhancement of 5'-NT activity was most 
likely not a protein. 
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Figure 5 -9 T h e e f fec t of sera f r o m contro l a n d 5 ' - N T i m m u n i s e d mice on 5'-
NT activity in T. spiralis ES 
Prior to infection sera were collected from control (C) and 5'-NT immunised (1) 
mice. Sera were also collected from the same animals 4 days (D4C, D41) and 35 
days (D35C, D35I) post T. spiralis infection. Sera were diluted 1/100 and used 
in a phosphate release assay utilising (A) 2.5 mM AMP and 100 ng ES, and (B) 
2.5 mM UDP and 1 |ig ES. Data were analysed using the unpaired two-tail 
Student's r-test and represent the mean + s.d.m of assays performed in duplicate 
using sera from groups of at least 4 mice. Significance values are shown relative 
to nucleotide + ES, ** p<0.01, *** p<0.001 and sera from immunised and 
control animals at the equivalent time point t t t p<0.001 . 
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Prior to infection sera were collected from control (C) and 5'-NT immunised (I) 
mice. Sera were also collected from the same animals 4 days (D4C, D41) and 
35 days (D35C, D35I) post T. spiralis infection. Sera were diluted 1/100 and 
used in a phosphate release assay utilising (A) 2.5 mM AMP and 20 ng 5'-NT, 
and (B) 2.5 mM UDP and 50 ng 5'-NT. Data were analysed using the unpaired 
two-tail Student's ?-test and represent the mean + s.d.m of assays performed in 
duplicate using sera from groups of at least 2 mice. All assays containing heat-
treated sera were significantly different to nucleotide 4 5'-NT alone, p<0.001. 
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5.3 Discussion 
The aim of this study was to determine whether immunisation of mice with the 
T. spiralis recombinant 5'-nucleotidase could confer protection against subsequent T. 
spiralis challenge infection. This was performed to provide new insight into the in vivo 
role of the secreted 5'-nucleotidase. Enzymes secreted into the host environment by 
parasites such as T. spiralis are likely to be involved in the invasion process and/or the 
survival and development of the parasite (Despommier, 1983). As shown here, the 5'-
NT is expressed and secreted by all the major life-stages of the parasite. This potentially 
suggests that secretion of the 5'-NT is not specifically involved in one particular aspect 
of the parasites life cycle, and may play a role at multiple stages of the infection. This 
implies that all the parasite life-stages have the potential to modulate purinergic 
signalling by altering the amount and type of nucleotides available to bind to host 
purinergic receptors. 
To determine whether immunisation with the recombinant 5'-NT successfully 
primed the immune response, various immunological parameters at both the local and 
systemic level were characterised. CD4^ T cells play a central role in protective immune 
responses against T. spiralis infection (Grencis et al., 1985; Ramaswamy et al., 1994). 
During the early phase of T. spiralis infection, CD4^ T cells residing within the MLN 
respond to parasite antigen, proliferate (Krco et al., 1982) and migrate (Riedlinger et al., 
1986; Wang et al., 1990) to the intestinal tissue, where they orchestrate the 
inflammatory changes that are ultimately responsible for parasite expulsion from the 
intestine. Consistent with other studies, infection with T. spiralis stimulated the basal 
level of MLN cell proliferation and potentiated T cell proliferation in response to the 
super-antigen SEE (Furze and Selkirk, 2005). These effects were not affected by 
immunisation with the 5'-NT. Other studies have reported that after immunisation with 
native parasite antigens, mice remain immune to challenge infections reflecting the 
persistence of a primed T cell population that can be rapidly restimulated upon 
challenge (Robinson et al., 1994). However, antigen recall experiments using the 
recombinant 5'-NT did not induce MLN cell proliferation, suggesting the immunisation 
regime used did not stimulate the clonal expansion of 5'-NT-specific T cells in the 
MLN. Potentially, this could have been due to the fact that the 5'-NT was administered 
sub-cutaneously during immunisation, thus generating a systemic rather than mucosal 
immune response. 
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In contrast to MLN cells, splenocytes extracted from 5'-NT-immunised mice 
proliferated when stimulated with the recombinant 5'-NT. Furthermore, T. spiralis 
infection had no effect on the level of basal or SEB-induced splenocyte proliferation, 
which is indirectly consistent with other reports that suggest lymphocytes do not 
infiltrate the spleen until 7-15 days post T. spiralis infection (Furze and Selkirk, 2005). 
This result clearly indicates that immunisation with the 5'-NT generated a systemic 
rather than a mucosal immune response. 
Protective immune responses and expulsion of parasitic nematodes in mice are 
dependent on the generation of a type 2 immune response (Grencis et al., 1991; Else et 
al., 1992; Lawrence et al., 1998; Finkelman et al., 1997). MLN cells fi-om T. spiralis-
infected mice transiently secrete high levels of the Th2 cytokines, IL-3, IL-4, lL-5, lL-9, 
IL-10 and IL-13 that peak during the first 4-13 days of infection (Grencis et al., 1991; 
Robinson et al., 1995a; Helmby and Grencis, 2003; Furze and Selkirk, 2005). In 
correlation with the observation that MLN cells extracted fi-om 5'-NT-immunised mice 
4 days post T. spiralis infection did not proliferate in response to the recombinant 5'-NT 
when stimulated in vitro, levels of IL-2 secretion were also not elevated in response to 
the 5'-NT. Considering that IL-2 produced by activated T cells is required to drive T cell 
proliferation and differentiation, these data explain why elevated proliferation was not 
observed in MLN cells extracted from 5'-NT-immunised mice. In addition, this suggests 
that a 5'-NT-specific T cell response had not been primed in the MLN. Notably, the 
basal level of IL-2 secretion was elevated in T. 5pzra/w-infected animals, which is a 
characteristic of this phase of the infection (Zhu and Bell, 1989). 
During T. spiralis infection, Th2 cytokine production in response to recall with 
parasite antigen is dominated by IL-5, and to a lesser extent IL-4, in MLN draining the 
intestine (Grencis et al., 1991; Furze and Selkirk, 2005). This response peaks 7 days 
post infection. In a similar manner, MLN cells extracted from 5'-NT-immunised mice 4 
days post-r. spiralis infection and stimulated with the recombinant 5'-NT secreted 
significantly more of the Th2 cytokines IL-4 and IL-5, and the pro-inflammatory 
cytokine TNF-a. It is likely that these cytokines were produced by 5'-NT-specific T 
cells in the MLN. Considering that IL-4 plays an important role in driving the 
development of Th2 cells and the generation of protective immunity to primary T. 
spiralis infection (Finkelman et al., 1997; Lawrence et al., 1998), the elevated levels of 
IL-4 in the immunised animals could act to help in protecting the host. In a similar 
manner, elevated levels of IL-5 could promote the generation and recruitment of 
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eosinophils (Coffinan et ai, 1989), which may also enhance parasite expulsion (Gurish 
et al., 2002). The elevated levels of TNF-a in 5'-NT-immunised mice could also 
activate macrophages and further promote inflammation. The 5'-NT-specific cytokine 
responses of splenocytes were not investigated in this study, as the focus was on 
determining whether an immune response was generated in the vicinity of the intestine 
i.e. the MLN. 
Transfer of immunity to a primary T. spiralis infection in the mouse can be 
achieved using immune sera from vaccinated animals (Jarvis and Pritchard, 1992; 
Robinson et al., 1995). Thus, it was deemed important to determine whether 
immunisation had generated an antigen-specific antibody response. The immunisation 
strategy used here successfully gave rise to high titres of 5'-NT-specific antibodies. 
During the initiation of a humoral immune response, IgM is the initial isotype produced 
and subsequent class switching is influenced by the type of cytokines present in the 
external milieu. Class switching to the IgGl and IgG2b isotype is driven by IL-4 and 
IL-5 produced by TH2 cells, whereas switching to IgG2a is more indicative of a THI 
environment (Gracie and Bradley, 1996). The antibody response generated during the 
5'-NT-immunisation process was dominated by IgGl and to a lesser extent IgG2b and 
IgG2a antibody isotypes. This suggests that immunisation using alum adjuvant 
generated a mixed immune response dominated by Th2 cells. This also correlates with 
the observation that elevated levels of the TH2-type cytokines, IL-4 and IL-5 were 
present in the supematants of MLN cells extracted from 5'-NT immunised mice during 
T. spiralis infection. 
IgM levels were not elevated in 5'-NT-immunised mice, which is inconsistent 
with another similar immunisation study that reported that vaccination of NIH mice 
using alum-adjuvant and T. spiralis ES induced predominantly mixed IgGl and IgM 
antibody isotypes prior to and at 7 days post infection (Robinson et al., 1994). 
Considering that the early stages of antibody responses are dominated by IgM produced 
by B cells that have not yet undergone isotype switching or affinity maturation, it can be 
suggested that the immunisation strategy used by Robinson et ai, (1994) was still 
stimulating naive B cells. In contrast, the complete lack of 5'-NT-specific IgM observed 
in the immunisation strategy used here implies that naive B cells were no longer being 
stimulated by the 5'-NT antigen, and the humoral response had already undergone 
isotype switching. This discrepancy could be due to the differences in the time course of 
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immunisation, as the regime used in this study was twice as long as that used by 
Robinson and co-workers. 
During the normal course of T. spiralis infection in mice, IgA levels in the sera 
are generally low and peak at day 15 post-infection (Goyal and Wakelin, 1993; Furze 
and Selkirk, 2005). Immunisation did not generate 5'-NT-specific IgA antibody isotypes 
in the sera, again suggesting a mucosal immune response had not been activated. A 
previous immunisation study using native T. spiralis antigens has also reported low 
levels of IgA in the sera of immunised animals, but elevated levels of IgA in intestinal 
lavage fluid (Robinson et al., 1995a). Potentially, elevated levels of IgA may also have 
been present in the intestines of 5'-NT-immunised animals, however this parameter was 
not measured. 
Immunisation using native parasite ES greatly increases the magnitude of the 
antibody response induced during the early phase of infection (Robinson et al. 1994, 
1995a). In contrast, infection of 5'-NT-immunised animals with T. spiralis did not 
stimulate a rapid secondary humoral immune response during the early phase of 
infection (day 4 p.i). This result may suggest that the amount of 5'-NT secreted into the 
host by T. spiralis during the intestinal phase of infection was insufficient to further 
boost antibody levels. This idea is consistent with the fact that the native secreted 5'-NT 
constitutes only a very small percentage of the total proteins secreted by T. spiralis 
(Gounaris, 2002). This discrepancy probably reflects the greater complexity of native 
ES which contains multiple immunogenic proteins that are secreted in great quantities 
by the parasite, and can thus be detected more readily by the host. 
Immune responses towards antigens usually involve antibodies directed at 
multiple epitopes, only a proportion of which will neutralise the function of the antigen. 
When this property was investigated, sera from 5'-NT-immunised animals inhibited 
recombinant 5'-NT activity, suggesting neutralising antibodies were present. 
Unexpectedly, sera from naive and sham-immunised, infected animals enhanced the 
enzymatic activity of the recombinant 5'-NT by approximately 3-fold. Sera from naive 
or infected animals also potentiated the activity of the native 5'-NT present in ES. 
Furthermore, sera fi-om 5'-NT-immunised mice extracted prior to, or throughout the 
course of infection, significantly reduced the activity of the recombinant and native 5'-
NT towards either 5'-monophosphate or -diphosphate substrates. This suggests that 
immunisation using the 5'-NT would generate antibodies that could neutralise the native 
T. spiralis 5'-NT secreted by the parasite during the course of the infection. 
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When sera from 5'-NT-immunised and sham-immunised mice were heat-treated 
and subsequently used in 5'-NT activity assays, sera from both groups of mice enhanced 
the activity of the 5'-NT. This suggests that a heat-stable molecule present in the sera of 
both immunised and non-immunised animals was responsible for enhancing the activity 
of the 5'-NT. Furthermore, heat-treatment of sera taken from immunised animals also 
showed that the neutralisation of 5'-NT activity was attributed to a heat labile protein, 
most likely IgGl considering that this was the most abundant isotype produced during 
the immunisation. Further experiments using a protein-A column to purify IgG 
antibodies from the sera would have been useful to determine whether this was the case. 
A possible scenario that explains the enhancing effect of sera on 5'-NT activity 
could involve the presence of a small molecule/ion/metabolite in the serum binding to 
the recombinant 5'-NT at a site other than the active site. This could induce a 
conformational change in the 5'-NT which results in increased activity of the enzyme. 
Potentially, the activating factor may already be present in T. spiralis ES, as sera did not 
enhance the activity of the native 5'-NT as potently as the recombinant 5'-NT. Further 
experiments to investigate whether serum alters the kinetic profile of the recombinant 
5'-NT and native 5'-NT could prove interesting to determine whether allostery is 
occurring. 
Despite immunisation with the 5'-NT generating a systemic immune response 
resulting in high titres of 5'-NT-specific antibodies in the sera and increased numbers of 
5'-NT-primed T cells in the spleen, no protection was conferred to T. spiralis infection. 
There was no difference in the kinetics of parasite expulsion or fecundity of adults 
between immunised and non-immunised animals. Potentially, the absence of protection 
against the enteric phase of infection in 5'-NT-immunised animals may have been due 
to the immunisation strategy not priming a 5'-NT-specific T cell response in the local 
draining lymph nodes of the intestine. 
As the immunisation failed to evoke a localised immune response, the results of 
this experiment are inconclusive, and the role of the 5'-NT in the enteric phase of 
infection still remains unknown. Further experiments that pursue immunisation as a tool 
to determine the role of the 5'-NT in T. spiralis infection should be aimed at generating 
a mucosal immune response. Potentially, this could be aided by use of different 
adjuvants or routes of administering the recombinant protein. For example other studies 
have reported the successful generation of an enhanced mucosal immune response by 
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orally or nasally immunising mice with native or synthetic parasite antigens and cholera 
toxin (Robinson et al., 1995c; McGuire et al., 2002) 
Immunisation of mice with the 5'-NT also failed to significantly affect the 
numbers of parasites encysting in the muscle, despite the presence of neutralising, 5'-
NT-specific antibodies in the sera. This may suggest that 5'-NT activity is not required 
for the migration of newborn larvae or nurse cell formation in the muscle. Alternatively, 
the neutralising antibodies generated by immunisation may not have been sufficient to 
completely inhibit all of the 5'-NT secreted by the parasites. This may have allowed the 
parasite to successfully complete its life-cycle. 
In summary, these experiments have shown that the 5'-NT is expressed by adult, 
newborn larvae and muscle stage larval parasites. Immunisation of mice with this non 
stage-specific recombinant protein generated a TH2-dominated systemic immune 
response, but did not induce protective adaptive immune responses in the intestinal 
environment. The immunisation strategy used generated high titres of 5'-NT-specific 
antibodies that could neutralise the activity of the 5'-NT in vitro. Unexpectedly, sera 
firom naive mice actually increased the enzymatic activity of the 5'-NT in vitro, 
potentially indicating this enzyme may have a higher specific activity than previously 
thought. Challenge of immunised animals with T. spiralis infective larvae did not confer 
protection against any stage of the parasites life cycle. The lack of protection against T. 
spiralis infection inferred by immunisation with the 5'-NT may be due to the inadequate 
T cell response generated in the MLN. In conclusion, sub-cutaneous immunisation of 
mice with the recombinant 5'-NT did not generate a sufficiently potent mucosal immune 
response and hence the importance of this secreted enzyme in T. spiralis infection still 
remains elusive. 
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Chapter 6 
Purinergic receptor expression in the murine intestinal 
epithelium during T. spiralis infection 
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6.1 Introduction 
The intestinal epithelium serves as a physical barrier between the external 
environment of the gut lumen and the internal mileau, and transports nutrients, ions and 
fluids. Epithelial cells maintain physiological homeostasis by regulating the amount of 
fluid in the lumen. This is achieved by modifying nutrient and ion absorption and ion 
secretion, and can also be further modulated by the enteric nervous system. Purinergic 
receptors play a significant role in regulating ion transport in epithelial tissues such as 
the gastrointestinal tract (Bucheimer and Linden, 2004). Extracellular nucleotide 
signalling in intestinal epithelia is a complex process and distinct receptors are involved 
in mediating responses at the apical (luminal) and basolateral cell membranes (Dubyak, 
2003). Moreover, different combinations of purinergic receptors are expressed by the 
multiple cell types that comprise the complex epithelial tissue. Elucidation of how 
extracellular nucleotides modulate purinergic receptor-induced epithelial cell function is 
further complicated by the presence of cell surface ecto-nucleotidases which readily 
metabolise nucleotides to products that can then interact with other purinergic receptor 
sub-types. 
During nematode infections the level of fluid in the lumen increases and smooth 
muscle becomes hypercontractile. This is referred to as the "weep and sweep" response 
which is thought to facilitate worm expulsion (Murray et al., 1971). The response is 
mediated by a variety of mechanisms involving epithelial cells, immune effector cells 
and the enteric nervous system. Nematode infections generally induce increased 
epithelial cell permeability, which may allow protective proteins from lymph and serum 
to gain access to the gut lumen, where they might be able to damage the parasite 
(McDermott et al., 2003; Madden et al., 2004). The absorptive properties of the 
intestinal epithelium are also decreased, which further contributes to the increased fluid 
accumulation in the lumen (Madden et al., 2002; 2004). The effect of nematode 
infection on epithelial cell ion secretion is more complex. For instance, ion secretion by 
epithelial cells is enhanced by enteric nerves though a reflex pathway that involves 
serotonin (5-hydroxytryptamine (5-HT)) and cholinergic stimulation. Mucosal mast 
cells release a number of soluble mediators, such as prostaglandin (PG) E] and 
histamine, which also increase epithelial cell secretion, putatively by enhancing 
neuroimmune interactions (Perdue et al., 1991; Madden et al., 2004). In contrast, when 
enteric nerves are inhibited by antagonists, it has been reported that nematode infection 
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directly inhibits the secretory responses of epithelial cells when activated by mast cell 
mediators (Madden et al., 2004). A parasite mediated inhibition of secretory responses 
would potentially limit the accumulation of fluid in the lumen that would usually 
facilitate worm expulsion, thus benefiting the parasites. 
Purinergic receptor stimulation of chloride ion secretion could also contribute to 
the secretory-flush response observed during intestinal nematode infections, as a variety 
of purinergic receptors are known to mediate chloride ion secretion from epithelial cells. 
For example, P2Y4 receptor stimulation with ATP or UTP has been shown to increase 
Cr secretion leading to fluid accumulation in the lumen (Cressman et al., 1999; Rob aye 
et al., 2003; Ghanem et al., 2005). To a lesser extent, stimulation of basolateral P2Y2 
receptors can also stimulate chloride ion secretion in the small intestine (Ghanem et al., 
2005). Adenosine signalling via Ai receptors present on luminal cell membranes and 
Aib receptors found on basolateral cell membranes, can stimulate chloride ion secretory 
responses from epithelial cells (Strohmeier et al., 1995; Ghanem et al., 2005). The Ais 
adenosine receptor (Barrett et al., 1989; Strohmeier et al., 1995) and the P2Yi and P2Y6 
receptors (Leipziger et al., 1997; Kottgen, 2003) have also been implicated in the 
regulation of ion transport in the colon. 
Infective T. spiralis larvae actively invade jejunal epithelial cells and live within 
the intestinal epithelium (Wright, 1979; ManWarren et al., 1997). Infection is associated 
with acute pathological changes within the epithelium such as villus atrophy and crypt 
hyperplasia, increased epithelial cell permeability, infiltration by mucosal mast cells and 
paneth and goblet cell hyperplasia (Kamal et al., 2001; Garside et al., 2000). T. spiralis 
invasion of the epithelium results in the release of nucleotides from damaged cells. This 
response may play a role in host defence by activating purinergic receptors on epithelial 
cells which stimulate ion secretion, leading to water efflux into the lumen. Potentially, 
the release of nucleotide metabolising enzymes by the parasite may serve to limit the 
accumulation of fluid in the lumen that would ordinarily facilitate worm expulsion. This 
may also act to dampen the potential debilitating effects of excess fluid loss on the host 
through diarrhoea. 
Host genetic factors strongly influence the expulsion of T. spiralis from the 
murine small intestine. Inbred mice strains are classified into rapid- and slow-
responders according to the speed at which they expel parasites from the intestine. 
Rapid-responder NIH mice expel parasites from the intestine within 10 days of infection 
and have lower muscle stage larvae burdens in comparison to slow-responder 
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C57BL/10 mice which can take up to 17 days to expel parasites (Wakelin et al, 1986). 
This is partially determined by the mouse major histocompatability complex (MHC) H-
2 (Wakelin and Donachie, 1983), as well as non-MHC linked responses (Wassom et al, 
1983). For example, the mast cell response in C57BL/10 mice is slower and of a lower 
magnitude than NIH mice (Tuohy et al., 1990). Innate immune responses in the 
epithelium also differ between strains, as exemplified by the expression of the lectin, 
intelectin 2. This molecule is suggested to serve a protective role as it is rapidly 
upregulated in the jejunum of NIH mice during T. spiralis infection, but is absent in 
slow-responder C57BL/10 mice (Pemberton et al., 2004). 
The aim of this investigation was to characterise the different sub-types of PI, 
P2Y and P2X receptors expressed in the murine jejunal epithelium during T. spiralis 
infection, using qualitative RT-PCR analyses. This would determine which types of 
extracellular nucleotides would potentially be able to interact with purinergic receptors 
expressed by the epithelium during T. spiralis infection. As host genetic factors 
determine the rate of expulsion of adult worms from the small intestine, fast (NIH) and 
slow (C57BL/10) responder strains of mice were used. This was performed to ascertain 
whether alterations in host purinergic receptor expression correlated with the kinetics of 
parasite expulsion. 
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6.2 Results 
Cells of the intestinal epithelium were extracted from the jejunum of mice using 
a method described by Russell et al., (2000) which was a modification of the EDTA 
perfiision technique originally pioneered by Bjerknes and Cheng (1981). This method is 
based on the principle that EDTA exfoliates both villus and crypt epithelium from the 
underlying basal lamina and muscularis mucosae. The extracted epithelial cells were 
subsequently used to generate RNA preparations. 
To exclude the possibility of genomic DNA contaminating epithelial RNA 
preparations, all samples of RNA were digested with DNase and used as templates in 
PCR reactions using P-actin primers. No PCR products were generated from all batches 
of epithelial RNA used (data shown in Appendix 1-7), indicating the absence of 
contaminating genomic DNA. cDNA was subsequently prepared from the RNA, and the 
amounts used standardised between different RNA batches via P-actin-specific PCR. 
Two mice of each sfrain (NIH and C57BL/10) were used per time point and mouse mast 
cell protease-1 franscripts were monitored by RT-PCR to confirm that the infection had 
been successful. 
6.2.1 P I pur inerg i c receptor express ion in the intest inal ep i the l ium of rapid- a n d 
s l o w - r e s p o n d e r mice d u r i n g T. spiralis in fec t ion 
As shown in Figure 6-1, naive, slow-responder C57BL/10 mice expressed 
relatively high levels of Ai receptor transcripts (Figure 6-1). Naive rapid-responder NIH 
mice expressed extremely low levels of Ai receptor transcripts and also low levels of 
AzB receptor transcripts (Figure 6-2). These results suggest that the two strains differ in 
their profile of basal PI receptor sub-type expression. 
RT-PCR analyses of P1 receptor transcripts in both strains of mouse showed that 
expression in the small intestine varied during the course of T. spiralis infection 
(summarised qualitatively in Table 6-1). Notably, between days 7 and 18 post infection 
(p.i.), basal level of A, receptor expression was decreased in the epithelium extracted 
from C57BL/10 mice (Figure 6-1). This implies that during the peak of intestinal 
pathology and parasite expulsion, the epithelium would not be responsive to adenosine. 
Levels of A; receptor expression did not return to pre-infection levels until day 21 p.i. 
(Figure 6-1), which correlates with the initiation of the resolution of intestinal 
pathology. 
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c a j a j a a j b a3 c a j a j ^ a j b a3 
N a i v e 
D a y 4 
D a y 7 
D a y 10 
D a y 14 
D a y 18 
D a y 21 
D a y 2 4 
D a y 28 
F i g u r e 6 -1 P u r i n e r g i c P I receptor express ion in C 5 7 B L / 1 0 intest inal 
e p i t h e l i u m d u r i n g T. spiralis in fect ion 
C57BL/10 mice were infected with 500 T. spiralis larvae and intestinal epithelium 
extracted at the indicated time points post infection. RNA was extracted, Dnase 
digested and 2 |ig used in a reverse transcriptase reaction to produce cDNA. 1 |il of 
cDNA was used as a template in PCRs utilising receptor specific primers. Data 
show the results obtained from 2 mice (1 and 2). The green triangle represents the 
presence of parasites in the intestine. 
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D a y 10 
D a y 14 
D a y 18 
D a y 21 
D a y 24 
D a y 28 
F i g u r e 6 -2 P u r i n e r g i c P I receptor express ion in N I H intest inal ep i the l ium 
d u r i n g T. spiralis in fec t ion 
NIH mice were infected with 500 T. spiralis larvae and intestinal epithelium 
extracted at the indicated time points post infection. RNA was extracted, Dnase 
digested and 2 |ig used in a reverse transcriptase reaction to produce cDNA. 1 pil of 
cDNA was used as a template in PCRs utilising receptor specific primers. Data 
show the results obtained from 2 mice (1 and 2). The green triangle represents the 
presence of parasites in the intestine. 
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T a b l e 6,1 Qual i ta t ive s u m m a r y of pur inerg ic P I receptor express ion in 
C 5 7 B L / 1 0 a n d N I H intest inal ep i the l ium d u r i n g T. spiralis infect ion 
Agarose gel pictures of PGR products amplified from cDNA derived from intestinal 
epithelial extracts of C57BL/10 and NlHmice infected with 500 T. spiralis larvae 
were analysed qualitatively and summarised according to the relative intensity of 
the PGR product formed. Data are categorised according to days post infection and 
murine epithelial extracts 1 and 2. 
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T. spiralis infection of NIH mice appeared to promote Ai, Ais and to a lesser 
extent A3 receptor expression (summarised qualitatively in Table 6-1). RT-PCR 
analyses showed that Ai and Aae receptors were upregulated as early as day 4 p.i. 
(Figure 6-2), which correlates with the initiation of pathological changes that occur in 
the epithelium. Notably, at day 10 p.i., a temporal down regulation of Ai, A2B and A3 
receptor expression occurred (Figure 6-2), suggesting that at the peak of parasite 
expulsion the epithelium of NIH mice may not be responsive to adenosine. This effect 
was short-lived as relatively high levels of Ai, Aib and to a lesser extent A3 receptor 
transcripts were detected again between days 14-21 post infection. Expression of PI 
receptor transcripts were not reduced to preinfection levels until day 24 post infection 
(Figure 6-2), which correlates with the resolution phase of intestinal pathology. 
6.2.2 P 2 Y pur inerg i c receptor express ion in the intest inal ep i the l ium of rapid-
a n d s l o w - r e s p o n d e r mice d u r i n g T. spiralis in fec t ion 
To investigate whether infection with T. spiralis alters the ability of the host 
intestinal epithelium to respond to nucleotides such as UDP, UTP, ADP and ATP, P2Y 
purinergic receptor expression was monitored. Naive C57BL/10 mice expressed high 
levels of transcripts corresponding to the P2Yi receptor and low levels of transcripts 
corresponding to the P2Yi3 receptor (Figures 6-3 and 6-4), which could indicate the 
epithelium was responsive to ADP. Naive NIH mice strongly expressed P2Yi receptor 
transcripts and low levels of transcripts corresponding to the P2Y2 receptor. These 
results suggest that the intestinal epithelium of fast-responder mice may be responsive 
to ADP, ATP and UTP nucleotides. Thus, it appears that the two strains of mice express 
different profiles of P2Y receptors in the naive state. 
Levels of P2Y receptor transcripts expressed in the epithelial compartment 
appeared to fluctuate throughout the time-course of infection in both strains of mice 
(summarised in Tables 6-2 and 6-3). Transcripts corresponding to the P2Y| receptor 
were detected throughout the infection time-course in both strains of mouse (Figures 6-
3 and 6-4). This suggests that the infection did not alter P2Y] receptor expression and 
implies the intestinal epithelium was continually responsive to ADP. 
A transient but low-level up-regulation of P2Y|2, P2Yi3 and P2Y|4 receptor 
expression was observed between days 14-18 p.i. in epithelium extracted from 
C57BL/10 mice (Figure 6-3). This correlates with parasite expulsion and the resolution 
of T. spiralis infection. Elevated levels of the P2Y]2, P2Y,3 and P2Y|4 receptors would 
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N a i v e 
D a y 10 
D a y 14 
D a y 18 
D a y 21 
D a y 2 4 
D a y 28 
F igure 6 -3 Pur inerg ic P 2 Y receptor express ion in C 5 7 B L / 1 0 intest inal ep i the l ium 
d u r i n g T. spiralis in fec t ion 
C57BL/10 mice were infected with 500 T. spiralis larvae and intestinal epithelium 
extracted at the indicated time points post infection. RNA was extracted, Dnase digested 
and 2 |ig used in a reverse transcriptase reaction to produce cDNA. 1 |il of cDNA was used 
as a template in PCRs utilising receptor specific primers. Data show the results obtained 
from 2 mice (1 and 2). The green triangle represents the presence of parasites in the 
intestine. 
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N a i v e 
D a y 10 
D a y 14 
D a y 18 
D a y 21 
D a y 2 4 
D a y 28 
F igure 6 -4 Pur inerg ic P 2 Y receptor express ion in N I H intest inal ep i the l ium d u r i n g T. 
spiralis in fec t ion 
NIH mice were infected with 500 T. spiralis larvae and intestinal epithelium extracted at 
the indicated time points post infection. RNA was extracted, Dnase digested and 2 (j.g used 
in a reverse transcriptase reaction to produce cDNA. 1 |il of cDNA was used as a template 
in PCRs utilising receptor specific primers. Data show the results obtained from 2 mice (1 
and 2). The green triangle represents the presence of parasites in the intestine. 
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T a b l e 6.2 Qual i ta t ive s u m m a r y of pur inerg ic P 2 Y receptor express ion in 
C 5 7 B L / 1 0 intest inal ep i the l ium d u r i n g T. spiralis in fect ion 
Agarose gel pictures of PCR products amplified from cDNA derived from intestinal 
epithelial extracts of C57BL/10 mice infected with 500 T. spiralis larvae were 
analysed qualitatively and summarised according to the relative intensity of the PCR 
product formed. Data are categorised according to days post infection and murine 
epithelial extracts 1 and 2. 
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+ = mouse 1 
+ = mouse 2 
+ = low expression level 
+ + = medium expression level 
+ + + = high expression level 
T a b l e 6.3 Qual i ta t ive s u m m a r y of pur inerg i c P 2 Y receptor express ion in N I H 
intest inal ep i the l ium d u r i n g T. spiralis infect ion 
Agarose gel pictures of PGR products amplified from cDNA derived from intestinal 
epithelial extracts of NIH mice infected with 500 T. spiralis larvae were analysed 
qualitatively and summarised according to the relative intensity of the PGR product 
formed. Data are categorised according to days post infection and murine epithelial 
extracts 1 and 2. 
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potentially make the epithelial compartment responsive to ADP and UDP-glucose at 
this time-point in the infection. 
In contrast to the C57BL/10 mice, transcripts corresponding to P2Yi2, P2Yi3 
and P2Yi4 receptors were transiently upregulated much earlier during the course of 
infection (day 4-7 p.i.) in the NIH strain (Figure 6-4, Table 6-3). Expression of these 
receptors appeared to be downregulated at days 10-14 post infection as transcripts were 
not detected (Figure 6-4). However, transcripts corresponding to these receptors also 
appeared to be transiently expressed in the epithelium of NIH mice quite inconsistently 
and at very low levels, later in the infection time-course (day 14-21 p.i.). At day 10 p.i, 
P2Y receptor expression appeared to be generally down-regulated in NIH mice, with 
only transcripts corresponding to the P2Yi detected (Figure 6-4). This would suggest 
that at the peak of parasite expulsion (day 10 p.i.) the epithelial compartment would be 
responsive to ADP. From day 14 p.i. onwards, P2Y2 receptor expression was gradually 
upregulated reaching pre-infection levels by day 18 p.i. (Figure 6-4). This correlates 
with the initiation of the resolution of intestinal pathology. 
In some cases, the P2Y receptor primers amplified PGR products of multiple 
sizes (Figure 6-3 and 6-4). This may be due to non-specific primer binding, or a splice 
variant form of the P2Y receptor. Notably, the P2Y2 receptor primer pair consistently 
ampUfied a PGR product of the expected size (440 bp), but also a larger PGR fragment 
of approximately 1 Kb (Figure 6-4). In some instances an intennediate sized band of 
-800 bp was also detected (Figure 6-4). To investigate whether this was due to non-
specific primer binding, the P2Y2 PGR product of the expected size (440 bp), and the 
largest PGR product (~1 Kb) were purified from agarose gels, and the 3' end of the gene 
sequenced using the reverse primer. As shown in Appendix 1-8 and 1-9, the sequence 
derived from both PGR products corresponded to the published P2Y2 receptor sequence, 
indicating the primers were detecting the P2Y2 receptor only. 
6.2.3 P2X purinergic receptor expression in the intestinal epithelium of rapid-
and slow-responder mice during T. spiralis infection 
The expression of ligand gated ion channel P2X receptors during T. spiralis 
infection was also monitored to determine whether cells in the epithelial compartment 
could respond to ATP. Generally, very low levels of P2X receptors were expressed in 
the uninfected epithelium of either mouse strain. However, some variation in P2X 
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receptor expression was observed throughout the course of infection (summarised in 
Tables 6-4 and 6-5). 
Transcripts corresponding to P2X receptors were not detected in the epitheHum 
extracted from naive C57BL/10 mice (Figure 6-5). Apart from a temporal, inconsistent 
expression of P2X2, PZXg, and P2X4 receptors at day 7 p.i., P2X receptors were not 
expressed in the epithelium of C57BL/10 mice during the first 14 days of infection 
(Figure 6-5). However, a transient upregulation of P2X2, P2X3, and P2X4 receptor 
expression was observed between days 18 and 21 p.i. (Figure 6-5). This occurred after 
parasite expulsion, during the resolution of intestinal pathology. From day 24 p.i. 
onwards, P2X receptor expression appeared to be downregulated as transcripts were not 
consistently detected (Figure 6-5), suggesting restoration of the basal state. 
Very low levels of P2X4 and P2X7 receptor transcripts were detected in naive 
NIH mice (Figure 6-6). Notably, the P2X7 receptor primers amplified multiple PGR 
products that were larger than the expected size (171 bp) (Figure 6-6). Potentially, this 
was due to non-specific primer binding, or a splice variant form of the P2X7 receptor. 
At day 10 p.i., P2X receptor transcripts in NIH intestinal epithelium were not detected 
by RT-PGR analyses, potentially indicating that the very low level of P2X4 and P2X7 
receptor expression observed in naive NIH mice had been downregulated, or the cells 
expressing these receptors were no longer present (Figure 6-6). Interestingly, at day 14 
p.i., P2X4 receptor transcripts were detectable again, as well as very low levels of P2Xi, 
P2X2 and P2X7 receptor transcripts (Figure 6-6). Low levels of P2X4 receptor 
transcripts could be detected at days 18 and 21 p.i., but expression of this receptor was 
not consistently observed from day 24 p.i. onwards (Figure 6-6). As shown in Figure 6-
6, levels of transcripts corresponding to P2X4 and P2X7 receptors were not detected at 
24 or 28 days post infection, indicating that expression of these receptor sub-types had 
not returned to basal levels. This potentially suggests the infection had induced a long-
term down-regulation of P2X receptor expression in NIH mice. 
6.2.4 mMCP-1 expression in the intestinal epithelium of rapid- and slow-
responder mice during T. spiralis infection 
Mast cells are usually uncommon in the intestinal mucosae of normal mice, but 
during T. spiralis infection extensive intraepithelial mast cell recruitment occurs, where 
mast cells migrate into the epithelium and express mast cell protease-1 (mMCP-1). In 
order to confirm the infection had been successfixl, mastocytosis was monitored 
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Naive 
Day 10 
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Day 18 
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Day 24 
Day 28 
Figure 6-5 Purinergic P2X receptor expression in C57BL/10 intestinal epithelium 
during T. spiralis infection 
C57BL/10 mice were infected with 500 T. spiralis larvae and intestinal epithelium 
extracted at the indicated time points post infection. RNA was extracted, Dnase digested 
and 2 |ig used in a reverse transcriptase reaction to produce cDNA. 1 |il of cDNA was used 
as a template in PCRs utilising receptor specific primers. Data show the results obtained 
from 2 mice (1 and 2). The green triangle represents the presence of parasites in the 
intestine. 
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Figure 6-6 Purinergic P2X receptor expression in NIH intestinal epithelium during T. 
spiralis infection 
NIH mice were infected with 500 T. spiralis larvae and intestinal epithelium extracted at 
the indicated time points post infection. RNA was extracted, Dnase digested and 2 pig used 
in a reverse transcriptase reaction to produce cDNA. 1 ^1 of cDNA was used as a template 
in PCRs utilising receptor specific primers. Data show the results obtained from 2 mice (1 
and 2). The green triangle represents the presence of parasites in the intestine. 
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Table 6.4 Qualitative summary of purinergic P2X receptor expression in 
C57BL/10 intestinal epithelium during T. spiralis infection 
Agarose gel pictures of PCR products amplified from cDNA derived from intestinal 
epithelial extracts of C57BL/10 mice infected with 500 T. spiralis larvae were 
analysed qualitatively and summarised according to the relative intensity of the 
PCR product formed. Data are categorised according to days post infection and 
murine epithelial extracts 1 and 2. 
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Point 
Actin P2Xi P2X2 P2X3 P2X4 P2X5 P2X6 P2X7 
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+ 
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+ 
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+ = mouse 1 
+ = mouse 2 
+ = low expression level 
+ + = medium expression level 
+ + + = high expression level 
Table 6.5 Qualitative summary of purinergic P2X receptor expression in NIH 
intestinal epithelium during T. spiralis infection 
Agarose gel pictures of PCR products amplified from cDNA derived from intestinal 
epithelial extracts of NIH mice infected with 500 T. spiralis larvae were analysed 
qualitatively and summarised according to the relative intensity of the PCR product 
formed. Data are categorised according to days post infection and murine epithelial 
extracts 1 and 2. 
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indirectly by measuring murine mast cell protease-1 (mMCP-1) expression in epithelial 
samples. Numbers of mucosal mast cells in the epithelium begin to increase within one 
week after infection with T. spiralis and peaks between 10 and 14 days p.i. depending 
on the genetic strain of mouse (Tuohy et al, 1990). As shown in Figure 6-7, in both 
NIH and C57BL/10 strains of mice, mMCP-1 transcript levels were barely detectable in 
uninfected animals. During the course of infection levels of mMCP-1 transcripts 
increased (Figure 6-7). This is consistent with similar studies that have used RNA 
extracted from total jejunum (Ghildyal et al., 1992; Knight et al., 2000) or epithelial 
isolates (Knight et al., 2004). Furthermore, levels of mMCP-1 transcripts appeared to 
peak earlier in NIH mice (day 7-10 p.i) than C57BL/10 mice (day 10-14), which 
correlates with the observation that NIH develop mastocytosis more rapidly than 
C57BL/10 mice (Tuohy et al., 1990). Overall, these analyses suggest the infections had 
proceeded normally, and the epithelial cell isolating technique used had been successful. 
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mMCP-1 
P -actin 
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B C57BL/10 
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Figure 6-7 mMCP-1 expression in intestinal epithelium during T. spiralis infection 
NIH (A) and C57BL/10 (B) mice were infected with 500 T. spiralis larvae and 
intestinal epithelium extracted on the indicated days post infection. RNA was extracted, 
Dnase digested and 2 |ig used in a reverse transcriptase reaction to produce cDNA. 1 |il 
of cDNA was used as a template in PCRs utilising mMCP-1 specific primers. P-actin 
was used as a positive control to confirm the integrity of the cDNA. Data show the 
results obtained from 2 mice (1 and 2). The green triangle represents the presence of 
parasites in the intestine. 
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6.3 Discussion 
The aim of this study was to compare purinergic receptor expression in the small 
intestine of rapid- and slow-responder strains of mice during T. spiralis infection. This 
would help to elucidate whether purinergic receptor expression correlated with parasite 
expulsion and pathological changes within the intestinal epithelium. 
Generally, rapid- and slow-responder strains of mice expressed distinct profiles 
of purinergic receptor expression prior to infection and exhibited altered purinergic 
receptor expression throughout the course of infection. There are two mechanisms by 
which altered expression could occur: i) up/down-regulation of purinergic receptor 
expression, ii) increase/decrease in populations of specific cell types within the 
epithelium expressing purinergic receptor sub-types. It is possible that both mechanisms 
may contribute to the alterations in expression observed here. Indeed, there are several 
studies reporting that both mechanisms may cause changes in transcript expression 
levels in the epithelial compartment during helminth infections. For instance, expression 
of intelectin 2 is upregulated by goblet cells during T. spiralis infection (Pemberton et 
al., 2004), and acetylcholinesterase expression is upregulated in epithelial cells during 
Nippostrongylus braziliensis infection (Russell et al., 2000). In contrast, upregulated 
mMCP-1 expression during T. spiralis infection is due to the migration of mucosal mast 
cells into the intestinal epithelium (Tuohy et al., 1990; Knight et al., 2000). It is 
important to note that altered transcription of a gene may not alter levels of the 
corresponding protein in a predictable manner. However, the functional significance of 
these observations will be discussed in terms of altered protein expression. 
Al and Aib receptors were detected in the epithelium of naive mice. However, 
mouse jejunum has previously been shown to express all PI receptor sub-types 
(Ghanem et al., 2005). These discrepancies in PI receptor expression are likely to be 
due to differences in the type of method used to extract epithelium fi-om the jejunum. 
The EDTA-stripping technique used in this study is likely to be far more selective than 
the method used by Ghanem and co-workers (2005), which involved scraping cells off 
the epithelium. 
Adenosine stimulates chloride ion secretory responses from epithelial cells at 
both the luminal and basolateral membrane. The action of luminal adenosine is 
mediated by the A, receptor (Ghanem et al., 2005), whereas AzB receptor activation has 
been postulated to stimulate chloride ion secretion from the basolateral membrane 
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(Strohmeier et al., 1995; Ghanem et ah, 2005). Neutrophils migrate into the intestinal 
epithelium during T. spiralis infection (Stadnyk et al., 2000). Upon transmigration into 
the intestinal epithelium, neutrophils are known to release AMP (Madara et al., 1993), 
which is rapidly hydrolysed to adenosine by 5'-ectonucleotidase (CD73) expressed on 
the apical surface of enterocytes (Strohmeier et al., 1997). Accumulation of adenosine 
in the intestinal lumen would stimulate Ai receptors resulting in chloride ion secretion 
from epithelial cells and the resulting influx of fluid into the lumen. During T. spiralis 
infection, a transient decrease in Ai receptor transcripts were detected in the epithelium 
of C57BL/10 mice during the peak of parasite expulsion (day 10-14 p.i.). Potentially, 
this may be a protective response by the host to limit Ai receptor activation by the 
luminal adenosine, which may serve to decrease the amount of fluid accumulating in the 
intestine and prevent the potential debilitating effects of fluid loss on the host through 
diarrhoea. T. spiralis also secretes an adenosine deaminase (Gounaris, 2002) which may 
serve to restrict Ai receptor-mediated fluid secretion from enterocytes. By converting 
extracellular adenosine to inosine, luminal Ai receptor activation will not occur and the 
parasite will prevent the fluid accumulation that would usually flush it away. These 
observations may reflect an equilibrium between effects detrimental to the host versus 
effects detrimental to the parasite. 
In comparison, naive NIH mice expressed relatively low levels of the A, 
receptor, levels of which appeared to be slightly elevated during the infection (day 4 to 
day 21). Upregulation of Ai receptor expression might suggest that the epithelial cells 
were more responsive to adenosine, which could induce increased chloride ion secretion 
and therefore the secretory-flush response of the intestine. Potentially, this difference 
between the two strains may contribute to the more rapid parasite expulsion observed in 
NIH mice. 
A transient reduction in PI receptor expression in the epithelium of NIH mice 
was noted at day 10 post-infection, which correlates with the peak of parasite expulsion. 
This would suggest that the epithelial compartment was unresponsive to adenosine at 
this crucial time-point, and again could indicate a damage-limitation response by the 
host, by controlling excess fluid loss. Further investigation into this observation could 
provide new insight into the role of PI receptors during parasite expulsion. A transient 
up-regulation of A3 and A2B receptor expression was also observed at days 7-14 p.i. and 
days 7-21 p.i. respectively (excluding the day 10 time point, where expression levels 
appeared to be decreased), which roughly correlates with parasite expulsion. As shown 
250 
in chapter 3, mucosal mast cells express the Aae and A3 receptors. Hence, up-regulation 
of these receptor sub-types may reflect the influx of mucosal mast cells that occurs 
around this time-point during the infection (Alizadeh and Wakelin, 1982). The lack of 
A2B and A3 receptor expression in the epithelium extracted from C57BL/10 could be 
due to the less intense mast cell response generated in this strain (Tuohy et al, 1990). 
Both rapid- and slow-responder strains of mice expressed transcripts 
corresponding to the P2Yi receptor. This is consistent with previous work that has 
shown that this receptor is expressed in the crypts and luminal epithelial surface of the 
small intestine (Giaroni et al., 2002). P2Yi receptors are also expressed in the myenteric 
neurones and smooth muscle of the murine small intestine (Giaroni et al., 2002). The 
majority of work surrounding the role of the P2Yi receptor in the intestine has focused 
on the ability of nucleotides to act as gut neurotransmitters and neuromodulators. 
Activation of P2Yi receptors by ATP or ADP has been reported to mediate relaxation of 
the longitudinal muscle in the mouse small intestine (Giaroni et al., 2002). Furthermore, 
sub-mucosal, and to a lesser extent, mucosal ATP can induce increased ion secretion 
flrom epithelial cells of the small intestine by stimulating P2Yi receptors expressed on 
secretomotor neurones (Fang et al., 2006). This may also contribute to parasite 
expulsion through the secretory-flush response. However, the role of non-neuronal 
P2Yi receptors in the intestinal epithelium is currently not known. 
Interestingly, P2Yi receptor expression appeared to be slightly down-regulated 
in C57BL/10 mice prior to parasite expulsion (day 4-10 p.i.). In contrast, no alteration 
in P2Yi receptor expression was observed in NIH mice throughout the course of 
infection. Due to the extensive expression of the P2Yi receptor by epithelial cells 
(Giaroni et al., 2002), it is likely that these differences may represent down-regulation 
of receptor expression, rather than altered cell populations. Potentially, down-regulation 
of P2Yi receptor expression in C57BL/10 mice may dampen-down as yet unknown 
extracellular nucleotide-mediated epithelial cell responses. 
Extracellular ATP can stimulate mucin secretion from the rat airway goblet cell 
line SPOCl (Abdullah et al., 2003) and conjunctival goblet cells (Jumblatt and 
Jumblatt, 1998) via the P2Y2 receptor. Furthennore, ATP and UTP can stimulate 
basolaterally expressed P2Y2 receptors to mediate chloride ion secretion in the small 
intestine (Ghanem et al., 2005). P2Y2 receptor expression, albeit at low levels, were 
detected in the epithelium of NIH mice only, and expression levels were not altered 
throughout the course of infection. It is possible that ATP and UTP released during the 
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invasion of the epithehum by infective larvae would be able to stimulate P2Y2 receptor 
mediated chloride ion secretion from epithelial cells, and mucin secretion from goblet 
cells. This may promote the secretory-flush response and contribute to the rapid 
expulsion of parasites observed in the NIH strain. The primers used to detect P2Y2 
receptor transcripts amplified multiple PCR products, of which only one was the 
expected size. Following sequencing of the first 200-300 bp of the 3' end, both PCR 
products corresponded to the published murine P2Y2 receptor sequence, implying that 
the primers were not non-specifically amplifying cDNA. It is unlikely that a splice 
variant of this gene was expressed as this receptor does not contain introns and there 
have been no reports in the literature detailing alternate expression of the P2Y2 receptor. 
The multiple PCR products formed are probably an artefact of the PCR reaction. 
C57BL/10 mice expressed low levels of the P2Yi3 receptor prior to infection. 
The P2Yi3 receptor was not expressed by naive NIH mice, again highlighting 
differences between the two strains of mice. To date, there have been no studies in the 
literature characterising P2Yi3 receptor expression in the gastrointestinal fract, so the 
possible function of this receptor remains unknown. Considering that this receptor is 
known to be highly expressed in nervous tissue (Fumagalli et al., 2004), it may play a 
role in neuronal ADP-mediated secretory responses as discussed previously. 
During T. spiralis infection, P2Y,2, P2Yi3 and P2Yi4 receptors were generally 
upregulated in both strains of mice. This appeared to occur earlier during the infection 
in NIH mice (day 4-7 p.i.) and later (day 14-21) in C57BL/10 mice, potentially 
correlating with the fast and slow rates of parasite expulsion in the NIH and C57BL/10 
strains respectively. The P2Yi2 receptor has previously been reported to be expressed in 
the rat distal colon submucosa, however a role for this receptor has not yet been 
assigned (Christofi et al., 2004). There have been no reports to date that have 
characterised P2Yi4 receptor expression in the intestinal tract. However, other studies 
have reported that P2Yi4 receptors, activated by UDP-glucose, can stimulate IL-8 
secretion from airway epithelial cells (Muller et al., 2005). Further experiments are 
required to determine whether P2Yi4 receptor activation stimulates intestinal epithelial 
cells to secrete proinflammatory cytokines. Potentially, the low level of P2Yi4 receptor 
expression observed during the infection may be due to other cell types that migrate to 
the epithelium during the infection. For example, neutrophils (Scrivens and Dickenson, 
2006), T cells (Scrivens and Dickenson, 2005) and immature dendritic cells (Skelton et 
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al., 2003) all express the P2Yi4 receptor and are also present during the enteric stage of 
T. spiralis infection. 
In the intestinal mucosa, epithelia are rapidly regenerated. Stem cells located in 
the crypt base move to the surface, apoptose and get exfoliated into the intestine. PZX? 
receptors are strategically located on the villus tips, and are thought to ensure intestinal 
epithelial regeneration (Groschel-Stewart et al., 1999). Prior to T. spiralis infection, 
P2X7 receptor expression was only detected in the epithelium of NIH mice (albeit at 
low levels) and not in C57BL/10 mice. Expression levels of the apoptotic P2X7 receptor 
appeared to remain constant throughout the infection in NIH mice, putatively 
suggesting the number of apoptotic cells expressing this receptor in the villus tips 
remained the same. PGR reactions utilising the P2X7 primers generated multiple PGR 
products of differing sizes. This is most likely due to differential splicing of the P2X7 
mRNA, as this receptor has previously been reported to produce up to seven different 
splice-variants (Gheewatrakoolpong et al., 2005). 
P2X2, P2X3, P2X4 and P2X6 receptors are not expressed by epithelial cells of the 
duodenal epithelium (Groschel-Stewart et al., 1999). However, P2X receptors have 
been shown to play an important role in synaptic transmission within the neural 
pathway mediating motor behaviour in the intestine (Katayama and Morita, 1989; 
Heinemann et al., 1999). Moreover, sub-mucosal neurones have been suggested to 
express functional P2Xi P2X2, P2X3 and P2X4 receptors in the mouse jejunum (De Man 
et al., 2003; Xiang and Bumstock, 2004). Hence, it is possible that the slightly 
upregulated expression of P2X2, P2X3 and P2X4 receptors in the epithelium of 
G57BL/10 mice is due to the presence of these receptors in the sub-mucosal nerve fibres 
that innervate the epithelial crypts. 
In other studies, antibodies have been successfully used to define the profile of 
purinergic receptor expression in the intestinal epithelium (Groschel-Stewart et al., 
1999; Giaroni et al., 2002), and so a similar approach could be used to follow-up the 
work presented here. This would determine whether alterations in receptor transcript 
expression actually translate into changes in protein levels. Furthermore, this would 
identify which cell types were expressing the receptors. The use of purinergic receptor 
knock-out animals would also be an extremely useful tool in determining the role of 
purinergic signalling in parasite expulsion. However, this would be a more general 
approach as all cell types would lack the purinergic receptor involved. Further work is 
also required to determine whether T. spiralis infection alters the effects of adenosine 
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and nucleotides on intestinal epithelial cell resistance, Na^'^-linked glucose absorption 
and ion secretion. This would not only provide insight into purinergic signalling in the 
small intestine during the infection, but could also determine the effects of parasite 
secreted proteins on intestinal function. 
In summary, this chapter has shown that purinergic receptor expression in the 
intestinal epithelium is altered throughout the course of infection, and that this appears 
to correlate with pathological changes in the epithelium. Furthermore, this seems to be 
dependent on the genetic background of the host, as rapid- and slow-responder strains 
of mice not only express slightly different sub-types of purinergic receptors, but display 
different patterns of receptor expression throughout the course of T. spiralis infection. 
Purinergic receptors implicated in the secretory-flush response appear to be expressed 
earlier in the fast responder strain, potentially indicating a role for these receptors in 
aiding parasite expulsion. 
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Conclusions 
Extracellular nucleotides are autocrine and paracrine signalling molecules whose 
receptor mediated effects regulate a wide range of physiological responses in 
mammalian tissues. Numerous studies have demonstrated that extracellular nucleotides 
can modulate inflammatory and other immune responses. Secretion of nucleotide-
metabolising enzymes by both ecto- and endo-parasites is thought to be an adaptation 
that has evolved to modulate the availability and local concentrations of extracellular 
nucleotides (Gounaris and Selkirk, 2005). This would be advantageous to all species of 
parasite that, through tissue damage or residence in the vascular system, induce the 
release of proinflammatory nucleotides. Presumably, these secreted enzymes serve to 
regulate purinergic receptor activation, thus potentially limiting a range of inflammatory 
responses. 
The hypothesis that T. spiralis secretes nucleotide-metabolising enzymes to 
actively down-regulate nucleo tide-induced immune responses during the invasive stages 
of its life-cycle was investigated. The actions of these enzymes are postulated to 
promote parasite survival within the host. The results presented here have shown for the 
first time that the T. spiralis secreted nucleotide-metabolising enzymes can interfere 
with the activation of key immune-cell types in vitro. 
Mucosal mast cells expressing mast cell protease-1 (mMCP-1) directly mediate 
the expulsion of adult T. spiralis parasites fi-om the small intestine, and contribute to the 
development of the local inflammatory response and the consequent enteropathy seen at 
this stage of the infection (Lawrence et ai, 2004; Knight et al., 2000). In vitro 
activation of bone marrow-derived mast cells that express mMCP-1 (and hence were of 
a mucosal phenotype), was used as a model to characterise the effects of purinergic 
signalling on mast cells. Concordant with other mast cell types, it was shown that these 
cells expressed multiple sub-types of purinergic receptors, including functional A2B, A3, 
P2Yi, P2Y2, P2X4 and putatively PlYs and CysLTl receptors. Expression of these 
purinergic receptor sub-types enabled the mBMMC to respond to nanomolar 
concentrations of ADP and ATP, and micromolar concentrations of adenosine, UDP, 
and UTP. The 5'-NT activity present in T. spiralis ES was able to modulate mBMMC 
purinergic receptor activation by degrading extracellular nucleotides. Overall, this 
appeared to result in reduced P2Y receptor activation, and where relevant, increased PI 
receptor activation. T. spiralis secreted proteins also modulated mBMMC activation by 
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altering the amount of adenosine available to interact with PI receptors. This effect 
could be attributed to the action of the T. spiralis adenosine deaminase which would 
deaminate adenosine to inosine, and prevent receptor activation. These results 
demonstrated for the first time that T. spiralis ES can directly modulate mast cell 
purinergic receptor activation. 
Subsequently, the complementary or opposing roles of purinergic receptor 
activation on mast cell effector functions were explored. Further experiments showed 
that AD? and ATP could induce mBMMC exocytosis resulting in the release of (3-
hexosaminidase and mMCP-1. Importantly, these nucleotides elicited the release of 
mMCP-1 via a mechanism that was not dependent on de-novo protein synthesis or the 
Golgi complex, indirectly suggesting adenine nucleotides induced the exocytosis of 
granules containing mMCP-1. Further characterisation of the purinergic receptor sub-
types involved in mediating this effect showed that ADP appeared to signal via 
stimulation of the P2Yi receptor. The purinergic receptor that mediated the effects of 
ATP was not fully characterised due to the lack of available antagonists. However, ATP 
was postulated to mediate its effects via stimulation of the P2X4 receptor on the basis of 
electrophysiological analysis. Degradation of the tight-junction protein occludin, by 
mMCP-1, aids parasite expulsion by increasing the paracellular permeability of the 
jejunum (McDermott et al., 2003). Thus, activation of mast cells with extracellular 
adenine nucleotides will potentiate the release of mMCP-1, further contributing to the 
generation of an inhospitable environment for parasites and aid parasite expulsion from 
the intestine. 
T. spiralis ES inhibited ADP-induced mMCP-1 release. This was mediated by 
the action of the secreted 5'-NT, which metabolised ADP to adenosine. T. spiralis ES 
also inhibited low concentrations of ATP inducing mMCP-1 release, possibly via the 
action of the secreted serine/threonine kinases and NDPK. The secretion of nucleotide 
metabolising enzymes by T. spiralis ES may serve to limit P2Y and P2X purinergic 
receptor activation on mucosal mast cells, thus limiting mMCP-1 release. This could 
favour parasite survival by reducing the permeability of the intestine, thus reducing the 
influx of solutes and water that would usually flush the parasite away. 
The effects that nucleosides and nucleotides have on a range of other mast cell 
functions were also investigated to determine the extent of the effects these signalling 
molecules could have on mucosal mast cells. Nucleosides and nucleotides could not 
direct the migration of mature mast cells, immature mast cells, or mast cell progenitors. 
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suggesting that these molecules are not directly involved in the migiation of mast cells 
to areas of damaged tissue. Furthermore, treatment of mature mast cells with 
nucleosides or nucleotides could not induce the release of factors that were 
chemoattractive to mast cell progenitors, implying that these signalling molecules could 
not promote the recruitment of mast cells either. Nucleotides and nucleosides were also 
unable to mediate de-novo generation of inflammatory and Th2 cytokines in mast cells. 
This was consistent with a variety of other studies that have shown that nucleotides can 
not directly stimulate cytokine production in other types of mast cells (Feng et al. 
2004). 
Stimulation of purinergic receptors by nucleosides and nucleotides have been 
reported to modulate, rather than directly stimulate mast cell activation (Tilley et al., 
2000; Reeves et al., 1997; Marquardt et al., 1978; Feng et al., 2004). During the 
intestinal phase of T. spiralis infection the increase in epithelial permeability has been 
postulated to allow the invasion of luminal bacteria (Lawrence et al., 2004), thus 
potentially exposing mucosal mast cells to pathogen associated molecular patterns 
(PAMPs), such as lipopolysaccharide (LPS). Due to the potential importance of TLR 
activation and purinergic-signalling in mucosal mast cells during T. spiralis infection, 
the effect of nucleosides and nucleotides on lipopolysaccharide (LPS)-induced TLR-4 
stimulation of mBMMC was investigated. 
Interestingly, the simultaneous activation of TLR-4 and purinergic receptors 
responsive to adenosine, ADP or ATP stimulated inhibitory pathways that led to the 
down-regulation of pro-inflammatory cytokine generation. In the presence of T. spiralis 
ES, the inhibitory effects of low concentrations of ADP were reduced. This suggests 
that parasite secreted proteins may act to enhance the amount of pro-inflammatory 
cytokines generated by TLR activation. The benefit of this to the parasite is not obvious, 
as this would promote pathology in the intestinal epithelium, possibly aiding parasite 
expulsion. Potentially, further work examining the characteristics of T. spiralis infection 
in TLR-4-deficient or MyD88-deficient mice may determine the importance of TLR-
activation during the intestinal phase of the infection. 
As in vitro experiments had shown the T. spiralis secreted 5'-NT could directly 
modulate purinergic signalling in immune cell types, it seemed important therefore to 
establish whether immunisation with this recombinant protein could protect mice from 
subsequent T. spiralis infection. Ultimately, the purpose of this experiment was to 
provide insight into the in vivo function of the secreted 5'-NT. 
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Challenge of 5'-NT-immunised animals with T. spiralis infective larvae resulted 
in a slightly reduced parasite burden in the muscle, however this did not reach statistical 
significance. This was despite the generation of high titres of 5'-NT-specific antibodies 
that could neutralise the activity of the 5'-NT in vitro. Notably, although the 
immunisation generated a TnZ-dominated systemic immune response, it did not induce 
protective adaptive immune responses in the MLN local to the intestine. Thus, further 
work is still required to develop an immunisation strategy that will generate a potent 
enough immune response in the intestinal environment. Considering that interest in 
mucosal adjuvants and vaccine delivery is currently an intense area of research, the next 
few years are likely to witness an increase in the rate of progress in this field. 
Potentially, if the immune response can be directed towards the gut mucosa, new 
opportunities for discovering the in vivo role of this enzyme will become available. 
An unexpected outcome of the 5'-NT immunisation experiment was discovering 
that sera from naive mice actually increased the enzymatic activity of the 5'-NT in vitro. 
This potentially indicates that this enzyme may have a higher specific activity than 
previously thought. Elucidating what kind of small molecule was causing this effect was 
beyond the scope of this project, but any kind of trace element, co-factor or metabolite 
present in sera could be responsible. 
This thesis has also addressed the broader aspects of purinergic receptor 
expression in the intestinal epithelial compartment during T. spiralis infection. This was 
performed to determine whether infection modulates the expression of purinergic 
receptors. Interestingly, purinergic receptor expression was altered throughout the 
course of T. spiralis infection, and this appeared to correlate with pathological changes 
in the epithelium. Furthermore, this seemed to be dependent on the genetic background 
of the host, as fast- and slow-responder strains of mice not only expressed slightly 
different sub-types of purinergic receptors, but displayed different patterns of receptor 
expression throughout the course of infection. Purinergic receptors implicated in the 
secretory-flush response appear to be expressed earlier in the fast responder strain, 
potentially indicating a role for these receptors in aiding parasite expulsion. 
Altered receptor expression could occur due to the up/down-regulation of 
purinergic receptors expressed by individual cell types, or an increase/decrease in 
specific cell populations within the epithelium expressing purinergic receptor sub-types. 
Further experiments using antibodies to define the profile of purinergic receptor 
expression on specific cell types in the epithelium would be a useful extension to the 
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work presented in this thesis. Furthermore, this would detennine whether alterations in 
receptor transcript expression actually translate into changes in protein levels. 
Experimental models of parasitic infection have been key tools to further 
understand how the immune system functions to combat infection and prevent disease. 
Currently, the mechanisms that initially alert the immune response to parasite invasion 
are still unknown. It is a tantalising prospect to consider that purinergic signalling, one 
of the most evolutionarily ancient signalling pathways known, may alert the immune 
response to the presence of invading parasites. The work described in this thesis has 
demonstrated that the nucleotide metabolising enzymes secreted by T. spiralis can 
modulate purinergic receptor activation and ultimately cellular functions. These 
experiments contribute towards dissecting how T. spiralis manages to out-run the host 
immune response, especially in the epithelial compartment. Further work aiming to 
define the complex roles purinergic signalling events play in helminth infections may 
potentially aid understanding of how intestinal inflammatory responses are induced and 
maintained, and go some way towards explaining why these parasites are so successful. 
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A Isotype control for c-kit staining 
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Appendix 1-1 Isotype control staining for FACS data 
mBMMC were stained for c-kit and FcsRl at a range of time points during 
culture. Isotype controls were analysed alongside corresponding antibodies at 
each time point and representative data are shown. Cells were stained with 
isotype control antibodies in order to set quadrants for subsequent analysis and 
to exclude non-specific staining. All isotype controls were used at the same 
concentration and under the same conditions as the conesponding fluorescently 
labelled antibody. Samples were analysed by flow cytometry and data are 
presented as flouresence intensity dot plots, as determined by forward and side 
scatter properties. For c-kit control staining, cells were incubated with (A) 
1 fig/ml rat IgG2b-PE. For Fc RI control staining, cells were incubated with 
(B) 1 |ig/ml rat anti-mouse IgE-FITC or (C) 1 pg/ml murine anti-DNP-albumin 
IgE. 
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Appendix 1-2 Purinergic receptor control RT-PCRs 
Positive control Reverse transcriptase (RT)-PCR data displaying PCR products of the expected sizes. Spleen 
cDNA was used as a template for the PI, PlY^, P2Y^, P2Y^, P2Y,2 and P2Y,^ receptor primer pairs. Mouse 
brain cDNA was used as a template for the P2Xg receptor. m B M M C cDNA was used as a templates for the 
P2Xj, P2X4, P2Yj and P2Y^ receptor primer pairs. Mouse intestinal epithelial cell cDNA was used as a 
template for P2X2 and P2X^ receptor primer pairs. CMT-93 epithelial cell cDNA was used as a template for 
P2X; and P2Xy receptor primer pairs. PCR amplification of |3-actin was used as a control (lane C). Samples 
were analysed on a 1.5 % (PI and P2Y receptors) or 2 % (P2X receptors) (w/v) agarose gel and PCR 
fragment size was evaluated using a 1000 base pair (bp) DNA ladder. The actual size (in bp) of the PCR 
products generated are indicated below each gel photo 
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- TGF-p + TGF-B 
Appendix 1-3 PCRs to control for genomic DNA contamination in RNA 
preparations extracted from mBMMC cultured in the absence or presence of 
TGF-p 
Control PCRs were carried out using DNase-treated RNA preparations and |3-actin 
primers (lane R). PCR amplification of P-actin using mBMMC cDNA as a template 
was used as a positive control (lane C). Samples were analysed on a 1.5 % (w/v) 
agarose gel and PCR fragment size was evaluated using a 1000 base pair (bp) DNA 
ladder. 
Adult 
R C 
500— 
Appendix 1-4 PCRs to control for genomic DNA contamination in RNA 
preparations extracted from adult, NBL, MSL T. spiralis parasites 
Control PCRs were carried out using DNase-treated RNA preparations and tubulin 
primers (lane R). PCR amplification of tubulin using adult, NBL or MSL cDNA as 
a template was used as a positive control (lane C). Samples were analysed on a 1.5 
% (w/v) agarose gel and PCR fragment size was evaluated using a 1000 base pair 
(bp) DNA ladder. 
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A Purified small CysLTl PCR product 
PGR 
-200 bp 
B CysLTl mRNA and PCR-product sequence aligmnent 
CysLTRl 421 
PCR 1 
CysLTRl 481 
PCR 8 
CysLTRl 541 
PCR 68 
T T C C T G G A G A A C A T G A A T G G A A C T G A A A A T C T G A C G A C A T C T C T C A T T A A T A A C A C G T G T 
C A C G T G T 
C A T G A C A C A A T T G A T G A A T T C C G A A A T C A A G T A T A C T C C A C T A T G T A T T C T G T G A T C T C T 
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G T T G T G G G T T T C T T T G G C A A T A G C T T T G T G C T C T A T G T C C T C A T A A A A A C A T A C C A T G A 
CysLTRl 601 
128 ^ 
T C A G C C T T C C A A G T A T A C A T G A T T A A T C T A G C C A T A G C A G A T C T A C T C T G T G T A T G T 
TCAGCCTTCCAAGTATACATGATT. 
CysLTl receptor 
reverse primer 
Appendix 1-5 Cysteinyl Leukotriene Receptorl (CysLTl) 
sequence alignment 
200 bp PCR-product 
The purified -200 bp CysLTRl PCR fragment (A) was sequenced and queried using the 
WU-Blast2 tool to search the EMBL nucleotide database. The PCR product (PCR) was 
subsequently aligned with the sequence of highest homology (murine CysLTl mRNA 
NCBI accession number NM 021476) using the ClustalW (EMBl) programme (B). 
Alignments are displayed using BoxShade 3.21 software. 
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A Purified large CysLTl PCR product 
-900 bp 
B Prosaposin mRNA and PCR-product sequence alignment 
CysLTl Forward primer 
potential miss-priming site 
Prosaposin 1381 S 
PCR 1 
CAGCACCAAGGAGGAAATCCTGGCCGCACTTGAGAAGGGCTGCAGCTTCCTGCCAGACC 
TGGCCGCACTTGAGAAGGGCTGCAGCTTCCTGCCAGACC 
Prosaposin 1441 
PCR 40 
Prosaposin 1501 
PCR 100 
Prosaposin 1561 
PCR 160 
Prosaposin 1621 
PCR 219 
Prosaposin 1681 
PCR 279 
Prosaposin 1741 
PCR 339 
Prosaposin 1801 
PCR 399 
CTTACCAGAAGCAGTGCGATGACTTTGTGGCTGAGTATGAGCCCTTGCTATTGGAGATCC 
CTTACCAGAAGCAGTGCGATGACTTTGTGGCTGAGTATGAGCCCTTGCTATTGGAGATCC 
TCGTGGAAGTGATGGATCCTGGATTTGTGTGCTCGAAAATTGGAGTTTGCCCTTCTGCCT 
TCGTGGAAGTGATGGATCCTGGATTTGTGTGCTCGAAAATTGGAGTTTGCCCTTCTGCCT 
ATAAGCTGCTGCTGGGAACCGAGAAGTGTGTCTGGGGCCCTAGCTACT 
ATAAGCTGCTGCTGGGAACCGAGAAGTGTGTCTGGGGCCCTAGCTACT 
TGGAGACTGCCGCCCGATGCAATGCTGTCGATCATTGCAAACGCCATGTGTGGAACTAGT: 
TGGAGACTGCCGCCCGATGCAATGCTGTCGATCATTGCAAACGCCATGTGTGGAACTAGT! 
TTCCCAGCTGCAGAAGTCACCTACTTGTGGGTCTAGGGTAATGAACACATAGATCTATTT| 
TTCCCAGCTGCAGAAGTCACCTACTTGTGGGTCTAGGGTAATGAACACATAGATCTATTTI 
GACTTAATAAGTAGGAACCCCCTTTGCCCTTCCCCCATCTCCTCTCCCTTACTGTAGCAT| 
GACTTAATAAGTAGGAACCCCCTTTGCCCTTCCCCCATCTCCTCTCCCTTACTGTAGCAT! 
TTCTGTCATGTAAGAGGTGCTGACAGCCACTTCCGTGTCCCCTTTCTGCTCGAAGGATGA 
TTCTGTCATGTAAGAGGTGCTGACAGCCACTTCCGTGTCCCCTTTCTGCTC 
Appendix 1-6 Cysteinyl Leukotriene Receptor 1 (CysLTl) 
sequence alignment 
-900 bp PCR-product 
The purified -900 bp CysLTl PCR fragment (A) was sequenced and queried using the 
WU-Blast2 tool to search the EMBL nucleotide database. The PCR product (PCR) 
was subsequently aligned with the sequence of highest homology (murine prosaposin 
mRNA NCBI accession number NM 011179) using the ClustalW (EMBI) programme 
(B). Alignments are displayed using BoxShade 3.21 software. 
265 
C57BL/10 NIH 
bp 
Naive 500 
Day 4 500— 
Day 7 500 
Day 10 500 
Day 14 500 
Day 18 500 
day 21 500 
Day 24 500 
Day 28 500 
500-
500 
500 
500 
500-
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500 
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Appendix 1-7 PCRs to control for genomic DNA contamination in mouse 
epithelial RNA preparations 
Control PCRs were carried out using DNase-treated epithelial cell RNA 
preparations and |3-actin primers (lane R). PCR amplification of |3-actin using 
epithelial cell cDNA as a template was used as a positive control (lane C). Data 
show the results obtained from 2 mice (1 and 2) of C57BL/10 and NIH strain. 
Samples were analysed on a 1.5 % (w/v) agarose gel and PCR fragment size was 
evaluated using a 1000 base pair (bp) DNA ladder. 
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A Purified large P2Y2 PCR product 
bp 
1000 
500 
4.1 Kb 
B P2Y2 mRNA and PCR-product sequence alignment 
P2Y2 1021 
PCR 1 
P2Y2 1081 
PCR 25 
P 2 Y 2 1141 
PCR 85 
P2Y2 1201 
PCR 145 
P 2 Y 2 1261 
PCR 205 
P 2 Y 2 1321 
PCR 265 
P 2 Y 2 1381 
PCR 325 
GTCTGTGCGCACCATTGCCTTGGTACTGGCCGTCTTCGCCCTCTGCTl 
GTCTGTGCGCACCATTGCCTTGGTACTGGCCGTCTTCGCCCTCTGCTl 
CAGGCGGCTGCTCAAACCGGCTTATGGGACCACAGGAGGTCTGCCTCGGGCCAAGCGCi 
CAGGCGGCTGCTCAAACCGGCTTATGGGACCACAGGAGGTCTGCCTCGGGCCAAGCGCi 
GCTGGGTCTGCTTTTTGCTGTGCCCTTTTCCGTAATCCTGGTCTGTTACGTGCTTATGGC 
GCTGGGTCTGCTTTTTGCTGTGCCCTTTTCCGTAATCCTGGTCTGTTACGTGCTTATGGC 
[TTGCCATGACACCTCGGCCCGAGAGCTCTTTAGCCATTTTGTGGCTTACAGCTCCGTCAT 
b b ^ b ^ ^ ^ b ^ b & ^ b i i ^ ^ ^ b b ^ ^ ^ & ' ^ ' ^ ' ^ g t g g c t t a c a g c t c c g t c a t 
TCACGCGCACCCTCTACTACTCCTTCCGATCACTTGACCTCAGCTGCCACACCCTC-
TCACGCGCACCCTCTACTACTCCTTCCGATCACTTGACCTCAGCTGCCACACCCTC, i 
CGCCATCAACATGGCATATAAGATCACCCGGCCGCTGGCCAGCGCCAACAGTTGTCTTG. 
CGCCATCAACATGGCATATAAGATCACCCGGCCGCTGGCCAGCGCCAACAGTTGTCTTG; 
CCCGGTACTGTACTTCCTGGCAGGGCAGAGACTTGTCCGCTTTGCCCGAGATGCCAAGCC 
CCCGGTACTCTACTTCCTGGCAGGGCAGAGACTTGTCCGCTTTG 
P2Y2 receptor 
reverse primer 
Appendix 1-8 PZY^ receptor ~1.1 kb PCR-product sequence alignment 
The purified ~1.1 kb PlY; receptor PCR fragment (A) was sequenced and queried using 
the WU-Blast2 tool to search the EMBL nucleotide database. The PCR product (PCR) 
was subsequently aligned with the sequence of highest homology (murine PZY; mRNA 
NCBI accession number NM_008773) using the ClustalW (EMBl) programme (B). 
Alignments are displayed using BoxShade 3.21 software. 
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A Purified small PZY? PCR product 
1000 
500 440 bp 
B PZYg mRNA and PCR-product sequence alignment 
P2Y2 1081 
PCR 1 
P2Y2 1141 
PCR 1 
GCTGGGTCTGCTTTTTGCTGTGCCCTTTTCCGTAATCCTGGTCTGTTACGTGCTTATGGC 
^GGCGGCTGCTCAAACCGGCTTATGGGACCACAGGAGGgCTGCCTCGGGCCAAGCGC 
GGCGGCTGCTCAAACCGGCTTATGGGACCACAGGAGGSCTGCCTCGGGCCAAGCGC 1 
P2Y2 1201 
PCR 59 
GTCTGTGCGCACCATTGCCTTGGTACTGGCCGTCTTCGCCCTCTGCT 
GTCTGTGCGCACCATTGCCTTGGTACTGGCCGTCTTCGCCCTCTGCT' 
P2Y2 1261 He 
PCR 119 & 
TCACGCGCACCCTCTACTACTCCTTCCGATCACTTGACCTCAGCTGCCACACCCTC 
TCACGCGCACCCTCTACTACTCCTTCCGATCACTTGACCTCAGCTGCCACACCCTC 
P2Y2 1321 BBBB 
PCR 179 
P2Y2 1381 
PCR 23 9 
CCCGGTACTCTACTTCCTGGCAGGGCAGAGACTTGTCCGCTTTGCCCGAGATGCCAAGCC 
CCCGGTACTCTACTTCCTGGCAGGGCAGAGACTTGTCCGCTTTGCC 
P2Y2 receptor 
reverse primer 
Appendix 1-9 P2Y2 receptor 440 bp PCR-product sequence alignment 
The purified 440 bp P2^^ receptor PCR fragment (A) was sequenced and queried using 
the WU-Blast2 tool to search the EMBL nucleotide database. The PCR product (PCR) 
was subsequently aligned with the sequence of highest homology (murine P2^^ mRNA 
NCBI accession number NM_008773) using the ClustalW (EMBI) programme (B). 
Aligmnents are displayed using BoxShade 3.21 software. 
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